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Abstract 
Activity based alterations in synaptic connectivity are thought to underlie the 
processes involved in learning and memory.  Measurable changes in neuronal 
activation by long-term potentiation (LTP) are widely investigated as a possible 
cellular correlate of this phenomenon, as it can be induced quickly to elicit long-
lasting modifications.  These long-term changes in the activity of neuronal circuits 
are sustained by an altered pattern of gene expression and protein synthesis.  The 
inducible transcription factor zif268 has been implicated in almost all models of 
neuronal plasticity.  Downstream targets of zif268 are widely believed to contribute 
to the duration and stabilisation of NMDA receptor dependent LTP which, in turn, 
can be linked to various models of learning and memory. However, these 
downstream targets are only just starting to receive attention.   
By utilising a wide range of contemporary neuroscience techniques covering 
molecular & cell biology approaches, this thesis proposes two known proteins, 
gephyrin and ubiquilin, as well as a novel gene (urma), as potential downstream 
targets of zif268.  Both gephyrin and ubiquilin are associated with GABAA 
receptors at inhibitory synapses.  Gephyrin is thought to cluster and anchor 
GABAA receptors at postsynaptic sites whilst ubiquilin is reported to regulate 
receptor surface expression.  We found that gephyrin mRNA and protein 
expression levels were downregulated in response to increased levels of zif268 by 
transient transfection in PC-12 cells and NMDA stimulation in primary cultured 
cortical neurones.  In addition, ubiquilin mRNA and protein levels were also 
downregulated within the same experimental paradigms, implying that both 
gephyrin and ubiquilin are downstream transcriptional targets of this plasticity-
related gene. 
A previously reported microarray experiment (James et al. 2005) contained 144 
ESTs significantly affected by the transient transfection of zif268 in PC-12 cells 
compared to control.  Bioinformatic analyses of these tags revealed interesting 
genomic areas pertaining to little published information.  After further investigation, 
EST AI169020 revealed a novel transcript that was downregulated in response to 
NMDA treatment of primary cortical neurones.  Additional data mining suggests 
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that urma may be a rarely expressed transcription factor.  Basal levels of urma 
mRNA were also decreased in the zif268 knockout mouse, as were ubiquilin 
mRNA levels. 
Zif268 is a regulatory immediate early gene, activating or suppressing downstream 
targets that play a role in the duration and stabilisation of LTP.  These results 
indicate that gephyrin and ubiquilin are potential mediators of NMDA receptor-
dependent plasticity, by modifying inhibitory-signalling.  In addition, zif268 may 
actively suppress a novel plasticity-related transcription factor, urma.  These 
findings may underlie important processes in learning and memory. 
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t-ERK   total ERK 
T-TBS   tris-tween buffered saline 
TH   tyrosine hydroxylase 
UIM   ubiquitin interacting motif 
XTT   tetrazolium salt 
Zif268   Zinc finger binding protein clone 268 
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Chapter 1 
1 General Introduction 
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1.1  Introduction 
This thesis identifies 3 novel target genes of the plasticity related immediate early 
gene zif268: gephyrin, ubiquilin and the novel gene, urma.  Zif268 is implicated in 
many different forms of neuronal plasticity.  Long-term potentiation (LTP) is a type 
of synaptic plasticity thought to be the cellular mechanism of memory formation.  
Like memory, synaptic plasticity can occur in short-term and long-lasting forms.  
Downstream targets of zif268 are widely believed to contribute to the duration and 
stabilisation of LTP and, therefore, to learning and memory.  These downstream 
targets of zif268 are only just starting to receive attention; a description follows in 
the text. 
Long-term changes in the activity of neuronal circuits are sustained by an altered 
pattern of gene expression and protein synthesis.  The importance of protein 
degradation is starting to emerge as an area of intense research, and therefore I 
will briefly introduce the proteasome (a protein complex that digests proteins 
marked for degradation) and its proposed involvement in LTP.  Intriguingly, zif268 
was recently linked to the neuroproteasome, a subject that will be addressed. 
In addition, I will introduce two GABAA receptor (GABAAR) associated proteins: 
ubiquilin, which regulates cell surface expression, and gephyrin, a scaffolding 
protein thought to cluster and anchor GABAARs at the postsynaptic membrane. 
1.1.1 Neuronal Plasticity 
Neuronal plasticity is a term used to describe the many and varied changes that 
occur within the brain as a result of internal and external stimuli i.e. development, 
injury and/or learning and memory.  These phenomena can lead to changes in the 
structure and function of synapses, neurones and neural networks.   
Animal models of neuronal plasticity include neuronal development in the visual 
cortex after light stimulation (Wiesel & Hubel 1963), spatial learning in the 
hippocampus (Bliss & Lomo 1973), long-term habituation in Aplysia (Dale et al. 
1988), fear conditioning in the amygdala (Rogan et al. 1997), olfactory memory 
formation in the olfactory bulb (Matsuoka et al. 1997), procedural memory in the 
striatum and cerebellum (Karachot et al. 2001) and eyeblink conditioning in the 
cerebellum (Kishimoto et al. 2001). 
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1.1.2 Long Term Potentiation 
LTP is widely believed to be a form of plasticity involved in learning and memory, 
thus providing an important key to understanding the cellular and molecular 
mechanisms that underlie memory formation and storage.  Long-lasting, activity-
dependent changes in the weight or strength of synaptic communication could 
constitute a basic mechanism underlying the brain translating experiences into 
memories (Walton et al. 1999). 
The most investigated form of synaptic plasticity – a measurable change in 
synaptic connections, is LTP.  It can be induced within fractions of seconds using 
short bursts of tetanic high frequency electrical stimulation to the connection 
between two neurones, eliciting modifications that can last for periods of weeks or 
even months.  This results in a semi-permanent trace of the past activation of the 
synapse.  Ultimately, upon induction of LTP and appropriate activation of specific 
neurones, it is generally believed that synapses can be strengthened by the 
production and persistence of long-term changes in the activity of neuronal 
circuits, developing and incorporating into a memory network. 
In 1894, Santiago Ramon y Cajal proposed that learning was not due to new cell 
growth, but to a strengthening of connections between existing neurones.  This 
was further elaborated by Hebb‘s Postulate (1949), which describes how the 
connection from pre-synaptic neurone A to post-synaptic neurone B can be 
modified.  He proposed that such a mechanism could stabilise the specific 
neuronal activity patterns in the brain, stating that: 
―When an axon of cell A is near enough to excite cell B and repeatedly 
or persistently takes part in firing it, some growth process or metabolic 
change takes place in one or both cells such that A‘s efficiency, as one 
of the cells firing B, is increased.‖ 
Several rules must be adhered to for successful LTP induction: a) Co-operativity: 
the existence of an intensity threshold for induction, b) Associativity: a weak input 
can be potentiated if active at the same time as a strong stimulus, c) Input 
Specificity: if an input is not active at the time of the tetanus, it will not share the 
potentiation (Bliss & Collingridge 1993). 
There are distinct phases of LTP in which the early phases seem to be controlled 
by second messengers and kinases, which modify existing proteins and lasts for 
Donna M McDade, 2007  Chapter 1, 23 
approximately 1 to 3 hours. The late phases of LTP depend on immediate early 
gene initiation of gene transcription and new protein synthesis, which starts after 
approximately 4 hours and can be maintained for weeks in vivo (Morris 2004). 
1.1.2.1 The hippocampus 
The hippocampal formation is found within the limbic system and comprises the 
entorhinal cortex, subiculum, dentate gyrus and the hippocampus proper.  The 
hippocampus itself is separated into 4 regions cornu ammonis (CA) 1, CA2, CA3 
and CA4 (Lorente de No 1934) (see figure 1.1). 
The perforant pathway is the major afferent projection into the hippocampus and 
originates from different layers of the entorhinal cortex.  It consists of a lateral and 
medial component: the lateral path begins in layers III and V and travels to the 
subiculum and the pyramidal cells of the CA1, whilst the medial section begins in 
layers II and IV and travels to the granule cells of the dentate gyrus and pyramidal 
cells of the CA3. 
Within the hippocampal formation, as a simplification, the major projections are the 
mossy fibre pathway and the Schaffer collateral pathway.  The mossy fibres link 
the granule cells of the dentate gyrus to the CA3 pyramidal neurones and the 
Schaffer collateral pathway projects from the CA3 to the CA1 cells.  In addition 
there are a myriad of other minor pathways that interlink all the regions of the 
hippocampal formation, although the CA3 neurones only innervate the CA1 
neurones (reviewed in Amarel & Witter, 1989). 
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Figure 1.1: Diagram of the hippocampal formation.  The entorhinal cortex layers II/IV gives rise 
to the medial perforant path (MPP) which extends to the dentate gyrus (DG) and CA3.  The mossy 
fibres (MF) also send information from the DG to CA3.  CA3 innervates CA1 via the Schaffer 
Collateral Pathway (SC) and to the CA1 region of the contralateral hippocampus via the 
Associational Commissural Pathway (AC).  The lateral perforant path travels to the subiculum (Sb) 
and CA1.  CA1 innervates the subiculum which, in turn, return to the lateral (LEC) and medial 
(MEC) entorhinal cortex.  Taken from 
http://www.bris.ac.uk/Depts/Synaptic/info/pathway/hippocampal.htm 
 
In accordance with Hebb‘s Postulate, Bliss & Lomo (1973) elicited long-lasting 
strong responses in postsynaptic granule cells of rabbits after tetanic stimulation of 
the presynaptic fibres of the perforant pathway.  It can be generated in a variety of 
brain regions, but the induction of LTP within the perforant path of the 
hippocampus shows a clear relationship with endogenous learning and memory 
(Bliss & Collingridge 1993). Memory deficits can be observed using 
electrophysiological procedures to saturate LTP within the hippocampal formation 
before learning, in a manner that prevents the capacity for further synaptic 
changes during learning (Barnes et al. 1994).  It can be produced throughout the 
limbic forebrain with few exceptions, however, pathways within the hippocampus 
show significantly greater LTP effects compared with pathways outwith the 
hippocampal formation (Racine et al. 1983). 
In addition to hippocampal LTP, other structures within the brain that can display 
LTP include the striatum, amygdala, cerebellum and cerebral cortex (Salin et al. 
1996; Charpier & Deniau 1997; Rogan et al. 1997). 
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1.1.3 Long Term Depression 
Another form of synaptic plasticity is long term depression (LTD).  This 
phenomenon can present itself in two separate forms: de novo LTD and 
depotentiation.  Depotentiation has the capability to reverse the effects of LTP at 
synapses after low frequency stimulation within the hippocampus (Barrionuevo et 
al. 1980).  De novo LTD may contribute to memory formation and consists of a 
use-dependent weakening of synaptic conductivity (reviewed in Linden & Connor 
1995).  LTD at the excitatory synapse between parallel fibres and Purkinje cells in 
the cerebellum has been attributed to the acquisition of classically conditioned 
eye-blink responses (Ekerot & Kano 1985). 
The induction of LTD can occur with high frequency and prolonged low frequency 
stimulation, depending on the brain region.  Area CA1 of the hippocampus 
requires low frequency stimulation over long periods of time for the induction of 
LTD (Dudek & Bear 1992).  In contrast, high frequency stimulation can induce LTD 
in the cerebellar cortex, neocortex, striatum and nucleus accumbens (Artola & 
Singer 1993).  LTP and LTD can be activated using similar stimulation parameters 
but LTP requires a stronger depolarisation and greater increase in Ca2+ 
concentration than LTD (Artola et al. 1990).   
LTD typically requires the NMDA receptor, although this is not essential (Mulkey & 
Malenka 1992; Anwyl 2006).  In contrast to LTP, LTD can occur at inactive 
synapses (anti-Hebbian or heterosynaptic LTD) as well as active synapses 
(Hebbian or homosynaptic LTD), and is generally regarded as the 'inverse' of LTP 
(Bolshakov & Siegelbaum 1994; Bear & Abraham 1996; Oliet et al. 1997). 
1.1.4 NMDA Receptor-dependent LTP 
LTP-inducing stimuli progressively depolarise the postsynaptic cell by releasing 
glutamate from the presynaptic cell.  A magnesium ion gates the calcium-
permeable glutamate-activated N-methyl-D-aspartate (NMDA)-type receptor 
(Nowak et al. 1984), necessitating a voltage-dependent activation.  Therefore, the 
NMDA receptor (NMDAR) contributes little to basal postsynaptic responses during 
low frequency synaptic transmission at most glutamatergic synapses.  However, 
once glutamate has evoked a large excitatory postsynaptic potential (EPSP), via 
activation of another glutamate receptor subtype, the -amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid (AMPA) receptor (AMPAR), the depolarisation of the 
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postsynaptic cell by an influx of Na+ and K+ (McLennan 1983) is sufficient to 
relieve the magnesium ion from the NMDAR channel.  Activation of the NMDAR 
therefore may only occur once the cell is sufficiently depolarised and glutamate 
has bound, allowing Ca2+ to enter the cell (Mayer & Westbrook 1987).  The flood 
of Ca2+ through the receptor channel increases the intracellular Ca2+ concentration 
giving the necessary signal for LTP induction (Harvey & Collingridge 1992).  As 
well as entering the cell via NMDAR, calcium also enters through voltage gated 
calcium channels and is released from intracellular stores.   
1.1.4.1 NMDAR-dependent LTP and the hippocampus 
The NMDAR is assembled from a combination of subunits designated NR1 and 
NR2A–D.  NR1, the essential receptor subunit of the NMDAR, has eight alternative 
splice variants that have different expression patterns within the human brain 
(Rigby et al. 1996). In the cerebral cortex and the hippocampus, NMDARs are 
assembled from NR1, NR2A, and NR2B subunits (Conti et al. 1997; Kaczmarek et 
al. 1997).  NR3 subunits are also likely to be present, at least at some 
developmental stages.  The hippocampus is one of the most NMDAR dense 
regions of the brain.  The Schaffer collateral/CA1 synapses and the perforant 
path/dentate gyrus synapses comprise two major hippocampal pathways involved 
in NMDA-dependent LTP.  NMDAR-dependent plasticity in the CA3-CA1 region of 
the hippocampus is the most intensively studied connection for synaptic plasticity.  
Rat in vivo and in vitro studies have implicated NMDAR as a necessary factor for 
LTP induction and maintenance in the CA1 region of the hippocampus (Harris et 
al. 1984; Wigstrom & Gustafsson 1986; Collingridge et al. 1988).  Specific NMDAR 
antagonists completely block the generation of associative LTP, but minimally 
effect basal synaptic transmission (Teyler 1987; Collingridge et al. 1983). In 
addition, transgenic mice overexpressing the NR2B subunit of the NMDAR were 
shown to have enhanced LTP in the hippocampus, and superior learning 
performances in several tasks when compared to wildtypes (Tang et al. 1999). 
LTP requires a postsynaptic calcium increase, and the rise of NMDAR-dependent 
intracellular calcium seems to be the critical trigger.  Increases in the uptake and 
retention of Ca2+ after tetanic stimulation in the hippocampus have been 
demonstrated (Baimbridge & Miller 1981; Kuhnt et al. 1985).  In addition, 
increasing the extracellular concentration of Ca2+ can increase LTP in the CA1 
region of the rat hippocampus (Mulkeen et al. 1988), whilst decreasing levels 
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surrounding rat hippocampal slices prevents LTP (Dunwiddie & Lynch 1979).  LTP 
induction can be blocked by EGTA, which binds free calcium ions (Lynch et al. 
1983), and anti-S-100, a calcium binding protein, prevents LTP in the CA1 of the 
hippocampus (Lewis & Teylor 1986).  In contrast, directly raising the amount of 
postsynaptic calcium by photolysis of caged calcium can increase LTP (Malenka 
et al. 1988).  It is unknown whether an increase in calcium alone is sufficient to 
trigger LTP or whether additional factors are required, probably provided by 
additional synaptic activity.  
1.1.5 LTP in the Cerebral Cortex 
Memories of sensory experiences are thought to form within the areas that 
process the sensory information, and therefore any synaptic neurone activated 
within the sensory cortices of the cerebral cortex would be permanently modified 
by that sensory event (Bear 1996).  In support of this, it has been found that 
neurones within the primary auditory cortex display altered responses once an 
auditory discrimination task has been learnt (Weinberger & Diamond 1987; 
Edeline et al. 1993), and neurones of the inferior temporal cortex display altered 
responses after face recognition tasks in primates (Rolls et al. 1989).  
The neocortex is the major site for storage of nonspatial declarative memory (i.e. it 
stores memories of facts and events that do not require spatial information).  Using 
the same high frequency stimulation that induces LTP in the CA1 region of the 
hippocampus, stimulation of neocortical layer IV induces LTP in neocortical layer 
III in mouse, rat and cat visual cortex and rat somatosensory cortex (Kirkwood et 
al. 1993; Castro-Alamancos et al. 1995).  LTP has also been induced in the 
human inferotemporal cortex, a region thought to accommodate visual memories 
(Chen et al. 1996).  Critical factors for these types of cortical LTP are the levels of 
NMDAR activation and availability (Markram et al. 1995).  
1.1.6 LTP in the Striatum 
Specific forms of associative learning and reward produce long-term changes in 
synaptic efficiency within the striatum (Reynolds et al. 2001; Schultz 2002).  In this 
area, dopamine mainly acts on D1 receptors, found on dynorphin and substance P 
containing spiny neurones that project to the substantia nigra, and D2 receptors, 
found on enkephalin containing spiny neurones that project to the globus pallidus 
(Le Moine et al. 1990; Gerfen et al. 1991; Levey et al. 1993).  These neurons are 
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of equal number and comprise approximately 90% of the total number of striatal 
neurones (Gerfen & Young 1988; Kawaguchi et al. 1990). 
D2 receptors, found presynaptically, inhibit the release of glutamate from 
corticostriatal synapses (Maura et al. 1988; Bamford et al. 2004), activation of D2 
receptors attenuates NMDA responses in the striatum (Cepeda et al. 1993) and 
inhibits calcium currents in isolated spiny striatal neurones (Surmeier et al. 1996).  
High frequency stimulation of the striatum unpredictably induces both LTP and 
LTD in vivo (Charpier & Deniau 1997; Reynolds & Wickens 2000; Reynolds et al. 
2001) and in vitro (Akopian et al. 2000; Partridge et al. 2000).  However, after 
chronic haloperidol administration, which blocks D2 receptors, high frequency 
stimulation of corticostriatal fibres invariably induces LTP, which is blocked by MK-
801 (Centonze et al. 2004).  Tetanic stimulation of cortical fibres projecting to the 
striatum in D2 receptor-null mice produces LTP which is blocked by the addition of 
D(-)-2-amino-5-phosphonoaleric acid (APV - an NMDAR antagonist that 
competitively inhibits the receptor binding site), suggesting a regulatory function 
for D2 receptors on synaptic plasticity expressed in striatal areas (Calabresi et al. 
1997). 
1.1.7 Cellular Cascades involved in LTP 
Once AMPARs have sufficiently depolarised the cell and released the voltage-
dependent Mg2+ block in the NMDAR, the resultant Ca2+ influx is probably 
restricted to the vicinity of the activated spines (Regehr & Tank 1990; Sabatini et 
al. 2002).   
A key component of LTP seems to be calcium-calmodulin-dependent protein 
kinase II (CaMKII) (Madison et al. 1991; Lisman 1994) which is activated by Ca2+ 
bound to calmodulin.  CaMKII, an oligomeric protein consisting of 10-12 subunits, 
is a major constituent of the postsynaptic density (PSD), and is therefore found in 
high concentrations close to the glutamate receptors that mediate synaptic 
transmission (Malenka et al. 1989).  Upon activation, it can translocate to 
synapses (Strack et al. 1997; Shen & Meyer 1999) and bind to NMDARs (Leonard 
et al. 1999).  CaMKII is able to undergo long term modification, resulting in a 
calcium influx by binding to the region around serine 1303 in the cytoplasmic 
domain of the NMDAR NR2B subunit (Leonard et al. 1999; Strack et al. 2000; 
Bayer et al. 2001).  This locks CaMKII in an activated state that cannot be 
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reversed by phosphatases (Bayer et al. 2001), leading to the generation of Ca2+-
independent activity, which increases after LTP induction.  Transgenic mice in 
which threonine 286 has been mutated to alanine have normal basal synaptic 
transmission, but do not exhibit LTP (Giese et al. 1998).  Persistently active 
CaMKII can mimic LTP (Pettit et al. 1994; Lledo et al. 1995), inhibitors of CaMKII 
prevent the induction of LTP (Malinow et al. 1989) tetanic stimulation of CA1 
increases CaMKII activity (Miyamoto & Fukunaga 1996) and APV blocks LTP-
associated CaMKII autophosphorylation (Fukunaga et al. 1996), indicating a key 
role for CaMKII in the early phases of LTP.  Behaviourally, mice with no alpha 
subunit of CaMKII display a deficit in learning (Silva et al. 1992), and mice with a 
point mutation at threonine 286 show no spatial learning in the Morris water maze 
(a spatial learning task) (Giese et al. 1998). 
The critical substrates of CaMKII within LTP are poorly understood.  One known 
substrate of CaMKII however, is the AMPAR.  AMPARs are tetrameric receptors, 
comprised of 2 subunits selected from GluR1–GluR4; these receptors allow Na+ to 
enter the cell, and play a major role in glutamate-induced membrane 
depolarization (Doble 1995).  After NMDA stimulation and calcium influx in 
cultured hippocampal cells, CaMKII autophosphorylates at threonine 286 and 
anchors to the NMDAR (Tan et al. 1994), phosphorylating AMPAR in the CA1 
region after the induction of LTP in this area (Barria et al. 1997b) and 
phosphorylates the GluR1 AMPAR at Ser831 in HEK293 cells (Barria et al. 1997a; 
Mammen et al. 1997).  It may also assemble insertion slots for newly delivered 
AMPARs (Lisman et al. 2002).  GluR1 knockout mice show normal basal synaptic 
transmission however, associative LTP is absent in region CA1 (Zamanillo et al. 
1999).  Phosphorylation of AMPAR results in potentiation of whole cell AMPAR 
mediated currents due to an increase in single channel conductance of existing 
receptors, or by recruiting new high-conductance-state AMPARs (Derkach et al. 
1999).   
CaMKIV is also transiently upregulated after LTP-inducing stimuli.  It is 
phosphorylated by CaMK kinase and acts on cyclic AMP-responsive element-
binding protein (CREB) at serine 133 which, in turn, leads to the expression of c-
Fos protein.  During LTP in the rat CA1, CREB and c-Fos expressions are 
increased; an effect that can be inhibited with the use of CaMK inhibitors 
(Kasahara et al. 2001). 
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CaMKII can activate the calcium-dependent adenylyl cyclase (Chetkovich & 
Sweatt 1993), which leads to local increases in cAMP, a possible downstream 
mediator of NMDA-dependent LTP (Chetkovich et al. 1991). Deficits in 
hippocampal LTP and memory tests can be found in mutant mice lacking adenylyl 
cyclase (Wu et al. 1995), and the early phase of LTP has been shown to rely on 
postsynaptic levels of cAMP (Blitzer et al. 1995).   
cAMP-dependent protein kinase, also known as protein kinase A (PKA) 
phosphorylates inhibitor-1, an endogenous protein phosphatase inhibitor, indirectly 
boosting CaMKII activity (Blitzer et al. 1998).  Like CaMK, PKA can phosphorylate 
CREB at serine 133 in response to elevated levels of cAMP (Gonzalez & 
Montminy 1989), and inhibition of PKA blocks the expression of LTP (Frey et al. 
1993; Matthies & Reymann 1993).  The timecourse of PKA actions in LTP seem 
rather controversial as the PKA inhibitor, H89, suppresses early phase LTP 
(Otmakhova et al. 2000), whereas Frey et al. (1993) found that inhibition of PKA 
specifically blocked late phase LTP.  Transgenic mice with a mutation in the 
regulatory subunit of PKA display a marked reduction of late phase LTP in area 
CA1 with concomitant deficiencies in spatial memory and contextual fear (Abel et 
al. 1997). 
PKC has also been implicated in LTP through the use of transgenic mice.  PKC 
gamma-mutant mice have a reduced capability for LTP in the hippocampus and 
display mild deficits in learning tasks (Abeliovich et al. 1993a, b).  In addition, 
reduced levels of PKC in the hippocampus decrease performance in the Morris 
water maze, effectively linking PKC and spatial memory (Wehner et al. 1990).  
Specific inhibitors of PKC decrease the potentiation of synaptic responses and can 
reduce the proportion of PKC associated with the membrane (Wang & Feng 1992; 
Reymann et al. 1988).  Again, there is controversy over the timings of LTP 
disruption with the use of differing PKC inhibitors and results suggest that it may 
be involved in both the early and late phases (Wang & Feng 1992).  Injecting PKC 
into the pyramidal cells of the CA1 elicits long lasting enhancement of synaptic 
transmission in a manner similar to LTP (Hu et al. 1987), and PKC seems to target 
many proteins with proposed LTP involvement.  One such protein, F1 (also known 
as B-50 and GAP-43) shows increased phosphorylation in the hippocampus 
immediately after, 1 hour after and even 3 days after the induction of LTP as well 
as after a spatial learning task (Lovinger et al. 1986); effects that are blocked by 
APV (Linden et al. 1988).  
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NMDAR activation, and the ensuing increase in intracellular calcium, causes an 
increase in activity of guanyl nucleotide exchange factors (GEFs), catalysing the 
exchange of GDP for GTP on low molecular weight GTPases such as Ras.  At the 
same time, the activity of the GTPase-activating proteins (GAPs), which aid the 
hydrolysis of GTP to GDP, is decreased.  The increase and corresponding 
decrease in activity of the GEFs and GAPs subsequently leads to an overall 
increase in Ras activity.  In addition, the activated kinases CaMK and PKC can 
both phosphorylate Ras.  KO mice deficient in Ras-GRF1 (Ras-guanine-nucleotide 
releasing factor 1) show a loss of LTP in the amygdala (Brambilla et al. 1997), and 
Ras activation is necessary for delivering AMPARs to the synapse during NMDAR-
dependent LTP in the hippocampus (Zhu et al. 2002). 
Ras can activate the tyrosine kinase src, which may participate in LTP induction by 
enhancing NMDA receptor function (Lu et al. 1998).  Src activity is increased by 
LTP induction, and blocking src prevents LTP within the CA1 of the hippocampus 
(Lu et al. 1998).  However, O'Dell et al. (1992) found that mutations in the src gene 
did not affect the induction or maintenance of LTP.  Ras also activates Raf, a 
serine/threonine protein kinase that phosphorylates the enzyme MAPK/ERK 
kinase (MEK).  Inhibition of MEK prevents hyperphosphorylation of extracellular 
signal-regulated kinase (ERK) (also known as mitogen-activated protein kinases 
(MAPK)), blocks LTP induction in the hippocampus (English & Sweatt 1997), and 
impairs the learning and memory of animals in spatial learning, fear conditioning 
and conditioned taste aversion (Atkins et al. 1998; Selcher et al. 1999; Schafe et 
al. 2000).  In addition, LTP-induced increases in AMPAR transmission via CaMKII 
are also disrupted by MEK inhibition, linking ERK activation and CaMKII activity 
(Zhu et al. 2002). 
The ERK isoforms -1 and -2 (ERK1 and ERK2), are widely expressed in the 
mammalian nervous system (Boulton et al. 1991; Fiore et al. 1993a), have been 
localised in neurones to the nucleus, cytoplasm and dendrites (Patterson et al. 
2001; Yuan et al. 2002), and are activated by glutamatergic signalling (Fiore et al. 
1993b; Xia et al. 1996).  LTP-inducing high frequency stimulation of the 
hippocampus activates ERK (English & Sweatt 1996), as does LTP in the dentate 
gyrus (Coogan et al. 1999), amygdala (Schafe et al. 2000) and cortex (Di Cristo et 
al. 2001).  However, the specific function of ERK in LTP remains unknown. 
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The induction of LTP in the dentate gyrus in vivo causes phosphorylation and 
nuclear translocation of ERK (Davis et al. 2000; Patterson et al. 2001), which then 
activates two sets of kinases – ribosomal protein S6 kinases (RSKs) and mitogen- 
and stress-activated kinases (MSKs).  With reference to area CA1 of the 
hippocampus, evidence suggests the cAMP-responsive element-binding protein 
(CREB) kinase, Rsk2, is critical for the maintenance of LTP within this area 
(Guzowski & McGaugh 1997; Bourtchuladze et al. 1994).  PKA and CaMKIV 
phosphorylate the transcription factor CREB at serine 133 (Dash et al. 1991; Deak 
et al. 1998) leading to the activation of several IEGs by binding to the CRE sites 
present in their promoter regions and, ultimately, regulating gene transcription.  In 
contrast, CaMKII can phosphorylate CREB at serine 142 which reduces CREB-
mediated transcription (Matthews et al. 1994; Wu et al. 2001).  LTP induction 
increases CREB phosphorylation (Bito et al. 1996) and transcription regulation 
requires the maintenance of CREB phosphorylation at serine 133, which has been 
attributed to Rsk2 via ERK (Hardingham et al. 2001; Wu et al. 2001).  However, 
Rsk2 targeted deletion does not seem to alter CREB phosphorylation (Sassone-
Corsi et al. 1999; Bruning et al. 2000).  More recently, Msk1, rather than Rsk2, has 
been linked to CREB phosphorylation in neurones (Arthur et al. 2004; Rakhit et al. 
2005).  Evidence from Aplysia, Drosophila, mice and rats demonstrates that 
region-specific cAMP-responsive transcription mediated by CREB is crucial in the 
establishment of long term, but not short-term, memory (Kaang et al. 1993; Yin et 
al. 1994; Bourtchuladze et al. 1994; Lamprecht et al. 1997; Yin & Tully 1996).  In 
addition, MEK inhibitors block CREB targeted gene transcription after LTP 
induction and fear dependent learning (Impey et al. 1998; Athos et al. 2002), and 
in CREB deficient mice, LTP induction decreases more rapidly than in control mice 
(Bourtchuladze et al. 1994).   
1.1.8 LTP Maintenance 
The stimulation of cell-surface receptors (e.g. NMDA receptors), and subsequent 
activation of cytoplasmic second-messenger systems, eventually results in an 
early wave of immediate early gene transcription.  The expression of these genes 
at the mRNA level rises markedly and transiently in the cell shortly after 
stimulation and in the absence of de novo protein synthesis.  Once translated, 
these inducible transcription factors re-enter the nucleus and regulate the 
expression of ‗late response genes‘.  Therefore the molecular changes in 
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neurones during transient memory formation that subsequently alter transcription 
are important in the conversion of short-term to long-term memory. 
Evidence suggests that all models of neuronal plasticity comprise 3 sequential 
LTP phases.  Phase 1 is dependent on existing protein modification and can last 
for the initial 2 hours after an LTP-inducing stimulus.  This phase is unaffected by 
transcriptional and translational inhibition.  Phase 2 is dependent on increased 
mRNA translation, subsequently synthesising new protein, and is present between 
2 and 8 hours after the initial stimulus.  Phase 3 is the most sustained phase of 
LTP and is dependent on increased gene transcription, as well as further protein 
and mRNA synthesis, allowing specific synapses to alter the efficiency of their 
transmission in order to become more effective (Morris 2004).  These distinct 
temporal phases can be seen experimentally in each of the major hippocampal 
excitatory synaptic pathways (Huang et al. 1996) and stable LTP, lasting for 
months, has been obtained for both medial and lateral perforant path synapses 
(Abraham et al. 2002). 
Pharmacological inhibition of activity-induced translation, and the speedy 
synthesis of de novo marker and reporter proteins in response to LTP, have 
determined that long-lasting forms of LTP require protein synthesis (Stanton and 
Sarvey 1984; Deadwyler et al. 1987; Frey et al. 1988; Mochida et al. 2001).  RNA 
synthesis inhibitors impair late phase LTP in the CA1 in vitro and in the dentate 
gyrus in vivo (Frey et al. 1996), and protein (and RNA) synthesis inhibitors impair 
long term memory formation whilst keeping short term memory intact (Squire et al. 
1980; Davis & Squire 1984).  Thus, protein synthesis is important for the 
mechanisms of memory consolidation to occur. 
The most problematic issues regarding LTP maintenance are the localisation of 
definitive synaptic modifications providing the foundation for enhanced 
transmission and the understanding of the mechanisms by which these 
modifications are made persistent.  Alterations observed include an increase in the 
amount of transmitter released, implying the necessity for a retrograde messenger 
(Dolphin et al. 1982), an increase in the density of glutamate receptors (Lynch et 
al. 1982), an increase in size of dendritic spines (Fifkova & Van Harreveld 1977) 
,and an increase in protein synthesis (Duffy et al. 1981).  Altered glutamate 
transporter levels have also been suggested to contribute to LTP and memory 
(Levenson et al. 2002; Shen & Linden 2005). 
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Synaptic plasticity relies on input and synapse specificity, so localisation of protein 
products for modifications and stabilisation in synaptic strength is an inherent 
need.  There are several schools of thought that attempt to explain how alterations 
in transcription lead to synapse specific modifications.  A definitive model has not 
been elucidated however, theories include the specific targeting of RNAs and 
proteins from the nucleus to activated synapses; the existence of a virtual 
conveyer belt that delivers proteins throughout the cell, but only increases synaptic 
strength in those synapses activated and ‗tagged‘; or the ability of synapses to 
translate their own mRNAs locally (Goelet et al. 1986; Sossin 1996; Schuman 
1997; Frey & Morris 1998). 
mRNA can be translated at synapses, as indicated by the presence of golgi 
elements, rough endoplasmic reticulum, polyribosomes, translation factors and 
large populations of mRNAs within dendrites and dendritic spines (Job & Eberwine 
2001;  Bradshaw et al. 2003; Inamura et al. 2003).  Glutamate receptor agonists 
induce the synthesis of new proteins in isolated dendrites and synaptoneurosomes 
(Weiler et al. 1997; Bagni et al. 2000; Yin et al. 2002).  LTP induction causes 
polyribosomes to move from dendritic shafts into spines (Ostroff et al. 2002), 
allowing local protein synthesis and translation in synaptic plasticity.  An hour after 
LTP-inducing high frequency stimulation (HFS), the total number of ribosomes, 
polysomes, and number of membrane bound ribosomes increase significantly in 
hippocampal CA1 pyramidal neurones (Wenzel et al. 1993).  In addition, local 
application of a protein synthesis inhibitor only impairs LTP in those local dendrites 
rather than dendrites found further down the cell in Schaffer-commissural 
synapses on CA1 pyramidal neurones in the murine hippocampus (Bradshaw et 
al. 2003).  MEK inhibitors effect LTP within 20 to 30 minutes following high 
frequency stimulation, and therefore ERK is probably unable to translocate to the 
nucleus, activate transcription and translation, then send the new gene product to 
potentiated synapses in such a short space of time (Ohno et al. 2001; Rosenblum 
et al. 2002; Selcher et al. 2003).  However, separating apical dendrites from their 
cell bodies allows the induction of LTP that lasts for approximately 3 hours, 
compared to 8-10 hours in intact slices.  This suggests that protein synthesis in 
isolated dendrites is sufficient for the early expression of translation dependent 
LTP but mRNA transcription in the soma is required for longer lasting potentiation 
(Frey et al. 1989). 
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1.1.9 The Immediate Early Gene Zif268  
Zinc finger binding protein clone 268 (zif268) (Christy et al. 1988), also known as 
Krox24 (Lemaire et al. 1988, Lemaire et al. 1990), nerve growth factor-induced 
gene A (NGFI-A) (Milbrandt 1987), early growth response gene-1 (Egr-1) 
(Sukhatme et al. 1988), tetradecanoyl phorbol acetate-induced sequence 8 (TIS8) 
(Lim et al. 1987), and ZENK (an acronym of zif268, egr-1, NGFI-A, Krox24), is an 
immediate early gene (IEG) that encodes an 82 and an 88kDa regulatory protein 
(depending on the initiator sequence) (Lemaire et al. 1990).  The gene is present 
in the mammalian genome as a single copy gene located on mouse chromosome 
18, and belongs to a multi-gene family of closely related transcription factors, the 
Egr proteins. 
As the name implies, zif268 is a zinc finger protein; it contains 3 zinc fingers in the 
DNA binding domain that allow the protein to control directly the transcription of 
other genes (Christy & Nathans 1989; Swirnoff & Milbrandt 1995).  There is a high 
homology in the 3 zinc finger sequences in all members of the Egr family 
suggesting that the proteins may bind to the same consensus sequence of 5‘-
GCG(G/T)GGGCG-3‘ (Christy & Nathans 1989; Cao et al. 1993; Swirnoff & 
Milbrandt 1995) found in the promoter regions of downstream target genes.  The 
other members of the Egr family are Egr-2, also known as Krox 20, Egr-3, also 
known as PILOT, and Egr-4, also known as NGFI-C and pAT133 (Joseph et al. 
1988; Crosby et al. 1991; Patwardhan et al. 1991; Mages et al. 1993).  Zif268 
protein has a modular organisation; there are distinct areas for DNA binding, and 
the activation or repression of transcription.  As befits a transcription factor, the 
zif268 protein has a nuclear localisation within the neurone, due to a bipartite 
signal in the DNA-binding domain, which is located in either the second or third 
zinc finger (Gashler et al. 1993).  In addition to the DNA binding site, zif268 
contains an activation domain that has not been fully characterised and an 
inhibitory domain located between the two.  This allows zif268 expression to be 
regulated by binding of the transcriptional co-factor proteins NGFI-A binding 
proteins 1 and 2 (NAB1 and NAB2) which interact with the inhibitory domain 
(Russo et al. 1995; Svaren et al. 1996).  Both NAB1 and NAB2 block the biological 
activity of zif268 (Russo et al. 1995; Svaren et al. 1996; Thiel et al. 2000), and 
interestingly, zif268 has been shown to control the expression of NAB2, allowing 
for autoregulation via a negative feedback loop (Ehrengruber et al. 2000).  Zif268 
is known to interact directly with other transcription factors/modulators; binding to 
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CREB-binding proteins (Ramirez et al. 1997), NFĸB (Chapman & Perkins 2000), 
NFAT (Decker et al. 2003) or C/EBP (Zhang et al. 2003) can all modify the 
transcriptional actions of zif268, suggesting that zif268 can exert a variety of 
effects depending on which other transcription factors are active at that time. 
In, or adjacent to, the promoter region of the zif268 gene are several different 
regulatory sites, including cyclic-AMP-responsive element (CRE) sites, serum 
response element (SRE) sites, activator protein 1 like motifs (AP-1), AP-2 like 
binding sequences, specificity protein 1 element (Sp1) -like motifs, and, in 
humans, an Egr/Zif268 response element (ERE) (Tsai-Morris et al. 1988; Christy & 
Nathans 1989; Sakamoto et al. 1991; Alexandropoulos et al. 1992b; Schwachtgen 
et al. 2000).  This abundance of regulatory sites allows several different signalling 
pathways and kinases to induce and modulate zif268, including Elk-1 binding to 
the SRE sites, CREB binding to the CRE sites and the Fos-Jun dimerised protein 
binding to the AP-1 site.  In addition, its own family members can bind to the ERE 
site and, for enhanced autoregulation, zif268 itself can also bind. 
During development, zif268 is expressed in the endothelial system, thymus, 
muscle, cartilage, bone and parts of the central and peripheral nervous system 
(McMahon et al. 1990; Watson and Milbrandt 1990).  In the rat brain, basal 
constitutive expression of zif268 mRNA is found in many areas including the 
primary visual cortex, entorhinal cortex, olfactory cortex, neocortex, and several 
subcortical regions including the hippocampus and striatum.  In the neocortex, 
zif268 is mainly expressed in layers IV and VI, and in the hippocampus it is 
expressed at its highest levels in CA1, to a lesser extent in CA2-CA4 and is 
virtually absent in the dentate gyrus (Schlingensiepen et al. 1991).  Protein 
expressions display a very similar pattern to that of mRNA  (Beckmann & Wilce 
1997). 
Zif268 was initially identified as a nerve growth factor response gene product in rat 
PC-12 cells, and an immediate-early serum and growth factor response gene 
product in mouse fibroblasts, before similar genes were identified in other species 
(Sukhatme et al. 1988; Milbrandt 1987; Christy et al. 1988; Suggs et al. 1990; Lau 
& Nathans 1987).   
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1.1.10 Zif268 activation in Long Term Potentiation 
As an inducible transcription factor, zif268 can be activated by a variety of 
pharmacological and physiological stimuli including growth factors, 
neurotransmitters, depolarization, peptides, nitric oxide, ischaemia, seizures, 
neurodegeneration, apoptosis and cellular stress (reviewed in Hughes & 
Dragunow 1995; Beckmann & Wilce 1997; Herdegen & Leah 1998).  Immediate 
early genes are rapidly and transiently activated after LTP induction, and therefore 
possibly constitute an early genomic response for triggering the mechanisms 
underlying persistent cell modification.  An important biological function of these 
modifications in neurones may be to underlie the maintenance or stabilisation of 
neuronal plasticity and the formation of long-term memories.  With reference to 
LTP, it has been shown that glutamate, as well as synthetic agonists targeted to 
specific types of glutamate receptors, are effective in activating zif268 (Condorelli 
et al. 1994).  The administration of NMDA and kainate to the cerebral cortex and 
hippocampus of rats in vivo effectively increases zif268 activity (Beckmann et al. 
1997).  The resultant increase in Ca2+ within the cytosol can also induce zif268 
expression (Murphy et al. 1991; Ghosh et al. 1994). 
Ras can be activated by the protein tyrosine kinase Src in response to an increase 
in intracellular calcium within PC-12 cells.  Src activation, which triggers the 
formation of an Shc/Grb2 complex (an adaptor protein/growth-factor-receptor 
binding protein 2), leads to Ras activation in PC-12 cells (Rusanescu et al. 1995), 
which, in turn, activates Raf and further downstream, ERK and zif268 (Qureshi et 
al. 1991; Alexandropoulos et al. 1992a).  Raf activates MAPK/ERK kinase (MEK) 
by phosphorylation which, in turn, phosphorylates the serine/threonine kinases 
ERK1 and ERK2, leading to their activation, and ultimately the modification of 
many different types of proteins, including transcription factors, like CREB.  In vivo 
stimulation of the glutamatergic corticostriatal pathway induces a transient 
activation of ERK, which is spatially coincident with the onset of zif268 expression 
in the lateral striatum (Sgambato et al. 1998).  Infusion of MEK inhibitors prior to 
LTP can prevent (Davis et al. 2000), or attenuate (Rosenblum et al. 2002), 
transcription of zif268 in the dentate gyrus.  However, zif268 activation in dentate 
granule cells by LTP induction of the perforant pathway did not produce a 
concurrent increase in the level of phosphorylated CREB in one study (Walton et 
al. 1999) and CREB mutant mice display normal constitutive levels of zif268 
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(Blendy et al. 1995).  This may suggest that CREB activity is not the major 
determinant of zif268 expression in hippocampal neurones. 
Another possible activator of zif268, Elk-1, binds to the SRE in upstream 
regulatory regions of IEGs (Wasylyk et al. 1998) and is activated simultaneously 
with ERK, CREB, and zif268 induction in vivo (Sgambato et al. 1998).  Elk-1 is 
activated by ERK and the c-Jun N-terminal protein kinase (JNK), leading to 
enhanced DNA-binding activity (Treisman 1995; Whitmarsh et al. 1995).  LTP 
induction in the dentate gyrus leads to the phosphorylation of ERK, Elk-1 and 
CREB and the transcriptional activation of zif268, whilst MEK inhibitors prevent the 
cascade, resulting in rapidly decaying LTP (Davis et al. 2000).  This points towards 
two parallel and possibly co-operating signalling pathways.  It remains unknown 
whether zif268 regulation is dictated by CRE or SRE-mediated transcription, 
although the contradictory CREB evidence coupled with the presence of 6 SRE 
sites compared to 2 CRE sites strongly suggests zif268 is controlled by SRE via 
MAPK-mediated Elk-1 activation.  A simplified schematic representation of zif268 
induction during LTP is presented in figure 1.2. 
1.1.11 Zif268 and Long Term Depression 
LTD is a synaptic mechanism of neuronal plasticity that involves a long-lasting 
decrease in synaptic efficiency following synaptic stimulation.  LTD can be induced 
by similar stimulus conditions, can persist as long as LTP (Abraham et al. 1994), 
and can be blocked by inhibitors of transcription and translation.  Behaviourally, 
spontaneous recovery of conditioned fear is associated with sustained prefrontal 
LTD (Herry & Garcia 2002, 2003).  Zif268 mRNA is upregulated after LTD 
induction at CA3/CA1 synapses (Lindecke et al. 2006), and increased protein 
levels correlate strongly with the persistence of heterosynaptic LTD in the 
perforant path (Abraham et al. 1994).  Therefore, zif268 induction may be a key 
factor in inhibitory (LTD) as well as excitatory (LTP) learning paradigms (Herry & 
Mons 2004). 
1.1.12 Zif268 & synaptic plasticity in the dentate gyrus 
Zif268 is a regulatory IEG, activating (or suppressing) downstream target genes 
that presumably play a role in the duration and stabilisation of LTP, in particular 
the production of LTP phase III.  The induction of long-lasting LTP in the dentate 
gyrus of awake rats consistently increases the expression of zif268 (Cole et al. 
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1989; Wisden et al. 1990), but, in contrast, continuous low frequency stimulation 
does not (Cole et al. 1989; Richardson et al. 1992; Worley et al. 1993).  Tetanic 
stimulation of the perforant path, inducing LTP at dentate gyrus synapses, results 
in ipsilateral upregulation of zif268 mRNA which is more prevalent in the dorsal 
than the ventral hippocampus (Cole et al. 1989; Richardson et al. 1992; Abraham 
et al. 1993; Williams et al. 2000).  The threshold for inducing zif268 expression is 
similar to the threshold intensity necessary to induce LTP phase III, but not phases 
I or II (Abraham et al. 1993; Worley et al. 1993). 
Zif268 upregulation correlates with the persistence of LTP rather than magnitude 
of induction (Richardson et al. 1992) and, after LTP induction, zif268 DNA binding 
activity to its response element rapidly increases in an NMDAR-dependent manner 
(Williams et al. 2000).  Conversely, blocking the induction of LTP by stimulation of 
the inhibitory commissural input to the dentate gyrus during perforant path 
tetanization blocks the LTP-associated increase in zif268 expression, as does 
NMDAR antagonism (Cole et al. 1989; Wisden et al. 1990; Worley et al. 1993; 
Salin et al. 2002). 
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Figure 1.2: A simplified schematic representation of zif268 activation during LTP.  The 
release of glutamate into the synaptic gap between neurones activates glutamate receptors and, in 
NMDAR-dependent LTP, the NMDA receptor.  This leads to several signal transduction cascades 
that ultimately activate zif268. 
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After perforant pathway tetanization, zif268 mRNA levels in the dentate gyrus peak 
with a 6 to 9 fold increase after around 20 minutes, but return to base-line within 2 
hours (Cole et al. 1989; Wisden et al. 1990).  Zif268 immunoreactivity peaks 
around 2 hours and returns to baseline after 8 hours.  This timecourse is too 
prolonged for the initial stages of LTP, which peaks within a couple of minutes 
following tetanization (Richardson et al. 1992), but is consistent with zif268 target 
genes contributing to phase III of LTP.  
1.1.13 Zif268 and neuronal plasticity throughout the brain 
Evidence pertaining to zif268‘s involvement in LTP within other areas of the brain 
suggests that it is not vital for all types of plasticity in all brain regions.  There are 
very few publications regarding zif268 activation coupled with LTP induction in 
regions other than the perforant path-granule cell synapse.  Zif268 mRNA is 
upregulated in the primary visual cortex after tetanic stimulation of the dorsolateral 
geniculate nucleus (Heynen & Bear 2001), and in the insular cortex after 
stimulation of the basolateral amygdala, although this was also induced by low 
frequency stimulation and was apparent throughout the entire cortex (Jones et al. 
1999).  Zif268 induction in the CA1 pyramidal cells of the rat hippocampus after 
LTP has been reported (Roberts et al. 1996) although, French et al. (2001) 
detected no changes in zif268 in the CA1 pyramidal cells of the hippocampus after 
induction of LTP by high-frequency stimulation of the commissural projection in 
freely moving rats, even though the LTP detected lasted for 5 days.  However, 
they did show zif268 could be modulated in response to electroconvulsive shock 
and their detection assay was rather insensitive (Prof. B. J. Morris, personal 
communication) so the negative result after LTP induction should be viewed with 
caution.  Overall therefore, zif268 may be region-specific and not LTP-specific in 
some systems, although zif268 induction in learning has been relatively 
widespread.  
1.1.14 Zif268 regulation during learning 
A rapid increase in zif268 expression has been associated with some, but not all, 
forms of learning and long-term memory in many different species.  In the 
macaque monkey, visual paired associative learning increases zif268 protein in 
the anterior temporal lobe, a finding that was not repeated in a simple visual 
discrimination task or in other IEG products (Okuno & Miyashita 1996; Tokuyama 
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et al. 2002).  Zif268 is also rapidly regulated during associative learning in other 
species, such as song learning in birds (Mello et al. 1992), whereby the 
upregulation is induced when song birds hear their own conspecies songs.  In 
addition, when a song is presented with a shock, there is a greater increase of 
zif268 in the caudomedial auditory telencephalon compared to the delivery of a 
song or a shock by themselves (Jarvis et al. 1995).  This implies a learning-related 
aspect to the zif268 induction. 
Within rats, associated learning tasks (Malkani & Rosen 2000) and spatial learning 
tasks (Fordyce et al. 1994) have displayed increases in zif268 expression.  After 
20 minutes training to locate the platform within a water maze, zif268 is 
upregulated in the hippocampus (Guzowski et al. 2001).  However, after extended 
spatial learning over several days, no overexpression of zif268 can be located, 
providing further evidence for the rapid and transient nature of zif268 activation 
(Richter-Levin & Segal 1988; Wisden et al. 1990).  C57 mice have a genetically-
defined higher basal level of zif268 compared to the DBA strain of mouse, and the 
C57 mice perform better in the water maze task than the DBA mice (Fordyce & 
Wehner 1993).  Animals housed in an enriched environment, which improves 
cognitive function (Hebb 1949), display a significant increase in zif268 mRNA in 
the CA3 and CA4 areas of the hippocampus compared to those raised in isolation.  
In addition, these animals performed better in a spatial learning task compared to 
controls (Toscano et al. 2006). Induction of zif268 within the acquisition phase of 
two-way avoidance training has been demonstrated with a marked accumulation 
of zif268 occurring within the hippocampus and visual cortex (Nikolaev et al. 
1992). 
Learning-related increases in zif268 expression have also been seen in the 
accessory olfactory bulb of female mice in response to pheromone signals and 
putative pheromonal constituents (Brennan et al. 1992; Brennan et al. 1999), and 
in the hippocampus after active avoidance learning (Nikolaev et al. 1992) or 
brightness discrimination (Grimm & Tischmeyer 1997).  In addition, zif268 
expression is elevated in the nucleus of the solitary tract, the parabrachial nucleus, 
the hypothalamic paraventricular nucleus and the central nucleus of the amygdala 
in animals trained in conditioned taste aversion (Lamprecht & Dudai 1995). 
Fear conditioning is rapidly acquired and has been shown to rely on the amygdala 
for the memory of fear, with the additional requirement of the hippocampus for 
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contextual conditioning (Kim & Fanselow 1992; Maren & Fanselow 1996; Rogan & 
LeDoux 1996; Frankland et al. 1998).  Contradictory results regarding the 
involvement of zif268 within the experimental paradigm of associating footshock 
with a tone or particular environment have been published.  Malkani & Rosen 
(2000), and Hall et al. (2000) both report an increase in zif268 mRNA in area CA1 
of the hippocampus following contextual fear conditioning in both controls and 
experimental groups, indicating that the result is not learning specific and merely 
due to novelty.  In the amygdala however, Malkani & Rosen (2000) noted an 
increase of zif268 in the lateral nucleus of the amygdala specifically in response to 
learning.  Hall et al. (2000) on the other hand, also noted a similar increase in the 
control group exposed to the training chamber relative to naïve controls.  In 
addition, a retention test 24 hours after learning reportedly produced no change in 
zif268 levels in the CA1 or amygdala in the experiment by Malkani & Rosen (2000) 
but did produce an increase in these areas in the experiment by Hall et al. (2001).  
Therefore, with regard to contextual fear learning, one group state that zif268 is 
involved in learning, but not retrieval (Malkani & Rosen 2000), and the other 
concludes that zif268 is involved in retrieval, but not learning (Hall et al. 2000).  
However, the latter group noted zif268 may also be involved in retrieval in the 
nucleus accumbens and cingulate cortex (Thomas et al. 2002).  Following on from 
their earlier work, Malkani & Rosen (2001) administered APV, an NMDA receptor 
antagonist known to block the acquisition of fear conditioning (Kim et al. 1991; 
Maren & Fanselow 1996; Lee & Kim 1998), and discovered that it also stopped the 
learning-induced increase in zif268 expression found by them in the lateral 
nucleus of the amygdala.  Lee et al. (2004) reported that zif268 was not required 
for memory consolidation in hippocampus-dependent contextual fear conditioning, 
but essential for reconsolidation (whereby a recalled memory is reinforced to 
become permanent).  Further studies are required to elucidate the exact role of 
zif268 in this particular mode of learning. 
Zif268 is also activated in simpler forms of learning.  In vitro, classical conditioning 
of the brainstem in turtles increases zif268 protein, which can be reversed with the 
application of APV, illustrating a dependency for NMDARs (Mokin & Keifer 2006). 
1.1.15 The effects of zif268 gene targeted deletion 
Topilko et al. (1997) generated mutant zif268 null mice by inserting the lacZ gene 
upstream of the initiation codon, with an additional frameshift mutation upstream of 
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the DNA binding domain, ensuring that zif268 was neither transcribed nor 
translated.  The pups were born normally and capable of survival to adulthood, but 
both male and female mice homozygous for mutation had a reduced body size 
and were sterile.  Analysis of tissues and organs revealed numerous deficits in the 
anterior pituitary and reproductive system. 
Comparing zif268 -/- mutant mice to wildtype littermates after induction of LTP in 
the dentate gyrus displays a comparable potentiation for 50 – 60 minutes after 
tetanisation.  However, measuring 24 and 48 hours after tetanus demonstrates 
that late LTP in the homozygous and heterozygous mutants decayed back to 
basal levels within 24 hours after induction. This demonstrates the necessity of 
activation of zif268 in the stabilisation of long-term LTP in the dentate gyrus (Jones 
et al. 2001). 
Behavioural analysis performed on zif268 -/- mutant mice has shown a strong 
deficiency in long-term memory formation tested on a variety of behavioural tasks, 
including olfactory discrimination, novel object recognition, conditioned taste 
aversion and the Morris water maze.  This effect was not exhibited during normal 
short-term retention evaluations, namely spatial behaviour in a T maze, object 
recognition and social transmission of food preference (Jones et al. 2001).  These 
data show that the deficits encountered in zif268 knockout mice are not specific to 
a particular task, but to a general deficit in the consolidation of memories. 
1.1.16 Downstream targets of zif268  
The gene products of zif268 can act as nuclear transcription factors to regulate the 
transcription of target genes.  Translation of both newly transcribed and pre-
existing mRNAs occurs within hours of LTP induction and plays an important role 
in maintaining LTP.  Up until 2005 and the publication by James et al. (2005), very 
few genes had been suggested as possible CNS targets for LTP-induced 
regulation by zif268.   
Synapsin I and synapsin II gene transcription is activated by an increase in zif268 
(Thiel et al. 1994; Petersohn et al. 1995).  In particular, the gene encoding 
synapsin I is found to be upregulated in the dentate gyrus granule cells after LTP 
(Hicks et al. 1997).  Synapsin is a protein of the exocytotic machinery, so this 
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regulation of a pre-synaptic protein downstream of zif268 activation suggests the 
propagation of plasticity through neural networks. 
Tyrosine Hydroxylase (TH), the enzyme involved in the biosynthesis of the 
catecholamines, was recently shown to contain an Egr-1 motif in its promoter 
region (Papanikolaou & Sabban 1999).  Transiently transfecting zif268 into PC-12 
cells is sufficient to drive the proximal rat TH promoter as measured by the 
increased activity of the CAT reporter gene (Papanikolaou & Sabban 2000).  
Phenylethanolamine N-methyltransferase (PNMT) catalyses the conversion of 
noradrenaline to adrenaline and has two potential ERE sites.  PNMT gene 
expression is enhanced when RS1 cells are transiently transfected with zif268 
(Ebert et al. 1994) or administered with phorbol 12-myristate 13-acetate (PMA), 
which stimulates endogenous zif268 (Morita et al. 1995).  However, PNMT has not 
been observed to change in models of learning behaviour.  Other specific target 
genes of zif268 include adenosine deaminase (Ackerman et al. 1991), 
acetylcholine esterase (Li et al. 1993), the -myosin heavy chain (Gupta et al. 
1991) and the cdk5-regulator, p35 (Harada et al. 2001).  
In 2005, James et al. published a microarray experiment that identified 153 
differentially expressed known genes as neuronal targets of zif268, the vast 
majority of which were significantly downregulated.  These included 
neurotransmitters and modulators, receptors, signalling genes, pre-synaptic 
elements and genes involved in synapse formation, the proteasome, the major 
histocompatability complex, the immune response, vesicle trafficking, the 
cytoskeleton, translation, chromaffin cell function and metabolic processes.  
Rigorous statistical analysis revealed that only 8 of these genes were likely to be 
false positives.  A random selection of candidate genes was verified in two CNS 
plasticity models in vitro and in vivo, as representative authentication of the cell 
line results.   
It seems that zif268 may be an activator or suppressor of transcription depending 
on the context in which the data is gathered.  James et al. (2005) found that the 
pattern of altered gene expression was different in differing areas of the brain, 
namely the hippocampus and the striatum.  In addition, TH was downregulated in 
the PC-12 cells, but has been reported as upregulated (Papanikolaou & Sabban 
2000) and indeed downregulated in other reports (Maharjan et al. 2005).  Also, 
PDGF-A is suppressed by zif268 in NIH3T3 cells, but enhanced in HEK293 cells 
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(Wang et al. 1999).  Most strikingly, in a single cell type – prostate carcinoma cells 
– zif268 mediates increased transcription of CREB-binding protein (CBP) after one 
stimulus (serum) and reduced CBP transcription after another stimulus (UV) (Yu et 
al. 2004).  The ability of zif268 to act as either a transcriptional activator or 
repressor may therefore depend on factors such as its phosphorylation state and 
interaction with other transcription factors. 
Within the many known genes identified by the microarray experiment as 
downstream targets of zif268 were gephyrin and ubiquilin (James et al. 2005).  
Gephyrin displayed a negative fold change of 1.36 and ubiquilin showed a 
negative fold change of 1.57.  These proteins are interesting as they have both 
been associated with the GABAAR, an inhibitory ligand-gated chloride channel.  
1.1.17 The GABAAR 
Whilst glutamate is the major excitatory neurotransmitter in the brain, gamma-
aminobutyric acid (GABA) is the major inhibitory neurotransmitter.  There are 3 
GABA receptor subtypes: A, B and C.  GABAA and GABAC are ionotropic 
receptors, allowing Cl- ions to enter the cell, resulting in hyperpolarisation and a 
reduction in cell excitability.  On the other hand, GABAB is a metabotropic-type 
receptor, allowing K+ to enter and reducing presynaptic levels of Ca2+ after 
activation of the associated G-protein.   
GABAARs are ligand gated inhibitory receptors that are distributed throughout the 
CNS.  They are arranged in a pentameric stoichiometry with subunits recruited 
from a range of 21 (currently known) different subunits ( 1-6, 1-4, 1-4, , , ,  and 
1-3) (Bonnert et al. 1999; Whiting 1999; Burt 2003).  The 1 2/3 2 combination is 
the predominantly expressed receptor isoform (Fritschy & Mohler 1995) and 
2 :2 :1  is the most likely ratio (Chang et al. 1996; Tretter et al. 1997; Farrar et al. 
1999).  Gephyrin and the 2 subunit are required for the clustering of GABAARs at 
postsynaptic sites (Essrich et al. 1998), gephyrin may bind to the 3 subunit 
(Kirsch et al. 1995), and can be co-localised with the 1, 2, 3, 3 and 2 
subunits in rat brain and dissociated cultures (Sassoe-Pognetto et al. 2000; 
Danglot et al. 2003).  Ubiquilin binds to the 1, 2, 3, 6, 1, 2 and 3 subunits 
of the GABAAR (Bedford et al. 2001). 
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Synaptically localised GABAARs allow phasic GABA-mediated transmission, which 
is produced by 0.3mM GABA within the synaptic cleft for less than 1 millisecond 
(Mody et al. 1994; Cherubini & Conti 2001; Nusser et al. 2001).  Once activated, 
GABAARs produce inhibitory postsynaptic potentials (IPSPs), the magnitude of 
which is determined by the number, and properties, of the receptors present, and 
the concentration and duration of GABA release.  In addition to phasic activation is 
tonic neurotransmission, produced by continuous activation of extrasynaptic 
receptors by micro-molar GABA levels, spilt from the synaptic cleft and always 
present in the extracellular space (Scanziani 2000; Semyanov et al. 2004; Mody & 
Pearce 2004).  Tonic inhibition may play a crucial role in regulating neuronal 
excitability by setting the threshold for action potential generation (Petrini et al. 
2004).  
1.1.18 Gephyrin  
Gephyrin is widely expressed throughout the mammalian CNS (Prior et al. 1992; 
Kirsch et al. 1993), binds to polymerised tubulin (Kirsch et al. 1991), and is co-
purified with the inhibitory glycine receptor (Langosch et al. 1992).  Its association 
with microtubules may aid the development of a subsynaptic lattice, or scaffold, 
below the plasma membrane anchoring receptors at the cytoplasmic face of the 
cell membrane, by binding directly, or possibly indirectly, to the cytoplasmic loops 
of receptor subunits (Kneussel et al. 1999b; Meier et al. 2001).  The synaptic 
anchoring of inhibitory receptors was established by antisense oligonucleotide 
depletion (Kirsch et al. 1993; Essrich et al. 1998), and gene knockout in mice 
(Feng et al. 1998; Kneussel et al. 1999a), which prevented the localisation of 
GlyRs and GABAARs to the synapse.  The role of gephyrin in GlyR clustering will 
be dealt with in more depth in chapter 4.  
1.1.19 Gephyrin and the Cytoskeleton 
The postsynaptic density (PSD) lines the cytoplasmic face of the cell membrane 
and comprises microtubules, neurofilaments and their associated proteins.  At the 
PSD of inhibitory synapses, gephyrin interacts with components of the 
cytoskeleton, and is thought to connect the cytoplasmic domain of glycine receptor 
and GABAAR polypeptides to 2 cytoskeletal systems, the microtubules (tubulin) 
and microfilaments (actin; via profilin). 
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An intact microtubular cytoskeleton seems to be essential for the stabilisation of 
postsynaptic gephyrin clusters.  Gephyrin clusters are enriched with G-actin (actin 
monomers) but there is no direct association between the two (Giesemann et al. 
2003), and gephyrin puncta are aligned with filamentous actin (F-actin) in 
dendrites, and are localised to inhibitory synapses (Bausen et al. 2006).  Mena 
(mammalian enabled)/VASP (vasodilator-stimulated phosphoprotein), the f-actin 
uncapping protein (Bear et al. 2002), directly interacts with G-actin (Walders-
Harbeck et al. 2002) and profilin (Reinhard et al. 1992; Reinhard et al. 1995; 
Gertler et al. 1996), an actin monomer binding protein that stimulates actin 
polymerization by increasing ADP/ATP exchange (Sohn & Goldschmidt-Clermont 
1994).  Therefore, Mena/VASP can recruit profilin/actin monomer complexes to 
actin filaments in order to allow further filament generation (Huttelmaier et al. 
1999; Bear et al. 2002).  Actin microfilaments are thought to control the inhibitory 
receptor density at postsynaptic sites.  Mena/VASP was found to precipitate and 
co-localise with gephyrin (Giesemann et al. 2003), and gephyrin also binds with 
profilin (Mammoto et al. 1998).  Both gephyrin and profilin colocalise and 
physically interact at inhibitory synapses in cultured neuronal cells and spinal cord 
sections (Giesemann et al. 2003).  Cultured spinal cord neurones treated with 
cytochalasin D (a drug that severs the actin cytoskeleton) show a reduction in 
postsynaptic gephyrin cluster size with an increase in packing density, whilst 
demecolcine (which disrupts microtubules) decreases the density of postsynaptic 
gephyrin clusters, increasing the cluster size (Kirsch & Betz 1995).  In addition, the 
lateral mobility of the inhibitory GlyR is restricted at postsynaptic sites by an 
interaction with the microtubules, and demecolcine decreases GlyR 
immunoreactivity apposed to presynaptic terminals (Kirsch & Betz 1995).  
However, depolymerisation of microtubules has no effect on the distribution 
pattern of GABAARs; they remain intact and maintain a synaptic localisation in 
mature hippocampal cultures (Allison et al. 2000), suggesting that some 
mechanism other than microtubules is required to anchor gephyrin and GABAAR 
at inhibitory synapses after synaptogenesis.  In addition, in HEK293 cells, 
intracellular gephyrin clusters do not appear to interact with, or depend on, actin 
filaments (Bausen et al. 2006). 
Gephyrin binds to dynein light chain-1 and –2 (Dlc-1 and –2) as determined by 
yeast dihybrid screening and biochemical assays.  Dlc-1 and –2 are components 
of microtubule motor proteins, and seem to interact with gephyrin whilst co-
localised at some inhibitory synapses, possibly suggesting a role in retrograde 
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gephyrin transport (Fuhrmann et al. 2002).  The subcellular localisation of gephyrin 
at the synapse may therefore depend on motor proteins.  In addition, disrupting 
microtubules with nocodazole or dynamitin, a dynein transport inhibitor, interferes 
with gephyrin‘s transport by dynein intermediate and heavy chains (Maas et al. 
2006). 
The Rho family small G proteins regulate various actin cytoskeleton-dependent 
cell functions including cell shape change, cell motility and cytokinesis.  Collybistin 
(from Greek : to exchange) is predominantly a brain specific GEF for 
small GTPases of the Rho/Rac-family thought to constitute an essential 
component of the signalling machinery that directs gephyrin to the developing 
postsynaptic membrane (Kins et al. 2000).  The splice variants I and II were 
detected as binding partners of the C-terminal domain of gephyrin by yeast 
dihybrid screening of newborn rat brain.  Collybistin I was redistributed to 
gephyrin-rich cytoplasmic aggregates when co-transfected into HEK293 cells.  
Collybistin II was able to induce submembrane gephyrin microaggregates, which 
recruited  subunit containing GlyRs (Kins et al. 2000).  In addition, a mutation in 
exon 2 of the human collybistin gene results in hyperekplexia and epilepsy, 
possibly due to the misdirected localisation of gephyrin and associated GlyR and 
GABAARs.  Therefore, collybistin could be a key protein for the postsynaptic 
localisation of gephyrin (Harvey et al. 2004). 
1.1.20 Gephyrin and GABARAP 
GABAAR-associated protein (GABARAP) has a tubulin-binding motif (Wang et al. 
1999; Wang & Olsen 2000), and colocalises with GABAAR in cultured cortical 
neurones (Wang et al. 1999), specifically binding its N-terminal domain to the 
GABAAR 2 subunit.  In addition GABARAP binds to gephyrin; however, in 
cultured neurones of gephyrin deficient mice, no difference is seen in GABARAP 
puncta localisations compared to wildtypes (Kneussel et al. 2000).  GABARAP is 
not localised at inhibitory postsynaptic sites but is found in intracellular 
compartments, particularly concentrated at the ends of the Golgi stacks where 
transport vesicles bud and fuse (Kittler et al. 2001).  Therefore, it could interact 
with GABAAR subunits, and gephyrin before they reach the synapse and ultimately 
play a role in receptor trafficking.  In addition, binding of the GABARAP C-terminus 
to tubulin, and the N-terminus to GABAAR, suggests a role in linking the receptor 
to the microtubules, presumably to deliver it to the plasma membrane.  Further 
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evidence has shown that overexpression of GABARAP in hippocampal neurones 
increases GABAARs at the cell surface (Leil et al. 2004).  However, GABARAP 
knockout mice show no differences in the number or synaptic distribution of 
GABAARs containing 2 subunits at gephyrin positive postsynaptic sites compared 
to wildtypes, suggesting that it may not be essential for trafficking or synaptic 
localisation after all (O'Sullivan et al. 2005). 
1.1.21 Gephyrin and the GABAA Receptor 
Gephyrin was originally linked to glycine receptors alone, however, it is found in 
brain regions known to contain little or no evidence of glycinergic synapses 
(Malosio et al. 1991; Kirsch et al. 1993).  Gephyrin immunoreactivity can be found 
in GABAergic synapses in cultured hippocampal (Craig et al. 1996), and cortical 
neurones (Essrich et al. 1998), as well as in areas such as the retina, olfactory 
bulb and spinal cord (Todd et al. 1996; Sassoe-Pognetto & Wassle 1997; Giustetto 
et al. 1998).  All presently available data, including gene depletion and knockout 
experiments, strongly indicates that gephyrin is associated with and essential for 
clustering of not only glycine receptors but specific GABAAR subtypes (Essrich et 
al. 1998; Betz 1998; Feng et al. 1998; Kneussel et al. 1999a).  However, 
biochemical evidence for a direct association of GABAARs subunits and gephyrin 
has not been demonstrated (Meyer et al. 1995), leading to the notion of a 
hypothesised linker protein that mediates the association of gephyrin with 
GABAARs.  Gephyrin is concentrated in the postsynaptic membrane at many 
inhibitory synapses, and is proposed to mediate clustering and/or synaptic 
anchoring of GABAAR through indirect binding to the 3 subunit (Kirsch et al. 
1995).  It has also been shown that gephyrin is essential for the postsynaptic 
clustering of GABAARs containing 1 or 2 and 2 subunits (Essrich et al. 1998; 
Kneussel et al. 1999a; Kneussel et al. 2001; Levi et al. 2004). 
There is evidence that infers some interdependence for the synaptic localisation of 
gephyrin and specific subtypes of the GABAAR.  Gephyrin antisense 
oligonucleotide treatment of cultured cortical and cultured hippocampal neurones 
displays a reduction in punctate synaptic staining for GABAAR 2 and 2 subunits.  
In addition, the generation of mice with a targeted loss of the GABAAR 2 subunit 
resulted in a loss of postsynaptic gephyrin and GABAAR clusters (Essrich et al. 
1998; Schweizer et al. 2003).  This can be reversed by the transgenic 
overexpression of the 3 subunit (Baer et al. 1999), presumably due to similar 
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regions within the subunit sequences.  Danglot et al. (2003) observed a decrease 
in the number of gephyrin clusters that did not contain GABAAR 2 subunits during 
maturation in hippocampal neurones.  Gephyrin deficient mice also display a total 
loss of postsynaptic clusters of GABAAR 2 and 2 subunits in cultured 
hippocampal neurones (Kneussel et al. 1999a), providing further evidence that 
suggests these subunits are essential for clustering.  However, Levi et al. (2004) 
utilised gephyrin -/- mice to assess the GABAergic phenotype of cultured 
hippocampal neurones and observed surface synaptic clusters of 1, 2 and 2 
subunits in gephyrin deficient neurones.  In spinal cord, GABAAR 3, 2/3, 2 
subunit receptor clustering has been described, in an impaired manner, in 
gephyrin knockout mice (Kneussel et al. 2001) suggesting that this clustering 
might be independent of gephyrin.  It is likely that there are probably gephyrin-
dependent and -independent mechanisms for GABAAR clustering. 
Surface labelling by immunohistochemistry of gephyrin knockout mice indicates 
that gephyrin contributes in part to clustering, but not surface insertion or 
stabilisation, of GABAAR 2 and 2 subunits (Levi et al. 2004).  Danglot et al. 
(2003) argue that gephyrin is more involved in synaptic stabilisation rather than 
cluster formation; they found that GABAAR 2 subunit clusters were observed in all 
hippocampal neurones before 10DIV, even when gephyrin clusters were only 
detected in a few neurones.  
The gephyrin gene is highly mosaic (Prior et al. 1992) increasing the likelihood of  
splice variant generation which may go some way to explain the receptor 
selectivity on postsynaptic gephyrin. 
1.1.22 GABAA receptor trafficking 
Receptor ion channels, specialised for chemotransmission between neurones, are 
highly concentrated at postsynaptic densities apposed to the appropriate 
presynaptic nerve terminals.  GABAAR density and localisation at the postsynaptic 
cell membrane determines neuronal excitability and can be affected by many 
factors, including neuronal activity.  The trafficking of receptors at inhibitory 
synaptic sites is an important feature of neuronal plasticity.  During periods of 
neuronal plasticity and development, the numbers of GABAARs is subject to large 
alterations (Fritschy & Brunig 2003).  Insulin can increase the number of GABAAR 
at the cell surface, whilst brain derived neurotrophic factor (BDNF) decreases the 
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synaptic number (Wan et al. 1997; Brunig et al. 2001).  GABAARs are subject to 
continuous turnover: quick recovery and reinsertion of GABAARs that have been 
endocytosed or have been synthesised de novo and stored intracellularly allows 
the rapid adaptation of neural excitability (Luscher & Keller 2001).  Figure 1.3 
displays a simplified diagram of GABAAR trafficking and targeting at the synapse. 
 
Figure 1.3: A simplified diagram of GABAA receptor trafficking and targeting at the synapse.  
Subunits of the GABAA receptor are synthesised in the endoplasmic reticulum and assembled into 
heteropentameric structures, predominantly from ,  and  subunits, most likely with the ratio of 
2 :2 :1 .  Assembled receptors are then targeted by the Golgi apparatus to the plasma membrane, 
whilst unassembled subunits are degraded.  Receptors at the cell surface are localised to the 
synapse, or are targeted to clathrin coated pits and removed from the membrane by endocytosis. 
Receptors within the endosomes can be either recycled to the cell surface or degraded by the 
proteasome.  Diagram adapted from Barnes (2000). 
 
GABAAR assembly occurs in the endoplasmic reticulum (ER), and an investigation 
within HEK293 cells revealed that receptors require the 1 and 2 subunits for ER 
exit and cell surface expression, with the aid of chaperone proteins (Connolly et al. 
1996b).  The  subunit can also determine the route to the surface (Connolly et al. 
1996a).  In cerebellar granule cells, the 2 subunit confers synaptic localisation, 
Donna M McDade, 2007  Chapter 1, 52 
whilst the δ subunit targets extrasynaptic sites (Jones et al. 1997; Brickley et al. 
1999; Sassoe-Pognetto et al. 2000).  It is suggested that synaptic targeting of 
GABAAR relies on gephyrin as well (Essrich et al. 1998).  Some of the subunits 
also undergo alternate splicing, generating additional heterogeneity (Burt & 
Kamatchi 1991).  For instance, the short 2 subunit ( 2S) is able to reach the 
plasma membrane when expressed alone, but the long form ( 2L), which differs by 
8 amino acids, remains in the ER (Connolly et al. 1999a).  Either splice variant, 
when expressed with 1 and 2, is necessary for receptor endocytosis (Connolly 
et al. 1999b). 
Once a GABAAR has reached the synaptic membrane, and remained for the 
requisite amount of time, the receptor may be mono-ubiquitinated, and those 
composed of /  or / /  subunits are recruited to clathrin coated pits and 
internalised by dynamin dependent constitutive endocytosis (Chapell et al. 1998; 
Connolly et al. 1999a; Connolly et al. 1999b; Ghansah & Weiss 2001; van 
Rijnsoever et al. 2005).  The  and  GABAAR subunits interact with the  and  
adaptins; components of the AP2 complex that recruits proteins into the clathrin 
pits (Marsh & McMahon 1999; Kittler et al. 2000).  Once internalised, GABAAR are 
located to a subsynaptic intracellular pool that stains positively for gephyrin (van 
Rijnsoever et al. 2005).  Approximately 70% of receptors are then recycled to the 
cell surface, and the remainder are degraded (Connolly et al. 1999b;  Kittler et al. 
2004), a fate that may be decided by ubiquilin (Bedford et al. 2001).  The constant 
cycling of receptors between the cell membrane and internal structures has been 
shown by blocking endocytosis; after 20 to 40 minutes the mIPSC amplitude 
increases by 50-100% (Kittler et al. 2000), and the formation of intracellular 
receptor clusters is impaired (van Rijnsoever et al. 2005).  In addition, blocking the 
interaction between the AP2 complex and the  GABAAR subunit confers an 
increased cellular response to the application of GABA (Herring et al. 2003). 
In addition to impaired receptor localisation in gephyrin knockout mice compared 
to wildtype, an increased accumulation of intracellular GABAAR immunoreactive 
microclusters is observed, suggesting an enhanced receptor internalisation in the 
absence of gephyrin, and hence a defect in intracellular trafficking (Kneussel et al. 
1999a). 
Donna M McDade, 2007  Chapter 1, 53 
1.1.23 The ubiquitin-proteasome pathway  
Ubiquitin is a small 76 amino acid protein that exists in cells singly or covalently 
conjugated to other proteins. It may act as a sorting signal in early endosomes to 
target receptors and proteins for degradation by the lysosomal and proteasomal 
pathways.  
The ubiquitin proteasome system is the major non-lysosomal pathway in 
eukaryotes for cellular protein degradation.  A poly-ubiquitin chain formed from 
ubiquitin monomers is covalently attached to proteins targeted for destruction.  
The ubiquitylation process involves E1 (Ub-activating enzyme), E2 (Ub-
conjugating enzyme), and E3 (Ub-ligase) enzymes (Hershko & Ciechanover 1998; 
Voges et al. 1999; Glickman & Ciechanover 2002).  Ubiquitin is ATP-dependently 
activated by E1 forming a thioester bond between a cysteine residue and 
ubiquitin‘s C-terminal.  Ubiquitin is then conjugated to E2 which binds to E3 with 
the target protein.  Ubiquitin is attached from its c-terminus glycine to the protein, 
or previous ubiquitin, through the -amino group of a lysine residue (most 
commonly K48 of ubiquitin if creating a chain).  Proteins can also be ubiquitylated 
on the -amino group of the N-terminal residue (Glickman & Ciechanover 2002). 
E2 and E3 then lengthen the ubiquitin chain, sometimes with the help of E4, an 
accessory factor (Koegl et al. 1999).  These multi-ubiquitin tagged substrates are 
recognised and delivered to the 2.5 MDa proteasome holoenzyme, the 26S 
proteasome.  
The ubiquitin-26S proteasome degrades target proteins ATP-dependently into 
short polypeptides and recycled ubiquitin.  It is comprised of a 20S core chamber 
with a 19S regulatory cap, which can assemble at each end.  Poly-ubiquitylated 
proteins are first recognised by an interaction with the 19S regulatory complex, 
which then appears to unfold them and guide them through the 20S catalytic core 
for degradation (Glickman & Ciechanover 2002). 
The 19S regulatory particle is comprised of approximately 18 subunits, and forms 
two structures, a lid and a base.  Within the base are six homologous ATPases 
(Rpt1-6) which are probably responsible for protein unfolding and guidance 
through 20S, via a gated channel (Groll et al. 1997; Braun et al. 1999; Horwich et 
al. 1999).  The base also contains three non-ATPases, Rpn1/S2, Rpn2/S1 and 
Rpn10/S5a (where nomenclature is yeast/human).  Rpn10 serves to stabilise the 
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lid and base, and is the only known subunit that binds tightly to poly-ubiquitin 
chains, but not mono-ubiquitin (Deveraux et al. 1995; Takeuchi et al. 1999; 
Wilkinson et al. 2000).  However, Rpn1 and 2 may be additional polyubiquitin or 
UBL binding sites (Davy et al. 2001; Saeki et al. 2002).  The lid seems to be 
important for effective ubiquitinated protein degradation, although its purpose is 
unclear (Glickman et al. 1998), and consists of a further eight non-ATPases, Rpn3, 
-5, -6, -7, -8, -9, -11 and -12. 
The 20S core particle comprises two structural  protein rings, which surround two 
catalytic  protein rings.  The  subunits interact with the ATPases found in the 
19S base, effectively attaching the two 26S particles together (Davy et al. 2001; 
Fu et al. 2001).  The  subunits contain the proteolytic active sites with each  ring 
containing a post-glutamyl site, a tryptic site and importantly, a chymotryptic site.  
The chymotryptic site plays a key role as blocking the catalytic activity of this 
protein can block all of the proteasomal activity (Kisselev et al. 1999). 
The multiple conjugating enzymes regulate the number of ubiquitin molecules 
conjugated to a target protein (Ciechanover & Schwartz 1998) however; at least 4 
isopeptide-bonded ubiquitins are needed for recognition by 26S (Thrower et al. 
2000).  Additional cellular regulation can be exerted by the removal of ubiquitins by 
deconjugating proteins (D'Andrea & Pellman 1998).  Conjugation of less than 4 
isopeptide-bonded ubiquitins can be referred to as mono-ubiquitination, which is a 
reversible post-translational modification that may play a role in receptor 
endocytosis at the plasma membrane (Hicke & Dunn 2003). 
Many, but not all of the known functions of ubiquitin conjugation involve the 
targeted degradation of the modified protein, which in turn can control many 
processes like cell cycle progression, development and apoptosis.  Covalently 
attached ubiquitin to proteins can also be used as a post-translational modification 
that can be identified by downstream protein receptors/interactors in non-
degradation cellular processes, for example, DNA repair, transcription, signal 
transduction and sorting of receptors (Hershko & Ciechanover 1998). 
There is also a non-ubiquitin proteasomal pathway that will not be dealt with in this 
thesis. 
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1.1.24 Ubiquilin is an Ubiquitin-like protein 
A highly conserved feature between ubiquilin and its homologous proteins (dealt 
with in more detail in chapter 5) is the inclusion of the ubiquitin-like (UBL) domain 
at the N-terminal and ubiquitin-associated (UBA) domain positioned at the C-
terminal.  Both the UBA and UBL domains have been implicated in the targeting 
and degradation of proteins by the ubiquitin-proteasome pathways. 
UBA domains are commonly occurring sequence motifs, present in one or two 
copies in some members of the ubiquitination pathway including ubiquitin 
conjugating enzymes, ubiquitin-carrier proteins and ubiquitin carboxy-terminal 
hydrolases.  They are also present in UV excision repair proteins, DNA repair 
enzymes, signal transduction proteins and certain protein kinases (Hofmann & 
Bucher 1996).  Fifteen of the 40 core residues within the domain are highly 
conserved, suggesting they are critical in determining the overall structure 
(Hershko & Ciechanover 1998).  In ubiquilin, the UBA domain serves to bind poly 
ubiquitin chains in vitro suggesting that it blocks ubiquitin chain elongation in vivo 
(Massey et al. 2004). 
UBL proteins are designated either Type 1 or Type 2.  Type 1 UBL proteins can be 
covalently linked to target proteins in the same way as ubiquitin and may be 
implicated in post-transcriptional modifications.  Type 2 UBL proteins are not 
ligated to other proteins, and are not fully understood (Hershko & Ciechanover 
1998).  However, they may be involved in ubiquitin dependent proteolysis due to 
interactions with the proteasome (see below).  Ubiquilin is a type 2 UBL protein 
(Ko et al. 2002).  
1.1.25 Ubiquilin and the proteasome pathway 
There is much speculation that ubiquilin is involved in the ubiquitin-proteasome 
pathway.  Kleijnen et al. (2000) were the first to show direct evidence that ubiquilin 
associates with both proteasomes and ubiquitin ligases in large complexes.  
Ubiquilin was found to complex with E6AP, a human E3 ligase, and the 20S 
catalytic core of the proteasome. This interaction with the proteasome was via the 
UBL domain of ubiquilin.  In addition, overexpression of ubiquilin increased the 
protein levels of p53, a substrate of E6AP, and I B , a substrate of another E3 
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type ligase, TRCP.  Ubiquilin overexpression had no effect on ubiquitin-
independent proteasome substrates however.  
Ko et al. (2004) demonstrated that the UBA of ubiquilin interacts with poly-ubiquitin 
chains as overexpression of ubiquilin led to increased accumulation of large poly-
ubiquitin chains, compared to a mutant lacking a C-terminus.  They also found that 
the N-terminus UBL interacted with the 19S subunits Rpn3, Rpn10a and Rpn10e, 
but not Rpn1 or -2.  Dsk2 (a yeast homologue of ubiquilin) also binds to 
polyubiquitylated substrates through the UBA domain of the C-terminus, and to 
subunits of the 19S and 20S particles of the proteasome through the N-terminus 
(Funakoshi et al. 2002).  
1.1.26 Ubiquilin, the Proteasome and GABAARs 
Ubiquitination of neural surface receptors is generally regarded as a cellular signal 
for endocytosis of these proteins, allowing for rapid downregulation of receptors at 
the plasma membrane.  Altering the number of GABAARs present at postsynaptic 
sites would effectively alter the response to GABA. Therefore, constant receptor 
insertion into the plasma membrane would maintain the overall cell surface 
receptor number.  Dynamin dependent constitutive endocytic removal of GABAARs 
at synapses via clathrin coated pits requires the 2 subunit of GABAARS and the 
linker protein AP2 (Connolly et al. 1999a; Kittler et al. 2000).  However, membrane 
trafficking to replenish the synapse with either recycled or newly synthesised 
receptors at the membrane is poorly understood, and in the case of GABAARs it is 
unknown whether ubiquitination is a necessary requirement.   
Bedford et al. (2001) used a series of experiments to isolate ubiquilin, a novel 
binding partner of the majority of GABAAR  and  subunits, the most commonly 
expressed GABAAR subunits in the CNS.  They located ubiquilin to intracellular 
compartments including the golgi apparatus and clathrin-coated pits.  Utilising 
ELISA, they monitored the effect of introducing a synthetic peptide, which would 
compete for ubiquilin binding with the GABAARs.  This decreased the number of 
receptors at the cell surface without effecting receptor internalisation.  Conversely, 
overexpression of ubiquilin dramatically increased the number of receptors located 
on the cell surface.  The same effect was witnessed after treatment with a 
proteasome inhibitor in A293 cells expressing either 1 or 3 subunits.  Ubiquilin 
therefore could enable insertion of GABAARs into the synaptic membrane and 
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increase the half-life of receptor subunits.  These findings could implicate the 
ubiquitin proteasome pathway as a modulator of synaptic function and plasticity. 
1.1.27 Long Term Potentiation and the Proteasome 
In different brain regions, the subunit composition of the proteasome varies (Noda 
et al. 2000; Ding & Keller 2001) with the pyramidal neurones of the cerebral cortex 
and hippocampus showing the highest proteasome levels (Mengual et al. 1996).  
In hippocampal neurones, proteins of the proteasome complex are localised in the 
dendrites near synapses, whilst displaying a higher density in the soma (Ehlers 
2003; Rezvani et al. 2003; Bingol & Schuman 2006) which, circumstantially, 
implicates the proteasome in synaptic signalling.  Indeed, an emerging concept is 
that the regulated degradation of proteins by the ubiquitin proteasome pathway is 
an important modulator of synaptic function and plasticity.  However, the precise 
role of the proteasome in synaptic plasticity requires elucidation as published 
reports point to both a facilitatory and suppressive function. 
In the ubiquitin-dependent proteasome pathway, once a target protein has been 
ubiquitinated, it is delivered to the proteasome.  However, recent evidence has 
shown an interaction of proteasomes with proteins physically proximal to 
degradation targets, suggesting that the proteasome moves towards the target 
protein (Glickman & Raveh 2005).  A persistent redistribution of proteasomes from 
dendritic shafts to functionally active spines, minutes after synaptic stimulation by 
KCl, has been observed (Bingol & Schuman 2006).  APV blocked KCl-induced 
movements of 19S and 20S, indicating that NMDAR activation is required.  NMDA 
perfusion into a localised site revealed a spatially restricted increase in 
proteasomal activity, which led to an increase in protein degradation.  The long-
lasting effects suggest the involvement of the actin cytoskeleton, which was found 
to be associated with 50% of the proteasomes in dendrites.  In addition, 
proteasomes have been reported to associate with the cytoplasmic tails of 
receptor complexes (Ferrell et al. 2000), suggesting a capacity for rapid 
remodelling of membrane-associated receptor complexes and for local and 
persistent remodelling of spines through on-site coordinated synthesis and 
degradation of proteins (Burbea et al. 2002; Ehlers 2003; Colledge et al. 2003; Juo 
& Kaplan 2004; Yi & Ehlers 2005).   
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The late phase of most, if not all, forms of synaptic plasticity is dependent on 
enhanced protein synthesis (Morris 2004), and complementary to this, protein 
degradation has emerged as a mechanism to control synaptic protein composition 
(Colledge et al. 2003).  Proteasome inhibitors lead to deficits in LTP and attenuate 
learning and memory (Jiang et al. 1998; Chain et al. 1999; Foley et al. 2000), 
whereas compromised proteasome function has been linked to aging and memory 
impairment in humans (Keller et al. 2000).  Karpova et al. (2006) found that the 
use of Cbz-leu-leu-leucinal (MG132), a cell permeable peptide aldehyde 
proteasome inhibitor, blocked late phase LTP by reducing the magnitude of fEPSP 
slope potentiation, suggesting that late LTP specifically depends on proteasome 
activity.  In addition, induction of LTP dramatically accelerates the degradation of 
proteins in the presence of anisomycin, which blocks translational activity, 
compared to a non-LTP control.  This effect was reduced in the presence of 
MG132.  Using time-lapse imaging, Karpova et al. (2006) were able to show that 
proteasome mediated protein degradation was induced very quickly after 
tetanization of the Schaffer collateral CA1 synapses, consistent with the idea that 
fast proteasome-mediated degradation of scaffolding proteins occurs soon after 
tetanization.  In cultured hippocampal neurones, internalisation of the glutamate 
receptors GluR1 and GluR2, induced by AMPA, requires protein degradation via 
the proteasome system (Colledge et al. 2003; Patrick et al. 2003).  The 
proteasome system effects PKA and MAPK-dependent signalling pathways in the 
sensory neurone synapses of Aplysia (Chain et al. 1999). 
In contrast to the above evidence, published reports have shown that inhibition of 
proteasome activity facilitates various forms of plasticity; it augments neurite 
outgrowth, increases presynaptic neurotransmitter release and enhances 
postsynaptic glutamate receptor sensitivity, (Obin et al. 1999; Speese et al. 2003; 
Zhao et al. 2003) suggesting that the proteasome suppresses plasticity.  There 
seems to be no explanation for this discrepancy at present. 
1.1.28 Regulation of the neuronal proteasome by zif268 
The link between the proteasome and LTP has recently been strengthened further 
by the finding that zif268 regulates some component genes of the neuronal 
proteasome.  James et al. (2006) monitored proteasome activity in zif268 
transfected PC-12 cells, and found a significant decrease over time when 
compared to cells transfected with an N-terminal deletion mutant of zif268 as a 
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control.  The truncated (control) form of zif268 is efficiently translocated to the 
nucleus, but does not bind to the Egr DNA recognition site.  The zif268 mutant 
displays an inhibitory effect on wildtype zif268-dependent gene transcription 
through an unknown mechanism (Gosslar et al. 1999).  
James et al. (2006) also found that proteasome activity was significantly elevated 
in zif268 knockout mice compared to control mice.  In particular they investigated 
psmb9, an inducible proteolytic β subunit of the 20S core and psme2, an 
interferon-induced subunit of the 19S regulator; transcriptional expression of which 
increases proteasome activity in the immunoproteasome (Harris et al. 2001; 
Cascio et al. 2002).  In addition, they also looked at SGK, a proteasomal kinase 
that protects synaptic glutamate receptors from proteasomal degradation 
(Boehmer et al. 2003; Boehmer et al. 2004; Schniepp et al. 2004), and Tap1, a 
subunit of the proteasome-associated antigen peptide transporter (Tap) complex, 
whose targeted deletion contributes to deficits in synaptic plasticity in mice (Huh et 
al. 2000).  In a series of experiments, they determined that mRNA levels of all 4 
genes were downregulated in PC-12 cells after transfection of zif268, and 
overexpressed in zif268 knockout mice when compared to wildtype controls.  In 
addition they found that the promoter activities of psmb9, Tap1 and SGK were 
suppressed in zif268 transfected PC-12 cells, and that all 3 genes were affected in 
an in vivo model of synaptic plasticity: dopamine antagonist-induced plasticity in 
the striatum via haloperidol administration.  Interestingly, it was discovered that 
striatal zif268 induction was associated with downregulated psmb9 and Tap1 but 
upregulated SGK. 
These findings are the first to uncover the important role of zif268 in regulating the 
neuroproteasome and open an exciting and novel area of research. 
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1.2 Study Aims & Objectives 
The main aims of this study were as follows: 
 To upregulate zif268 in physiologically relevant conditions in order to 
investigate the induction of genes in response to cellular activation.  
 To extend the findings of James et al. (2005) and verify two of the known 
genes identified as downstream targets of zif268: gephyrin and ubiquilin. 
 To data mine the ESTs identified in the microarray experiment performed by 
James et al. (2005) to highlight areas of interest within the genome that have 
not yet been fully characterised. 
 To perform any necessary experimentation required to confirm suspected 
unknown transcripts that may to be regulated by zif268. 
 To theorise the downstream effects of LTP within the whole cell by monitoring 
the cellular actions of zif268 targets at synapses that are not activated by 
tetanically-induced glutamate. 
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2 Materials and Methods 
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2.1  Bioinformatics 
A selection of putative zif268 target EST (expressed sequence tag) genes were 
characterised using various bioinformatic tools.  In order to do this, EST nucleotide 
sequences were retrieved using the National Center for Biotechnology Information 
database (NCBI, Bethesda, MD, USA; http://www.ncbi.nlm.nih.gov/), and similarity 
searches of the sequences with the Rattus norvegicus genome were carried out 
using BLAST (Basic Local Alignment Tool) at Ensembl (www.ensembl.org).  A 3-
phase approach was used to catalogue and annotate these cDNA fragments.  
Firstly, a search was performed for any known gene located at the same 
chromosomal point.  Any EST not in the vicinity of an Ensembl known annotated 
gene, but within approximately 4kb to an Ensembl predicted or genscan gene 
(Burge & Karlin 1997) and/or several other ESTs was put forward for further 
investigation.  In the second phase, the relationship(s) of the gene predictions 
were examined using the orthologous sequences.  If a gene prediction had been 
derived from hypothetical data, and not from any known genes of any organism, it 
suggested that any findings in this area would be novel.  Thirdly, any area that was 
related to mental retardation in the comparable chromosomal area in Homo 
sapiens was of particular interest.  This approach gleaned 4 ESTs for further 
experimental study (using the PC-12 cell line and verifying in primary cortical 
neurones): AA998964, AI169020, AI112362 and AI176839.   
2.2  Cell Culture Preparation 
2.2.1 Primary dissociated cortical cell cultures 
All cell culture reagents were purchased from Invitrogen PLC, Paisley, UK unless 
otherwise stated.  Pregnant Wistar rats (300-400 g, gestation day 17-18 (E17-
E18)) were euthanized with an intraperitoneal injection of sodium pentobarbitone 
(Euthatal, Vericore Ltd., Dundee, UK) (1300 mg/kg).  Embryos were removed by 
Caesarean section; decapitated and placed in ice-cold Minimum Essential Media 
(MEM) supplemented with 5 g/mL penicillin-streptomycin.  Brains were separated 
from the crania and the cortex removed, minced and washed three times in ice-
cold MEM.  Thereafter, the cortical tissue was dissociated in 5 mLs of a 2.5% 
trypsin solution for 30 minutes at 37oC (in a 5% CO2 incubator).  The trypsin was 
inactivated by the addition of 5 mls foetal bovine serum (FBS), and the tissue 
washed, pelleted (500g for 2 minutes at 4 C) and mechanically dissociated by 
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trituration (through a sterile pasteur pipette) three times in ice-cold MEM.  The 
resulting dissociated neurones were re-suspended in Dulbecco‘s Modified Eagle‘s 
Media (DMEM, containing GlutaMAX  I and 4500 mg/L D-Glucose 
(supplemented with 20% FBS and 5 g/mL penicillin-streptomycin)) and seeded 
onto 6-well plates (Corning, Fisher Scientific, Loughborough, UK) or 8-well 
multichamber slides (Nunc, Fisher Scientific, Loughborough, UK), which had been 
previously coated with poly-D-lysine (4 g/mL) (Sigma-Aldrich, Dorset, UK) and 
mouse laminin (6 g/ L).  The neurones were incubated at 37oC in 5% CO2 for up 
to 48 hours, after which they were incubated in 2 mLs per well of Neurobasal  
media containing penicillin-streptomycin (5 g/mL) and 20% B27 serum-free 
supplement at 37oC in 5% CO2.  The Neurobasal  media was partially changed 
every 2 - 3 days until the primary cortical cultures were used for further study.  A 
residual 500 µL of media was left covering the cells during media changes in order 
to minimise cellular stress. 
2.2.2 PC-12 Cell Line 
The PC-12 rat pheochromocytoma cell line (CRL-1721™, American Type Culture 
Collection, VA, USA) was cultured in DMEM (containing GlutaMAX  I and 4500 
mg/L D-Glucose) supplemented with 10% heat-inactivated FBS and 5 g/mL 
penicillin-streptomycin (Invitrogen, Paisley, UK).  Cells were maintained in a 75 
cm2 cell culture flask at 37oC in 5% CO2, and passaged every 7 days using 
trypsin-EDTA (0.25% trypsin, 1 mM EDTA) (Invitrogen, Paisley, UK). 
2.3 In Vitro Culture Treatments 
2.3.1 NMDA Stimulation Time-course 
Primary cortical neurones were utilised at varying times in vitro depending on the 
assay.  For western blotting and RT-PCR procedures, primary neurone cultures 
were harvested at 7-10 DIV.  For immunocytochemistry, although technically very 
challenging, cells were used at 21 DIV.  At this developmental stage (21 DIV), the 
majority of gephyrin clusters are synaptic and a large proportion of these are 
associated with GABAARs (Danglot et al. 2003).  The neurones were seeded in 
either 8-well multichamber slides or 6-well plates and were treated with either 100 
µM N-methyl-D-aspartate (NMDA) in 20 mM KCl (added as 20 μL of a 10 mM 
NMDA in 2 M solution of KCl) dissolved in distilled water or a distilled water vehicle 
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for differing time periods.  The time-course involved cell stimulation for 3 hours, 6 
hours or 24 hours.  Treatment and control cells were always processed in parallel 
from a single culture.  Neurones were either fixed with formaldehyde (Fluka, 
Sigma-Aldrich, Dorset, UK) for immunofluorescence (see section 2.5), RNA 
extracted for RT-PCR (see section 2.4), or protein extracted for Western blotting 
(see section 2.6). 
2.3.2 Transient Transfection 
PC-12 cells, 72 hours after passage and seeded in either 6-well plates or 8-well 
multichamber slides, were pre-incubated for 2 hours in DMEM (containing 
GlutaMAX  I and 4500mg/L D-Glucose) supplemented with 10% heat-inactivated 
FBS and 50 ng/mL NGF-7S (Sigma-Aldrich, Dorset, UK).  This facilitated the 
differentiation of the cells into a neuronal-like cell type (Greene & Tischler 1976). 
The murine zif268 cDNA expression vectors, pzif268 and ptrzif268, have been 
described previously (James et al. 2005).  Both plasmids are based on the pCMV5 
(Genbank accession number AF239249) plasmid vector.  pzif268 expressed full 
length zif268, whereas ptrZif268 is an N-terminally deleted ( N3-372) version of 
zif268.   Separately, 2 g of endotoxin-free pzif268 plasmid or 2 g of ptrzif268 
DNA was added to PC-12 cells or primary cortical neurones when seeded in 6-well 
plates.  In 8-well multichamber slides, 0.5 g of the plasmid vectors was added.  
Cells were transiently transfected using the cationic lipid reagent Lipofectamine™ 
2000 (Invitrogen, Paisley, UK) (2 l per 1 g of DNA).  The required amounts of 
DNA and Lipofectamine™ 2000 were separately diluted in Opti-MEM® with 
GlutaMAX™ (Invitrogen, Paisley, UK) for 5 minutes at room temperature (RT).  
The diluted DNA and diluted Lipofectamine™ 2000 were then mixed together and 
incubated at RT for 20 minutes before addition to the wells.  The transfection 
efficiencies of primary neurones with Lipofectamine 2000 is reported at 20-30% 
(Dalby et al. 2004) and for PC-12 cells is 85% 
(http://www.invitrogen.com/Content/SFS/ProductNotes/F_Lipofectamine%202000b
-040923-RD-MKT-TL-HL050602.pdf).  PC-12 cells also received 2 M of the 
adenyl cyclase activator, forskolin, before all cells were incubated for 48 hours at 
37oC in 5% CO2.  James et al. (2005) discovered that forskolin was required in 
order for zif268 to transactivate target gene transcription in PC-12 cells. Neurones 
were either fixed for immunofluorescence (see section 2.5), RNA extracted for RT-
PCR (see section 2.4) or protein extracted for Western blotting (see section 2.6). 
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2.4 Reverse Transcriptase Polymerase Chain Reaction 
2.4.1 RNA Extraction 
The protocol for animal tissues in the RNeasy  Mini Kit (Qiagen, Crawley, UK) 
was utilised, and directions followed as per manufacturer‘s instructions.  For 
cultured neuronal (7-10 DIV) or PC-12 cells, the cell media was removed 
thoroughly from plated cells by washing with ice cold 0.1 M phosphate buffered 
saline (PBS) (Sigma-Aldrich, Dorset, UK), before covering with 600 l of lysing 
buffer RLT (containing -Mercaptoethanol ( -ME)).  Cells were immediately 
scraped into a BioPulveriser Tube, containing Lysing Matrix D, and homogenised 
using the Hybaid Ryboliser (Thermo Electron Corporation, Cheshire, UK).   
For whole tissue (see section 2.8.2, page 81), 30 mg of an adult female Wistar rat 
brain was removed, mechanically disrupted with a mortar and pestle containing 
600 l buffer RLT (containing -ME), then placed in a BioPulveriser Tube, 
containing Lysing Matrix D tube and homogenised using the Hybaid Ryboliser.  
For either preparation the resultant mixture was carefully removed, placed in a 
clean Eppendorf and 600 l of 70% ethanol added and mixed.  Samples were 
loaded onto RNeasy mini columns and centrifuged for 15 seconds at 9,000 g in a 
5804 R centrifuge (Eppendorf, Cambridge, UK).  This was followed by the addition 
of 700 l Buffer RW1, spun for 15 seconds at 9,000 g, then two times 500 l Buffer 
RPE (containing ethanol) was added, the first centrifuged for 15 seconds and the 
second for 2 minutes.  Elution was performed by placing the column in a fresh 
eppendorf with the addition of 30 l RNase-free water added to the membrane and 
the column spun for 1 minute at 9,000 g.  Samples were either then stored at –
20 C or used immediately to synthesise first strand cDNA. 
2.4.2 First Strand cDNA Synthesis 
First strand cDNA synthesis from total RNA was performed using the 
Superscript  First-Strand Synthesis System for RT-PCR (Invitrogen, Paisley, UK).  
Firstly, RNA samples were quantified using the RNA/DNA calculator GeneQuant 
(Pharmacia Biotech, Amersham, Buckinghamshire, UK).  cDNA was synthesised 
from 1 g or 500 ng of total RNA from PC-12 cells or primary neurones 
respectively.  RNA was placed in a DNase, RNase-free eppendorf tube with 1 L 
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10 mM dNTP (Deoxynucleotide-triphosphate) mix, 1 L random hexamers (50 
ng/ L) and DEPC-treated water up to 10 L.  Each sample was incubated at 65 C 
for 5 minutes and placed on ice.  Then, 2 L 10x RT (Reverse Transciptase) 
buffer, 4 L 25 mM Mg2Cl2, 2 L 0.1 M DTT (Dithiothreitol) and 1 L RnaseOUT  
Recombinant RNase Inhibitor was prepared, vortexed, added to each sample and 
controls and mixed thoroughly.  All samples and controls were incubated at 25 C 
for 2 minutes before the addition of 1 L SuperScript  II RT (50 U/ L) to each 
tube.  All tubes were mixed and incubated at 25 C for 10 minutes, 42 C for 50 
minutes followed by 15 minutes at 72 C, then placed on ice.  After the addition of 1 
L RNase H to each tube to degrade residual RNA, all samples were incubated at 
37 C for 20 minutes.  The resultant 20 L cDNA sample was then diluted with 80 
L DNase-free water. 
2.4.3 Amplification of Target DNA 
As an initial step, PCR tubes and equipment were UV irradiated for a minimum of 
10 minutes, denaturing any DNA present and therefore removing any possible 
contaminants.  Each tube was then filled with 18 L ultrapure water, 5 L 5x PCR 
buffer (500 L 10x PCR Buffer [containing Tris·Cl, KCl, (NH4)2SO4,15 mM MgCl2; 
pH 8.7 (Qiagen, Crawley, UK), 10 L each of 100 mM dATP, dTTP, dGTP, dCTP 
(Promega, Southampton, UK) and 460 L ultrapure water], 1.25 L 20 M 
appropriate primer (see table 2.5; section 2.11), 0.25 L HotStarTaq™ (5 U/ L) 
(Qiagen, Crawley, UK) and 0.5 L cDNA.  GAPDH was used as a steady state 
control for normalisation.  The PCR program employed involved an initial Taq 
activating step of 95 C for 15 minutes, followed by cycles of 94 C for 45 seconds 
(DNA denaturing), 60 C for 45 seconds (annealing of the primers to 
complementary DNA), and extension at 72 C for 1 minute.  The number of cycles 
was empirically determined for each DNA sequence of interest (detailed within 
table 2.6; section 2.11, page 89). 
2.4.4 Gel Electrophoresis & Analysis 
After the addition of 5 L Blue/Orange 6x Loading Buffer (Promega, Southampton, 
UK), samples were electrophoresed on 1.5% agarose (Roche Diagnostics, 
Sussex, UK) gels prepared with 0.5xTBE buffer (Invitrogen, Paisley, UK) and 1 L 
GelStar® Nucleic Acid Gel Stain (Cambrex, Berkshire, UK) per 10 mL gel.  
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Samples were typically electrophoresed at 100 V for 1 hour.  Images were 
captured with a GelCam, attached to a GH10 0.8x electrophoresis hood (BioRad, 
Hertfordshire, UK), or examined and processed using a MCID image analysis 
system (MCID 5, Canada).  In this paradigm we adjusted for variances by 
employing ANCOVA (analysis of co-variance), with GAPDH pixel intensity as the 
co-variate.  This statistical procedure is capable of measuring and removing the 
effects of pre-existing individual differences in samples, for example different 
efficiencies of mRNA extraction, cDNA synthesis and treatment. 
2.5 Immunocytochemistry 
2.5.1 Fixation & Staining 
Primary cortical cultured neurones, 21 DIV, were fixed using 4% formaldehyde 
(Fluka, Sigma-Aldrich, Dorset, UK) in 0.1 M PBS (see section 2.12.3) for 20 
minutes at 4oC.  After three washes with 0.1 M PBS, blocking serum (0.1 M PBS 
with 15% normal goat serum (Vector, Peterborough, UK)) was added to the cells 
for one hour at RT.  The blocking serum was removed, whereupon cells were 
immersed in a solution of 0.1 M PBS and 0.5% Triton-X100 (Sigma-Aldrich, 
Dorset, UK) containing 3% normal goat serum and either 1:100 mouse anti-
Gephyrin (Cat. No. 610585, BD Biosciences, Oxford, UK), 1:100 rabbit anti-
Ubiquilin (Cat. No. 662052, Calbiochem, Merck Biosciences, Nottingham, UK), 
1:100 mouse anti-GABAA receptor -chain (Cat. No. MAB341, Merck Biosciences, 
Nottingham, UK) or 1:200 rabbit anti-GABAA receptor 2 (Cat. No. AGA-005, 
Alomone Labs Ltd., Jerusalem, Israel) over night at 4oC.  
After washing the cells three times with 0.1M PBS, neurones were incubated for 
60 minutes at RT in the dark with either Alexa 594 goat anti-mouse or goat anti-
rabbit (Cat. No. A11032 and A11037 respectively, Molecular Probes, Invitrogen, 
Paisley, UK) diluted 1:100 with 0.1M PBS containing 5% normal goat serum.  
Following a further three washes with 0.1M PBS, the slides were left until almost 
dry before being preserved using the ProLong Antifade Kit (Molecular Probes, 
Invitrogen, Paisley, UK), which is specifically designed to protect fluorescence for 
long periods of time.  1 mL of component B (mounting medium) is added to a vial 
of component A (antifade reagent), mixed carefully and applied to the slide with 
the coverslip placed on top.  Once the mounting medium had dried overnight the 
coverslip was sealed with nail varnish and the slides stored at -20oC. 
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2.5.2 Confocal Microscopy, Image Analysis and Statistics 
A Bio-Rad MRC 1024 confocal microscope (Bio-Rad, Hertfordshire, UK) mounted 
on a Nikon microscope (Nikon, Surrey, UK), utilising LaserSharp 2000 software 
(Bio-Rad, Hertfordshire, UK), for image viewing was used to capture images.  The 
parameters for each set of images were uniform for the protein stained.  
Immunofluorescence was captured with a x40 oil immersion objective, box size 
1024 x 1024, x2.0 digitally zoomed, z-stack images with steps of 0.5-1.0μm and 
Kalman N=4.  Gephyrin and GABAA receptors were detected with the red laser 
power at 30, while ubiquilin was detected with a red laser power of 3 due to the 
intensity of staining.  All images were stacked using Confocal Assistant version 
4.02 (Freeware, Build 101, Todd Clark Brelje, University of Minnesota, USA), and 
analysed using Image J (Freeware, 1.34s, National Institute of Health, USA).  All 
results were analysed 'blind', without knowledge of the sample treatment.  The 
threshold for each individual z-stack was assessed, and set when background was 
at a minimum with diffuse staining throughout the cell.  Each neurite was then 
isolated and the particles counted, mean intensity of punctate staining determined, 
and the punctate and neurite areas measured.  Cell body puncta were not 
included in case results were skewed due to target protein variablilities in this area 
compared to neurites. 
2.6 Western Blot 
2.6.1 Sample Preparation 
Adherent PC-12 or primary cortical cultured cells (7-10 DIV) were initially washed 
with ice-cold 0.1 M PBS, then lysed with ice-cold RIPA buffer (see section 2.12.1), 
scraped into clean eppendorf tubes and agitated on ice for 15 minutes.  Cell 
extracts were centrifuged at 11,700 g for 15 minutes at 4oC, and the supernatants 
stored at -20oC. 
2.6.2 Assessment of Total Protein Content 
The Bradford (Bio-Rad) Protein Assay (Bradford 1976) was employed to 
determine the total protein concentration of each sample.  Duplicate standard 
solutions were created from a stock solution of 2.0 mg/mL BSA (see table 2.1) in 
order to create a standard curve.   
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Cortical neurone and PC-12 samples, defrosted and kept on ice, were mixed 
thoroughly before 10 L was removed and diluted with de-ionised water 1:100 and 
1:200 respectively.  Differing dilutions were used for the different cell types as PC-
12 cells were generally twice as confluent as the primary neurones.  Two aliquots 
of 400 L of either sample were then placed in a clean eppendorf tube.  Bio-Rad 
Protein Assay Dye Reagent Concentrate (Bio-Rad, Hertfordshire, UK) was allowed 
to reach room temperature then diluted 1:1 with de-ionised water.  200 L of the 
dye solution was added to each sample, mixed thoroughly, and allowed to 
incubate at room temperature for 5 minutes.  After vortexing again, 200 L of each 
duplicate standard and sample was pipetted into a 96 well plate, the absorbance 
read at 595 nm on an Opsys MR photometer (Dynex Technologies, West Sussex, 
UK), and protein concentration calculated by linear regression using Revelation™ 
QuickLINK software v4.03 (Dynex Technologies, West Sussex, UK).  A successful 
assay was determined by a straight-line generated from the standard solutions 
(where r2 ≥ 0.99), variations between the sample and standard duplicates was less 
than 20%, and all sample protein determinations fell within the set 0.0 - 2.0 mg/mL 
concentrations (i.e. protein concentration determination by extrapolated data was 
repeated).  All samples were then normalised, by dilution with lysis buffer, to the 
lowest registered protein concentration before continuing with further 
experimentation, or storing at -20oC. 
Tube BSA Volume 
( L) 
De-ionised Water 
Volume ( L) 
Final Concentration 
(mg/mL) 
A 0 400 0.00 
B 50 350 0.25 
C 100 300 0.50 
D 200 200 1.00 
E 300 100 1.50 
F 400 0 2.00 
Table 2.1 Protein Standards for the Bradford (Bio-Rad) Protein Assay 
2.6.3 NuPAGE® Bis-Tris Electrophoresis 
Instructions were followed as per the NuPAGE® Electrophoresis System 
instruction booklet (Invitrogen, Paisley, UK).  Each normalised sample was 
deforested on ice and prepared using 65 L normalised protein, 25 L NuPAGE  
LDS Sample Buffer and 10 l NuPAGE  Reducing Agent (0.5 M DTT) and heated 
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to 70oC for 10 minutes.  After loading 10 L of Full Range Rainbow recombinant 
protein molecular weight marker (RPN 800, Amersham Biosciences, 
Buckinghamshire, UK), equal amounts of total protein (20 L maximum) were 
loaded onto NuPAGE  pre-cast 4-12% Bis-Tris polyacrylamide gels housed in an 
XCell SureLock™ Mini-Cell (Invitrogen, Paisley, UK).  The gel was submerged in 
1x SDS NuPAGE  MOPS Running Buffer with 0.25% NuPAGE  Antioxidant 
within the inner buffer chamber (all NuPAGE  products, Invitrogen, Paisley, UK).  
The samples were then electrophoresed at 200 V using a PowerPac Basic™ 
power supply (Bio-Rad, Hertfordshire, UK) for 45 minutes if the protein of interest 
was less than 50 kDa, or 1 hour if the protein was more than 50 kDa. 
2.6.4 NuPAGE® Transfer 
After electrophoresis, the gel was transferred to an Invitrolon™ PVDF membrane, 
in a filter paper sandwich (Invitrogen, Paisley, UK).  All blotting pads and filter 
papers were initially soaked in 700mLs of a 1L solution made from 50mLs 
20xNuPAGE  Transfer buffer, 100mLs methanol, 1mL NuPAGE  Antioxidant and 
850mLs deionised water.  The PVDF membrane was placed in methanol before 
rinsing in the transfer buffer in order to improve antigen binding.  Next, the transfer 
blot was assembled within the cathode core by assembling 3 blotting pads, a filter 
paper, the gel, the PVDF membrane, a second filter paper and a further 3 blotting 
pads.  After ensuring no air bubbles were present between any of the layers, the 
anode core was placed on top, the blot module wedged into the XCell II™ Blot 
Module chamber (Invitrogen, Paisley, UK), and filled with the remaining 300 mLs 
of transfer buffer.  The outer chamber of the module was filled with deionised 
water and transfer was performed at 30 V using PowerPac Basic™ power supply 
(Bio-Rad, Hertfordshire, UK) for 45 minutes. 
2.6.5 Blot Efficiency Test 
A visual inspection of the membrane to ensure the uniformity of transfer, 
normalisation of proteins and accuracy of gel sample loading, was achieved by 
submerging the membranes in Ponceau S Solution (Sigma-Aldrich, Dorset, UK) 
immediately after transfer.  After 5 minutes the membrane was agitated in 
deionised water, and the transferred protein bands visualised and scrutinised.  If 
the bands appeared consistent, specifically within the expected size range of the 
protein, the membrane was briefly submerged in 0.1 M sodium hydroxide (BDH 
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Laboratory Supplies, Poole, UK), then placed in clean deionised water for a few 
minutes until the staining was removed. 
2.6.6 Immunodetection 
The membranes were blocked in 3% non-fat dried milk powder (Marvel, Premier 
International Foods (UK) Ltd., Lincolnshire, UK) for 2 hours, and then soaked in 
the appropriate primary antibody in 1% milk powder in T-TBS (see section 2.11.2 
for buffer ingredients).  Antibodies used, and their dilutions, were as follows: anti-
gephyrin, 1:500 (Cat. No. 610585, BD Biosciences, Oxford, UK), anti-ubiquilin, 
1:500 (Cat. No. 662052, Calbiochem, Merck Biosciences, Nottingham, UK), anti-
zif268 (Egr-1 (588)), 1:250 (Cat. No. sc-110, Santa Cruz Biotechnology, Calne, 
UK), rabbit anti-p70 S6 Kinase, 1:500, (Cat. No. 9202L), rabbit anti-p4E-BP1 
(Thr37/46), 1:1,000, (Cat. No. 9459L), mouse anti-pERK (p44/42 MAP Kinase; 
Thr202/Tyr204), 1:2,000, (Cat. No. 5120), rabbit anti-total ERK, 1:2,000 (Cat. No. 
9102) and rabbit anti-pCREB (Ser133), 1:250 (Cat. No. 9191), (all from Cell 
Signalling, Hertfordshire, UK).  Membranes were incubated with the antibody at 
4 C overnight before washing 3 times for 15 minutes in T-TBS, then placed in the 
appropriate secondary antibody, either peroxidase-conjugated AffiniPure anti-
mouse IgG 1:10,000 or anti-rabbit IgG 1:10,000 (Cat. No. 115-035-166 and 111-
035-144 respectively, Jackson Laboratories, Stratech, Suffolk, UK) for 1 hour with 
agitation at RT.  Thereafter, the membrane was washed 3 times for 15 minutes in 
T-TBS before covering with ECL plus Western Detection System (Amersham Plc, 
Buckinghamshire, UK) as per the manufacturer‘s instructions.  Briefly, after 
equilibrating to RT, 100 L of solution B was added to 4 mLs of solution A and 
placed on the membrane, protein side up, for 5 minutes at RT with agitation.  The 
exception was the zi268 antibody, which was probed with a goat anti-rabbit, HRP-
conjugate 1:10,000, and protein bands visualised with the Visualizer™ Western 
Blot Detection Kit (both from Upstate Signalling, Hampshire, UK).  The 
manufacturer‘s instructions were followed, combining Detection Reagent A and 
Detection Reagent B in a 1:2 ratio, allowing 3 mLs overall.  The solution was then 
allowed to equilibrate to RT before covering the membrane for 5 minutes with 
agitation. 
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2.6.7 Imaging 
The blot was developed using Hyperfilm™ ECL high performance 
chemiluminescence film and a HyperProcessor, automatic autoradiography film 
processor (both Amersham Plc, Buckinghamshire, UK).  Photographs of blots 
were taken using a Panasonic WV-BP500 camera (Berkshire, UK).  Film analysis 
was performed on a Macintosh computer using the public domain NIH Image 
program (developed at the U.S. National Institutes of Health and available on the 
Internet at http://rsb.info.nih.gov/nih-image/).  All measurements were performed 
by hand and reported by the NIH program.  Each lane density and area was 
measured three times for an average reading, the background density was 
subtracted from the lane density, and this value was multiplied by the area of the 
band.  For normalisation, each value was then transformed to a percentage of 
control. 
2.7  Promoter-Reporter Assay 
2.7.1 Gephyrin Promoter Primer Design 
The sequences for the gephyrin promoter primer pair were designed to target the 
cDNA sequence of Rattus norvegicus provided by NCBI and utilising information 
provided by Ramming et al. (1997).  The primers were designed using the 
sequence of the M. musculus gephyrin 5‘ untranslated region (UTR) (Genbank 
accession numbers Y10882 and Y10883).  The primers were predicted to flank a 
region of 882 base pairs of the mouse gephyrin UTR.  The primer pair sequences 
'Gephyrin Promoter Fwd' and 'Gephyrin Promoter Rev' are described in Table 2.5; 
see section 2.11. 
A second set of mouse gephyrin specific primers were designed to amplify, from 
the product of the first round PCR, the DNA sequence containing recognition 
sequences for restriction endonucleases subsequently used directionally to clone 
the gephyrin promoter into pBLCAT3 (a promoter-less CAT vector, Genbank 
accession number X64409).  Inspection of the pBLCAT3 plasmid map revealed 
adjacent SalI and XbaI restriction enzyme sites situated within the multiple cloning 
site (MCS) of the vector.  Neither of these restriction sites were predicted to be 
present within the sequence amplified during the first round of PCR amplification 
of the gephyrin 5‘ UTR. 
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The primer pair sequences, called 'Gephyrin Promoter Fwd SalI' and 'Gephyrin 
Promoter Rev XbaI', whereby bold letters denote the palindromic 6 base pair 
recognition sequences for the SalI and XbaI restriction enzymes, are shown in 
table 2.5; see section 2.11. 
2.7.2 Genomic DNA Isolation 
Total DNA was isolated from cultured PC-12 cells, using the DNeasy  Tissue 
Handbook (Qiagen, Crawley, UK), and the manufacturer‘s protocol followed.  
Briefly, PC-12 cells were rinsed in 0.1 M PBS before scraping from the wells in 
200 L of fresh 0.1 M PBS and placing into an eppendorf tube.  200 L Buffer AL 
and 20 L Proteinase K were added to the cell suspensions before mixing 
thoroughly by vortexing and heating at 70 C for 10 minutes.  200 L of 96-100% 
ethanol was then added, and the mixture applied to a DNeasy Mini Spin Column in 
a collection tube and centrifuged at 7,200 g for 1 minute.  The flow-through was 
discarded and 500 L Buffer AW1 added to the spin column, centrifuged at 7,200 
g for 1 minute and the flow through discarded again.  500 L Buffer AW2 was 
added, and the column centrifuged at 12,600 g for 3 minutes, before discarding 
the flow through.  The column was then placed in a clean fresh eppendorf tube 
and 200 L Buffer AE added to the membrane to elute the genomic DNA.  This 
was incubated at room temperature for 1 minute before centrifuging for 1 minute at 
7,200 g. 
2.7.3 Polymerase Chain Reaction (PCR) 
Two rounds of PCR were performed to prepare the gephyrin promoter for 
directional cloning into pBLCAT3.  In the first round the reaction contained 12.5 L 
DNase and RNase-free water, 5 L 5x PCR buffer, 3 L of PC-12 genomic DNA, 1 
L of an equimolar mixture of the forward and reverse primers (10 M of Gephyrin 
Promoter Fwd & 10 M Gephyrin Promoter Rev; see table 2.5), 0.5 L 50x dNTP 
mix, 2.5 L GC Melt and 0.5 L advantage-GC2 polymerase (BD Biosciences, 
Oxford, UK).  The PCR program employed was 94 C for 3 minutes followed by 30 
cycles of 94 C for 30 seconds, 68 C for 3 minutes with a final extension of 68 C 
for 3 minutes.  In order to validate the presence of a single amplicon at the 
predicted size, 5 L of the PCR reaction was co-electrophoresed on an ethidium 
bromide stained 0.5x TBE 1% agarose gel with 100 base pair markers (Promega, 
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Southampton, UK).  To remove unincorporated dNTPs and primers the remaining 
20 L of the reaction was PCR purified using Qiagen's PCR Purification Kit 
(Qiagen, Crawley, UK).  Instructions were followed as per the manufacturer‘s 
handbook.  Briefly, 100 L of buffer PB was added to the PCR sample mix (5 
volumes buffer to 1 volume sample) and the resulting mixture applied to a 
QIAquick column and centrifuged.  All centrifugation steps were carried out at 
11,700 g for 60 seconds.  The flow-through was discarded and the membrane 
washed with 750 L Buffer PE, centrifuged and the flow-through discarded.  After 
an additional spin the QIAquick column was placed in a fresh eppendorf tube and 
the DNA eluted from the column after centrifugation for 1 minute, with 50 l Buffer 
EB. 
The second round of PCR used the same PCR reaction mixture, but contained 3 
L of a dilute amount of the DNA synthesised during the first round of PCR.  An 
estimate of the concentration of template synthesised during the first round of PCR 
was determined using the DNA/RNA calculator, GeneQuant as previously 
described.  Subsequently, the PCR product was diluted to approximately 1 fg/ L 
and this solution used as a source of DNA template for a second round of PCR 
using an equimolar mixture of 10 M Gephyrin Promoter Fwd SalI & 10 M 
Gephyrin Promoter Rev XbaI primers (as detailed in table 2.5).  The PCR 
programme was repeated, and the resultant PCR product purified using the 
Qiagen PCR Purification Kit as before.  The purified DNA was quantified using 
GeneQuant as previously described. 
2.7.4 Restriction Endonuclease Digestion 
Separately, approximately 160 ng of the gephyrin 5‘UTR PCR product (the ‗insert‘) 
and 100 ng of pBLCAT (the ‗vector‘) were digested with the restriction 
endonucleases SalI and XbaI (Promega, Southampton, UK).  The recognition sites 
for these enzymes are 5‘-GTCGAC-3‘ and 5‘-TCTAGA-3‘ for SalI and XbaI 
respectively.  Digests (20 L) were performed in 1x Buffer D containing 
approximately 2 g acetylated bovine serum albumin (BSA) (both from Promega, 
Southampton, UK).  Digest mixtures were vortexed before incubating overnight at 
37 C, whereupon 4 l of 6x loading dye (Promega, Southampton, UK) was added 
to each eppendorf tube and mixed.  Both the ‗insert‘ and ‗vector‘ digests were 
electrophoresed on a 1% agarose 0.5x TBE buffer gel with 1 L GelStar® Nucleic 
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Acid Gel Stain (Cambrex, Berkshire, UK) per 10 mL gel, for 1 hour at 100 V.  The 
vector and insert products were excised from the gel, placed in the same 
eppendorf and purified using the QIAquick Gel Extraction Kit (Qiagen, Crawley, 
UK).  Instructions were followed as per the manufacturer‘s handbook.  Three 
volumes of Buffer QG were added to 1 volume of combined vector and insert gels 
before incubating at 50ºC for 10 minutes, with periodic vortexing.  One gel volume 
of isopropanol was then added, mixed and the sample placed in a QIAquick 
column.  After centrifuging at 11,700 g for 1 minute, 0.5 mL of Buffer QG was 
added to the column and centrifuged again at 11,700 g for 1 minute.  The column 
was washed with 0.75 mLs Buffer PE before centrifugation at 11,700 g for 1 
minute, the flow through discarded, and the centrifugation repeated.  The column 
was placed in a clean eppendorf tube and the DNA eluted with 50 L Buffer EB, 
incubated at room temperature for 1 minute and centrifuged for 1 minute at 11,700 
g. 
2.7.5 Ligation & Transformation 
The Quick Ligation  Kit (New England BioLabs Inc., Hertfordshire, UK) was 
utilised, and instructions followed from the manufacturer‘s directions.  10 L of 
2xQuick Ligation Buffer was added to 10 L of the combined vector and insert 
DNA sample and vortexed.  After the addition of I L of Quick T4 DNA Ligase the 
sample was incubated for 5 minutes at room temperature before placing on ice.  
One Shot® TOP10 Chemically Competent E.coli cells (Invitrogen, Paisley, UK), 
previously stored at –80 C were thawed and 50 L added to 2 L of the DNA 
sample and mixed.  The mixture was placed on ice for 30 minutes before heat 
shock at 42 C for 30 seconds.  250 L of room temperate S.O.C. media was then 
added and the mixture incubated for 1 hour at 37 C, shaking at 200 rpm.  After 
spreading 50 L of the sample on warmed imMedia™ ampicillin agar (Invitrogen, 
Paisley, UK) for recombinant E.coli strains, the plates were incubated overnight at 
37 C. 
2.7.6 Plasmid Purification 
Successful transformation of the E.coli cells with the gephyrin promoter was then 
determined.  Plasmid DNA was isolated from transformed TOP10 E.coli cells 
(Invitrogen, Paisley, UK), using QIAprep Miniprep columns and reagents (Qiagen, 
Crawley, UK).  The manufacturer‘s protocol was followed.  Briefly, cells were 
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pelleted by centrifugation and re-suspended in 250 L Buffer P1, then 250 L P2 
and inverted 6 times. Buffer N3 (350 L) was then added, and the tube inverted 6 
times gently before centrifuging at 11,700 g for 10 minutes.  All further 
centrifugation steps were also carried out at 11,700 g.  The supernatant was 
applied to the QIAprep® Spin Column and centrifuged for 60 seconds.  The 
column membrane was then washed with 0.5 mL of Buffer PB and centrifuged for 
60 seconds.  After the flow through had been discarded, the membrane was 
washed again using 0.75 mL Buffer PE and centrifuged for 60 seconds.  The flow 
through was discarded and the column centrifuged again to remove any additional 
wash buffer.  The QIAprep® column was then placed in a clean centrifuge tube.  
To elute the DNA, 50 L of Buffer EB was pipetted directly onto the membrane, 
incubated for 1 minute at room temperature and centrifuged for 1 minute.  From 
the resultant plasmid DNA sample, 5 L was digested with 0.2 L BSA Acetylated 
(10 mg/mL), 1 L SalI (10 U/ L), 1 L XbaI (10 U/ l), 2 L 10x Buffer D (All 
Promega, Southampton, UK), 10.8 L ultrapure water and incubated overnight at 
37 C.  The following day, 20 l of the restriction endonuclease digests were mixed 
with 4 L 6x loading buffer (Promega, Southampton, UK) and electrophoresed on 
a 1% agarose 0.5x TBE buffer gel with 1 L GelStar® Nucleic Acid Gel Stain 
(Cambrex, Berkshire, UK) to every 10 mL gel, for 1 hour at 100 V. 
2.7.7 Endotoxin-Free Plasmid Purification 
Endotoxin-free plasmid preparations were prepared using the EndoFree® Plasmid 
Maxi Kit (Qiagen, Crawley, UK), and the manufacturer‘s protocol followed.  Briefly, 
a single E.coli colony was used to inoculate a starter culture of 5mL imMedia™ 
ampicillin broth (Invitrogen, Paisley, UK).  After incubation for 8 hours at 37 C 
shaking at 200 rpm, 0.1 mL of this starter culture was diluted into 100 mL fresh 
imMedia™ ampicillin broth (Invitrogen, Paisley, UK) and incubated overnight at 
37 C vigorous shaking at 200rpm.  The next day, the cultures were centrifuged at 
4,500 g for 10 minutes at 4 C, after which the supernatant was removed and 
discarded.  The bacterial pellet was resuspended in 10 mLs Buffer P1 (containing 
100 g/mL RNase A) and 10 mLs Buffer P2, mixed by inverting 6 times and 
incubated at room temperature for 5 minutes.  The QIAfilter cartridge was 
assembled and placed in a clean 50 mL tube.  After incubation, ice cold Buffer P3 
was added to the lysate, inverted 6 times, poured into the cartridge and incubated 
at room temperature for 10 minutes.  After incubation, the plunger was inserted 
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into the cartridge and the lysate filtered. Buffer ER (2.5 mLs) was then added; the 
sample inverted 10 times and incubated on ice for 30 minutes.  Meanwhile, a 
QIAGEN-tip 500 was equilibrated with the addition of 10 mLs Buffer QBT, which 
then passed through the column by gravity.  After incubation, the sample was 
added to the equilibrated column and allowed to pass through by gravity.  The 
QIAGEN-tip was then washed twice with 30 mLs Buffer QC and finally eluted with 
15 mLs Buffer QN; all solutions were allowed to filter of their own accord.  DNA 
precipitation was achieved by the addition of 10.5 mLs room temperature 
isopropanol, which was then mixed and centrifuged immediately at 4,500 g for 1 
hour at 4 C.  The supernatant was discarded and the pelleted DNA washed with 5 
mLs of room temperature endotoxin-free 70% ethanol and centrifuged at 4,500 g 
for 30 minutes.  The resulting DNA pellet was carefully dried before re-dissolving 
in 100 L endotoxin-free Buffer TE.  The plasmid DNA concentration was then 
determined by GeneQuant. 
2.7.8 Co-Transfection  
PC-12 cells, seeded in 6 well plates, were pre-incubated with 50 ng/mL NGF-7S 
(Sigma-Aldrich, Dorset, UK) in DMEM (containing GlutaMAX  I and 4500 mg/L D-
Glucose) supplemented with 10% heat-inactivated FBS for 2 hours.  The test well 
then received 3.5 g of the cloned gephyrin promoter, 2 g of endotoxin-free 
pzif268 and 0.2 g of β-GAL cloned into a pCMV vector.  β-GAL was used to 
correct for variations in transfection efficiencies.  Four control wells were also 
transiently transfected; control 1 received 3.5 g of the cloned gephyrin promoter, 
2 g of endotoxin-free ptrzif268 and 0.2 g of β-GAL, control 2 received 3.5 g of 
the cloned gephyrin promoter, 2 g of pCMV5 empty vector and 0.2 g of β-GAL, 
control 3 received 3.5 g of the pBLCAT3 empty vector, 2 g of endotoxin-free 
pzif268 and 0.2 g of β-GAL and finally, control 4 received 3.5 g of the pBLCAT3 
empty vector, 2 g of pCMV5 empty vector and 0.2 g of β-GAL.  Transfection 
was achieved using 2 L of Lipofectamine™ 2000 (Invitrogen, Paisley, UK) per 1 
g DNA, and performed as per the previous description (see section 2.3.2).  The 
experiment was performed in duplicate with only one set of PC-12 cells receiving 2 
M forskolin to determine the different effects with and without the adenyl cyclase 
activator.  All wells were then incubated for 48 hours at 37oC in 5% CO2. 
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2.7.9 CAT & β-GAL Enzyme-Linked Immunosorbant Assay 
2.7.9.1 Sample Preparation 
Cells were washed 3 times in ice cold PBS before lysing with 1 part Lysis Buffer 
provided in the CAT & β-GAL ELISA kits (Roche Diagnostics, Sussex, UK) mixed 
with 4 parts ultra pure water.  To allow for co-transfection studies, the lysis buffer 
provided is optimised for full compatibility between CAT and β-GAL ELISA's.  
Firstly, 400 L of the buffer was added to each well and left to stand for 30 minutes 
at room temperature.  Cells were then scraped into an eppendorf tube and 
centrifuged at 12,600 g for 10 minutes at 4 C.  A 100 L aliquot of the supernatant 
was then removed and transferred to a clean eppendorf for protein determination.  
The remaining 300 L was transferred to a separate clean eppendorf tube and 
snap-frozen on dry ice before storage at -70 C. 
2.7.9.2 BCA (Bicinchoninic Acid) Protein Assay 
This copper-based assay was used to quantify the total amount of proteins found 
in each sample.  Directions were followed as per manufacturer‘s instructions 
(BCA™ Protein Assay Kit, Pierce, Northumberland, UK).  The instructions for the 
microplate procedure with 3 replicates of standards and samples were adhered to.  
Firstly, protein standards were prepared using the supplied 2.0 mg/mL BSA diluted 
with the same diluent as the samples; solution 8 of either the CAT or β-GAL ELISA 
kit (Roche Diagnostics, Sussex, UK) diluted 1 part to 5 parts ultra-pure water.  See 
table 2.2 for the dilution scheme of protein standards used to determine the 
standard curve. 
The BCA™ working reagent (WR) was then prepared using the following equation: 
(9 standards + # unknowns) x (3 replicates) x (200 l WR per sample) = total volume 
WR required 
Preparation of WR involved mixing 50 parts of BCA™ Reagent A to 1 part BCA™ 
Reagent B and vortexing.  25 L of each standard and pure undiluted sample was 
pipetted in triplicate into a 96 well plate before the addition of 200 L of WR to 
each well.  The plate was then mixed thoroughly on a shaker for 30 seconds after 
which it was incubated at 37 C for 30 minutes, and then allowed to cool to room 
temperature.  The absorbance was then measured at 595 nm with an Opsys MR 
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photometer (Dynex Technologies, West Sussex, UK), calculated by quadratic 
regression using Revelation QuickLINK software v4.03 (Dynex Technologies, 
West Sussex, UK) and all samples normalised. 
2.7.9.3 Preparation of CAT & β-GAL Enzyme Standards 
All ELISA kit solutions were equilibrated to room temperature before 
experimentation.  CAT and β-GAL enzyme standards were prepared as per the 
manufacturer's instructions (see table 2.3 and 2.4) before loading 200 L in 
duplicate of each standard into the wells of the microtitre plate (MTP) provided.  
200 L of the samples was then added to the CAT ELISA plate.  The remaining 
sample was diluted 1:5 and 200 L of the diluent added to the β-GAL ELISA plate. 
2.7.9.4 ELISA Assay 
Both MTP modules were covered and incubated at 37 C for 1 hour after which the 
solutions were removed and the wells rinsed with washing buffer.  The CAT ELISA 
wells were washed 5 times and the β-GAL wells 3 times for 30 seconds each.  200 
L of a freshly prepared solution of digoxigenin-labelled (DIG) CAT or β-GAL 
antibody, anti-CAT-DIG (2 g/mL) or anti-β-GAL-DIG (0.5 g/mL), was then 
applied to the respective MTP modules, covered and incubated at 37 C for 1 hour.  
The modules were washed as before, after which 200 L of a freshly prepared 
solution of an antibody to digoxigenin conjugated to peroxidase (POD), anti-DIG-
POD (150 mU/mL), was then applied to both MTP modules, before covering and 
incubation at 37 C for 1 hour.  Both MTP modules were then washed again as 
before.  The β-GAL module received 200 L of the peroxidase substrate ABTS to 
each well for approximately 5 minutes before being read on an MRX photometer 
(Dynex Technologies, West Sussex, UK) at 405 nm (reference wavelength 490 
nm) linked to Revelation™ software (Dynex Technologies, West Sussex, UK).  
The CAT module received 200 L of the peroxidase substrate ABTS including 
substrate enhancer for approximately 45 minutes with agitation.  The CAT ELISA 
module was then read on the same photometer. 
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Tube BSA Volume 
( L) 
Lysis Buffer Volume 
( L) 
Final Concentration 
( g/mL) 
A 300 of stock 0 2000 
B 375 of stock 125 1500 
C 325 of stock 325 1000 
D 175 of tube B 175 750 
E 325 of tube C 325 500 
F 325 of tube E 325 250 
G 325 of tube F 325 125 
H 100 of tube G 400 25 
I 0 400 0 
Table 2.2: Protein Standards for the BCA Protein Assay 
 
Step CAT Enzyme 
working dilution 
(approx. 1 ng/mL) 
Sample Buffer  Approx. CAT Enzyme 
concentration  
(ng/mL) 
0 0 1000 L 0 
1 1000 L 0 1.0 
2 500 L of Step 1 500 L 0.5 
3 500 L of Step 2 500 L 0.25 
4 500 L of Step 3 500 L 0.125 
Table 2.3: Standards for the CAT ELISA, used to produce a calibration curve for the CAT 
enzyme 
Step β-GAL Stock 
Solution  
(approx. 25 ng/mL) 
Sample Buffer Approx. β-GAL 
enzyme concentration 
(pg/mL) 
0 0 1000 L 0 
1 50 l 950 L 1250 
2 500 L of Step 1 500 L 625 
3 500 L of Step 2 500 L 312 
4 500 L of Step 3 500 L 156 
5 500 L of Step 4 500 L 78 
Table 2.4: Standards for the β-GAL ELISA, used to produce a calibration curve for the β-GAL 
enzyme 
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2.8 Identification of the Novel Gene related to EST AI169020 
2.8.1 Product Verification 
Bioinformatically, it was discovered that EST AI169020 could be associated with 
the predicted transcript ENSRNOT00000012253 (www.ensembl.org), located on 
chromosome 4 of Rattus norvegicus.  Therefore, exon-intron boundary spanning 
primers of this transcript were designed (designated Tr12253; see table 2.5; 
section 2.11). 
Differentiated PC-12 cells cDNA was used in a PCR reaction to validate the 
Tr12253 Fwd & Tr12253 Rev primers. In addition, the EST AI169020 Fwd primer 
was combined with the Tr12253 Fwd primer (as they were designed on 
complementary DNA strands) in order to verify that a single product could be 
produced.  The PCR reaction and PCR programme were performed as previous 
experiments (see section 2.4.3) with the AI169020 Fwd & AI169020 Rev primers, 
Tr12253 Fwd & Tr12253 Rev primers or Tr12253 Fwd & EST Ai169020 Fwd 
primers.  Two controls were also performed using 2 of the same sets of primers, 
but replacing PC-12 cDNA with ultrapure water.  Products were then separated on 
a 1.5% agarose gel as previously described (section 2.4.4). 
2.8.2 Product Generation and Sequencing 
The next stage involved verifying a single product with the Tr12253 Fwd & EST 
Ai169020 Fwd primers using adult Wistar rat cerebral cortex.  The RNA was 
extracted as previously described (section 2.4.1) and first strand cDNA synthesis 
achieved using Superscript  First-Strand Synthesis System for RT-PCR 
(Invitrogen, Paisley, UK).  After quantifying the total RNA present by GeneQuant, 
cDNA synthesis was performed using 1 L Oligo(dT)12-18 (0.5 g/ L), 1 L 10 mM 
dNTP mix and 8 L (1.37 g) RNA.  The suggested controls were also performed, 
namely No RT Control (No Superscript  II RT added in the later stage) and 
Control RNA (the supplied RNA was used instead of the primary cortical RNA).  
The sample and controls were incubated at 65 C for 5 minutes and placed on ice.  
2 L 10xRT buffer, 4 L 25mM Mg2Cl2, 2 L 0.1M DTT and 1 L RnaseOUT  
Recombinant RNase Inhibitor was then added to the sample and controls, mixed 
thoroughly and incubated at 42 C for 2 minutes.  After the addition of 1 L of 
SuperScript  II RT to the sample and Control RNA, but not to No RT Control, the 
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tubes were mixed gently and incubated at 42 C for 50 minutes followed by 15 
minutes at 72 C, then placed on ice.  1 L RNase H was added to each tube and 
all eppendorf tubes incubated at 37 C for 20 minutes.  cDNA samples were then 
quantified using the RNA/DNA calculator GeneQuant instrument. 
The sequencing was carried out by Geneservice (Cambridge, UK), who required 
10 L of 20 ng/ L concentration of purified product per reaction and 10 L of 3.2 
pmol/ L primers with a GC content of 50-55% and Tm 55-60 C.  To this end, the 
cDNA sample was diluted 1 in 5 with ultrapure water, and PCR performed with 
three eppendorf tubes containing 9 L adult rat cerebral cortical cDNA, 5 L 
5xPCR buffer, 1.25 L Tr12253 Fwd & EST AI169020 Fwd primers, 0.25 l 
HotStar Taq and 9.5 L dH2O.  In addition, extra PCR reactions were carried out 
using 9 L cDNA of the two controls, No RT Control and Control RNA.  The PCR 
programme was as previously described (section 2.4.3; 45 cycles), and the 
products electrophoresed on a 1.5% agarose as detailed in section 2.4.4.  The 
cDNA of the samples (not controls) were excised from the gel and separately 
purified using the QIAquick Gel Extraction Kit (Qiagen, Crawley, UK).  To ensure 
the required concentration and quantity of product was reached, 3 of the purified 
PCR reactions were combined.  Primers were designed bioinformatically using 
Ensembl (www.ensembl.org) utilising the predicted sequence of the novel gene 
ascertained from EST and predicted gene information, allowing the design of 3 
additional primers producing approximately 500 base pair product sizes with 
approximately 100 base overlaps (see table 2.5 for details). 
2.8.3 Novel Gene Cloning 
Once the sequence had been determined and returned from Geneservice, it was 
submitted to two websites predicting initiation codons and protein sequences 
(http://www.hri.co.jp/atgpr/ and http://ca.expasy.org/tools/dna.html), both of which 
returned the same data.  From this information, new primers were designed to 
flank the coding region in order to clone the novel gene sequence into the pCR®II-
TOPO® vector (Invitrogen, Paisley, UK). 
The primer sequences were designed to anneal upstream of the ATG start codon, 
but not to include the TAG stop codon, in order that any later cloning into tagged 
vectors would include any tag positioned downstream of the multiple cloning site.  
Primers amplified a product of 724 bases and are detailed in table 2.5.  The PCR 
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reaction was prepared as previously described (section 2.4.3) with 0.5 L purified 
cDNA from Wistar adult rat cortex.  The PCR programme (previously described in 
section 2.4.3; 30 cycles) was followed by sample electrophoresis on a 1% agarose 
gel (see section 2.4.4) at 100V for 1.5 hours, allowing full separation of bands.  
The 724 base pair band was then excised and purified using the QIAquick Gel 
Extraction Kit (Qiagen, Crawley, UK) as described in section 2.7.4.  
The TOPO TA Cloning® Version P manual was used to clone the novel gene 
insert into the pCR®II-TOPO vector.  4 L of purified PCR product was added to 
the provided 1 L Salt Solution and 1 L TOPO® vector (both Invitrogen, Paisley, 
UK), mixed gently and incubated at room temperature for 5 minutes, before 
placing on ice.  2 L of this reaction was then added to thawed One Shot® TOP10 
Chemically Competent E.Coli cells (Invitrogen, Paisley, UK), gently mixed and 
incubated on ice for 30 minutes.  After heat shock for 30 seconds at 42 C, 250 l 
of room temperate S.O.C. media was added and the mixture incubated for 2 hours 
at 37 C, shaking at 200 rpm.  75 L from the transformation was then spread on 
pre-warmed imMedia™ Kan agar (Invitrogen, Paisley, UK) and incubated 
overnight at 37 C.   
From the resultant transformants, 3 colonies were used to inoculate 5 mLs 
imMedia™ Kan broth (Invitrogen, Paisley, UK), placed on an orbital shaker at 200 
rpm, and incubated overnight at 37 C.  The plasmid DNA was then isolated and 
purified using the QIAprep® Miniprep Handbook for purification of plasmid DNA 
(Qiagen, Crawley, UK) as before (section 2.7.6).  To verify the clones contained 
the novel gene insert, the plasmid was digested with the endonuclease restriction 
enzyme EcoR1.  This involved 5 L plasmid DNA, 0.2 L BSA Acetylated (10 
mg/mL), 1 L EcoR1 (10 U/ L), 2 L 10x Buffer H (All Promega, Southampton, 
UK), 11.8 L ultrapure water incubated overnight at 37 C.  The following day, 20 
L of the digests were mixed with 4 L 6x loading buffer (Promega, Southampton, 
UK) and electrophoresed on a 1.5% agarose 0.5x TBE buffer gel for 1 hour at 
100V, then soaked in 5 L GelStar® Nucleic Acid Gel Stain (Cambrex, Berkshire, 
UK) per 50 mL 1x TBE buffer (Invitrogen, Paisley, UK). 
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2.9 Genotyping 
2.9.1 Purification of DNA from rodent tails 
Zif268 null mice are sterile, therefore breeding heterozygous zif268 mutant mice 
(donated by P. Charnay, Paris, France) provided mice with a targeted inactivation 
of the zif268 gene, as well as additional heterozygotes and wildtypes.  The 
DNeasy  Tissue Handbook provided the protocol for purifying total DNA from 
rodent tails, and the instructions followed.  Approximately 0.5 cm length of mouse-
tail, harvested at 4-6 weeks old, was placed in a centrifuge tube and fully covered 
with 180 L of Buffer ATL.  After the addition of 20 L proteinase K, tubes were 
vortexed to mix, and the tails incubated at 55 C on a rocking platform overnight.  
400 L of Buffer AL-ethanol mixture was then added and the sample thoroughly 
mixed.  To bind DNA, the sample was pipetted into a DNeasy Mini spin column 
with collection tube, centrifuged at 7,200 g for 1 minute and the flow-through 
discarded.  To wash the DNeasy membrane and bound DNA, 500 L of buffer 
AW1 followed by 500 L of buffer AW2 were added to the spin column, 
centrifuging at 7,200 g for 1 minute after buffer AW1, and for 3 minutes at 11,700 g 
after AW2.  The spin column was placed in a clean eppendorf tube and 200 L of 
Buffer AE pipetted directly onto the membrane.  After incubation for 1 minute at 
room temperature, the sample was centrifuged at 7,200 g for 1 minute.  The 
elutant containing the DNA was then removed from the eppendorf tube and placed 
back onto the membrane before centrifuging again. 
2.9.2 Polymerase Chain Reaction 
Firstly, all equipment was UV irradiated for 30 minutes.  Then, to each PCR tube 
was added: 5 L 5xPCR mixture, 1.25 L 100 M mix of zif268 forward and 
reverse primers including the LacZ forward (as described in Topilko et al. (1997), 
and detailed in table 2.5), 0.25 L HotStar Taq, 10 L mouse DNA and 8.5 L 
distilled water.  The PCR programme consisted of 35 cycles of 1 minute at 94 C, 2 
minutes at 55 C and 2 minutes at 72 C.  Samples were then separated on a 1.5% 
agarose gel as previously described (section 2.4.4). 
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2.10  In Situ Hybridisation 
2.10.1 Tissue preparation 
In this study, 11 knockouts and 11 wildtypes, matched for age and sex, were 
selected for experimentation.  Five each of the wildtypes and knockouts were 
treated with 1 mg/kg haloperidol (Sigma-Aldrich, Dorset, UK) (dissolved in 0.5% 
hydroxypropyl methyl cellulose (HPMC)) (Fisher Scientific, Loughborough, UK) 
intraperitoneally and 6 of each were treated with the same volume of 0.5% HPMC 
(vehicle).  All animals were humanely killed 6 hours after injection and according to 
UK Home Office guidelines governing the ethical use of animals.  The brains were 
removed and rapidly frozen on dry ice and stored at -80ºC.  20 m sections were 
cut on a cryostat through Bregma 1.00 mm and -0.40 mm, thaw-mounted onto 
frosted poly-L-lysine-coated slides and air-dried.  Sections were fixed in fresh, ice 
cold 4% paraformaldehyde in 1x PBS for 5 minutes.  Following a 3 minute rinse in 
DEPC-treated PBS, sections were transferred to 70% ethanol for 3 minutes and 
then stored in 95% ethanol at 4ºC. 
2.10.2 Preparation of probes 
DNA antisense oligonucleotide probes were designed to be complimentary to the 
mouse mRNA sequence of enkephalin as haloperidol has been shown to increase 
enkephalin and zif268 levels in the striatum (Morris et al. 1988).  The 
oligonucleotide sequence was: 
Enkephalin:  TGCATCCTTCTTCATGAAGCCGCCATACCTCTTGGCAAGGATCTC 
Homology analysis using BLASTn searches of the databases available through 
Ensembl (www.ensembl.org) identified no known mouse sequences to which this 
probe was likely to hybridise other than the desired mRNA sequence.  A working 
stock solution of 0.3 pmol/ L was made using TE buffer, and the concentration of 
this working solution checked by GeneQuant (Pharmacia Biotech, Amersham, 
Buckinghamshire, UK) as before.  Radioactive probes were made by end-labelling 
the oligonucleotides (MWG Biotech, Ebersberg, Germany) with [35S]dATP (Perkin 
Elmer, Buckinghamshire, UK) using terminal deoxynucleotidyl transferase (Roche 
Diagnostics, Sussex, UK).  This involved mixing 2 L of oligonucleotide with 2 L 
5x TdT Reaction buffer, 0.6 L 25mM CoCl2, 2 L DEPC-treated H2O and 2.5 L 
Donna M McDade, 2007  Chapter 2, 86 
[35S]dATP to an eppendorf tube, vortexing the solution and adding 2 L TdT 
enzyme (800 U/reaction).  This was mixed by pipetting and incubated on a heat 
block for 1 hour at 37ºC, after which 60 L DEPC-treated H2O was added.  To 
remove unincorporated nucleotides, the QIAquick Nucleotide Removal Kit 
(Qiagen, Crawley, UK) was utilised and the instructions followed as per the 
manufacturer‘s protocol.  Briefly, 467 L of buffer PN was added to the labelled 
oligonucleotide eppendorf tube and mixed.  The solution was then applied to a 
provided column and centrifuged at 5,400 g for 1 minute before the column was 
washed with 2 x 500 L buffer PE (including ethanol), centrifuging for 1 minute at 
5,400 g, then for 1 minute at 11,700 g after the second wash.  To elute the probe, 
the column was placed in an RNAse-free eppendorf tube, 100 L of buffer added 
to the column and then centrifuged for 1 minute at 11,700 g.  The labelled 
oligonucleotide was then counted on an LSA-2200 Liquid Scintillation Analyser 
(Perkin Elmer, Buckinghamshire, UK) to ensure a count range of 50,000 dpm/ L to 
200,000 dpm/ L, after which 1 L of 1M DTT (dithiothreitol) was added to 
preserve the probe from oxidation. 
2.10.3 Hybridisation 
Slides were removed from ethanol and allowed to air dry for up to 1 hour.  1.5 L 
of labelled oligonucleotide and 1.5 L of 1mM DTT were added to 150 l of 
hybridisation buffer (see 2.12.5), applied to the slides and covered with Parafilm® 
"M", laboratory film (American National Can™ Company, IL, USA) avoiding 
bubbles.  The slides were placed in a dish with a towel soaked in 4x SSC (see 
2.12.4) for humidity and incubated at 42oC overnight.  The next day slides were 
submerged in 1x SSC for 30 minutes at room temperature followed by 1x SSC at 
55oC for 30 minutes with agitation, before washing in 0.1x SSC, followed by 70% 
ethanol then 100% ethanol.  Slides were allowed to air dry for 30 minutes before 
exposing to BioMax MR Emulsion film (Kodak, London, UK) for approximately 1 
week.  Films were developed using a HyperProcessor, automatic autoradiography 
film processor (Amersham Plc, Buckinghamshire, UK).   
2.10.4 Imaging 
Photographs of sections were taken using a Panasonic WV-BP500 camera 
(Berkshire, UK).  Film analysis was performed on a Macintosh computer using the 
public domain NIH Image program. 
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2.11  PCR Primers and Cycle Details 
Each primer was designed to be exon-intron boundary spanning, except for 
GAPDH, in order to preclude genomic amplification from DNA.  Primers were also 
designed to have similar melting temperatures (Tm) of no more than 65 C and a 
GC (guanine and cytosine) content of approximately 40%-60%.  All the primers 
designed for use within this thesis are detailed in table 2.5. 
In order to obtain the maximum amount of information from the log linear phase of 
the RT-PCR reaction (described in section 2.4), the results from every second 
cycle number was utilised.  Three of the cycles were then used to create a straight 
line.  The novel gene PCR reaction was monitored over 3 consecutive cycles 
however, as the log linear phase was too short to monitor over 5 cycles.  The cycle 
numbers for each amplicon in each cell type examined are detailed in table 2.6. 
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Primer Name Sequence Orientation 
Section 2.4.3   
Ubiquilin Fwd: 5'-CTCGGTCCAGCAGTTCAAAGAGGAAAT-3' sense 
Ubiquilin Rev: 5'-TCCTCCAAGTCCACCTAAACCAAAGGAG-3' anti-sense 
Gephyrin Fwd: 5'-CTTGCTGCAAAGATTCCAGACTCCATC-3' sense 
Gephyrin Rev: 5'-CTCGCCCCATTCCATCTCGGTAAT-3' anti-sense 
EST AI169020 Fwd: 5'-CAAAATGAATTCAAATGACGCAACA-3' sense 
EST AI169020 Rev: 5'-ACTTTGTCGTAAGCTGCTTGGAATG-3' anti-sense 
EST AI176839 Fwd: 5'-CAAGAATAGACCAACACTGGCATCC-3' sense 
EST AI176839 Rev: 5'-GATATTCATTTGCAGATGGCTGGAC-3' anti-sense 
GAPDH Fwd: 5'-CCGCTGATGCCCCCATGTTTGTGAT-3' sense 
GAPDH Rev: 5'-GGCATGTCAGATCCACAACGGATAC-3' anti-sense 
Section 2.7.1   
Gephyrin Promoter Fwd:  5'-GTTCTGCCACCCATGCCGCTT-3' sense 
Gephyrin Promoter Rev:  5'-GATCATTCCCTCGGTCGCCATG-3' anti-sense 
Gephyrin Promoter Fwd SalI:  5‘-ATGTCGACGTTCTGCCACCCATG-3‘ sense 
Gephyrin Promoter Rev XbaI:  5‘-GTTCTAGAGATCATTCCCTCGGTCGC-3‘ anti-sense 
Section 2.8   
Tr12253 Fwd:  5'- AGACAATCGCGTGGCCTACATG -3'  sense 
Tr12253 Rev: 5'-GCTTTTTATCCTCCTCCTCAGAATCTG-3' anti-sense 
EST Ai169020 Fwd: 5'-CAAAATGAATTCAAATGACGCAACA-3'  sense 
Sequence 2:  5'-GGATCCAGATTCAGTTCCTG-3' sense 
Sequence 3:  5'-GCTCTTCACCGCTTTTCTTC-3' sense 
Sequence 4:  5'-TCCGGAGACTTATGGCAATG-3' sense 
Novel Gene Fwd:  5'-AGACAATCGCGTGGCCTACAT-3'  sense 
Novel Gene Rev:  5'-CGGCGAGTCTGAGCTTGAACT-3'  anti-sense 
Section 2.9   
Krox24 Fwd: 5'-GAGTGTGCCCTCAGTAGCTT-3' sense 
Krox24 Rev:  5'-GGTGCTCATAGGGTTGTTCGCT-3' anti-sense 
LacZ Rev:  5'-AACGACTGTCCTGGCCGTAACC-3' anti-sense 
Table 2.5: Details of all the primers designed for this thesis.  The table is split into relevant 
sections for ease of use and are detailed as described in the text. 
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Amplicon  Cell Type Cycle Number 
GAPDH PC-12 24 
 Primary Cortical Neurones 22-26 
 Adult Cerebral Cortex 25-29 
Gephyrin PC-12 30 
 Primary Cortical Neurones 30-34 
 Adult Cerebral Cortex 33-37 
Ubiquilin PC-12 25 
 Primary Cortical Neurones 28-32 
 Adult Cerebral Cortex 31-35 
AI176839 PC-12 30 
 Primary Cortical Neurones 32-36 
AI169020 PC-12 35 
Urma Primary Cortical Neurones 29-31 
 Adult Cerebral Cortex 30-34 
Table 2.6: Details of PCR cycle numbers monitored for each amplicon in each of the cell 
types examined. 
 
2.12  Solutions & Buffers 
2.12.1 Radioimmunoprecipitation (Ripa) Buffer 
 Concentration Quantity* Supplier 
Trizma Base 0.5 M 60 mg Sigma-Aldrich, Dorset, UK 
NaCl 0.15 M 87.6 mg BDH, VWR, Poole, UK 
Igepal 1% 100 L Sigma-Aldrich, Dorset, UK 
Triton 0.5% 50 L Sigma-Aldrich, Dorset, UK 
SDS 0.1% 10 mg BDH, VWR, Poole, UK 
Protease Inhibitor 
Cocktail 
 1 tablet Roche Diagnostics, Sussex, UK 
* Dissolved in 10 mLs de-ionised water.  Stored at 4 C.  pH 7.4 
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2.12.2 T-TBS 
 Concentration Quantity* Supplier 
NaCl 1 M 58.44 g BDH, VWR, Poole, UK 
Trizma Base 0.1 M 12.1 g Sigma-Aldrich, Dorset, UK 
* Dissolved in 1L de-ionised water.  10x stock solution.  pH 7.5.  Dilute 100 mLs in 1L de-
ionised water then add 0.5mLs Tween-20.  Stored at room temperature. 
2.12.3 10x PBS 
 Concentration Quantity* Supplier 
NaCl 1.3 M 75.79 g BDH, VWR, Poole, UK 
Na2HPO4 70m M 9.93 g BDH, VWR, Poole, UK 
NaH2PO4 30m M 4.68 g BDH, VWR, Poole, UK 
* Dissolved in 1L de-ionised water.  Filter, DEPC treat and autoclave.  Stored at room 
temperature. 
2.12.4 20x SSC 
 Concentration Quantity* Supplier 
NaCl 3 M 175.32 g BDH, VWR, Poole, UK 
Na Citrate 0.3 M 88.23 g BDH, VWR, Poole, UK 
* Dissolved in 1L de-ionised water.  Filter, DEPC treat and autoclave.  Stored at room 
temperature. 
2.12.5 Hybridisation Buffer 
 Concentration Quantity* Supplier 
Formamide 100% 25 mL Fluka, Sigma-Aldrich, Dorset, UK 
SSC 20x 10 mL See 2.11.4 
Na3PO4 0.5 M 2.5 mL BDH, VWR, Poole, UK 
Na4P2O7 0.1 M 0.5 mL BDH, VWR, Poole, UK 
Polyadenylic Acid 5 mg/mL 1 mL Sigma-Aldrich, Dorset, UK 
Dextran Sulfate  5 g Fisher Scientific, Loughborough, UK 
* Dissolved in 50mLs DEPC-treated water.  Stored at 4 C. 
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3 Induction of LTP-related Proteins in Cultured Cortical 
Neurones 
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3.1 Introduction 
Under experimental conditions, inducing LTP usually involves the maintenance of 
brain slices in a constant stream of artificial cerebrospinal fluid (aCSF) with 
continual oxygen perfusion whilst applying electrical LTP-inducing tetanic stimuli 
via capillary electrodes along neural pathways or across neuronal membranes.  In 
2001, a new and simple pharmacological methodology was developed that 
allowed the chemical induction of NMDAR-dependent LTP within murine cultured 
primary hippocampal neurones (Lu et al. 2001).  This involved the selective 
activation of synaptically located NMDARs, which are physiologically stimulated by 
glutamate release from presynaptic terminals.  This was achieved by applying an 
extracellular solution, which was similar to aCSF1 but contained an increased 
glucose concentration, presumably reflecting the increased glucose requirement of 
cultured neurones (typical glucose concentrations within culture media are 
approximately 20-30 mM).  Importantly, the extracellular solution contained no 
Mg2+, which is usually present at approximately 3 mM in aCSF, or at 1 mM for 
electrophysiological LTP inducing experimental paradigms (within Neurobasal™ 
culture media, this is 0.38 mM).  The extracellular solution did contain glycine, the 
co-agonist of NMDAR, with the addition of strychnine to block the activation of 
non-NMDA related glycine receptors, as well as other pharmacological agents 
(detailed in the methods).  This was reported as a significant advance over 
previous approaches.  For example, application of NMDA may not reliably produce 
LTP, possibly reflecting the activation of extra-synaptic NMDA receptors, which 
have been linked to LTD (Lu et al. 2001). 
Spontaneous miniature excitatory postsynaptic currents (mEPSCs) measured from 
single neurones can represent one or two quanta of transmitter release.  An 
increase in the amplitude of the mEPSCs can be indicative of LTP (Manabe et al. 
1992; Oliet et al. 1996).  Lu et al. (2001), and subsequently Man et al. (2003), 
found that a three minute application of glycine perfused with the extracellular 
solution, and then washed out, rapidly increased the amplitude and frequency of 
mEPSCs.  This phenomenon was eliminated when synaptic NMDARs, activated 
by the spontaneous release of glutamate, were selectively blocked by pre-treating 
cultures for 10 minutes with MK-801 (an open channel blocker of NMDAR 
                                         
 
1
 aCSF contains approximately (mM): NaCl, 120; NaHCO3, 26; KCl, 3; NaH2PO4, 1.25; Glucose, 
10; CaCl2, 2; and MgSO4, 1-3. 
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(MacDonald & Nowak 1990; Rosenmund et al. 1993)).  The subsequent 
application of glycine for 3 minutes then failed to enhance mEPSCs. 
Using the same method, but with an increased exposure to glycine of 15 minutes, 
Ehlers (2003) looked at changes in the post synaptic density (PSD) and protein 
turnover within cultured cortical synapses and the effects these had on CREB and 
ERK phosphorylation (pCREB and pERK respectively).  He found that activation of 
synaptic NMDARs with the application of the extracellular solution, including 200 
M glycine for 15 minutes, induced a 2 to 3 fold increase in induction of both 
CREB and ERK proteins when analysed by immunoblotting.  
ERK is significantly activated after glutamate treatment, NMDA treatment or high 
frequency stimulation sustained for 3 to 15 minutes and CREB is activated after 5 
to 15 minutes (Kurino et al. 1995; Iida et al. 2001; Liu et al. 1999; Sgambato et al. 
1998).  In 2003, Ehlers stimulated cultured rat hippocampal neurones (14 – 30 
DIV), for 15 minutes with glycine in order to allow phosphorylation of ERK and 
CREB, as measured by western blot. 
Arachadonic acid (AA) mimetics, such as ETYA, may also chemically induce LTP.  
LTP inducing tetanic stimulation of the hippocampal CA1 region induces the 
release of AA via the activation of ionotropic glutamate receptors and can alter 
synaptic transmission alone by increasing the slope of field excitatory postsynaptic 
potentials in a manner similar to LTP (Nishizaki et al. 1999).  In addition, AA has 
been shown to induce LTP in 0.1mM magnesium (Kato et al. 1991) and can 
increase the amplitude of EPSPs (Ramakers & Storm 2002).   
In the series of experiments presented in this chapter, an attempt was made to 
repeat and optimise the above protocols to permit the induction of LTP within 
cultured cortical neurones.  The basic paradigm involved the application of the 
extracellular (control) solution and the addition of glycine for 15 minutes, which 
was subsequently removed and the neurones harvested for immunoblotting to 
detect phosphorylation levels of CREB and ERK proteins.  The ability to produce 
neurochemical changes characteristic of LTP in cultured neurones would greatly 
facilitate studies into the mechanisms of late-phase LTP. 
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3.2 Aims and Objectives 
 Optimise the experimental protocol to suit available laboratory conditions. 
 Pharmacologically induce LTP in cultured primary cortical neurones. 
 Repeat the experiment described in Ehlers (2003) by measuring ERK and 
CREB phosphorylation levels during pharmacologically induced LTP. 
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3.3 Method Development 
3.3.1 Experiment 1: LTP in culture 
3.3.1.1  Control Salt Solution 
The following control salt solution was prepared using the description in Lu et al. 
(2001).  The solution is composed of, NaCl, KCl, Glucose and CaCl2, which are all 
present in aCSF.  In addition it contains HEPES, a buffer, strychnine, which blocks 
glycine receptors, bicuculline, a competitive antagonist of GABARs and TTX, 
which blocks voltage-gated sodium channels. 
 Concentration Quantity* Supplier 
NaCl 140mM 0.4g BDH, VWR, Poole, UK 
CaCl2 1.3mM 65μl
a Fisher Scientific, Loughborough, UK 
KCl 5mM 750μlb BDH, VWR, Poole, UK 
25mM HEPES 25mM 0.3g Sigma-Aldrich, Dorset, UK 
Glucose 33mM 0.3g Fisher Scientific, Loughborough, UK 
Strychnine 1μM 375μlc Fisher Scientific, Loughborough, UK 
Bicuculline 20μM 1mld Tocris, Avonmouth, UK 
Tetrodotoxin 0.5μM 7.5μle Tocris, Avonmouth, UK 
* Dissolved in 50mls de-ionised water.  Stored at 4 C. 
a of a 1M stock solution 
b of a 333.3mM stock solution (2.485g in 100mls de-ionised water) 
c of a 133μM stock solution (4.45mg in 100mls de-ionised water) 
d of a 1mM stock solution (25mg bicuculline in 4.9mls de-ionised water, diluted 
1:10 with de-ionised water) 
e of a 3.3mM stock solution 
3.3.1.2 Protocol 
As Ehlers (2003) used cultured primary cortical neurones at 14-30 DIV, we utilised 
primary cortical neurones of similar ages (15 - 25 DIV).  These were seeded in 3 
wells of a 6 well plate and denoted sample 1, 2 or 3.  Sample 1 received the 
control salt solution, sample 2 the LTP test and sample 3 an MK-801 control 
(figure 3.1).  Firstly, the Neurobasal  media (Invitrogen, Paisley, UK) was 
removed and replaced with 2 mLs control salt solution (detailed above in section 
3.3.1.1) for all samples.  Immediately thereafter, 10 μM MK-801 was added to 
sample 3 and the plate incubated at 37oC in 5% CO2 for 10 minutes.  After this 
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period, 200 μM glycine was added to the LTP test well (sample 2) and to the MK-
801 control (sample 3) and the plate incubated for 15 minutes at 37oC in 5% CO2.  
An additional culture plate was simultaneously stimulated and incubated for 2 
hours at 37oC in 5% CO2.  Samples were then harvested, the protein normalised 
and a western blot performed as per the western blotting procedure described in 
section 2.6 (including ponceau S staining to check for equal levels of total protein). 
 
Figure 3.1: Diagram of a stylised 6 well plate illustrating the conditions of LTP in cultured 
cortical neurone experiments.  Each plate contained a control (sample 1), LTP test (sample 2) 
and MK-801 control (sample 3) wells and the composition of each solution is detailed. 
3.3.1.3 Results 
In this first experiment, the published materials and methods in Ehlers (2003) 
provided the protocol.  A 15-minute 200 μM glycine stimulation in the presence of 
the control salt solution (which contained no Mg2+) was followed by a western blot 
to assess ERK 1/2 (p44/42 MAPK) dual phosphorylation at threonine 202 and 
tyrosine 204, as an indicator of LTP.  In addition, cultured neurones stimulated for 
2 hours were assessed for zif268 activation.  As can be seen in figure 3.2, there 
was no significant difference between pERK levels in control and LTP test 
samples.  There did seem to be an increase in pERK protein levels in cells pre-
treated for 10 minutes with MK-801, however.  Zif268 immunoreactivity was not 
affected by experimentation (see figure 3.2). 
3.3.2 Experiment 2: The effect of phosphatase inhibitor, okadaic acid, 
on LTP in culture 
Okadaic Acid is an inhibitor of protein phosphatase type-1 and type-2a, which de-
phosphorylate phosphoproteins (Haystead et al. 1989).  Protein phosphatases 
were therefore addressed as possible mediators of the unchanged phosphorylated 
proteins within this experimental paradigm.  The experiment was conducted in the 
same way as experiment 1 however, 100 nM of the phosphatase inhibitor, okadaic 
acid (Tocris Cookson Ltd., Avonmouth, UK), was added to each well at the same 
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time as the control salt solution.  The experiment then proceeded as previously 
detailed. 
3.3.2.1 Results 
Applying 100 nM okadaic acid to all samples before the addition of 200 μM glycine 
had no obvious effect on CREB phosphorylation at serine 133 or ERK 1/2 
phosphorylation in either controls (sample 1 and 3) or the test well (sample 2) 
(figure 3.3, n=2).   
 
 
 
Figure 3.2: Experiment 1 - LTP in culture.  Representative western blots of pERK and zif268 
immunoreactivity from cultured cortical neurones after sample 3 was pre-incubated with 10 μM MK-
801 for 10 minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes (for 
pERK) or 2 hours (for zif268), as described in experiment one.  Lanes displayed: Sample 1, control; 
Sample 2, LTP test; Sample 3, MK-801 control.   pERK, n=3, zif268, n=1. 
 
 
 
 
Figure 3.3: Experiment 2 – The effect of okadaic acid.  Representative western blots of pERK 
and pCREB immunoreactivity from cultured cortical neurones after all samples received 100 nM 
okadaic acid with the control solution.  Sample 3 was then pre-incubated with 10 μM MK-801 for 10 
minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes, as described 
in experiment 2. Lanes displayed: Sample 1, control; sample 2, LTP test; Sample 3, MK-801 
control. n=2. 
3.3.3 Experiment 3: The effect of phosphatase inhibitor, cantharidin, 
on LTP in culture 
This experiment was conducted as experiment 1, however, 0.38 mM Mg2+ was 
added to the control well (sample 1) with the addition of the control salt solution.  
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This served to lower the baseline of LTP-induced protein phosphorylation.  All 
subsequent experiments (i.e. experiments 4 to 10) included 0.38 mM Mg2+ in the 
control (sample 1) well.  Cantharidin (Tocris Cookson Ltd., Avonmouth, UK) (2 μM) 
an inhibitor of protein phosphatase 2a, was also applied to each well (sample 1, 2 
and 3).  The experiment then proceeded as before, with a 10 minute pre-
incubation period of 10 μM MK-801 for sample 3, followed by the addition of 200 
µM glycine to the LTP test and MK-801 control for 15 minutes before the samples 
were harvested for western blotting. 
3.3.3.1.1 Results 
In this experiment, total ERK (tERK) protein was also probed to confirm the 
normalisation of ERK protein in all experimental paradigms.  Overall, there was no 
apparent difference between pERK or pCREB protein levels in both controls and 
the test well (figure 3.4, n=2). 
 
 
 
 
Figure 3.4: Experiment 3 – the effect of cantharidin.  Representative western blots of tERK, 
pERK and pCREB immunoreactivity from cultured cortical neurones after treatment with 2 μM 
cantharidin with the control solution.  Sample 3 was then pre-incubated with 10 μM MK-801 for 10 
minutes followed by the addition of 200 μM glycine to samples 2 & 3 for 15 minutes, as described 
in experiment 3.  Lanes displayed: Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 
control. n=2. 
3.3.4 Experiment 4: The effect of osmolarity on LTP in culture 
Osmolarity refers to the total molar concentration of the solutes.  Rapid changes in 
extracellular osmolarity can have profound effects on cell homeostasis.  The 
published data from Invitrogen Plc (Paisley, UK) regarding the Neurobasal  
media, to which was added penicillin-streptomycin (5 g/mL) and 20% B27 serum-
free supplement, allowed the calculation of the overall osmolarity used in neuronal 
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cells maintenance to be approximately 210 – 250 mosmol-1.  The salt solution was 
325 – 345 mosmol-1 (Lu et al. 2001), requiring an adjustment period for the 
cultured cells in which the osmolarity could be raised and allow the cells to adapt.  
In order to increase the osmolarity of the media, 100 mM sucrose was added to 
the cultured primary cortical neurones overnight by removing the Neurobasal  
media from all the samples and replacing it with Neurobasal  media containing 
1.71g sucrose per 50mls media.  The next day, the experiment proceeded as per 
experiment 3, with the control salt solution application occurring immediately 
before the application of 2 μM cantharidin to all samples. 
3.3.4.1 Results 
The Neurobasal  media bathing the neurones was fortified with 100mM sucrose, 
and the cells incubated at 37oC in 5% CO2 overnight in order to raise the 
osmolarity of the extracellular solution.  The protein levels of pERK and pCREB 
remained unchanged in the LTP test well (sample 2) after raising the resting 
osmolarity of the media before treating with 2 μM cantharidin, when compared to 
both the control well (sample 1) and MK-801 control (sample 3), as determined by 
western blotting (figure 3.5, n=2). 
 
 
 
Figure 3.5: Experiment 4 – the effect of osmolarity on LTP in culture.  A representative 
western blot of pERK & pCREB immunoreactivity from cultured cortical neurones after increasing 
the osmolarity of the media and treating with 2 μM cantharidin and control solution simultaneously. 
Sample 3 was then pre-incubated with 10 μM MK-801 for 10 minutes followed by the addition of 
200 μM glycine to samples 2 & 3 for 15 minutes, as described in experiment 4. Lanes displayed: 
Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
3.3.5 Experiment 5: The effect of decreasing glycine cell solution 
bathing time on LTP in culture 
On the advice of Professor Mike Ehlers and Dr Mikyoung Park, (Howard Hughes 
Medical Institute, Duke University), the glycine bathing time was reduced.  
Therefore, as before, the Neurobasal  media for all cultured cortical neurones 
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was fortified with 100 mM sucrose the night prior to experimentation.  The next 
day, all neurones received the control solution and sample 1 also received 0.38 
mM Mg2+.  Then, 200 μM glycine was applied to samples 2 and 3, with the 
simultaneous addition of 10 μM MK-801 to sample 3, and cells incubated at 37oC 
in 5% CO2 for 3 minutes.  After this period, all solutions were removed.  
Immediately thereafter, fresh control solution was added to all samples.  Sample 1 
also received 0.38 mM Mg2+, sample 3 received 10 μM MK-801 and the plate was 
incubated for 12 minutes at 37oC in 5% CO2.  Samples were then harvested, the 
protein normalised and a western blot performed as per the western blotting 
procedure described in section 2.6. 
3.3.5.1 Result 
After direct contact with Professor Mike Ehlers and Dr Mikyoung Park, Howard 
Hughes Medical Institute, Duke University the protocol for inducing LTP was 
adjusted.  The addition of glycine for 3 minutes to the LTP test well had no 
significant effect on ERK protein phosphorylation compared to controls (see figure 
3.6, n=2).  CREB phosphorylation did seem to increase in the LTP test well 
compared to sample 1 control, however there was no obvious difference between 
the LTP test well and the MK801 control. 
 
 
 
 
Figure 3.6: Experiment 5 – the effect of decreased glycine cell bathing time.  Representative 
western blots of tERK, pERK and pCREB immunoreactivity from cultured cortical neurones after 
increasing the osmolarity of the media and treating with control solution in all samples with the 
addition of 0.38 mM Mg
2+
 to sample 1, 200 μM glycine to samples 2 & 3 and 10 μM MK-801 to 
sample 3 simultaneously for 3 minutes.  This was followed by the removal of all solutions and 
replacement of fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+
 to sample 
1 and 10 μM MK-801 to sample 3, as described in experiment 6.  Lanes displayed: Sample 1, 
control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
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3.3.6 Experiment 6: The effect of decreased glycine concentration on 
LTP in culture 
High concentrations of glycine could be counteractive to LTP induction (Lu et al. 
2001) and therefore the effects of a decreased glycine concentration were 
investigated.  This experiment was repeated as per experiment 5 however, only 50 
μM glycine was added to sample 2 (LTP test) and sample 3 (MK-801 control) wells 
for 3 minutes. 
3.3.6.1 Result 
The addition of 50 μM glycine to the LTP test well and MK-801 control well instead 
of 200 μM glycine had no effect on the level of activation of ERK protein as 
measured by dual phosphorylation at threonine 202 and tyrosine 204, as seen in 
figure 3.7 (n=2).  There was also no apparent difference in pERK protein 
phosphorylation levels between the sample 1 control and the LTP test well 
(sample 1). 
 
 
Figure 3.7: Experiment 6 – the effect of decreased glycine concentration.  Representative 
western blots of tERK and pERK immunoreactivity from cultured cortical neurones after increasing 
the osmolarity of the media and treating with control solution in all samples with the addition of 0.38 
mM Mg
2+
 to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to sample 3 
simultaneously for 3 minutes.  This was followed by the removal of all solutions and replacement of 
fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+
 to sample 1 and 10 μM 
MK-801 to sample 3, as described in experiment 7.  Lanes displayed: Sample 1, control; Sample 2, 
LTP test; Sample 3, MK-801 control. n=2. 
3.3.7 Experiment 7: The effect of decreased glycine concentrations 
with unchanged cell culture media osmolarity 
This was a repeat of experiment 6 using 50 μM glycine however, the Neurobasal  
media remained unchanged and was not fortified with sucrose the night prior to 
experimentation. 
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3.3.7.1 Result 
In this experiment, the media was not fortified with sucrose to elevate osmolarity in 
the wells of the cultured cortical neurones.  Applying 50 μM glycine for 3 minutes 
to samples 2 and 3 with the addition of the control solution has slightly decreased 
the level of phosphorylated ERK protein compared to the sample 1 control and 
MK-801 sample 3 control (see figure 3.8, n=2). 
 
 
 
 
Figure 3.8: Experiment 7 – the effect of decreased glycine concentration with unchanged 
cell culture media.   Representative western blots of tERK, pERK and pCREB immunoreactivity 
from cultured cortical neurones after treating with control solution in all samples with the addition of 
0.38 mM Mg
2+
 to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to sample 3 
simultaneously for 3 minutes.  This was followed by the removal of all solutions and replacement of 
fresh control solution to all 3 samples, with the addition of 0.38 mM Mg
2+
 to sample 1 and 10 μM 
MK-801 to sample 3, as described in experiment 8.  Lanes displayed: Sample 1, control; Sample 2, 
LTP test; Sample 3, MK-801 control. n=2. 
3.3.8 Experiment 8: The effect of ETYA on LTP in culture 
ETYA is an analogue of AA, which has been implicated in LTP induction.  We 
therefore investigated the effects of ETYA on levels of phospo-ERK protein levels 
in cultured cortical neurones.  Firstly, 100 mM sucrose was added to the cultured 
primary cortical neurones the night prior to experimentation.  The next day, sample 
1 received the control salt solution (fortified with 0.38 mM Mg2+), whilst sample 2 
and sample 3 received the control salt solution only.  Immediately thereafter, 200 
μM glycine was added to samples 2 and 3 and 5 μM ETYA (Alexis Biochemicals, 
Nottingham, UK), an AA analogue, applied to sample 3.  The plate was then 
incubated for 15 minutes at 37oC in 5% CO2, and the experiment completed as 
before. 
tERK 
pERK 
pCREB 
44kDa 
42kDa 
44kDa 
42kDa 
43kDa 
     Sample 1    Sample 2        Sample 3 
Control Solution:          +                 +     + 
Glycine:             _              +     + 
MK-801:             _              _     + 
 
Donna M McDade, 2007  Chapter 3, 103 
3.3.8.1 Result 
The addition of ETYA to sample 3 with the glycine application provided no 
observable differences between total ERK proteins and phosphorylated ERK 
proteins in the LTP test wells compared to both the sample 1 control and MK-801 
sample 3 control (see figure 3.9, n=2). 
 
 
Figure 3.9: Experiment 8 – the effect of ETYA on LTP in culture.  A representative western blot 
of tERK & pERK immunoreactivity from cultured cortical neurones after increasing the osmolarity of 
the media and treating the cells with the addition of 0.38 mM Mg
2+
 to sample 1, 200 μM glycine to 
samples 2 & 3 and 5 μM ETYA to sample 3 for 15 minutes, as described in experiment 9.  Lanes 
displayed: Sample 1, control; Sample 2, LTP test; Sample 3, LTP and ETYA test. n=2. 
3.3.9 Experiment 9: The effect of a modified salt solution on LTP in 
culture 
A new control solution was prepared which contained the original ingredients (see 
section 3.3.1.1), with the exception of TTX and bicuculline, in order to maximise 
any possible LTP-like activity.  The night prior to experimentation, the Neurobasal
 media was fortified with 100 mM sucrose and applied to all the sample wells 
containing cultured cortical neurones.  The next day the new control solution was 
applied to all samples with the simultaneous addition of 0.38 mM Mg2+ to sample 
1, 50 μM glycine to samples 2 and 3 and 10 μM MK-801 to sample 3.  All samples 
were then incubated at 37oC in 5% CO2 for 3 minutes.  After this period, the 
solutions were removed and fresh control solution added to all wells.  Sample 1 
then received 0.38 mM Mg2+, sample 3 received 10 μM MK-801 and the plate was 
incubated for 12 minutes at 37oC in 5% CO2.  Samples were harvested, the protein 
normalised and a western blot performed as per the western blotting procedure 
described in section 2.6. 
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3.3.9.1 Result 
Removing 0.5 μM TTX and 20 μM Bicuculline from the control solution and 
stimulating NMDAR with 200 μM glycine for 3 minutes simultaneously did not alter 
the phosphorylation state of ERK protein when compared to cells treated with the 
addition of MK-801 or cells that had not been exposed to glycine (see figure 3.10, 
n=2). 
 
 
Figure 3.10:  Experiment 10 – the effect of removing TTX and bicuculline from the LTP salt 
solution.  Representative western blots of tERK and pERK immunoreactivity from cultured cortical 
neurones after treating with control solution lacking TTX and Bicuculline in all samples with the 
addition of 0.38 mM Mg
2+
 to sample 1, 50 μM glycine to samples 2 & 3 and 10 μM MK-801 to 
sample 3 simultaneously for 3 minutes.  This was followed by the removal of all solutions and 
replacement of fresh control solution lacking TTX and Bicuculline to all 3 samples, with the addition 
of 0.38 mM Mg
2+
 to sample 1 and 10 μM MK-801 to sample 3, as described in experiment 10.  
Lanes displayed: Sample 1, control; Sample 2, LTP test; Sample 3, MK-801 control. n=2. 
3.3.10 Zif268 is NMDAR dependently upregulated in cultured 
cortical neurones 
In order to upregulate zif268 in a physiologically relevant paradigm, primary 
cortical neurones (10DIV) were stimulated with 100 μM NMDA.  In the first 
instance, neurones were treated with either (1) vehicle, (2) 100 μM NMDA in 
20mM KCl, (3) 10 µM MK-801, or (4) 100 μM NMDA in 20mM KCl and 10 µM MK-
801 for 6 hours (see figure 3.11, n=1).  Cytosolic proteins were then harvested and 
a western blot performed to visualise zif268 levels.  Basal levels of zif268 protein 
were not detectable in the vehicle treated sample.  After 6 hours, zif268 was not 
changed in the sample treated with MK-801 alone when compared to vehicle.  
There was a very small increase in zif268 protein levels in the sample treated with 
NMDA and MK-801, however, a noticeable increase was detected in the sample 
treated with 100 μM NMDA in 20mM KCl. 
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Figure 3.11:  Zif268 upregulation after NMDA stimulation.  A western blot of zif268 
immunoreactivity from cultured cortical neurons (10 DIV) treated for 6 hours with either (1) vehicle, 
(2) 100 µM NMDA in 20 mM KCl, (3) 10 µM MK-801, or (4) 100 µM NMDA in 20 mM KCl and 10 
µM MK-801. n=1. 
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3.4 Discussion 
In these experimental paradigms, the results obtained by others for the induction 
of LTP in cultured neurones could not be reproduced.  Lu et al. (2001) used the 
perfusing solution as a control, which contained the same components as the 
control solution used in the experiments contained within this thesis (apart from 
the addition of Mg2+ in experiments 4 - 10).  In Ehlers (2003), when measuring the 
phosphorylation of ERK and CREB, the control was the culture media alone (Dr 
Mikyoung Park, personal communication).  We observed no changes in 
phosphorylation states of ERK or CREB when compared to control in any of the 
experiments performed.  Lu et al. (2001) presented evidence that MK-801 pre-
treatment could block the induction of LTP within cultured cells however, there 
were no changes in the activation of ERK or CREB when treated with MK-801, 10 
minutes before or at the same time as glycine, compared to the LTP solution 
alone. 
In the first experiment an increase in pERK could only be seen by the addition of 
MK-801 to the cultured neurones.  This could be due to a problem with protein 
normalisation, as total ERK was not measured providing a measurable basal level 
of protein within the cells.  MK-801 blocks synaptic NMDARs; therefore it is 
possible to assume that non-synaptic NMDARs could be involved in the increased 
ERK activation relative to non-MK-801 treated cells.  However, both ERK and 
CREB are shut off by the activation of extrasynaptic NMDAR (Ivanov et al. 2006; 
Hardingham, 2006) and in Ehlers (2001) a separate solution is used to specifically 
activate these receptors, which includes CNQX (an AMPAR/kainate receptor 
antagonist), nifedipine (a calcium channel blocker) and 100 µM NMDA. 
All the experimental samples were maintained on ice from lysis to denaturation for 
western blotting.  This maintains a low temperature, causing phosphatase 
inhibition.  However, as there were no phosphatase inhibitors in the lysis buffer, 
we therefore addressed the possible problem of phosphatases by the addition of 
different compounds in the experimental paradigm.  Okadaic acid binds to and 
inhibits serine/threonine protein phosphatases, allowing the accumulation of 
phosphorylated substrates (Tachibana et al. 1981; Guy et al. 1992).  
Serine/threonine protein phosphatase type 1 (PP1) and protein phosphatase type 
2a (PP2a) are the dominant protein phosphatases acting on phosphoproteins 
(Haystead et al. 1989) and PP2a has been implicated in dephosphorylating ERK2 
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in vivo (Sontag et al. 1993).  Okadaic acid treatment of PC-12 cells has been 
shown to cause an increased phosphorylation of ERK (Miyasaka et al. 1990), in 
addition, evidence suggests that CREB can be regulated by PP1 (Hagiwara et al. 
1992; Alberts et al. 1994) and/or PP2 (Wadzinski et al. 1993; Wheat et al. 1994).  
Therefore, the addition of okadaic acid to all samples was an attempt to decrease 
any dephosphorylating actions of the phosphatases present in the cell extracts.  
However, as the results show, this approach was unsuccessful in allowing us to 
promote activation of either ERK or CREB in the LTP-inducing cultures when 
compared to controls. 
As a further attempt to address the possible effects of phosphatases acting on 
CREB and ERK phosphorylation states, cantharidin was added to cultures along 
with the control solution.  This protein phosphatase inhibitor, like okadaic acid, also 
suppresses the activities of both PP1 and PP2a (Honkanen 1993; Li et al. 1993b; 
Knapp et al. 1998).  As with previous experiments, the addition of cantharidin did 
not assist ERK and/or CREB protein phosphorylation in the LTP test samples.  
Any future experiments would probably benefit from the addition of phosphatase 
inhibitors in the RIPA buffer, rather than altering the experimental solution. 
An increased extracellular osmolarity causes decreases in cell volume and can 
cause neurotransmitter release (Basarsky et al. 1994).  Cell shrinkage can lead to 
changes in cellular functions by concentrating intracellular macromolecules, 
leading to increased macromolecular activity, and activation of membrane 
transporters (Parker & Colclasure 1992).  It can also lead to protein and glycogen 
inhibition as well as stimulating glycogenolysis and proteolysis, (whereas cell 
swelling has the opposite effect) (Haussinger et al. 1994).  The cellular 
homeostasis was maintained therefore by increasing the osmolarity of the cell 
culture media the night prior to experimentation, allowing the cells to adjust to 
environmental changes outwith the critical experimental time period.  Testing 
cellular responses to the LTP inducing solution with or without sucrose fortification 
of the cell culture media displayed no differences in ERK or CREB activation when 
compared to controls. 
Professor Mike Ehlers and Dr Mikyoung Park, (Howard Hughes Medical Institute, 
Duke University) advised that the control solution, glycine and MK-801 should be 
added to the wells simultaneously, as the addition of the control salt solution 
without the Mg2+ was already activating the synaptic NMDARs during the MK-801 
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preincubation.  They also recommended that the glycine activation should only be 
for a total of 3 minutes.  Incorporating these changes into the experimental 
procedure produced no differences in the phosphorylation of ERK or CREB 
between the control, MK-801 control or LTP samples.  There is a possibility that 
the pre-incubation of MK-801 is a necessary step for the effective blocking of 
NMDAR channels and therefore any further attempts may require the addition of 
MK-801 to the culture media 10 minutes before the addition of the control solution 
and glycine. 
Applying 200 µM of glycine to cells is a suprasaturating level (Lu et al. 2001), and 
it has been reported that saturating the NMDAR at the synapse will induce glycine-
primed endocytosis and therefore leave a lower number of receptors available to 
engage in LTP (Nong et al. 2003; Martina et al. 2004).  Therefore, we decided to 
decrease the glycine concentration to 50 µM to look at LTP induction within 
cultured cells.  This had no effect on the phosphorylated proteins involved in the 
LTP signalling pathway. 
ETYA (5,8,11,14-eicosatetraynoic acid) is a polyunsaturated fatty acid analogue of 
AA and current published results indicate that AA can facilitate LTP induction 
(Williams et al. 1989; Drapeau et al. 1990; O'Dell et al. 1991).  However, 
application of ETYA at a concentration sufficient to mimic AA actions (Ramakers & 
Storm 2002) did not elevate pERK or pCREB levels. 
The LTP inducing solution (control solution with the addition of glycine) contained 
strychnine to block glycine receptors.  In addition, it contained bicuculline, a 
competitive antagonist of, primarily, the ionotropic GABA receptors.  These would 
serve to limit inhibitory actions on the cell.  HEPES is an organic chemical buffer 
that maintains physiological pH and TTX selectively blocks voltage-gated sodium 
channels, therefore blocking the passage of action potentials.  TTX was removed 
from the solution in order to allow the passage of action potentials along the 
neurones and because of evidence that it could cause a large decrease in the 
levels of pERK (Chandler et al. 2001).  Bicuculline was also removed to reduce 
any excessive activity in control culture wells.  This produced no effect on the 
activation of ERK or CREB after the addition of glycine when compared to the non-
glycine control or MK-801 control.  
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The experiments described in the results section involved the manual removal and 
application of all solutions.  However, in Lu et al. (2001) each well was 
continuously superfused (1 mL/min) from a single barrel of a computer-controlled 
multibarreled perfusion system, with glycine supplementation applied from an 
alternate barrel.  This small, but significant, alteration could be a major factor in the 
failure of ERK and CREB phosphorylation.  There is a possibility that solutions 
were not entirely removed, leaving residual unwanted compounds within the wells.  
If they were indeed completely removed, this would lead to rapid homeostatic 
changes within the cells, and possibly oxygen and electrolyte starvation between 
solution changes.  In addition, cultured cortical neurones were utilised in this study 
rather than cultured hippocampal neurones in the literature.  However, the 
mechanisms of synaptic plasticity are believed to show extensive commonalities 
between the cortex and the hippocampus. 
English & Sweatt (1996), investigating the role of ERK in hippocampal LTP, found 
that p42 ERK, but not p44, is activated in area CA1 after direct activation of PKC 
and NMDAR, and after LTP inducing high frequency stimulation.  We found no 
evidence to support this within cultured cortical neurones. 
Zif268 protein levels were also unchanged by application of the LTP salt solution.  
Therefore, NMDA stimulation was used to induce zif268 in order to gauge 
downstream effects.  The caveat with this technique is that it causes changes not 
only to zif268, but also to many other genes, proteins and processes within the 
cells.  Nevertheless, it is a physiologically relevant paradigm and consistent with 
the NMDAR-dependent LTP involved in synaptic plasticity.  In order to show zif268 
induction, NMDA in KCl was applied to cultured cells and the results compared 
with several controls.  KCl was used to depolarise the cell in order to relieve the 
magnesium block within the NMDAR, which activated zif268 as detected by 
western blot.  This effect was attenuated with the addition of MK-801.  As 
additional controls, the effects of the experimental vehicle and MK-801 alone were 
separately analysed and were found not to induce zif268.  Therefore, NMDA 
activates a profusion of cellular targets, which also includes increasing zif268 
expression.  In this particular western blot the Visualiser system was used as it 
seemed to detect low levels of protein more effectively than ECL.  The zif268 
antibody is directed towards the C-terminal, and has been characterised and 
referenced for many years (Murphy et al. 2004; Thyss et al. 2005). 
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In summary, phosphorylation states of the ERK and CREB proteins did not differ 
from total ERK amounts or either of the controls suggesting that these proteins 
were not activated in any paradigms tested.  The results suggest that the 
described protocols, while possibly capable of inducing a short term facilitation of 
synaptic transmission, may not induce the pattern of change in signalling 
pathways that are characteristic of LTP in hippocampal or cortical tissue.  
However, NMDA and KCl treatment of cortical neurones in culture increases pERK 
levels (Rakhit et al. 2005) and pCREB levels (Conway & Morris, unpublished) in 
an MK-801 sensitive manner.  The evidence that zif268 levels are also increased 
(figure 3.12) suggests that exposure of cultured neurones to NMDA, in the 
presence of a mild depolarising agent such as 20 mM KCl, produces many of the 
biochemical changes associated with LTP.  NMDA application can induce LTP in 
the presence of ACPD, an mGluR agonist, which was APV dependent (Fujii et al. 
2003).  In addition, it can potentiate synaptic transmission in the hippocampus 
(Kauer et al. 1988; Broutman & Baudry 2001).  Lee et al (2001) found that a 3-
minute application of 20 μM NMDA induced LTD in the CA1, which was measured 
for 1 hour.  Broutman & Baudry (2001), describe a 5 minute 50 μM NMDA 
application initially inducing LTD, which then increases EPSP amplitudes above 
baseline after 1 hour.  Therefore, the duration of NMDA application, and 
subsequent measurement of activity, may be time sensitive for LTP induction.  
However, whether or not NMDA/KCl induces LTP, it appears to activate a 
plasticity-signalling pathway of ERK - CREB - zif268 and hence is of use to study 
events downstream of zif268 induction. 
 
 
111 
Chapter 4 
4 Gephyrin as a downstream target of zif268 
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4.1  Introduction  
Gephyrin (Prior et al. 1992) was originally identified as a peripheral membrane 
protein (Schmitt et al. 1987) and is a ubiquitously expressed 93 kDa receptor-
associated protein.  In mouse the gephyrin gene spans 457 kb, containing 30 
exons, and is located on chromosome 12D2.  In humans it is 668 kb with 27 exons 
located on chromosome 14q23.3 (Rees et al. 2003).  The gene encodes a protein 
containing an N-terminal G-domain, a C-terminal E-domain (which show high 
similarity to and are therefore named after, the E.Coli proteins MogA and MoeA 
respectively) and a proline-rich linker region in the centre.  The N-terminal domain 
forms a trimer and the C-terminal forms a dimer leading to the synaptic assembly 
of a gephyrin hexagonal submembrane lattice, onto which receptors are anchored 
(Kneussel & Betz 2000; Schwarz et al. 2001; Sola et al. 2001). 
4.1.1 Gephyrin Splice Variants 
Gephyrin is a highly mosaic gene due to the numerous exons in both mouse and 
human; many gephyrin gene variants have been identified.  Splicing occurs in all 
three domains with each domain containing at least 3 variable exons. Alternative 
splicing has been found to affect the functions of gephyrin in mouse, but not 
human, and is ideal for dealing with the diverse functional demands of this protein.   
In mouse there are ten exons that can be spliced out, denoted C1-C7 and C4 -C6  
(Paarmann et al. 2006).  The C7 cassette contains a stop codon (Sola et al. 2004) 
effectively truncating the protein at the C-terminus, interfering with the interaction 
of many of gephyrin‘s binding partners.  Nova proteins, neuronal regulators of pre-
mRNA splicing, control the C3 cassette in neurones (Ule et al. 2003), indicating 
the possible importance of C3 in the periphery.  The inclusion of C5  may interfere 
with GlyR anchoring in hippocampal and spinal cord neurones (Meier & Grantyn 
2004).  Cassette 1 does not produce detectable hybridisation results within rat 
adult and developing brains (Kirsch et al. 1993), suggesting little or no mRNA 
signals for this particular exon.  This evidence led to the avoidance of cassette 1 
when designing in situ hybridisation oligonucleotide probes for experimentation 
within this thesis. 
Alternative splicing may be tissue specific suggesting that gephyrin‘s function may 
be altered in each case.  For example, there are copious quantities of cassette C3 
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in the liver (Prior et al. 1992), whilst C5 seems more abundant in muscle than 
other tissues (Ramming et al. 2000). 
4.1.2 Regional & Cellular Distribution of Gephyrin 
Gephyrin and its variants are found in peripheral tissues in the heart, muscle, 
retina, testis, spleen, kidney, lung and liver, as well as in the central nervous 
system (Hermann et al. 2001; Prior et al. 1992). 
Immunoreactivity of gephyrin in the brain is widely distributed and can largely be 
found at its most intense in layers III, V and VI of the neocortex.  The hippocampal 
formation shows high levels of immunoreactivity, especially in the granule cell 
layer of the dentate gyrus.  The amygdaloid nuclei show varying amounts, while 
the thalamic nuclei show high to moderate amounts.  It is distributed 
heterogeneously throughout the medulla and shows intense labelling in the pons 
(Waldvogel et al. 2003). 
At a cellular level, gephyrin immunoreactivity is found on the plasma membrane of 
the soma and dendrites, probably representing postsynaptic sites.  
Immunoreactivity is also found intracellularly, presumably reflecting the 
intracellular localisation of recently formed protein, which is en route to receptor 
membrane sites (Waldvogel et al. 2003). 
4.1.3 The role of Gephyrin & Glycine Receptors 
Gephyrin co-purifies with the mammalian glycine receptors (GlyRs) found in rat 
spinal cord (Pfeiffer et al. 1982; Graham et al. 1985).  Gephyrin binds via its MoeA 
domain to an 18-amino-acid amphipathic sequence in the large intracellular loop 
connecting transmembrane segments 3 and 4 of the GlyR  subunit (Meyer et al. 
1995; Kneussel et al. 1999b).   As mentioned in the introduction, gephyrin seems 
to play a crucial role in the postsynaptic clustering of GlyRs and GABAARs, 
although information regarding the relationship between GABAARs and gephyrin 
can often be contradictory.  The role of gephyrin at glycinergic synapses can point 
towards a possible generalized mechanism for inhibitory receptor accumulation at 
synapses by gephyrin. 
Both GlyRs and GABAARs belong to a superfamily of ligand-gated ion channels 
that share common structural and functional features as well as similar 
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transmembrane topologies (Moss & Smart 2001; Schrader et al. 2004).  The GlyR 
is composed of the  and  subunits, 2 glycosylated integral membrane proteins 
which have a stoichiometry of either three  to two  subunits (Langosch et al. 
1988) or two  to three  subunits (Grudzinska et al. 2005).  Four genes encode 
the  subunits (GLRA1-4) together with a single  polypeptide gene (GLRB).  
GlyRs allow the passage of chloride ions through the central pore of the 
pentameric receptor formed by the M2 -helical segments of the individual 
subunits.  This hyperpolarizes the cell in mature neurones, thereby preventing 
action potentials.  Glycine is the major inhibitory neurotransmitter in the spinal cord 
and brainstem. 
Gephyrin binds to heteromeric GlyR with high affinity (Kirsch et al. 1995), and in 
cultured spinal neurones anchors and immobilises GlyRs on the subsynaptic 
cytoskeleton (Kirsch & Betz 1995) suggesting that gephyrin organises the 
development, localisation and clustering of GlyRs at inhibitory post-synaptic 
membrane specialisations (Kirsch et al. 1996).  It has been shown that the loss of 
gephyrin expression via antisense depletion of primary neurones (Kirsch et al. 
1993) or by gene knockout in mice (Feng et al. 1998), prevents the synaptic 
clustering of GlyRs.  Single expression of GlyR  (but not ) subunits targeted to 
intracellular gephyrin aggregates in HEK293 cells show that gephyrin binding is 
mediated by the  subunit (Kirsch et al. 1995).  In addition, the  subunit is 
responsible for receptor assembly and channel properties (Kirsch 2006). 
During embryonic development, gephyrin accumulates at spinal postsynaptic sites 
prior to the GlyR (Kirsch et al. 1993; Bechade et al. 1996), and promotes receptor 
clustering in an activity dependent manner (Kirsch & Betz 1998). It has been 
proposed that glycine induces calcium signals, triggering transmitter release in 
embryonic cultured neurones (Kirsch & Betz 1998).  This causes gephyrin to 
accumulate at the cytoplasmic face of nerve terminal-postsynaptic cell 
specialisations in spinal cord and other regions of the CNS (Triller et al. 1985; 
Altschuler et al. 1986).  Gephyrin binds with high affinity to polymerised tubulin 
(Kirsch et al. 1991) and microfilaments (Kirsch & Betz 1995; Giesemann et al. 
2003) as well as to the GlyR (Meyer et al 1995; Kneussel et al. 1999).  Gephyrin 
clusters could then trap GlyRs creating a postsynaptic GlyR matrix increasing 
gephyrin cluster size further, possibly by way of local cytoskeleton reorganisation.  
Extrasynaptic receptors from non-innervated plasma membrane would then be 
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removed.  Similar information regarding the accumulation of GABAARs and 
gephyrin at postsynaptic specialisations still requires clarification. 
In young cultured neurones (early DIV), spontaneous formation of gephyrin-GlyR 
clusters at non-innervated plasma domains are consistently observed (Kirsch & 
Betz 1995) (Levi et al. 1999).  However, these accumulations may precede 
gephyrin-dependent clustering, creating a two-step process (Meier et al. 2000b).  
In spinal interneurones, newly synthesised GlyRs diffuse in the plasma membrane 
as stable clusters (Rosenberg et al. 2001) and the interaction of GlyR with 
gephyrin increases its rate of accumulation at synapses. During development, 
gephyrin is associated with intracellular somatic and dendritic vesicles both in vitro 
and in vivo (Colin et al. 1996; Colin et al. 1998).  After partial glycine denervation, 
gephyrin is detected with vesicles in the area of the golgi apparatus (Seitanidou et 
al. 1992).  
Transfecting gephyrin-GFP reveals that many GlyR puncta are co-localised with 
gephyrin around the nucleus and throughout the cytoplasm in COS-7 cells and 
3DIV spinal cord neurones (Hanus et al. 2004).  This interaction alters the 
behaviour of intracellular aggregates of gephyrin-GFP-GlyR compared to 
aggregates of gephyrin-GFP alone.  When in the presence of the GlyR binding 
domain, aggregates are seen to move more rapidly, with a directed movement 
away from or toward the centre of the cell compared to the gephyrin-GFP 
aggregates.  It was also found that microtubule depolymerisation by 1 M 
nocodazole dramatically reduced the displacements of gephyrin-GFP aggregates 
associated with the binding domain, suggesting that they usually travel along the 
microtubules along the secretory pathway.  Movements of gephyrin-GFP 
aggregates were not affected.  Moreover, by using temperature changes to block 
GlyR in and then release it from the trans-golgi network, it was shown that 
gephyrin accelerates the accumulation of GlyR and increases the number of 
receptors at the plasma membrane of the soma, followed by the neurites.   
4.1.4 Additional functions of Gephyrin 
Homozygous disruption of the murine gephyrin gene is lethal at birth (Feng et al. 
1998), and autoimmunity to gephyrin has been reported in a patient with Stiff-Man 
Syndrome (SMS) (Butler et al. 2000).  In addition, gephyrin knockout mice display 
a loss of molybdenum coenzyme (MoCo) dependent enzyme activities in liver and 
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intestine and share the same phenotype as human hereditary hyperekplexia 
(Johnson et al. 1989), a neurological disorder caused by mutations to glycine 
receptors (Shiang et al. 1993; Rees et al. 1994; Rees et al. 2002) and MoCo 
deficiency (Reiss et al. 2001).  Gephyrin catalyses crucial steps in MoCo 
biosynthesis, specifically in the incorporation of molybdenum, which is important 
for the activity of different oxidoreductases (Johnson et al. 1989) and is a highly 
conserved process from bacteria to mammals.  There are significant sequence 
similarities between gephyrin and MoCo biosynthesis proteins from bacteria 
(Nohno et al. 1988), invertebrates (Kamdar et al. 1994) and plants (Stallmeyer et 
al. 1995).  Indeed, transfection of rat gephyrin has been shown to rescue the 
phenotype of MoCo biosynthesis mutants in E.Coli and plants (Stallmeyer et al. 
1999).  This is a novel non-neuronal catalytic function of gephyrin in intermediary 
metabolism that is not connected to synaptogenesis, and is a possible explanation 
for the ubiquitous expression and distinct splice variants of the gephyrin gene in all 
mammalian tissue (Prior et al. 1992). 
Gephyrin has also been found to interact with RAFT1, the rapamycin and FKBP12 
target protein (Sabatini et al. 1999).  This could regulate the subsynaptic 
translational machinery thought to initiate protein synthesis in dendritic 
subcompartments and will be dealt with in more depth in chapter 6. 
Overall there is considerable evidence that gephyrin is widely expressed and has 
the capacity to form many isoforms with distinct functions.  This may enable 
gephyrin to perform multiple functions in relation to synapse formation and 
maintenance.  As detailed previously, gephyrin is linked to the postsynaptic 
clustering of GlyRs as well as GABAARs and therefore may play a key role in 
inhibitory neurotransmission.  This chapter attempts to expand our knowledge of 
gephyrin with reference to synaptic plasticity and introduces this scaffolding 
protein as a novel downstream target of zif268.  
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4.2 Aims & Objectives 
 Identify and verify the presence of gephyrin within the PC-12 cell line. 
 Validate the original microarray experiment by transfecting PC-12 cells with 
full length or truncated zif268 and investigating any changes in gephyrin 
RNA and protein levels. 
 Extend the findings found in PC-12 cells by using primary cortical neurones 
stimulated with either NMDA or vehicle over 24 hours and investigating 
gephyrin expression at the RNA and protein levels. 
 Look at Gephyrin RNA and protein levels harvested from zif268 knockout 
and wildtype mice to investigate the effects of genetic manipulation. 
 Investigate whether gephyrin mRNA levels are altered after administration 
of haloperidol, which induces zif268 in striatal neurones, in wildtype mice 
and in mice with a targeted genetic deletion of zif268. 
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4.3 Results 
4.3.1 PC-12 cells stain positively for gephyrin 
Identification of gephyrin expression within the PC-12 cell line was achieved using 
immunocytochemistry on partially differentiated and undifferentiated cells using a 
mouse anti-gephyrin antibody. Secondary antibody staining alone was essentially 
used as a control to illustrate that there is no non-specific staining in cells treated 
with or untreated with nerve growth factor (figure 4.1 A & B).  There is a marked 
difference in cells probed with anti-gephyrin.  In undifferentiated cells, distinct 
puncta can be seen throughout the cytoplasm (figure 4.1C).  Nerve growth factor 
treated PC-12 cells show a neuronal-like shape with the appearance of processes.  
Gephyrin immunoreactivity can be seen throughout the cell and processes and 
displays stronger staining than undifferentiated PC-12 cells (figure 4.1D). 
4.3.2 Gephyrin is downregulated in PC-12 cells after transient 
transfection with zif268 
RT-PCR was performed using GAPDH primers and exon-intron spanning primers 
for gephyrin.  Gephyrin RNA was significantly downregulated after transient 
transfection of 1 μg/mL full-length zif268 cDNA in PC-12 cells pre-treated with 50 
ng/mL nerve growth factor when compared to cells transfected with 1 μg/mL of 
truncated zif268 cDNA (p<0.05, one sample t-test, n=5; see figure 4.2).  Gephyrin 
displays a decrease of 28% in RNA levels of PC-12 cells transfected with full-
length zif268 compared to controls. 
Figure 4.3 is a representative blot of a PVDF membrane stained with Ponceau S 
solution directly after protein transfer and immediately prior to blocking.  Uniformity 
of protein bands allowed the continuation of the western blot. 
Gephyrin protein levels display a significant downregulation of 7% in PC-12 cells 
transiently transfected with full-length zif268 compared to control (p<0.05, one-
tailed one sample t-test, n=6; see figure 4.4 A & B).   
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Figure 4.1: Confocal images of gephyrin in PC-12 cells. A, undifferentiated PC-12 cells stained 
only with 1:100 anti-mouse Alexa 594 secondary antibody. B, PC-12 cells pre-incubated for 2 hours 
with 50ng/mL NGF-7S and stained only with anti-mouse Alexa 594 secondary antibody. C, 
undifferentiated PC-12 cells stained with 1:100 anti-gephyrin and 1:100 anti-mouse Alexa 594. D: 
PC-12 cells pre-incubated for 2 hours with 50ng/mL NGF-7S and stained with 1:100 anti-gephyrin 
and 1:100 anti-mouse Alexa 594 secondary antibody.  Scale bar 15 m. 
4.3.3 Gephyrin is time-dependently downregulated in cultured cortical 
neurones after NMDA treatment 
As mentioned in Chapter 2, cultured cortical neurones prepared for western 
blotting and RT-PCR were 7-10 DIV.  Neurones treated immunocytochemically 
were 21 DIV.  It was reasoned that whole cell measures of gephyrin did not require 
localisation at the synapse, and therefore did not need to be aged for 21 days, 
which was technically very challenging.   
Throughout this thesis, three statistical tests are performed.  The one sample t-test 
is used when comparing treated PC-12 cells to control and analyses the mean 
value of the sample to a known value, which, in this thesis, is 100% (the control 
value).  In addition, the ANOVA was used when comparing primary neurones 
treated with NMDA for differing lengths of time.  This tests the analysis of variance 
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between groups and is preferable to performing numerous t-tests.  The ANCOVA 
is utilised when there is a shared covariate (in this case, GAPDH) and a control 
and treated group.  This compares two linear regressions and is a statistical 
control for the variability found in some reference genes (Bond et al. 2002). 
 
Figure 4.2: The effect of zif268 on gephyrin mRNA levels in PC-12 cells.  Graph comparing 
gephyrin mRNA levels from PC-12 cells transiently transfected with either truncated or full-length 
zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented as 
gephyrin normalised pixel intensity after normalisation to the corresponding GAPDH.  All data 
expressed as a mean percentage of control (mean signal after expression of truncated zif268)  
SEM, *p<0.05, one sample t-test, n=5. 
 
 
 
Figure 4.3: Representative image of a western blot of a PVDF membrane stained with 
Ponceau S solution directly after transfer.  This blot contains two lanes of cytosolic lysates from 
PC-12 cells transiently transfected with truncated zif268 (Tr) and two lanes of cytosolic lysates from 
PC-12 cells transiently transfected with full-length zif268 (Fl). 
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Figure 4.4: The effect of zif268 on gephyrin protein levels in PC-12 cells.  A, Representative 
western blot comparing gephyrin immunoreactivity in PC-12 cells transiently transfected with either 
truncated or full-length zif268. B, Graph comparing gephyrin protein levels from PC-12 cells 
transiently transfected with either truncated or full-length zif268 as determined by western blotting. 
Results are presented as gephyrin normalised pixel intensity. All data expressed as a mean 
percentage of control (mean signal after expression of truncated zif268)  SEM, *p<0.05, one-tailed 
one sample t-test, n=6. 
Gephyrin mRNA harvested from 6 hour NMDA stimulated primary neurones (7-10 
DIV) was significantly downregulated in the RT-PCR reaction when compared to 
neurones treated with vehicle for 6 hours (p<0.01, F (1,16) = 11.69, ANCOVA, 
n=4; see figure 4.5).  In contrast, at 24 hours gephyrin mRNA was not significantly 
altered in primary cortical neurones stimulated with NMDA compared to neurones 
stimulated with vehicle (p>0.05, F(1,15) = 1.84, n=4; figure 4.6).  It can be seen 
within the graph that the regression lines do not touch and that the 3 datasets 
(representing information taken at 3 different cycle numbers) are clearly defined.  
The log values have been used within the statistical analysis as this can decrease 
the variability found when comparing various arbitrary numbers (pixel intensity), 
without changing the relationship between the numbers. 
Utilising immunocytochemistry, an overall effect of NMDA stimulation was found 
on gephyrin immunoreactivity when compared to vehicle treated primary cultured 
cortical neurones (p<0.01 F(1,30) = 15.67, 3-way ANOVA (factors: time, treatment 
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zif268 
93kDa 
B 
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and culture), n=6; see figure 4.7).  In particular, gephyrin protein levels are 
downregulated when stimulated for 3 hours with NMDA, displaying 29.83% ± 8.39 
less immunoreactivity per square micron compared to vehicle-treated cells 
(p<0.05, Tukeys post hoc test).  Figure 4.8 shows representative images of 
neurones stimulated for 3 hours with either with 100 μM NMDA in 20 mM KCl or 
vehicle.  There was no overall effect of time (p = 0.283, F(2,30) = 1.32) and no 
interaction between treatment and time (p = 0.522, F(2,30) = 0.67).  For 
normalisation and resultant statistical analysis, the log value of pixel intensities 
was used.  For graphical representation all values are presented as percentages 
of control (vehicle treatment). 
Gephyrin protein levels determined by western blotting of cultured cortical 
neurones also show an overall effect of NMDA stimulation when compared to 
vehicle treated cells (p<0.01, F (1,23) = 28.12, 3-way ANOVA (factors: culture, 
time and treatment); see figure 4.9 A & B).  Specifically, there was a significant 
downregulation of gephyrin immunoreactivity of primary cortical neurones 
stimulated for 3 hours with 100μM NMDA in 20mM KCl showing 37.82% ± 10.19 of 
immunoreactivity compared to vehicle treated cells (p<0.01, Tukeys post hoc test).  
There was also an overall effect of the duration of NMDA stimulation compared to 
vehicle treated cells and a significant effect of the interaction between treatment 
and duration of treatment compared to control (p<0.01, F(2, 23) = 5.82 and 
p<0.05, F(2,23) = 4.20 respectively, 3-way ANOVA).   
4.3.4 Gephyrin RNA and protein levels are not effected in zif268 
knockout mice 
Figure 4.10 is a representative DNA genotyping agarose gel of wildtype, 
heterozygous, and zif268 knockout mice.  When genotyped, zif268+/+ mice show a 
wildtype allele of 362 base pairs, zif268+/- display the wildtype allele and a 
disrupted allele of 520 base pairs, whereas zif268-/- only have the disrupted allele 
present (Topilko et al. 1997).   
A comparison of mRNA levels of gephyrin from zif268 knockout and wildtype mice 
by RT-PCR show no significant differences (p>0.05 F(1,13) = 0.08, ANCOVA, 
wildtype, n=3, zif268 knockout, n=4; see figure 4.11).  In addition, comparing 
gephyrin immunoreactivity signal intensities from western blots extracted from 
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either wildtype or zif268 knockout mice also show no effects of a zif268-targeted 
deletion (see figure 4.12 A & B). 
 
Figure 4.5: The effect of 6 hours NMDA stimulation on gephyrin mRNA in cultured neurones.  
Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, determined 
by RT-PCR of primary cultured cortical neurones stimulated for 6h with either 100μM NMDA in 
20mM KCl or vehicle.  #p<0.01 F(1,16)=11.69, ANCOVA, n=4. 
 
 
Figure 4.6: The effect of 24 hours NMDA stimulation on gephyrin mRNA in cultured 
neurones. Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, 
as determined by RT-PCR of primary cultured cortical neurones stimulated for 24h with either 
100μM NMDA in 20mM KCl or vehicle. ANCOVA revealed no significant effect of NMDA treatment, 
p>0.05, F(1,15) = 1.84, n=4. 
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Figure 4.7: The effect of NMDA stimulation on gephyrin protein levels in cultured neurones.  
Graph illustrating the effect of treatment of 3, 6 or 24 hour stimulation of 100μM NMDA in 20mM 
KCl or vehicle on gephyrin immunoreactivity of 21 DIV primary cultured cortical neurones as 
detected by immunocytochemistry. Results are presented as the number of puncta measured per 
square micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells 
 SEM.  Effect of NMDA #p<0.01 F(1,30) = 15.67, 3-way ANOVA, *p<0.05, Tukeys post hoc test, 
n=6. 
 
 
 
Figure 4.8: Images of gephyrin within cultured neurones after 3 hours NMDA stimulation.  
Representative primary cultured cortical neurones (21 DIV) treated for 3 hours with vehicle (A) 
compared to those treated with 100 μM NMDA in 20 mM KCl (B), probed with anti-gephyrin and 
visualised with a confocal microscope as per the immunocytochemistry protocol.  When measuring 
the number of puncta, the particles present in the cell, visualised within a z-stacked image, were 
analysed by Image J, before the dendritic measurement area was defined and the number of 
puncta counted.  Scale bar 15 μm. 
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Figure 4.9: The effect of NMDA stimulation on gephyrin protein levels in cultured neurones 
by western blot.  A, Representative western blot of cultured cortical neurones stimulated with 
100μM NMDA in 2mM KCl or vehicle for either 3, 6 or 24 hours. B, Graph comparing gephyrin 
immunoreactive signal intensities from western blots of primary cortical neurones (7-10 DIV) 
stimulated for 3, 6 or 24 hours with 100μM NMDA in 20mM KCl or vehicle. Results are presented 
as normalised pixel intensity and expressed as a mean percentage of control (vehicle treatment)  
SEM.  Effect of NMDA #p<0.01, F (1,23) = 28.12, effect of time p<0.01, F(2, 23) = 5.82, interaction 
of treatment and time p<0.05, F(2,23) = 4.20, effect of culture p<0.01, F(5,23) = 18.58, 3-way 
ANOVA,  **p<0.01, Tukeys post hoc test, n=6. 
 
 
 
Figure 4.10: Representative image of genotyping results for the zif268 knockout colony. The 
wildtype allele is a 362 base pair band.  The disrupted allele is 520 base pairs long and is found in 
zif268 knockout mice.  Heterozygotes display both a wildtype and a disrupted allele.  WT = 
wildtype, HZ = heterozygote, KO = zif268 knockout mouse. 
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Figure 4.11: The effect of a zif268 targeted deletion on gephyrin mRNA in the adult cortex.  
Graph illustrating gephyrin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of adult cerebral cortex tissue from either wildtype or zif268 knockout mice.  
ANCOVA found no significant effect of zif268 targeted gene deletion, p>0.05 F(1,13) = 0.08.  
Wildtype, n=3, zif268 knockout, n=4. 
 
 
 
Figure 4.12: The effect of a zif268 targeted deletion on gephyrin protein levels in the adult 
cortex.  A, Representative western blot comparing gephyrin immunoreactivity in adult cortical 
tissue from wildtype and zif268 knockout mice. B, Graph comparing gephyrin immunoreactivity 
signal intensities from western blots of adult cerebral cortex tissue extracted from either wildtype or 
zif268 knockout mice. Results are presented as normalised pixel intensity and expressed as a 
mean percentage of control (wildtype tissue)  SEM.  Wildtype, n=5, zif268 knockout, n=3.  
Zif268 knockout Wildtype A 
B 
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4.3.5 Haloperidol administration to zif268 knockout and wildtype mice 
effectively induces enkephalin in the striatum 
Haloperidol administration in vivo increases glutamate release from corticostriatal 
terminals and produces LTP of corticostriatal transmission (Calabresi et al. 1997; 
Cepeda et al. 2001) by D2 receptor blockade.  This model of CNS plasticity also 
significantly increases zif268 and enkephalin within the striatum (Morris et al. 
1988; Nguyen et al. 1992; Simpson & Morris 1994; Keefe and Gerfen 1995; 
Cochran et al. 2002).  Haloperidol-induced responses within zif268 knockout mice 
were therefore measured indirectly by way of enkephalin mRNA levels.   
Enkephalin mRNA levels in the striatum were determined by 35S in situ 
hybridisation after intraperitoneal administration of 1 mg/kg haloperidol or vehicle 
in zif268 knockout or wildtype mice.  Figure 4.13A shows a representative image 
of enkephalin upregulation in the striatum.  Approximately 6 hours after treatment, 
no animals showed signs of catalepsy.  Enkephalin mRNA was significantly 
increased by 7% in all mice administered with haloperidol when compared to 
vehicle treated animals (p<0.01, F(1,17) = 10.70, 3-way ANOVA (factors: 
treatment, genotype and sex), haloperidol treated, female n = 4, male n = 6, 
vehicle treated, female n = 4; male n = 8, see figure 4.13B).  There was also a 
significant effect of sex (p<0.05, F(1,17) = 7.36, 3-way ANOVA; not shown).  There 
was no effect of genotype on the mRNA levels of enkephalin in the striatum 
(p>0.05, F(1,17) = 2.33, 3-way ANOVA).  
Gephyrin oligonucleotide 35S and 33P labelling was unfortunately unsuccessful 
within the time constraints of the PhD.  This, therefore, means that the gephyrin 
mRNA levels of wildtype and zif268 knockout throughout the brain after 
administration of haloperidol or vehicle will not be presented in this thesis. 
4.3.6 Zif268 interacts with the promoter region of the gephyrin gene in 
PC-12 cells 
A promoter reporter assay was performed to investigate the activity of the gephyrin 
promoter in response to increased zif268 levels.  This experiment involved cloning 
the gephyrin promoter into a vector expressing chloramphemiol acetyl transferase 
(CAT).  The CAT reporter construct was transiently co-transfected into PC-12 cells 
with plasmid vectors expressing either full length zif268 (pzif268) or a truncated 
version of zif268 (ptrzif268), allowing us to monitor the transactivity of zif268 acting 
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on putative cis-binding elements of the gephyrin promoter, thereby influencing 
gephyrin gene expression.  Cells were co-transfected with a -Gal expression 
vector to control for any variation in transfection efficiency.   
The murine gephyrin promoter (described in Ramming et al. (1997)) was used to 
perform a BLAST search of the Rattus norvegicus genome (www.ensembl.com).  
This had significant similarity to rat gephyrin RNA X66366, which then provided 
more of the 5‘ upstream sequence for the gephyrin promoter within rat.  Firstly, 
flanking promoters were designed, and a PCR reaction amplified the targeted 
gephyrin promoter from genomic DNA.  This produced the predicted amplicon of 
approximately 882 base pairs.   
 
 
Figure 4.13: The effect of haloperidol on enkephalin mRNA in the striatum of zif268 
knockout and wildtype mice.  A, Localisation of enkephalin mRNA by in situ hybridisation in 
wildtype mouse brain - coronal section at striatal level.  B, Graph illustrating the effect of 1 mg/kg 
haloperidol administration to zif268 knockout and wildtype mice on enkephalin mRNA levels in the 
striatum compared with vehicle administration as detected by in situ hybridisation. Results are 
expressed as mean pixel intensity  SEM.  Effect of haloperidol treatment **p<0.01, F(1,17) = 
10.70, effect of sex p<0.05, F(1,17) = 7.36, 3-way ANOVA.  No significant effect was found for 
genotype p>0.05, F(1,17) = 2.33.  Haloperidol, n= 10 (wildtype, n= 5, zif268 knockout n= 5), 
vehicle, n= 12 (wildtype, n= 6, zif268 knockout, n= 6).  
Using the PCR product as a DNA pool for the second round of PCR, primers, 
containing restriction endonuclease recognition sites, were used to generate DNA 
strands containing both the gephyrin promoter and digestion sites for future 
Striatum 
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directional ligation with the vector.  pBLCAT3 is a promoter-less vector allowing a 
synthetically inserted non-native promoter to drive transcription (see figure 4.14).  
Investigation of the MCS and gephyrin promoter region revealed 2 restriction 
enzyme recognition sites (SalI and XBaI) which were present in the MCS but not in 
the promoter.  Primers were therefore designed to bind to the gephyrin promoter 
region, with the additional 6 base restriction enzyme recognition sites added to the 
5‘ end of each primer, allowing incorporation of the SalI site at the 5‘ end and the 
XBaI site at the 3‘ end of the promoter during the elongation phase of the PCR 
reaction (see figure 4.15).  The 4.3 kb vector and promoter were then separately 
digested with the restriction enzymes and electrophoresed to ensure the correct 
molecular weights were obtained.  After ligation, TOP10 cells were transformed 
with the gephyrin promoter-containing vector and the clones were verified by 
doubly digesting with the SalI and XbaI restriction enzymes followed by 
electrophoresis of the resultant products (see figure 4.16). 
PC-12 cells were transiently transfected with the β-GAL expression vector and 
either the empty vector (pBLCAT3) or the gephyrin promoter-driven pBLCAT3 
(pGPHN), and either full-length zif268 (pzif268), truncated zif68 (ptrzif268) or 
empty vector (pCMV5).  The experiment was performed both in the presence and 
absence of forskolin.  All previous transient transfections were conducted in the 
presence of forskolin after the finding that elevated cAMP, usually present during 
neuronal plasticity, was required for the modulation of synapsin1 expression by 
zif268 (James et al. 2004).  For the purposes of the promoter reporter assay, 
transient transfections were performed in the presence and absence of forskolin in 
order to delineate the necessity of this adenyl cyclase activator for the modulation 
of gephyrin expression by zif268.  The subsequent ELISA results prominently 
show that β-gal activity is significantly decreased when cells are treated with 
forskolin (p<0.01, one-way ANOVA, see figure 4.17).  The following CAT results 
are therefore presented in their raw form and not normalised to β-gal transfection 
efficiencies.  Results are presented as a percentage of control (empty vector or 
ptrzif268 as detailed). 
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Figure 4.14: A diagram of the promoter-less CAT vector pBLCAT3.  In the top right hand 
corner the MCS is clearly detailed, including the SalI and XbaI sites which were used directionally 
to clone the gephyrin promoter into the vector.  Taken from 
http://www.addgene.org/pgvec1?f=d&cmd=genvecmap&vectorid=5260&format=html&mtime=1143
220471 
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Figure 4.15: Diagram of the double stranded DNA gephyrin promoter with annealed primers 
designed to each contain restriction enzyme sites at the 5’ ends.  During the elongation phase 
of the PCR, DNA polymerase within the reaction will synthesise new strands of DNA incorporating 
the restriction enzyme sites onto the ends of the newly formed complementary strand. 
 
 
Figure 4.16: An image of an agarose gel containing the gephyrin promoter insert with the 
pBLCAT3 vector electrophoresed for 1 hour after restriction enzyme digestion with SalI and 
XbaI.  Numbers denote base pairs.  The contrast has been adjusted to reverse the polarity of the 
image for enhanced visualisation of the molecular weight bands. 
 
Plasmid 
vector 
pBLCAT3 
Gephyrin 
promoter 
insert 
1000 
850 
650 
MW Ladder 
Donna M McDade, 2007  Chapter 4, 132 
 
Figure 4.17: The effect of forskolin on β-gal activity.  Graph illustrating β-gal activity in PC-12 
cells transiently transfected with β-gal in the presence or absence of 2 µM forskolin for 48 hours as 
detected by ELISA.  Results are presented as optical density (OD) values  SEM. **p<0.01 one-
way ANOVA, F(1, 28) = 174.43, n=3. 
Co-transfecting pzif268 had little effect on pBLCAT3 as measured by CAT activity 
in the presence of forskolin, compared to the CAT activity of the pBLCAT3 when 
co-transfected with pCMV5.  However, in the absence of forskolin, the ELISA 
detected a significant decrease in pBLCAT3 CAT activity in cells co-transfected 
with pzif268 compared to pBLCAT3 activity when co-transfected with pCMV5 
(one-sample t-test, p<0.05; see figure 4.18) suggesting zif268 action on the CAT 
empty vector independent of the gephyrin insert.  However, expressing pzif268 
and pGPHN relative to pzif268 co-transfected with pBLCAT3 revealed a significant 
suppressive action in the presence of forskolin (p<0.05, one sample t-test, n=3, 
see figure 4.19) suggesting zif268 action on gephyrin.  There was no significant 
effect in the absence of forskolin. 
Comparing the effect of pzif268 to ptrzif268 on the gephyrin insert, the effect of 
pzif268 on pGPHN was not significantly different to the effect of ptrzif268 on 
pGHPN in the presence of forskolin.  In the absence of forskolin, pzif268 
significantly decreased pGPHN activity, compared to pGPHN co-transfected with 
ptrzif268 (p<0.05, one sample t-test, n=3, see figure 4.20).  Inserting the gephyrin 
promoter into pBLCAT3 significantly affects the CAT activity as measured by 
ELISA in the absence of forskolin (p<0.05, one sample t-test, n=3; see figure 
4.21).  A similar tendency was observed in the presence of forskolin, although it 
did not reach statistical significance. 
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Figure 4.18: The effect of pzif268 on CAT activity.  Graph illustrating CAT activity in PC-12 cells 
transiently co-transfected with pzif268 and pBLCAT3 in the presence or absence of 2 µM forskolin 
for 48 hours as detected by ELISA.  Results are presented as optical density values and expressed 
as a percentage of the optical density values of corresponding control cells (transiently co-
transfected with pCMV5 and pBLCAT3 in the presence or absence of forskolin)  SEM. *p<0.05, 
one sample t-test, n=3. 
 
 
Figure 4.19: Effect of the gephyrin promoter on CAT activity in the presence of zif268.  Graph 
illustrating CAT activity in PC-12 cells transiently co-transfected with pzif268 and pGPHN in the 
presence and absence of 2 µM forskolin for 48 hours as detected by ELISA.  Results are presented 
as optical density values and expressed as a percentage of the optical density values of 
corresponding control cells (transiently co-transfected with pzif268 and pBLCAT3 in the presence 
or absence of forskolin)  SEM. *p<0.05, one sample t-test, n=3. 
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Figure 4.20: The effect of zif268 on the gephyrin promoter.  Graph illustrating CAT activity in 
PC-12 cells transiently co-transfected with pzif268 and pGPHN in the presence and absence of 2 
µM forskolin for 48 hours as detected by ELISA.  Results are presented as optical density values 
and expressed as a percentage of the optical density values of corresponding control cells 
(transiently co-transfected with ptrzif268 and pGPHN in the presence or absence of forskolin)  
SEM. *p<0.05, one sample t-test, n=3. 
 
 
Figure 4.21: The effect of gephyrin on CAT activity.  Graph illustrating CAT activity in PC-12 
cells transiently co-transfected with pCMV5 and pGPHN in the presence and absence of 2 µM 
forskolin for 48 hours as detected by ELISA.  Results are presented as optical density values and 
expressed as a percentage of the optical density values of corresponding control cells (transiently 
co-transfected with pCMV5 and pBLCAT3 in the presence or absence of forskolin)  SEM. 
*p<0.05, one sample t-test, n=3. 
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4.4 Discussion 
The data presented in this thesis is the first to implicate gephyrin as a downstream 
target gene of the plasticity-related zif268 transcription factor.  The results show 
that increased amounts of zif268 within neurones decrease gephyrin mRNA and 
protein levels. 
The gephyrin antibody used throughout is directed against the C-terminal E-
domain, an area crucial for many of gephyrin's binding partners, and has been 
frequently cited in the literature as being highly specific for use with western 
blotting (Feng et al. 1998; Kneussel & Betz 2000) and immunofluorescence 
(Giesemann et al. 2003).   
In the first instance, gephyrin was localised within the PC-12 cell line.  A brief 
period of nerve growth factor stimulation differentiated the cells partially.  PC-12 
cells become a neuronal-like cell type once treated with NGF and can stop 
dividing, extend processes from the cell body and become electrically excitable.  
The cells were probed with anti-gephyrin and subsequently displayed distinct 
puncta when compared to cells probed only with the secondary antibody as 
control.  This provided evidence that gephyrin protein is expressed in PC-12 cells.  
The punctate labelling is consistent with previous reports in neurones (Craig et al. 
1996), and in PC-12 cells may relate to the non-receptor clustering functions of 
gephyrin. 
We then verified findings from the original microarray data presented by James et 
al. (2005).  Confirmatory analysis involved the transient transfection of PC-12 cells 
with either a full length or a truncated version of zif268.  The truncated form of the 
zif268 transcription factor is inactive due to an N-terminal deletion ( N3-372), 
inhibiting endogenous full-length zif268.  Harvesting mRNA after 48 hours and 
utilising RT-PCR displayed a decrease in gephyrin expression in the presence of 
full-length zif268 when compared to truncated zif268.  This was mirrored in the 
findings when investigating gephyrin protein levels by western blot after zif268 
transient transfection, revealing a small, but significant, decrease in gephyrin 
expression.  In this particular experiment, a one-tailed one-sample t-test was used 
as a decrease in gephyrin protein was anticipated from the RNA findings. 
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Ponceau S was used in all western blotting experiments (PC-12 and primary 
cultured cortical neurones) to check the uniformity of protein transfer, the 
normalisation of protein concentration starting material and loading of lysate onto 
the polyacrylamide gel.  If all the sample lanes stained equally, especially within 
the sizing area expected for the protein, then the experiment was continued.  If an 
uneven distribution of stained proteins was witnessed, the samples were either re-
assayed for normalisation of protein concentration or re-loaded onto the gel 
depending on the nature of variation.  Hence, it is very unlikely that the differences 
in protein levels detected could result from uneven loading or transfer of protein 
samples.  Blotting with an antibody against a ―housekeeping" protein, such as 
actin or GAPDH, would also have helped to confirm protein loading was consistent 
for each lane. 
It seems somewhat surprising that a transcription factor would suppress gene 
expression rather than activate transcription, especially when considering the 
pivotal role of zif268 in learning and memory.  However, as demonstrated in 
James et al. (2005), it is becoming increasingly evident that zif268 target genes 
are generally down regulated (Fukada & Tonks 2001; Bahouth et al. 2002; Davis 
et al. 2003; Zhang & Liu 2003).  The findings presented in this chapter therefore 
reinforce the suppressive nature of this particular transcription factor as previously 
published.   
Transient transfection of zif268 into neuronal cells was attempted for 
immunocytochemistry however, this was technically very challenging.  There is an 
increased tendency for neurones to migrate towards each other and 'clump' 
together the longer the cells are in vitro. Combined with the low transfection 
efficiency, which necessitates the use of assay methods with cellular resolution, 
such as immunocytochemistry, this can make it very difficult to find measurable 
cells, especially when the cell to be measured is dictated arbitrarily by transfection 
success within viable cells.   
The RT-PCR results were derived from information gleaned over three data points 
as this allows for a high degree of confidence in the results obtained.  GAPDH is 
treated as a steady state control that is not affected by treatment (Spanakis 1993; 
Spanakis & Brouty-Boye 1994), however, when dealing with PCR over time there 
is a need to adjust for the effect of independent biological variables, as reference 
genes have been found to alter with treatment type (Bond et al. 2002).  ANCOVA 
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allows for an improvement in the sensitivity of analysis and enables the variation 
common to both test and reference gene to be explained and removed from the 
analysis (Bond et al. 2002). 
After 6 hours of NMDA stimulation, gephyrin mRNA levels in cortical neurones (7-
10 DIV) are significantly decreased compared to controls.  By 24 hours, mRNA 
levels have returned to basal levels.  By western blot detection, gephyrin protein 
levels are not significantly different from controls at 3 or 6 hours of NMDA 
stimulation but are significantly downregulated at 24 hours in cultured cortical 
neurones (7-10 DIV).  These results are consistent, whereby an increase in zif268 
expression would decrease gephyrin mRNA levels, which would eventually lead to 
a decrease in gephyrin protein.  In contrast are the results found by 
immunocytochemistry.  In this experiment, gephyrin protein levels are found to be 
downregulated at 3 hours in cultured cortical neurones (21 DIV) stimulated with 
NMDA, but not significantly after 6 or 24 hours, when compared to controls.  There 
are several reasons for this seeming discrepancy.  Firstly, and most obviously, the 
techniques used are very different.  Whilst measurements obtained from 
immunocytochemistry can be localised appropriately, in this case within dendrites, 
western blotting and RT-PCR harvests all proteins within all cells giving a more 
global idea of the effects of experimentation.  Secondly, the length of time the 
cultures spent in vitro was dramatically different for each experiment.  Cultured 
cortical neurones treated immunocytochemically were approximately 14 days 
more mature than the cultured cells processed for western blotting and RT-PCR.  
Although it was reasoned that whole cell measures of gephyrin protein didn‘t 
require localisation at the synapse, this could have a marked effect on the results.  
At 21 DIV approximately 90% of gephyrin clusters are synaptic and 85% of these 
are co-localised with GABAARs at synaptic sites. However, at 7-10 days, the 
number of gephyrin clusters associated with GABAARs is decreased dramatically 
to approximately 25% (Danglot et al. 2003).  In addition, there is a clear tendency 
for the dendritic gephyrin immunoreactivity to be suppressed by NMDA treatment 
at both 6 and 24 hours as well as 3 hours, implying that there may be a sustained 
suppression of gephyrin expression.  It is also possible that the early fall in 
gephyrin levels are mediated by some non-transcriptional mechanism, such as 
increased degradation.   
The NMDA treatment experiments within this thesis used a concentration of 100 
µM in 20mM KCl.  As excessive or prolonged activation of NMDARs leads to 
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increased intracellular calcium concentrations, excitotoxicity and neuronal cell 
death, an XTT assay (Roehm et al. 1991) was performed (Professor B.J. Morris, 
personal communication). This colorimetric assay, based on the reduction of a 
tetrazolium salt (XTT), showed no change in the number of viable striatal or 
cortical neurones in primary culture after 24 and 48 hours treatment with 100 µM in 
20mM KCl.  Further tests of this nature, for longer periods of time, would ensure 
that the zif268 results reported here were true results of a plasticity-related 
pathway and not the beginnings of an excitotoxic pathway. 
RT-PCR of adult cerebral tissue from zif268 knockout mice shows no difference 
detected in gephyrin expression when compared to wildtype controls; a result 
reflected in the western blotting results.  This is most likely due to the fact that 
zif268 is a member of the large Egr family, generating the potentiality of 
compensation.  Egr-2, egr-3 and egr-4 for instance encode proteins that can bind 
to the zif268 binding motif and there is considerable overlap in their binding sites 
and functional roles (Crosby et al. 1992; Vesque & Charnay 1992; Swirnoff & 
Milbrandt 1995).  In fact, it is known that egr-4 can compensate for zif268 in the 
zif268 knockout mouse (Tourtellotte et al. 2000) and egr-3 has been found to co-
localise with zif268, suggesting the possibility of further compensation (Yamagata 
et al. 1994).  Egr 2 and egr3 are also regulated by the induction of LTP (Yamagata 
et al. 1994; Williams et al. 1995).  Indeed, gephyrin is an essential cellular 
component, as homozygous disruption of the murine gephyrin gene is lethal at 
birth, suggesting that gephyrin is dispensable for embryonic development but 
absolutely essential for postnatal survival (Feng et al. 1998). Therefore the 
knockout mice would need to be developmentally effective at compensating for 
zif268 loss.  Hence the lack of any detectable change in gephyrin expression in 
the zif268 knockout mice does not preclude an important role for zif268 as the 
transcriptional regulator of the gephyrin gene.   
A model of CNS plasticity was used to increases zif268 and enkephalin within the 
striatum by way of haloperidol administration in vivo (Morris et al. 1988; Nguyen et 
al. 1992; Simpson & Morris 1994; Keefe and Gerfen 1995; Cochran et al. 2002).  
Haloperidol-induced responses within zif268 knockout mice were measured 
indirectly by way of enkephalin mRNA levels, which showed a significant increase 
when compared with animals treated with vehicle.  The induction of enkephalin 
was smaller than expected.  This may reflect the genetic background of the mice, 
as this has been shown to have a profound effect in the response of striatal 
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neurones to haloperidol treatment (Patel et al. 1998).  In addition, it may be that 
the desired effect of increased glutamate at synapses did not occur due to 
haloperidol antagonistic actions on NR2B-containing NMDARs (Gallagher et al. 
1998).  There were no effects of genotype within the results confirming that 
enkephalin levels are not altered by the presence or absence of zif268.  This is 
consistent with previous studies in the hippocampus (Johnston & Morris 1994).  It 
was hypothesised that, even in the absence of any change in the basal level of 
gephyrin expression in the zif268 knockout mice, there might be an impairment in 
any response to haloperidol treatment.  Unfortunately, measuring gephyrin levels 
by in situ hybridisation could not be completed within the time constraints imposed. 
The mouse gephyrin promoter is described by Ramming et al. (1997) and was 
used to identify the rat gephyrin promoter region with the use of bioinformatics.  
Once the likely promoter region had been identified it was cloned for transfecting 
into PC-12 cells with either full length or truncated zif268.  Within this promoter 
region, there were 3 potential zif268 sites, 3 potential Sp1 sites and a general zinc 
finger transcription factor known to enhance promoter activity (Dynan et al. 1986), 
amongst other transcription factor binding sites (www.genomatix.de).  The 
promoter reporter assay, a CAT ELISA, is used quantitatively to measure CAT 
expression in eukaryotic cells transfected with a plasmid bearing a CAT encoding 
reporter gene.   
A -gal ELISA was performed in order to monitor transfection efficiencies, but it 
was found that -gal is significantly affected by the presence of forskolin.  This can 
be explained either by the fact that forskolin is decreasing the rate of transfection 
or that forskolin is causing the enzyme to decrease its activity.  Since there are 
reports suggesting that forskolin may increase -galactosidase activity (Löser et al. 
1998), the latter explanation is likely, and any differences in cell types may 
contribute to the reversal of effect.  This effect negates the use of this protein as a 
means to normalise for any variation in transfection efficiencies and so data were 
analysed without further normalisation. 
The results from the CAT ELISA were several fold.  Firstly, we looked at the effect 
that transfecting zif268 into the cell had on CAT activity.  Full-length zif268 
significantly decreased CAT expression, which is puzzling as pBLCAT3 is a 
promoter-less vector and therefore should not have been affected.  Although 
zif268 was suppressing the CAT empty vector, transfecting gephyrin with zif268 
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led to a further significant decrease in CAT activity, suggesting regulation of the 
gephyrin promoter by full-length zif268.  This effect was also significantly reduced 
when compared to truncated (control) zif268.   
The surprising result that pGHPN displays less CAT activity than pBLCAT3 led to 
further data mining (using MatInspector) of the targeted promoter region.  A 
diagrammatic overview (figure 4.22) displays a few of the pertinent transcription 
factor binding sites.  Of particular interest is the potential Neural Restrictive 
Silencer Element (NRSE) site, which is found in promoters which binds NRSF 
(Neural Restrictive Silencer Factor)/REST (Repressor Element-1 silencing factor), 
a known endogenous transcriptional repressor of several genes encoding 
neurotransmitter receptors and ion channels in neurones (Chong et al. 1995; 
Schoenherr & Anderson 1995; Schoenherr et al. 1996; Shimojo & Hersh 2006).  
This NRSE is conserved in human, rat and mouse upstream regions at equivalent 
positions, relative to the gephyrin transcriptional start site.  In PC-12 cells, NRSF 
transcriptionally represses the Na+ channel type II (Tapia-Ramirez et al. 1997).  It 
has been proposed that NRSF is localised to the nucleus PKA dependently as, in 
environments which lack PKA, NRSF remains in the cytosol, repressing overall 
NRSF activity and allowing increased target gene expression (Shimojo & Hersh 
2006).  Therefore, there may be an influence of cAMP levels in NRSF function, 
which might predict less suppression of promoter activity by NRSF in the presence 
of forskolin.  There are some suggestions that this may be the case in these 
results (figure 4.21). 
  
 
 
 
 
Figure 4.22  Diagram of the targeted gephyrin promoter cloned into the pBLCAT3 promoter-
less vector plasmid.  Positions of some of the known binding sites are annotated. Zif268 
recognition sequences are located at positions -408 to -392, -294 to -278 and -22 to -6 relative to 
the end of the cloned gephyrin sequence and putative CAT transcription start site (at 0).  Sp1 
(Stimulating protein 1) recognition sequences are located at positions -193 to -179, -42 to -28 and -
24 to -10 relative to the end of the cloned gephyrin sequence.  The NRSE (Neural Restrictive 
Silencer Element) recognition site is at position -316 to -296.  
CAT 
-412 
Zif268 
NRSE 
Sp1 
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It can be proposed that the introduction of the gephyrin ‗promoter‘ region upstream 
of the CAT coding sequence suppresses expression via this NRSE.  Ramming et 
al. (1997) observed increased expression of their reporter gene downstream of the 
mouse gephyrin promoter, but they used a longer ‗promoter‘ fragment that may 
contain other elements that interact with the NRSE.  The promoter-reporter results 
also confirm our earlier findings that full-length zif268 decreases gephyrin 
expression when compared to truncated zif268. 
Zif268 expression decreased the activity of the cloned gephyrin promoter, relative 
to both empty vector and the truncated zif268 expression vector.  This is 
consistent with a direct action of zif268 on one or more of the potential zif268 
binding sites shown in figure 4.22, to suppress transcriptional activity.  The effect 
was more marked in the absence of forskolin than in the presence of forskolin.  
However, the original microarray detection of gephyrin transcripts being modulated 
by zif268 and the confirmatory studies monitoring gephyrin mRNA and protein 
levels in PC-12 cells after zif268 transfection, were performed in the presence of 
forskolin.  A likely explanation for this apparent discrepancy is that complete 
endogenous gephyrin promoter is not fully represented by the ~1 kb fragment 
studies here.  It is well known that functionally important promoter elements are 
frequently located more than 1 kb upstream of the transcription start site, or 
downstream, in coding or intronic regions.  Such elements in the endogenous 
gene may modify the response to zif268. 
The 'promoter' region cloned in our study also contained an overlapping 
recognition site for Sp1 and zif268.  Competition or interaction of Sp1 and zif268 
binding is considered important for gene regulation and occurs in many promoters 
(Huang et al. 1997; Srivastava et al. 1998; Fukada and Tonks 2001; Davis et al. 
2003).  The ability of zif268 to modulate gephyrin expression could therefore 
involve competitive binding with Sp1. 
Overall, we have presented strong evidence that gephyrin is a direct downstream 
target of zif268 and is generally suppressed during periods of neuronal plasticity 
(Chhatwal et al. 2005).  Gephyrin‘s interactions with the cytoskeleton and 
GABAARs, introduced in the general introduction, will be discussed with relevance 
to zif268-induced downregulation in the general discussion. 
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5 Ubiquilin as a downstream target of zif268 
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5.1 Introduction  
5.1.1 Ubiquilin and related homologues 
In humans there are currently four known ubiquilin genes: ubiquilin 1 (Mah et al. 
2000), ubiquilin 2 (originally called Chap1) (Kaye et al. 2000), ubiquilin 3 (Conklin 
et al. 2000) and ubiquilin 4 (A1Up) (Davidson et al. 2000).  Ubiquilin and its forms 
are also known as Plic-1 and Plic-2 (Proteins that Link IAP (integrin-associated 
protein) with the cytoskeleton) in mouse (Wu et al. 1999), DA41 in rat (Ozaki et al. 
1997a), XDRP1 in frog (Funakoshi et al. 1999) and Dsk2 in yeast (Biggins et al. 
1996).  In addition, alternative names in humans are hPlic-1 and hPlic-2, (Kleijnen 
et al. 2000) and human DA41 (Hanaoka et al. 2000). 
Ubiquilin 1 was discovered in humans by Mah et al. (2000) as a novel 66kDa 
interactor with presenilin proteins, which are linked to early onset Alzheimer's 
Disease (AD), a property that will be discussed later in this chapter.  It has 2 
transcript variants, one with exon 8 (transcript 1) and one without (transcript 2) and 
was found to have a 60% homology with XDRP1 (Xenopus Dsk2-related protein 1) 
discovered in Xenopus laevis (Funakoshi et al. 1999).  XDRP1 is a nuclear 
phosphoprotein and binds to cyclin A1 and A2, proteins that seem to be 
importantly involved in mitosis, as their degradation is necessary to enter the next 
cell cycle and is highly regulated.  This interaction requires the N-terminal UBL 
domain of XDRP1 and inhibits cyclin A degradation, allowing overall involvement 
of XDRP1 with the spindle function in mitosis, and therefore cell cycle regulation.  
Dsk2, human Chap1 and DA41 have also been implicated as regulators of the cell 
cycle (Biggins et al. 1996; Kaye et al. 2000; Ozaki et al. 1997b). 
Plic-1 and Plic-2 were discovered in 1999 by Wu et al. and share over 80% 
sequence identity.  Plic-1 displays 84% homology to ubiquilin 1 and Plic-2 shows 
60% homology.  It has since been found that ubiquilin 1 is more closely related to 
Plic-1, and ubiquilin 2 more close to Plic-2.  They were found by yeast dihybrid 
screening using two isoforms of IAP with distinctly different cytoplasmic tails.  
Integrins associate with microfilaments, and IAP is thought to mediate the 
interaction of both Plic-1 and -2 with integrin v 3.  In addition, Plic proteins were 
found to interact with IAP and vimentin, anchoring the intermediate filaments to the 
plasma membrane.  Moreover, the transfection of either Plic-1 or -2 into a stable 
cell line containing an IAP isoform increased the area of the cell when compared 
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to control.  Therefore, the affiliation of the Plic proteins and IAP could lead to 
alterations in the cytoskeleton. 
Kliejnen et al. (2000) also utilised yeast dihybrid screening, to find cDNAs 
encoding human Plic-2 and Plic-1.  As mentioned in the Chapter 1, this was the 
first paper to propose that the Plic proteins had an association with the 
ubiquitination machinery and the proteasome. 
Ubiquilin staining pattern is variable in different cell types (Mah et al. 2000).  
However, analysis of tissue distribution in mouse Plic-1, rat DA41 and human 
DA41 show that it is ubiquitously expressed (Ozaki et al. 1997a; Wu et al. 1999; 
Hanaoka et al. 2000).  Northern blot analysis of human tissues found that ubiquilin 
is highly expressed in the brain and pancreas. In addition, in adult human 
neurones, ubiquilin localises to the nucleus, cytoplasm and to long axonal 
processes (Mah et al. 2000). 
5.1.2 The Role of Ubiquilin in Neurodegenerative Disease 
5.1.2.1 General Aggresomal Diseases 
Massey et al. (2004) located ubiquilin proteins within the inner core of 
aggresomes, structures involved with the sequestration of misfolded proteins in 
cells.  This could suggest a role for ubiquilin within general aggresomal disease 
states.  Small protein aggregates singularly form throughout the cytoplasm and are 
quickly dynein-dependently transported on microtubules to form a large 
aggresome (Johnston et al. 1998; Garcia-Mata et al. 1999).  In an attempt to 
dispose of the aggresome, chaperones, the ubiquitination machinery and the 
proteasome arrive, closely followed by autophagosomes and lysosomes 
(Mortimore et al. 1996).  The many known aggresome-related diseases provide 
circumstantial evidence that aggresomes are involved in cellular degeneration in 
disease states.  Possible mechanisms for cell death include the sequestration of 
chaperones and proteasomes, a disruption of cellular trafficking (Johnston et al. 
2000), and the ability of aggresomes to attract other proteins on a ‗like for like‘ 
basis, whereby aggresomal proteins attract structurally similar proteins (Huang et 
al. 1998). 
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5.1.2.2 Alzheimer’s Disease 
The majority of recent publications regarding ubiquilin have argued over the 
relevance and role it may play in Alzheimer‘s disease (AD).  AD is a 
neurodegenerative disorder responsible for the majority of dementia cases found 
in the elderly.  It is characterised by amyloid plaques and neurofibrillary tangles 
formed in various brain areas.  The majority of cases are found in individuals over 
the age of 65, however, the less common early-onset AD can affect approximately 
5% of the overall number of AD patients (Farrer et al. 1997). 
So far three genetic mutations have been related to early onset familial (FAD) AD: 
-amyloid precursor protein (APP), presenilin-1 (PSEN1) and presenilin-2 
(PSEN2) (Hardy 1997; Price et al. 1998), and only one genetic mutation has been 
related to late-onset AD in the ε4 allele of apolipoprotein E (APOE) (Kamboh 
2004).  However, there are genetic variations found in AD, so many more genes 
probably need to be identified (Daw et al. 2000), in addition, it is not fully 
understood how mutations in these known genes can cause AD. Ubiquilin was 
found as a novel interactor of both PSEN1 and PSEN2 (Mah et al. 2000).  An in 
vitro binding assay provided evidence that only the UBA containing COOH-
terminal of ubiquilin was able to bind the presenilins.  Co-expression of ubiquilin 
with PSEN2 resulted in a marked increase of PSEN2 protein accumulation, 
compared with overexpression of PSEN2 alone, in the presence and absence of 
proteasome inhibitors. In addition, they discovered by immunohistochemistry that 
neurones containing neurofibrillary tangles (from AD patients) had more intense 
ubiquilin staining than control neurones. 
The catalytic core of the -secretase complex is formed from presenilin proteins 
and is responsible for cleaving APP, leading to a build up of fragments in the 
extracellular space (Edbauer et al. 2003; Kimberly et al. 2003; De Strooper 2003).  
In order for the catalytic core to form, the presenilins must undergo 
endoproteolysis by ‗presenilinase‘ to create C-terminal and N-terminal fragments 
(Thinakaran et al. 1996; Kim et al. 1997; Thinakaran et al. 1997; Ratovitski et al. 
1997), which interact with each other and are responsible for the -secretase 
activity (Esler et al. 2000; Li et al. 2000).  Ubiquilin is thought to promote the 
accumulation of presenilin full-length proteins, and to regulate its endoproteolysis 
by blocking access to the ‗presenilinase‘, an unknown activity.  Ubiquilin also 
modulated the levels of other key members of the -secretase complex such as 
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pen2 and nicastrin (Massey et al. 2005).  Further evidence linking ubiquilin with 
the presenilin proteins includes the co-localisation of ubiquilin and PSEN1 in 
primary cultured neurones.  In addition, evidence suggests an interaction between 
the two proteins at the cell surface.  However, this interaction was not significantly 
different in AD patients compared to controls (Thomas et al. 2006). 
The first clinical study linking ubiquilin with AD was by Bertram et al. (2005) 
utilising two family-based samples.  They used neural tissue from 25 late-onset AD 
patients and 17 controls and studied a single nucleotide C/T polymorphism located 
within the ubiquilin gene (UBQ-8i) that they state was consistently mutated in AD 
brains.  They also found that the level of ubiquilin transcript 2 was increased in AD 
brains.  However, genotyping the transcript 2 sample for the UBQ-8i risk allele did 
not reveal significant linkage to AD, possibly due to their small sample size.  This 
article created a wave of responses, most of which disagreed with the findings 
(Bensemain et al. 2006; Brouwers et al. 2006; Slifer et al. 2006; Smemo et al. 
2006). 
5.1.2.3 Huntingdon’s Disease 
The fatal, hereditary, neurodegenerative Huntingdon‘s Disease (HD) is caused by 
the expansion of a CAG repeat found in exon 1 of the gene encoding huntingtin 
protein.  This gene product is then translated with an expanded polyglutamine 
(polyQ) stretch, which is thought to cause intracellular nuclear aggregates to form 
(Scherzinger et al. 1997; Michalik & Van Broeckhoven 2003).  Numerous proteins 
interact with the aggregates, which are ubiquilin rich, but it is unclear whether 
these aggregates are protective or toxic.  Doi et al. (2004) identified ubiquilin 1, as 
well as ubiquilin 2, as novel proteins that interact with aggregates, in addition to 
their interaction with ubiquitin.  PolyQ aggregates have been reported to contain 
several UBA domain-containing proteins, as well as ubiquitin interacting motif 
(UIM) domain-containing proteins (Donaldson et al. 2003; Wang et al. 2000; 
Davidson et al. 2000).  PolyQ aggregates are thought to sequester ubiquitin-
interacting proteins through these domains, disrupting normal neuronal function.  
Recently, Wang et al. (2006) co-transfected ubiquilin into neuronal cells with a 
GFP-tagged protein containing 74 polyQ repeats (GFP-Htt(Q74-3)) and found that 
overexpression of ubiquilin promotes increased cell survival.  They also showed 
that cells stably expressing GFP-Htt(Q74-3) were more sensitive to oxidative 
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stress induced by exposure to H2O2 or serum deprivation than a lower polyQ 
repeat protein, GFP-Htt(Q28-2).  The GFP-Htt(Q74-3) cell death was reduced by 
approximately 80% and 50% respectively when ubiquilin was transiently 
transfected into the cells.  They also investigated the effects of reducing ubiquilin 
by siRNA in the GFP-Htt(Q74-3) stably expressing HeLa cells.  They observed a 
corresponding halt in cell proliferation, an increase in cell death and the 
accumulation of expanded GFP-immunoreactive aggregates when knocking down 
ubiquilin.   
5.1.3 Additional Functions of Ubiquilin 
Prolonged exposure to nicotine can upregulate the surface expression of nicotinic 
acetylcholine receptors (nAChRs) in neurones (Wonnacott 1990; Darsow et al. 
2005).  Ubiquilin was found to bind to the mouse 3 subunit of nAChRs by yeast 
dihybrid screening (Ficklin et al. 2005).  By co-transfecting ubiquilin and the 3 
nAChR subunit into COS-7 cells they found that ubiquilin redistributed the subunit 
to the 20S proteasome subunit.  They also found that ubiquilin decreased the 
surface expression of receptors in a stably expressed 3 and 2 subunit HEK293 
cell line.  In addition, ubiquilin was able to reduce the number of surface nAChRs 
upregulated by nicotine in cultured mouse superior cervical ganglion cells.  Taken 
together, this may mean that ubiquilin can limit nAChR subunits for assembly and 
trafficking.  
Protein-disulfide isomerase (PDI) forms and rearranges disulfide bonds within the 
rough endoplasmic reticulum (RER) in order to aid the folding of proteins (Lyles & 
Gilbert 1991).  An increase in the amount of unfolded proteins within the ER can 
lead to a stress response (Sidrauski et al. 1998), which in mild cases, can be dealt 
with by stress proteins like PDI.  PDI has been shown to up-regulate in response 
to hypoxia in vitro and brain ischemia in vivo in glial cells (Tanaka et al. 2000). 
Ubiquilin has been identified as a PDI-interacting protein and therefore a possible 
protective factor against hypoxia.  Ubiquilin binds in vitro and in vivo to PDI‘s C-
terminus and, when over-expressed, could be found localised to the ER.  Ubiquilin 
mRNA and proteins levels were increased in response to hypoxia in astrocytes 
and co-expression of ubiquilin and PDI had a protective effect against hypoxia in 
human neuroblastoma cells (Ko et al. 2002). 
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Ubiquilin also interacts with Eps15 (epidermal growth factor (EGF) receptor 
pathway substrate 15) a protein that interacts with AP2, the linker protein involved 
in clathrin coated pit formation (Benmerah et al. 1995; Morgan et al. 2003).  The 
UIM (ubiquitin-interacting motif) domains of Eps15, Eps15R (Eps15-related) and 
another endocytic protein, Hrs, interact with ubiquilin through the UBL domain 
although this interaction was not related to endocytic compartments (Regan-
Klapisz et al. 2005). 
Overall, there is considerable evidence that ubiquilin is involved in the cell cycle, 
the cytoskeleton, proteasome activity and ligand gated ion channel receptors and 
signalling molecules and is implicated in certain neurodegenerative diseases.  This 
chapter introduces ubiquilin as a downstream target of zif268, implicating this 
relatively new protein in synaptic plasticity. 
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5.2 Aims & Objectives 
 Identify and verify the presence of ubiquilin within the PC-12 cell line. 
 Validate the original microarray experiment by transfecting PC-12 cells with 
full length or truncated zif268 and investigating ubiquilin expression at RNA 
and protein levels. 
 Extend the findings found within the cell-line by utilising primary cortical 
neurones stimulated with either NMDA or vehicle over 24 hours and 
investigating ubiquilin expression at the RNA and protein levels. 
 Look at ubiquilin RNA and protein levels harvested from zif268 knockout 
and wildtype mice to investigate the effects of genetic manipulation. 
Donna M McDade, 2007  Chapter 5, 150 
5.3 Results 
5.3.1 PC-12 cells stain positively for ubiquilin 
To assess ubiquilin expression within the PC-12 cell line, immunocytochemistry 
was performed on partially differentiated and undifferentiated cells using a rabbit 
anti-ubiquilin antibody. As illustrated in Figure 5.1A & 5.1B, using only a secondary 
antibody as a control shows very little or no staining on cells treated or untreated 
with nerve growth factor.  In contrast, undifferentiated cells stained with anti-
ubiquilin show diffuse staining and distinct puncta (figure 5.1C).  PC-12 cells 
treated with nerve growth factor for 2 hours before fixing with formaldehyde show 
the appearance of dendrite-like processes.  In addition, they show ubiquilin 
immunoreactivity throughout the cells, including punctuate staining along 
processes, and display stronger staining than the undifferentiated cells (figure 
5.1D). 
5.3.2 Ubiquilin is downregulated in PC-12 cells after transient 
transfection with zif268 
Transient transfection of 1 g/mL full-length zif268 into PC-12 cells treated with 50 
ng/mL nerve growth factor showed a statistically significant reduction in ubiquilin 
RNA when compared to cells transfected with 1 g/mL of a truncated control 
zif268 (p<0.05, one sample t-test, n=5; see figure 5.2).  RT-PCR was performed 
using GAPDH primers and exon-intron spanning primers for ubiquilin.  A single 
cycle within the logarithmic linear phase was taken for each transcript and the log 
GAPDH normalised pixel intensity value subtracted from the log ubiquilin 
normalised pixel intensity value.  This revealed a 13% reduction in ubiquilin RNA 
in PC-12 cells transiently transfected with full length zif268 compared to control.  
Utilising western blotting, it was found that protein levels of ubiquilin were not 
significantly downregulated within the same experimental paradigm, with full length 
transiently transfected zif268 PC-12 cells displaying a non-significant 8% reduction 
in normalised pixel intensity when compared to control (n=6; see figure 5.3 A & B). 
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Figure 5.1: Confocal images of ubiquilin staining in PC-12 cells.  A, undifferentiated cells 
stained only with 1:100 anti-rabbit Alexa 594.  B, PC-12 cells pre-incubated for 2 hours with 
50ng/mL NGF-7S and stained only with 1:100 anti-rabbit Alexa 594.  C, undifferentiated PC-12 
cells stained with 1:100 anti-ubiquilin and 1:100 anti-rabbit Alexa 594.  D, PC-12 cells pre-
incubated for 2 hours with 50ng/ml NGF-7S and stained with 1:100 anti-ubiquilin and 1:100 anti-
rabbit Alexa 594.  Scale bar 15 m. 
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Figure 5.2: The effect of zif268 on ubiquilin mRNA in PC-12 cells.  Graph comparing ubiquilin 
RNA levels as assessed by signal intensities at a single RT-PCR cycle from differentiated PC-12 
cells transiently transfected with either full length or truncated zif268.  Results are presented as 
ubiquilin normalised pixel intensity after normalisation to corresponding GAPDH values.  All data 
expressed as mean percentage of control  SEM. *p<0.05 one sample t-test, n=5. 
 
 
 
 
Figure 5.3: The effect of zif268 on ubiquilin protein levels in PC-12 cells A, Representative 
image of western blot comparing ubiquilin protein levels from PC-12 cells transfected with either full 
length or truncated zif268. B, Graph comparing protein levels of differentiated PC-12 cells 
transiently transfected with either full length or truncated zif268, as determined by western blotting.  
Results are presented as ubiquilin normalised pixel intensity.  All data expressed as a mean 
percentage of control  SEM, n=6.   
A 
B 
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5.3.3 Ubiquilin is time-dependently downregulated in cultured cortical 
neurones after NMDA treatment 
NMDA stimulation (100µM NMDA in 20mM KCl) of cultured primary cortical 
neurones for 6 hours displayed a statistically significant downregulation of 
approximately 23% in ubiquilin RNA levels when compared to vehicle as 
determined by RT-PCR (p<0.01, ANCOVA, n=4; see figure 5.4).  Statistically, we 
employed the ANCOVA in order to adjust for variances, with GAPDH as the 
covariate.  Looking at protein levels, ubiquilin is significantly downregulated when 
stimulated with NMDA for 3 hours (29.8  5.8% of control) and 6 hours (30.9  
7.3% of control) as determined by immunocytochemistry (p<0.05 and p<0.01 
respectively, two-way ANOVA with Tukeys post-hoc test; see figure 5.6).  Figure 
5.7 contains representative confocal images of primary cultured neurones treated 
for 3 hours with NMDA or control. 
In contrast, when comparing RNA and protein levels after 24-hour stimulation with 
NMDA, ubiquilin is not significantly different from primary cortical neurones treated 
with vehicle for 24 hours (see figures 5.5 and 5.6).  Western blotting of protein 
levels after 3 hours, 6 hours or 24 hours NMDA stimulation showed no significant 
differences when compared with controls (see figure 5.8A & B). 
5.3.4 Ubiquilin RNA is downregulated in zif268 knockout mice 
A comparison of RNA extracted from zif268 knockout mice and their associated 
wildtype counterparts by RT-PCR show that ubiquilin is significantly 
downregulated (ANCOVA p<0.01; see figure 5.9).  At the protein level however, 
western blotting shows no significant difference between zif268 knockout mice and 
the wildtypes (figures 5.10 A & B). 
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Figure 5.4: The effect of 6 hours NMDA stimulation on ubiquilin mRNA in cultured neurones. 
Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of cultured primary cortical neurones stimulated for 6 hours with either 
100µM NMDA in 20mM KCl or Vehicle.  Effect of NMDA treatment #p<0.01, F(1,15)=8.45, 
ANCOVA n=4. 
 
 
 
Figure 5.5: The effect of 24 hours NMDA stimulation on ubiquilin mRNA in cultured 
neurones.  Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity 
as determined by RT-PCR of cultured primary cortical neurones stimulated for 24 hours with either 
100µM NMDA in 20mM KCl or Vehicle.  n=4. 
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Figure 5.6: The effect of NMDA stimulation on ubiquilin protein levels in cultured neurones. 
Graph illustrating the effect of treatment of cultured cortical neurones (21DIV) for either 3 hours, 6 
hours or 24 hours with either 100µM NMDA in 20mM KCl or vehicle on ubiquilin immunoreactivity, 
as detected by immunocytochemistry.  Results are presented as the number of particles measured 
per square micron and expressed as a mean percentage of the signal in control (vehicle treated) 
cells  SEM.  Effect of treatment, #p<0.01, F(1,27) = 22.44, two-way ANOVA.  Effect of time 
**p<0.01, *p<0.05, Tukeys post hoc test, n=5 
 
 
Figure 5.7: Images of ubiquilin within cultured neurones after 3 hours NMDA stimulation.  A 
representative image comparing primary cultured cortical neurones (21 DIV) treated for 3 hours 
with vehicle (A) or with 100 μM NMDA in 20 mM KCl (B), probed with anti-ubiquilin and visualised 
with a confocal microscope as per the immunocytochemistry protocol.  Arrows depict the measured 
puncta within cells A and B.  Scale bar 15 μm. 
 
A B 
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Figure 5.8: The effect of NMDA stimulation on ubiquilin protein levels in cultured neurones 
by western blot A: Representative western blot of ubiquilin immunoreactivity in cultured cortical 
neurones stimulated for either 3 hours, 6 hours or 24 hours with either 100µM NMDA in 20mM KCl 
or vehicle and  probed with anti-ubiquilin. B: Graph comparing ubiquilin immunoreactive signal 
intensities from western blots of cultured cortical neurones (7-10 DIV) stimulated for either 3 hours, 
6 hours or 24 hours with either 100µM NMDA in 20mM KCl or vehicle.  Results are presented as 
normalised pixel intensity and expressed as a mean percentage of control (vehicle treatment)  
SEM.  ANOVA revealed no significant effect of NMDA treatment and no significant interaction with 
time.  Effect of NMDA F(1,18) = 2.07, p>0.05, interaction of time and treatment F(2,18) = 0.55, 
p>0.05, n=4. 
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Figure 5.9: The effect of a zif268 targeted deletion on ubiquilin mRNA in the adult cortex. 
Graph illustrating ubiquilin log pixel intensity as a function of GAPDH log pixel intensity, as 
determined by RT-PCR of adult cerebral cortex tissue from either wildtype or zif268 knockout mice.  
#p<0.01 F(1,11) = 11.90, ANCOVA, n=3. 
 
 
 
 
Figure 5.10: The effect of a zif268 targeted deletion on ubiquilin protein levels in the adult 
cortex.  A: Representative western blot comparing ubiquilin immunoreactivity signal in cortical 
tissue from wildtype and zif268 knockout mice.  B: Graph comparing ubiquilin immunoreactivity 
signal intensities from western blots of adult cerebral cortex tissue extracted from either wildtype or 
knockout zif268 mice.  Results are presented as normalised pixel intensity and expressed as a 
mean percentage of total control (wildtype tissue)  SEM.  Wildtype, n=7, knockout zif268, n=5. 
A 
B 
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5.4 Discussion 
This is the first study to identify ubiquilin as a downstream target gene of the 
inducible transcription factor zif268.  Ubiquilin RNA and protein levels are 
downregulated by increased amounts of zif268 and ubiquilin mRNA levels are 
decreased in cortical tissue from zif268 knockout mice, implying that ubiquilin is a 
transcriptional target of this plasticity related gene. 
Initial experiments used a pheochromocytoma derived cell line in order to establish 
the validity of the original microarray experiment (James et al. 2005).  In the first 
instance, PC-12 cells were partially differentiated with nerve growth factor.  
Applying an anti-ubiquilin antibody revealed punctate staining throughout the 
cytoplasm and processes, confirming the presence of ubiquilin protein.  The 
ubiquilin antibody used has not been widely cited, however, it is directed towards 
amino acid residues 2-18 of ubiquilin and displayed a high level of specificity in 
western blot experiments. 
The upregulation of zif268 by transient transfection in the presence of forskolin 
produced a significant decrease in ubiquilin RNA when compared with a truncated 
control form of zif268.  This validated the significant result achieved previously by 
James et al. (2005).  At the protein level however, no significant result was 
achieved.  Western blotting has changed very little since its development in 1979 
(Towbin et al. 1979).  Among this technique's limitations is the problem of 
restricted quantitative capability and PCR is generally a more sensitive method of 
detection (Liu et al. 2004). 
We next looked at the effect increasing zif268 had on cultured dissociated primary 
cortical neurones.  Zif268 protein levels peak at 2 hours after stimulation 
(Richardson et al. 1992) whereby it enters the nucleus to regulate downstream 
targets.  Therefore, cells were harvested at 2 time points in order to delineate any 
time dependent effects of zif268 stimulation.  At 6 hours, ubiquilin RNA levels were 
significantly decreased in cells stimulated with NMDA when compared to vehicle-
stimulated cells.  This result is echoed in the protein levels, which are also 
significantly decreased when looking at the immunocytochemistry results.  An 
additional time point of 3 hours stimulation was examined with the protein levels 
allowing a further insight into ubiquilin actions after zif268 induction.  At 3 hours, 
ubiquilin protein levels are significantly decreased when compared to controls.  
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However, at 24 hours both RNA and protein levels have returned towards a basal 
level, inferring that zif268's actions could be time-dependent.  This is consistent 
with the ubiquilin gene being regulated by transient induction of zif268 following 
NMDA receptor stimulation.  
Changes in ubiquilin protein levels were apparent using immunocytochemical 
techniques.  The paraformaldehyde fixation stage of immunofluorescence 
procedures can produce artefacts in immunocytochemistry.  In addition, 
unfortunately, optimal antibody concentrations were determined by visualisation 
with an inverted light microscope, before the availability of image capture with the 
confocal microscope.  The specific laser used in the confocal microscope has a 
wavelength of 568nm, which means that the fluorescent Alexa 594 secondary 
antibody is only reaching 50% excitation.  This required an increase in laser power 
which uniformly increased background and could have created less than optimal 
conditions for ubiquilin immunoreactivity detection.  However, we attempted to 
circumvent any possible problems with generic staining by using the Image J 
program.  This allows a certain threshold to be set in order to minimise any 
background noise, which can be individually altered for each image, and all the 
results were performed blind.  Hence, the data obtained can be viewed with 
considerable confidence.  Earlier data from our laboratory (McDermot & Morris, 
unpublished) showed no evidence of apoptosis or necrosis at extended times after 
this NMDA treatment protocol.  It is also encouraging to note that the return of 
ubiquilin RNA and protein to basal levels after 24 hours suggests that any changes 
at earlier time points were due to a genuine downregulation in ubiquilin and not to 
cell death. 
Western blotting to detect protein levels of ubiquilin after zif268 induction by 
NMDA stimulation produced no significant results at 3 hours, 6 hours or 24 hours.  
However, contradictory results in protein levels detected by western blot compared 
to immunocytochemistry have been obtained by others (Salvador-Silva et al. 2001; 
Lindahl & Keifer 2004) and may reflect the fundamental difference between the 
techniques: western blotting detects whole cell proteins whilst 
immunocytochemistry has a more directed approach.   
When comparing RNA levels of zif268 knockout mice compared to wildtypes a 
significant reduction in ubiquilin was detected.  This result was surprising, as an 
absence of zif268 would suggest an increase in ubiquilin RNA.  There are many 
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inherent problems with knockout mice however, especially those that deal with 
immediate early genes (Prof. Hugh Piggins, Manchester University; personal 
communication).  There is an element of redundancy in many control systems 
allowing for developmental compensation.  In particular, there is strong evidence 
that another member of the Egr family, Egr4 can compensate for the absence of 
zif268 in these knockout mice (Tourtellotte et al. 2000).  Propitiously, it does 
demonstrate that ubiquilin is ultimately a target of zif268, as ubiquilin's expression 
is significantly affected by zif268's absence.  The western blot did not detect any 
changes in ubiquilin protein levels in zif268 knockout mice compared to wildtypes, 
possibly due to limitations inherent in the technique.  As a complimentary 
experiment to the RNA work and to extend protein detection, we had hoped to 
culture zif268 knockout and wildtype cortical tissues for 21 days, genotype the 
cultures by removing additional tissue at dissection, and perform 
immunocytochemistry with the ubiquilin antibody.  Unfortunately, colony breeding 
was intermittent, delivering minimal litter sizes and creating time constraint 
problems. Ubiquilin labelling in zif268 knockout and wildtype mice treated with 
haloperidol to produce an in vivo model of synaptic plasticity sadly did not produce 
results.  More time would be needed to optimise the oligonucleotide labelling.  
Overall, however, these results provide strong support for the hypothesis that 
ubiquilin expression is regulated by zif268. 
The overall hypothesis of the effect zif268 has on ubiquilin concerns the effects 
this may produce in GABAARs at the synapse, which will be discussed later.  The 
number of cellular functions in which ubiquilin has been implicated leads to further 
consequences of ubiquilin downregulation that could affect a myriad of different 
systems.  Ubiquilin is localised to neuropathological inclusions in AD, PD (Mah et 
al. 2000) and HD (Doi et al. 2004) and has been shown to modulate the 
accumulation of presenilin proteins (Mah et al. 2000).  This suggests that 
increased ubiquilin levels are involved in or associated with neuronal disease.  
Zif268 expression is decreased in AD transgenic mouse models modelling amyloid 
deposition (APP+PS1) (Dickey et al. 2003; Dickey et al. 2004), although zif268 
actions still remain controversial in neurodegenerative diseases (Rensink et al. 
2002).   
In addition, ubiquilin is upregulated in response to hypoxia (Ko et al. 2002), 
whereas zif268 mRNA expression is inhibited (Hung et al. 2000).  Zif268 has many 
different roles, as it is induced by DNA damaging agents (Quinones et al. 2003), 
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and may have a role in the cellular reaction to hyperoxia (Jones and Agani 2003) 
and apoptosis (Pignatelli et al. 2003).  Chaperones assist the folding of newly 
synthesised proteins and refolding of proteins damaged by stress and cellular 
injuries.  Incorrectly folded proteins are delivered to the ubiquitin-proteasome 
system, and ubiquilin is known to act post transcriptionally like a molecular 
chaperone (Funakoshi et al. 1999; Davidson et al. 2000; Kaye et al. 2000).  A 
decrease in ubiquilin therefore may increase the number of misfolded and 
unrepaired proteins within the cell, increasing the number of proteins delivered to 
the proteasome.   
At the level of the cytoskeleton, mouse Plic-1 and Plic-2 have an involvement in 
linking integrins via integrin-associated proteins to the intermediate filaments (Wu 
et al. 1999).  Ubiquilin, therefore, could connect the plasma membrane and the 
cytoskeleton and may be involved in regulating adhesion and migration, an 
important property for synaptic plasticity.  
In summary, the diversity of studies leave it unclear exactly what the 
consequences of altered ubiquilin expression will be.  Clearly, a lot more 
experimentation is required to find out the many and varied roles of this protein.  
Nevertheless, the data provides strong evidence that expression of the ubiquilin 
gene is regulated during plasticity by zif268. 
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6 Potential downstream effects of the modulation of 
gephyrin & ubiquilin expression by zif268 
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6.1  Introduction  
Gephyrin and ubiquilin have been functionally linked to both the GABAAR and 
mTOR (mammalian target of rapamycin).  In order to gain a greater understanding 
of the possible downstream consequences in response to altered zif268 
expression, the effects potentially resulting from changes in gephyrin and ubiquilin 
levels were the subjects of a preliminary investigation. 
6.1.1 The GABAAR at the synapse 
GABAARs are ligand-gated chloride channels that exist in numerous distinct 
subunit combinations, but the 1 2 2 combination is the most predominantly 
expressed receptor multimers, followed by 2 3 2 and 3 3 2 (Fritschy et al. 
2003).  GABAARs containing  and  subunits can reach the cell surface (Connolly 
et al. 1996b) however, there is a necessity for the  subunit for synaptic 
localisation (Essrich et al. 1998).  Gephyrin has been linked with the 1-3, 3 and 
2 subunits of the GABAARs at postsynaptic sites (Kirsch et al. 1995; Essrich et al. 
1998; Sassoe-Pognetto et al. 2000; Danglot et al. 2003), and ubiquilin binds to the 
1-3, 6 and 1-3 subunits of the GABAAR (Bedford et al. 2001).  Reduced 
gephyrin expression is predicted to decrease the number of GABAARs clustered at 
synaptic sites, while decreased ubiquilin expression is predicted to reduce 
GABAAR number via enhanced proteasomal degradation. 
6.1.2 Downstream effectors of mTOR  
mTOR, also known as FRAP (FKBP-rapamycin-associated protein), RAFT1 
(rapamycin and FKBP target) and RAPT1 (rapamycin target) (Brown et al. 1994; 
Chiu et al. 1994; Sabatini et al. 1994; Sabers et al. 1995) is a highly conserved 
serine-threonine kinase regulated by growth factors, and is involved in the 
regulation of translation activity. The dendritic translation of a subset of mRNAs 
involved in the protein-synthesis dependent induction of LTP is regulated by 
mTOR (Raught et al. 2001; Tang et al. 2002; Cammalleri et al. 2003).  mTOR is  a 
target of the immunosuppressant drug, and is inhibited by, rapamycin (Kunz et al. 
1993; Helliwell et al. 1994).  Rapamycin inhibits high frequency stimulation-
induced protein synthesis, long term facilitation in Aplysia and late-phase LTP in 
the hippocampus (Casadio et al. 1999; Tang et al. 2002; Cammalleri et al. 2003; 
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Karpova et al. 2006).  Figure 6.1 depicts a summary of the many ways that mTOR 
can be activated within cells. 
Downstream targets of mTOR mainly comprise those proteins involved in 
ribosome recruitment to mRNA.  4E-BP1 (eIF4E-binding protein) is a repressor of 
mRNA translation until it becomes phosphorylated, an enzymatic action carried out 
by mTOR.  eIF4E, a eukaryotic initiation factor that binds to the 5‘cap of mRNA 
allowing the 40S ribosomal subunit to bind (Gingras et al. 1999), is inhibited when 
bound by 4E-BP1 (Schmelzle & Hall 2000).  Phosphorylation of 4E-BP1, initially at 
Thr37 and Thr46 (Gingras et al. 1999), by mTOR releases it from eIF4E, allowing 
the initiation factor to bind with eIF4G, form a complex in association with eIF4A 
and permit translation (Haghighat et al. 1995; Marcotrigiano et al. 1999; Gingras et 
al. 1999). 
mTOR also phosphorylates and activates p70 ribosomal S6 kinase (S6K), which 
leads to translational activation and ultimately, cell growth (Montagne et al. 1999; 
Radimerski et al. 2002). p70 S6K phosphorylates the 40S ribosomal protein S6 
and allows the increased translation of mRNAs coding for components of the 
translational machinery, specifically the 5‘TOP (terminal oligopyrimidine tract) 
mRNAs, including all the ribosomal proteins and elongation factors (Schwab et al. 
1999; Gingras et al. 2001). 
Rapamycin blocks phosphorylation of mTOR and, therefore, 4E-BP1 and p70 S6K 
inactivation and activation respectively.  It has been demonstrated that both 4E-
BP1 and p70 S6K are inhibited/activated by rapamycin in vivo and phosphorylated 
by mTOR in vitro (Brunn et al. 1997; Burnett et al. 1998).  P70S6K or 4E-BP1 
phosphorylation can be used as an in vivo readout of mTOR activity. 
Utilising yeast di-hybrid systems, it has been found that mTOR interacts with both 
ubiquilin and gephyrin (Sabatini et al. 1999; Wu et al. 2002).  We reasoned that in 
PC-12 cells, containing no GABAARs, gephyrin and ubiquilin may modulate 
cellular signalling through mTOR.  To this end we monitored levels of phospho-4E-
BP1 and phospho-p70 S6K as an indication of mTOR activity. 
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Figure 6.1: A simplified diagram of the activation and downstream effects of mTOR on 
protein synthesis.  Growth factors activate receptors (R depicts the growth factor receptor) 
leading to the activation of many protein kinases and signalling pathways, ultimately culminating in 
the activation of mTOR.  eIF4E, an initiation factor, is inhibited when bound by its repressor 4E-
BP1.  The phosphorylation of 4E-BP1 by mTOR releases eIF4E and activates translation.  mTOR 
also phosphorylates the S6 kinase, activating translation.  Diagram produced from information 
reviewed in Hay and Sonenberg (2004) and Asnaghi et al. (2004). 
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6.2 Aims & Objectives 
 Investigate the effect of NMDA stimulation on the number of GABAA 
receptor 2/3 and 2 subunits localised to the plasma membrane of primary 
cultured cortical neurones. 
 Study the effects of altered zif268 expression on mTOR effectors, p70 S6 
kinase and 4E-BP1. 
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6.3 Results 
6.3.1 GABAAR  2/3 numbers are not altered in response to NMDA 
stimulation 
Primary cortical neurones were aged in vitro for 3 weeks as most GABAARs are 
expressed postnatally (Laurie et al. 1992) and inhibitory synapse maturation takes 
approximately 21 days in cultured hippocampal neurones (Craig et al. 1996; Levi 
et al. 2002).  
No effect of NMDA stimulation was found on the density of punctate GABAAR  
chain immunoreactivity when compared to vehicle treated cultured primary cortical 
neurones by immunocytochemistry (p>0.05, 2-way ANOVA, n=6; see figure 6.2 
and 6.3).  Specifically, there was no overall effect of treatment or time and no 
interaction between treatment and time.  However, there was a tendency for 
NMDA treatment to reduce the density of the labelled puncta at later time points.  
For normalisation and resultant statistical analysis, the log value of pixel intensities 
was used.  For graphs, all values are presented as percentages of vehicle treated 
cells. 
 
Figure 6.2: The effect of NMDA stimulation on the density of puncta immunoreactive for the 
GABAAR  chain in cultured cortical neurones.  Graph illustrating the effect of treatment of 3, 6 
or 24 hour stimulation of 100μM NMDA in 20mM KCl or vehicle on GABAA 2/3 subunits 
immunoreactivity of 21 DIV primary cultured cortical neurones as detected by 
immunocytochemistry. Results are presented as the number of puncta measured per square 
micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells  SEM, 
The effect of treatment, p>0.05, F(1,29)=1.20, 2-way ANOVA, n=6. 
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Figure 6.3: Images of GABAA  chains within cultured neurones after 6 hours NMDA 
stimulation.  A representative image comparing primary cultured cortical neurones (21 DIV) 
treated for 6 hours with 100 μM NMDA in 20 mM KCl (A) or vehicle (B), probed with anti- GABAA 
2/3 subunit antibody and visualised with a confocal microscope as per the immunocytochemistry 
protocol.  Arrows depict examples of the measured puncta within cells A and B.  Scale bar 15 μm. 
 
6.3.2 GABAA 2 subunits are downregulated in response to NMDA 
stimulation 
Using immunocytochemistry, an overall effect of NMDA treatment was found on 
the density of punctate GABAA 2 subunit immunoreactivity within cultured primary 
cortical neurones when compared to control (vehicle treated) cells (p<0.01 effect 
of treatment, F(1,11) = 9.16, 2-way ANOVA, factors: time and treatment, n=3; see 
figure 6.4).  There was no overall effect of time (p = 0.311, F(2,11) = 1.30) and no 
interaction between treatment and time (p = 0.257, F(2,11) = 1.54).  The log value 
of pixel intensities was used for normalisation and resultant statistical analysis.  
For graphical presentation all values are presented as percentages of control 
(vehicle treatment).  Figure 6.5 contains representative confocal images of primary 
cortical neurones treated with either vehicle or NMDA for 3 hours. 
A B 
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 Figure 6.4: The effect of NMDA stimulation on the density of puncta immunoreactive for 
GABAA 2 subunit in cultured cortical neurones.  Graph illustrating the effect of treatment of 3, 
6 or 24 hour stimulation of 100μM NMDA in 20mM KCl or vehicle on the GABAA 2 subunit 
immunoreactivity of 21 DIV primary cultured cortical neurones as detected by 
immunocytochemistry. Results are presented as the number of puncta measured per square 
micron and expressed as a mean percentage of the signal in control (vehicle-treated) cells  SEM, 
The effect of treatment #p<0.01, F(1,11)=9.16, 2-way ANOVA n=3. 
 
 
Figure 6.5: Images of GABAA 2 subunits within cultured neurones after 3 hours NMDA 
stimulation.  A representative image comparing primary cultured cortical neurones (21 DIV) 
treated for 6 hours with 100 μM in 20 mM KCl (A) or vehicle (B), probed with anti- GABAA 2 and 
visualised with a confocal microscope as per the immunocytochemistry protocol.    Arrows depict 
examples of the measured puncta within cells A and B.  Scale bar 15 μm. 
 
A B 
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6.3.3 Phosphorylation of mTOR targets is not altered in response to 
zif268 overexpression in PC-12 cells 
4E-BP1 and p70S6K phospho-protein levels within PC-12 cells transiently 
transfected with 1 g/mL full-length zif268 pre-treated with 50 ng/mL nerve growth 
factor show no effect compared to control (truncated) transfected cells as 
determined by western blotting (p>0.05, one sample t-test, n=3; see figures 6.6 A 
& B and 6.7 A & B).  
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Figure 6.6: The effect of zif268 on phospho-p70S6K protein levels in PC-12 cells.  A, 
Representative western blot comparing phospho-p70S6K immunoreactivity in PC-12 cells 
transiently transfected with either truncated or full-length zif268. B, Graph comparing phospho-
p70S6K protein levels from PC-12 cells transiently transfected with either truncated or full-length 
zif268 as determined by western blotting. Results are presented as phospho-p70S6K normalised 
pixel intensity. All data is expressed as a mean percentage of control  SEM, n=3. 
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Figure 6.7: The effect of zif268 on phospho-4E-BP1 protein levels in PC-12 cells.  A, 
Representative western blot comparing phospho-4E-BP1 (Thr37/Thr46) immunoreactivity in PC-12 
cells transiently transfected with either truncated or full-length zif268. B, Graph comparing 
phospho-4EB-BP1 protein levels from PC-12 cells transiently transfected with either truncated or 
full-length zif268 as determined by western blotting. Results are presented as phospho-4E-BP1 
normalised pixel intensity. All data is expressed as a mean percentage of control  SEM, n=3. 
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6.4 Discussion 
6.4.1 GABAAR density in response to NMDAR stimulation 
This chapter attempted to investigate the joint downstream effects of gephyrin and 
ubiquilin downregulated by an increase in zif268 levels.  Gephyrin is thought to 
mediate clustering and/or synaptic anchoring (Craig et al. 1996; Kneussel et al. 
1999a) and ubiquilin is involved in membrane trafficking of GABAARs (Bedford et 
al. 2001).  Hence it can be postulated that decreased expression of gephyrin and 
ubiquilin following zif268 induction might affect synaptic GABAAR levels.  
The application of NMDA for up to 24 hours produced no significant effect on the 
density of receptors containing the  chain.  However, receptors containing the  
subunit displayed an overall effect of NMDA treatment when compared to vehicle 
treated cells.   
The co-transfection of GABAAR 3 subunits and gephyrin into HEK293 cells 
causes the intracellular co-localisation of both elements (Kirsch et al. 1995), and 
co-expressing ubiquilin with receptors containing the 3 subunit creates co-
localised clusters below the plasma membrane (Bedford et al. 2001).  The 2 
subunit is necessary for GABAA receptor cell surface expression (Connolly et al. 
1996b), and therefore the extracellular antibody against the 2/3 subunits 
recognizes most GABAA receptor subtypes in cortical neurones and was used by 
Bedford et al. (2001) and Danglot et al. (2003) among many others. 
The  subunit, along with gephyrin, is critical for synaptic targeting (Essrich et al. 
1998), and so 2 subunits were visualised to look specifically at gephyrin clustering 
of GABAAR at synapses.  The antibody was utilised by O‘Sullivan et al. (2005) and 
was directed at extracellular sequences of the subunit and so only visualised those 
receptors at the cell surface.  Without the use of double labelling, we were not able 
to differentiate between synaptic and extrasynaptic GABAAR clusters, however, at 
21 DIV, 82.2% of gamma subunits are synaptically located (Danglot et al. 2003). 
A thorough investigation into the percentage of ubiquilin associated with GABAAR 
within or just below the synaptic membrane has not been published, however, 
90% of gephyrin clusters at 21DIV are synaptic and, although these were not 
always associated with the 3 subunit, only 1.8% of  subunits are localised at the 
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synapse without gephyrin (Danglot et al. 2003).  The fact that  2/3 clusters were 
not significantly affected by NMDA, but  subunits were, may be due to the fact 
that 33.4% of 2/3 clusters are extrasynaptic at 21 DIV whilst only 11.6% of 
clusters containing both gephyrin and  are extrasynaptic.  As gephyrin and 
ubiquilin are associated predominantly with the synapse, the higher percentage of 
extrasynaptic  2/3 subunits may have negatively affected the measured puncta.  
Alternatively, as  subunit containing GABAARs decreased, there could have been 
compensatory effects from other GABAARs containing  (e.g. 1), but not  
subunits, that served to maintain receptor numbers at the cell surface, and 
remained undetected in this particular experiment.  However, it is interesting to 
note that the GABAAR  subunit graph is strikingly similar to the gephyrin graph for 
NMDAR stimulation over 24 hours (Figures 6.4 and 4.8 respectively).  The results 
are therefore consistent with induction of zif268 following NMDAR activation 
leading to reductions in synaptic GABAARs via reduced gephyrin expression. 
Both gephyrin and ubiquilin are significantly downregulated after NMDA treatment 
in cultured cortical neurones (chapters 4 & 5).  As noted above, NMDA treatment 
will have many actions on neurones apart from zif268 induction and likely 
suppression of gephyrin and ubiquilin levels.  Therefore the reduced density of 
GABAAR-immunoreactive clusters observed (with the  subunit-specific antibody) 
cannot be unequivocally linked to the actions of zif268 via gephyrin and ubiquilin.  
Nevertheless, the hypothesis of reduced synaptic GABAAR density after NMDAR 
stimulation was generated on the basis of detection of gephyrin and ubiquilin as 
zif268 target genes, and the results are certainly consistent with, mediation by this 
pathway. 
It is possible that GABAARs within the cytoplasm after NMDA treatment will be in 
diffuse 'microclusters' throughout the cell and not ordered into synaptic clusters by 
gephyrin (Kneussel et al. 1999a).  It is known that the inhibition of gephyrin leads 
to dramatic decreases in GABAAR clusters (Essrich et al. 1998; Feng et al. 1998; 
Kneussel et al. 1999a).  Image J was used to detect immunoreactivity and allowed 
the enforcement of a threshold for relative optical density and mean puncta size, 
which was found empirically for each z-stacked image.  This makes it unlikely that 
micro-clusters would have been measured as they would be below the minimum 
size.  Although the assumption is that internalised receptors have not been 
measured, there is the possibility that they have in fact been counted and may 
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skew the results.  This would mean that the results presented are a global count of 
GABAARs, though they would still be in favour of receptor downregulation after 
NMDA induced zif268 activation.  In addition, immunocytochemistry can produce 
artefacts from the paraformaldehyde fixation of immunofluorescence procedures, 
and it is known that extracellular antibodies can have difficulty gaining access to 
synapses.  However, all the results presented were investigated blind, and the 
result for GABAAR  subunits show a significant (p<0.01) effect of NMDA 
treatment, suggesting that there is a genuine reduction in clustered GABAARs after 
NMDA treatment. 
A number of further experiments were planned to test whether zif268 can be 
unequivocally linked to the regulation of GABAAR density.  In particular,  subunit 
immunoreactive cluster density was to be assessed after transfection of cortical 
neurones with active or inactive zif268 and in cortical neurones cultured from 
wildtype or zif268 knockout mice.  However, following various technical problems, 
there was insufficient time for these studies. 
6.4.2 mTOR in response to changes in zif268 expression levels 
4E-BP1 and p70 S6K are downstream effectors of mTOR, promote cell growth 
(Schmelzle & Hall 2000), and are implicated in diseases such as cancer and 
diabetes (Vogt 2001).  Both are found at postsynaptic sites (Tang et al. 2002) and 
can be activated by the ERK pathway activating mTOR (Kelleher et al. 2004).  In 
addition, both are phosphorylated during hippocampal LTP.  Therefore, mTOR 
could be part of pathway that regulates protein synthesis during LTP.   
Phosphorylation of 4E-BP1 by mTOR dissociates it from eIF-4E, relieving the 
translational block; the concurrent phosphorylation of p70 S6K also increases 
protein synthesis.  Transient transfection of full-length zif268 in PC-12 cells had no 
effect on either phospho-4E-BP1 or phospho-p70 S6K when compared to 
truncated (control) zif268.  Transient transfection of zif268 in PC-12 cells 
significantly reduces mRNA levels of gephyrin and ubiquilin; in addition, 4E-BP1 
and p70 S6K have both been detected and activated in PC-12 cells in previous 
studies (Kleijn & Proud 2000).   
In rat embryos mTOR and gephyrin are expressed widely, with large amounts 
located to the CNS.  In rat brain they are localised to synaptic vesicles and 
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presynaptic membranes.  Sequence similarity between mTOR and the glycine 
receptor means that gephyrin can bind mTOR in this region.  Mutations in the 
mTOR binding region cannot bind gephyrin and subsequently do not activate 4E-
BP1 or p70 S6K, suggesting that gephyrin may be necessary for mTOR function in 
HEK293 cells.  In addition, gephyrin may control the localisation of mTOR in HeLa 
cells to cellular membranes (Sabatini et al. 1999).  We found no evidence to link 
decreased gephyrin levels with the mTOR effectors, 4E-BP1 or p70 S6K, in PC-12 
cells. 
Ubiquilin was found to bind to mTOR through a yeast 2-hybrid experiment, 
however, there seemed to be no evidence of cellular co-localisation, although both 
proteins were found to co-sediment in some fractions of membrane proteins.  
mTOR did not phosphorylate ubiquilin in vitro, ubiquilin does not effect mTORs 
phosphorylation of 4E-BP1 or p70S6K and therefore the functional activity remains 
unclear (Wu et al. 2002).  Our results also showed no effect of ubiquilin on mTOR, 
via 4E-BP1 or p70 S6K, in PC-12 cells. 
Rapamycin has been shown to inhibit zif268 expression in rat myoblast cells 
(Sarker & Lee 2004), and so mTOR can increase zif268 expression by activating 
p70 S6K. This suggests that zif268 is in fact a target of mTOR and may explain 
why we witnessed no effect of altering zif286 levels.  mTOR may activate its 
downstream effector, p70 S6K, and activate zif268 which would then decrease the 
levels of gephyrin and ubiquilin within the cells.  Bypassing mTOR activation by 
artificially increasing zif268 levels through transient transfection would then explain 
why no changes in mTOR were detected. 
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7 Novel gene urma is a downstream target of zif268 
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7.1  Introduction  
Bioinformatics is a vital discipline that provides the computational management of 
all kinds of biological information.  It has revolutionised our understanding of basic 
biological processes, and is a valuable tool capable of turning data into 
knowledge.  Database technologies and software tools enable the collection, 
display, storage and retrieval of large volumes of detailed and complex gene and 
protein sequence data which, when combined with molecular function, results in a 
considerable amount of information.  Bioinformatics can include DNA and protein 
sequences, genotype, expression microarray, protein structure and many other 
kinds of genetic and genomic data, which can be compared, interpreted and 
analysed through the use of a computer.  With genomics technologies generating 
experimental data ranging from gene sequences, to gene expression levels, to 
protein-protein interactions, it is possible to delineate preparatory functional 
genomics before physical experimentation. 
Known genes found on existing biological databases are derived from a range of 
expressed genes.  Undiscovered genes are expressed at very low levels, and only 
occur at certain developmental stages or are cell type specific.  The identification 
of these genes can include the approach of Expressed Sequence Tag (EST) 
analysis, whereby partial cDNA clones are sequenced from mRNA, ensuring the 
partial capture of expressed genes.  EST sequences can be found on the NCBI 
website (http://www.ncbi.nlm.nih.gov/) and generally represent 200–800 bp of 
sequence information extending towards the gene origin, usually from the mRNA 
3' end. 
Within microarrays, thousands of expressed gene cDNA tags are arrayed on a 
glass slide and incubated with labelled first-strand cDNA produced from cellular 
mRNA.  The subsequent hybridisation of the endogenous sequence to the 
complementary array-based sequence allows relative quantitation of expression 
levels within a given paradigm. This technology allows widespread changes in 
expression patterns to be probed in a single experiment. 
In 2005, James et al. published data from a microarray experiment performed on 
PC-12 cells and verified in primary hippocampal neurones.  Increased zif268 
protein levels were induced in a cell line by transfecting a plasmid construct 
containing the zif268 gene, whilst primary cultured neurones received NMDA in 
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the presence of KCl.  Known genes from the Affymetrix GeneChip® A were 
monitored, categorised, investigated and reported as downstream targets of 
zif268.  In addition to the published data, there were also GeneChips® B & C 
which, in contrast to the defined genes on GeneChip® A, mainly contained ESTs.  
Those tags affected by experimentation were subsequently identified as parts of 
known, or unknown, genes by bioinformatics (please see appendix). 
This chapter looks at two of these ESTs in greater detail as downstream targets of 
zif268 and presents one of them, AI169020, as a potential novel gene, named 
urma (from the Gaelic for ‗brand new‘). 
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7.2 Aims & Objectives 
 Investigate all of the ESTs significantly altered in the microarray experiment 
performed by James et al. (2005). 
 Select interesting ESTs for further investigation as potential novel genes. 
 Determine the exact locus and sequence of any prospective novel gene 
candidates. 
 Complete bench work performed on PC-12 cells and primary cortical 
neurons to validate any predictions. 
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7.3 Results 
7.3.1 Microarray results present 144 ESTs as downstream targets of 
zif268 
Significant Analysis of Microarrays (SAM) software (Tusher et al. 2001) was 
utilised to calculate the expression levels of mRNA extracted from full-length 
zif268 transfected PC-12 cells compared to a transfections with a control 
(truncated) form of zif268 (as published by James et al. (2005)).  SAM allows the 
false positive rate to be set by the user, permitting the selection of the number of 
candidate genes with respect to the likelihood of false positives.  On Genechips B 
& C, 72 ESTs were selected on each chip with a false discovery rate of 7.02 and 
1.26 respectively.  This means that, of the 144 ESTs affected by treatment, 
approximately 8 of them are likely to be false positives. 
Each of the ESTs was investigated in turn and the results are detailed in the 
appendix.  After the retrieval of EST sequence data from NCBI 
(www.ncbi.nim.nih.gov/), tags were compared to the Rattus norvegicus genome as 
detailed on Ensembl in January 2004 (www.ensembl.org) by BLAST analysis.  
Criteria were set allowing the identity of ESTs to be revealed as part of a known 
and annotated gene or as an unknown transcript as detailed in Chapter 2.  From 
this list, AI169020 and AI176839 were highlighted as potentially interesting.  
AI176839 is found on Rattus norvegicus chromosome 3q42, which shows high 
synteny with Homo sapiens chromosome 20q13, whilst AI169020 is located on 
Rattus norvegicus chromosome 4q13, which shows high synteny with Homo 
sapiens chromosome 7q21.2.  Furthermore, ESTs AA998964 and AI112362 were 
also highlighted, due to minimal information regarding their origin and their close 
proximity to one another (4q13, between 27.98MB and 28.16MB), suggesting that 
they may be part of one transcript.  AA998964 and AI112362 are currently under a 
separate investigation and will not be dealt with in this thesis. 
7.3.2 AI176839 is down regulated in PC-12 cells after transient 
transfection of full-length zif268 
In the first instance, results from the microarray were verified in PC-12 cells by 
repeating the transient transfection performed by James et al. (2005).  mRNA was 
harvested and primers designed against the EST were used to produce an 
amplicon of approximately 209 bps.  The sequence of AI176839 is detailed in 
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figure 7.1 along with the primer locations.  RNA expression is significantly 
downregulated in PC-12 cells transiently transfected with 1 g/mL full-length zif268 
when compared to cells transiently transfected with 1 g/mL of a control truncated 
zif268 (one sample t-test, p<0.001, n=5; see figure 7.2).  A single cycle within the 
logarithmic linear phase was taken and GAPDH values were used to normalise the 
data.  This gave a 50% reduction in AI176839 RNA in PC-12 cells transiently 
transfected with full-length zif268 compared to control. 
 
Figure 7.1:  cDNA sequence data for EST AI176839.  This data was detailed in and retrieved 
from the NCBI website (http://www.ncbi.nlm.nih.gov/).  Sequence data in bold represents the 
forward primer location and underlined sequences represent reverse primer targets. 
  
Figure 7.2:  The effect of zif268 transfection on AI176839 RNA in PC-12 cells.  Graph 
comparing EST AI176839 RNA from PC-12 cells transiently transfected with either truncated or full-
length zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented 
as AI176839 normalised pixel intensity after normalisation to the corresponding GAPDH value.  All 
data is expressed as a mean percentage of control  SEM, **p<0.001, one sample t-test, n=5. 
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7.3.3 AI176839 is downregulated in primary cortical neurones after 
NMDA stimulation to induce zif268 
NMDA stimulation (100µM NMDA in 20mM KCl) of cultured primary cortical 
neurones for 6 hours displayed a statistically significant downregulation of 
approximately 10% in EST AI176839 RNA levels when compared to vehicle as 
determined by RT-PCR (ANCOVA, p<0.05, F(1,16)=6.48, n=4; see figure 7.3).  A 
window of 5 PCR cycles within the logarithmic phase of the PCR reaction was 
established empirically for both AI176839 and the co-variate, GAPDH.   
In contrast, evaluating RNA levels after 24-hour stimulation of primary cortical 
neurones with NMDA, EST AI176839 RNA is not significantly different from 
primary cortical neurones treated with vehicle for 24 hours (p=0.606, F(1, 16) = 
0.28, n=3, see figure 7.4). 
 
Figure 7.3:  The effect of 6 hour NMDA stimulation on AI176839 RNA levels in primary 
cortical neurones.  Graph illustrating AI176839 ln pixel intensity as a function of GAPDH ln pixel 
intensity, as determined by RT-PCR of cultured primary cortical neurones stimulated for 6 hours 
with either 100µM NMDA in 20mM KCl or Vehicle.  ANCOVA, #p<0.05, F(1, 16) = 6.48, n=4. 
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Figure 7.4: The effect of 24 hour NMDA stimulation on AI176839 RNA levels in primary 
cortical neurones.  Graph illustrating AI176839 ln pixel intensity as a function of GAPDH ln pixel 
intensity as determined by RT-PCR of cultured primary cortical neurones stimulated for 24 hours 
with either 100µM NMDA in 20mM KCl or Vehicle.  ANCOVA, p>0.05, F(1, 16) = 0.28, n=3. 
 
7.3.4 AI169020 may be part of novel predicted transcript 
ENSRNOT00000012253 
AI169020 is found on chromosome 4 between genomic locations 27305926 and 
27306502 bases.  In 2005, further investigation of AI169020 with Ensembl version 
34 suggested that it might be part of the novel predicted transcript 
ENSRNOT00000012253, which was a transcript of gene 
ENSRNOG00000009163.  This was due to the fact that many ESTs were found in 
the area of the genome between and including EST AI169020 and transcript 
ENSRNOT00000012253, with very little known annotated data (see figure 7.5).  In 
addition, a genscan prediction (Burge & Karlin 1997) was present within the same 
genomic contig.  Data mining Ensembl for all the orthologue predictions of 
ENSRNOT00000012253 led to the Mus musculus gene prediction NM_026583 
(ensembl gene identifier ENSMUSG00000058503) on chromosome 5A1, which 
led to Homo sapiens gene XP_376148.1 (Ensembl known gene prediction 
ENSG00000183055, transcript ENST00000332869) on chromosome 5q12.1, 
which in turn was linked to protein reference sequence NP_690002.1.  This 
referred to a hypothetical protein LOC257415 isoform 1 [Homo sapiens] from gene 
"MGC40405". 
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In order to find the reference and original data from which this information was 
derived, NCBI was consulted and 'Homo sapiens hypothetical protein MGC40405 
(MGC40405), mRNA' (744 bp) found.  However, this had the gene identifier 
NM_152789 and the nucleotide sequence for translation to predicted protein 
LOC257415 (XP_376148.1, Ensembl gene identifier ENSG00000183055; 
transcript ENST00000332869) is not the same nucleotide sequence as 
NM_152789.  In addition, the nucleotide sequence was placed on Homo sapiens 
chromosome 7 (7q21.1) by NCBI and not 5 (5q12.1) as per Ensembl.  However, 
on UniProt (www.ebi.uniprot.org) hypothetical protein MGC40405 (their entry 
name and accession number Q8N0W8) was placed on chromosome 7q21.3.  
 
Figure 7.5: BLAST analysis of AI169020 on Ensembl.   A screengrab of the genomic area 
surrounding EST AI169020.  Of note are the highlighted ESTs and GENSCAN gene.  In addition, 
the predicted transcript ENSRNOT00000012253 is also of interest.  
 
Further investigation uncovered a protein LOC257415 isoform 2, which displayed 
a marked similarity to the predicted protein of transcript ENSRNOT00000012253 
and to protein MGC40405 (see figure 7.6). 
The information for hypothetical protein MGC40405 was derived from human brain 
tissue mRNA and submitted to EMBL/GenBank/DDBJ databases and published by 
Strausberg et al. (2002) and Scherer et al. (2003).  The nucleic acid records are 
supported by experimental data however the protein sequence is predicted.  
Performing a BLAST search with MGC40405 nucleotide sequence against the rat 
AI169020 
ENSRNOT00000012253 
ESTs 
GENSCAN 
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genome places it in the same vicinity as AI169020 and ENSRNOT00000012253, 
highlighting this genomic area of interest (see figure 7.7).  In addition, BLAST 
searching the MGC40405 nucleotide sequence against the human genome places 
it on chromosome 7q21.2.  
 
Figure 7.6: Sequence data for transcript ENSRNOT00000012253, LOC257415 and MGC40405.  
A list of information presented for transcript ENSRNOT00000012253 and its predicted protein 
along with the information it was derived from, LOC257415 isoform 1 (as found on 
www.ensemble.org).  In addition, the sequence data for protein LOC257415 isoform 2 and the 
nucleotide and predicted protein sequence of MGC40405 (as found on www.ncbi.nim.nih.gov/). 
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Figure 7.7: A BLAST search of the MGC40405 nucleotide sequence.  A screen grab from an 
Ensembl BLAST search of MGC40405 places the sequence in the same genomic area (4q13) as 
the EST AI169020 and the transcript of interest, ENSRNOT00000012253. 
The accumulation of contradictory evidence suggested that, in contrast to the 
information presented by Ensembl, the protein sequence was actually that of 
LOC257415 variant 2, not variant 1 and the MGC40405 protein was localised to 
chromosome 7.  Overall, there is the implication that this is indeed an area of 
interest with little verified data, warranting further investigation. 
7.3.5 AI169020 is not significantly downregulated in PC-12 cells after 
transient transfection with zif268 
The microarray transient transfections were repeated in PC-12 cells by replicating 
the experiments performed by James et al. (2005).  The sequence of AI169020 is 
detailed in figure 7.8 along with the primer locations.  RNA expression was not 
significantly affected in PC-12 cells transiently transfected with 1 g/mL full-length 
AI169020 
ENSRNOT00000012253 
MGC40405 
BLAST 
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zif268 when compared to cells transiently transfected with 1 g/mL of a control 
truncated zif268 (n=5; see figure 7.9) although there was a tendency for 
decreased expression in the zif268-transfected cells. 
7.3.6 AI169020 and ENSRNOT00000012253 primers produce an 
amplicon from PC-12 cells RNA 
Using RNA extracted from PC-12 cells, several reactions were simultaneously 
monitored via PCR for 45 cycles.  EST AI169020 forward and reverse primers 
produced a predicted amplicon of 148 bps and ENSRNOT00000012253 forward 
and reverse primers (Tr12253 Fwd and Rev) produced a predicted amplicon of 
371 bps, with the addition of minor products, when electrophoresed on a 1.5% 
agarose gel.   
 
Figure 7.8: cDNA sequence data for EST AI169020.  This data was detailed and retrieved from 
the NCBI website (http://www.ncbi.nlm.nih.gov/).  Sequence data in bold represents the forward 
primer location and underlined sequences represent reverse primer targets. 
 
 
Figure 7.9: The effect of zif268 transfection on AI169020 RNA in PC-12 cells.  Graph 
comparing EST AI169020 RNA from PC-12 cells transiently transfected with either truncated or full-
length zif268, as assessed by signal intensities at a single RT-PCR cycle.  Results are presented 
as AI169020 normalised pixel intensity after normalisation to the corresponding GAPDH value.  All 
data is expressed as a mean percentage of control  SEM, n=5. 
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In addition, the forward primer of AI169020 and Tr12253 Fwd (the sequences are 
presented on opposite strands) produced an amplicon of approximately 1,200 
base pairs with a minor product at approximately 570 bps.  As negative controls, 
the Tr12253 Fwd and Rev primers and the AI169020 Fwd and Tr12253 Fwd were 
also investigated with no cDNA present.  The Tr12253 Fwd and Rev primers 
produced no bands (see figure 7.10), however, the AI169020 Fwd and Tr12253 
Fwd produced a minor band of a few tens of bases, which is likely to be primer-
dimers.   
 
Figure 7.10: Agarose gel image of the novel product PCR fragment.  PCR amplified products 
electrophoresed on a 1.5% agarose gel after 45 cycles.  M, 100 bp DNA marker (Promega, 
Southampton, UK), 1, EST AI169020 forward & reverse primers, 2, Tr12253 forward & reverse 
primers, 3, EST AI169020 forward & Tr12253 forward primers, 4, ENSRNOT12253 forward & 
reverse primers, no cDNA, 5, EST AI169020 forward & Tr12253 forward primers, no cDNA. 
 
7.3.7 AI169020 and ENSRNOT00000012253 primers produce a novel 
transcript from adult rat cerebral cortex mRNA 
cDNA was generated from rat cerebral cortex tissue using Oligo(dT), which 
hybridises to 3‘ poly(A) tails, ensuring that only expressed mRNAs were used as 
template.  The cDNA was then amplified with AI169020 and Tr12253 Fwd primers 
for 45 cycles in order to generate enough product to sequence.  Previous attempts 
at PCR had unfortunately necessitated such a high number of cycles in order to 
achieve the cDNA concentration required.  Primers were designed utilising a 
predicted sequence of the novel gene ascertained from EST and predicted gene 
information.  Firstly, all the ESTs present between AI169020 and transcript 
M 
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ENSRNOT00000012253 were collated in order from 5‘ to 3‘ (using the AI169020 
sense strand to orientate).  This comprised ESTs BF542993, CF977261, 
CB765971, BF288214 and BF522287, none of which were present on the 
Affymetrix GeneChips and therefore were not present in the microarray 
experiment (James et al. 2005).  Sequential BLAST analyses were performed to 
find overlapping regions of sequence, allowing all 6 ESTs (including AI169020) 
and ENSRNOT00000012253 to form a coherent single theoretical cDNA strand.  
This created 1414 bps of theoretically expressed sequence, which was used as 
the basis of the novel transcript (see figure 7.11 A & B).  Primers were designed 
using this information and sequenced from AI169020 as the lead primer (as this 
was the originally affected transcript from the microarray experiment).  The actual 
sequence returned contained a number of bases denoted ‗N‘, which were 
manually identified by scrutinising the chromatogram and verifying with the details 
found on NCBI (see figure 7.12 A & B).  However, the sequencing company only 
provided a single read and, combined with any PCR-introduced errors, it is 
possible that the DNA sequence may contain some inaccuracies.  The sequence 
returned comprised 1477 bases and showed approximately 90% homology to the 
predicted sequence (figure 7.12 C), suggesting the discovery of a novel gene 
which I propose to call urma.   
7.3.8 Urma may code for a novel transcription factor of unknown 
function 
With the addition of the AI169020 EST and Transcript ENSRNOT00000012253 
sequences outwith the primers, the total length of urma identified is 1879 bases.  
As AI169020 is a 3‘ EST, the correct orientation is on the complementary strand to 
that sequenced. 
By running the entire nucleotide sequence through two different websites ExPASy 
and ATGpr (Nishikawa et al. 2000) (http://ca.expasy.org/tools/dna.html and 
http://www.hri.co.jp/atgpr/ respectively; see figure 7.13) the results returned were 
exactly the same and therefore, the predicted protein sequence of urma is: 
MNPIAMARSRGPIQSSGPTIQDYLNRPRPTWEEVKEQLEKKKKGSKALAEFEEKMNENWKKELEKH
REKLLSGNESSSKKRQKKKKEKKKSGRYSSSSSSSSDSSSSSSDSEEEDKKQTKRRKKKKSHCHKS
PETSVSDSDSDSKDGSKKKKKSKDITEREKDTKGLSKKRKMYEDKPLSSESLSESDCGEVQAKKKK
SGEERERTTDKAKKRRKHKKHSKKKKKKAASSSSDSP 
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A 
1. AI169020 
AAAACAAGTG TTTACTAAAA TTCTGGCAAT AGCTTTATGT AACAAGATAC AGCATACCAG 
GCCTGCCACT CAACTTGTTT GTGGTAAGTC TCAGCTTCAA ATGAAGCCGT AAAAACAAAA 
ACCAAAAGTC TGCTTTTTAA TGCTAAATAT TTGAAAGTGT CCATTAAACA AGTTATGAAC 
TTAAGACAGA AGAGTTAGTA AAAGCTAAAC CTGCAGCCTA ACAAAGTTTA ACAAAACATG 
AAGTGTCTAC ACTGGCTACT AAAAATCTCC GACTGGTTAA ACTTGTGTAA ACATGCGCTT 
TACAACTGTA GCTGTCAAGT CAGAAAGTAC AGTGTCTACT AACCATCCCT TCCAAAGCCA 
AGTGTAGTCA AAATGAATTA AATGACGCAA ACAACGTAAC CTAAAAACAT CAGTTATTAT 
TGATGTGGAG TAATTCCAGG CTTTGGGGGC TTCTCATGCT CAAAGGGCCG GTACCTCTGG 
TTCATTCCAA GCAGCTTACG ACAAAGTCTA AGGATGTCAT TAACCTCAGT CAGGGCAGGA  
CTGAC  
 
2. BF542993 
CACGAGGTTT GACTACACTT TGGCTTTGGA GAGGGATGGT TTAGTACACA CTGGTACTTT 
CTGAGCTTGA CAGCTGACAG TTGTAAAGCG CATGTGTTAC ACAAGTTTTA ACCAGTCAGG 
AGATTTCTAC GTAGCCAGTG ATAGACACTT CATGTTTTGT ATAAACTTTG TTTAGGCTGC 
AGTGTTTAGC TTTTAACTAA CTCTTGCTGT CTTAAGTTCA TAACTATGTT TAATGGCACA 
CTTTCAAGAT ATTTAGCATG TAAAAAGCAG GACTTTTGGT TTTTGTTTTT AACGGCTTCA 
TATTGAAGCT GAGACTTACC ACAAACAAGT TGAGTGGCAG GCCTGGTATG CTGTATCTTG 
TTACATAAAG CTATTGCCA 
 
3. CF977261 
GGGGAACTGA ATCTGGATCC ATCTTTTAAG ATGTAACCAG AAATAACGAG TAAAGATTTT 
CAAAGTAGGG ATTTCATTAA TATTTCAAAA TCCTTACTCT GTAGATAAGT ATATTTTAAT 
TTTTCCCCAC GTATGCTTTG ATTTACTTGG GGAAGGAGCT TTTAAAGAGG GGGTGGTTTG 
CTATCTCTTT AGCTACCAGA ACAGCGTGCC TTTGATCTCA CACATCCTAC TTTTGTGGAC 
ACAGTAGCCA TGCTTCCTGG GAGGACAGAG CTGGGCACGG TCAGTCCTGC CCTGACTGAG 
GTTAATGACA TCCTTAGACT TTGTCGTATG CTGCTTGGAA TGAACCAGAG GTACCCGGCC 
CTTTGCAGCA TGAGAAAGCC CCCAAAGCTC TGGAATTACC TCCACATCAA TAATAACTGA 
ATGTTTTTAG GGTTACGTTG TGTTGCGTCA TTTGAATTCA TTTTGACTAC ACTTTGGCTT 
TGGAGAGGGA TGGTTTAGTA AACACTGGTA CTTTCTGAGC TTGACAGCTG ACAGTTGTAA 
AGCGCATGTG TTACACAAGT TTTAACCAGT CAG 
 
4. CB765971 
CGTAGCATCC AGAAGACCAG GGTCCTTACA GAGTGCAATG TCAAAGGAGC TCTCAACTGT 
GAAGATTATG ACTTACTTAG TAACGTGCAT GAATCCCCTT GTTTTTAGAC TTGTCCTGGA 
CTAGTCAGTA GTCACTTGGA TTCCGCTGTG TGAAGGGCCA TGAATGTTGC CTGCTGCTTG 
AACACCTTTT CCTCTTCCAG TGCTTGGTGA CTCTGGGAGA TAGTACTTTG CAGTCATACT 
AGTGGTTAAG ATATTTGGAA TAAAGCTAAT ATTTTTTACT AGAAGTACTT AAGAATAAAT 
CAACAGGAAC TGAATCTGGA TCCATCTTTT AAGATGTAAC CAGAAATAAC GAGATGACTC 
TAGTAAAGAT TTTCAAAGTA TGGATTTCAT TAATATTTCA AAATCCTTAC TCTGTAGA 
 
5. BF288214    
CAGTTCCTGT TAATTTATTC TTAAGTACTT CTAGTAAAAA ATATTAGCTT TATTCCAAAT 
ATCTTAACCA CTAGTATGAC TGCAAAGTAC TATCTCCCAG AGTCACCAAG CACTGGAAGA 
GGAAAAGGTG TTCAAGCAGC AGGCAACATT CATGGCCCTT CACACAGCGG AATCCAAGTG 
ACTACTGACT AGTCCAGGAC AAGTCTAAAA ACAAGGGGAT TCATGCACGT TACTAAGTAA 
GTCATAATCT TCACAGTTGA GAGCTCCTTT GACATTGCAC TCTGTAAGGA CCCTGGTCTT 
CTGGATGCTA CGGCGAGTCT GAGCTTGAAC TGGCAGCCTT CTTTTTCTTC TTCTTGCTGG 
GTTTCTTATG CTTCCTTCTC TTTTTAGCTT TGTCTGTTGT TCTCTCTCGC TCTTCACCGC 
TTTTCTTCTT TTTCGCTTGC ACCTCTCCAC AGTCTGACTC TGACAATGAC TCANC 
 
6. BF522287 
CACGAGGGCT TTGTTGAGCT TTTGTGGGAG GGAAATGGCT TTGATATTTT AGTTTCTAAA 
TCCTGTGAAT ATGGCATCTG TTTCTTAGAC ACTAGATTGA TTTCACTAAG TGCTTGAGAG 
ACTTAGTAAA AGAAACCAAT TCCTGCATCT CACAAGCTTT AATTGTTTTG TGCTTGGTCA 
AGTATTCATC TTCTTCTTCA TCGAGCTCTG ATTCTTCCAG CAGTTCTTCA GATTCTGAGG 
AGGAGGATAA AAAGCAAACA AAAAGAAGGA AGAAAAAGAA GAGCCATTGC CATAAGTCTC 
CGGAGACCTC CGTGTCGGAT TCAGACTCAG ACAGCAAGGA CACTAAAGGA CTCAGCAAAA 
AGAGAAAGAT GTATGAGGAT AAACCTTTGT CATCTGAGTC ATTGTCAGAG TCAGACTGTG 
GAGAGGTGCA AGCGAAAAAG AAGAAAAGCG GTGAAGAGCG AGAGAGAACA AC 
 
7. ENSRNOT00000012253 
ATGGGGAAGC GAGACAATCG CGTGGCCTAC ATGAATCCAA TAGCAATGGC TCGGTCAAGG  
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GGTCCAATCC AGTCTTCAGG ACCAACAATC CAGGATTATC TGAATCGACC AAGGCCTACC 
TGGGAGGAAG TGAAGGAGCA GCTGGAAAAG AAAAAGAAGG GCTCCAAGGC TTTGGCTGAG 
TTTGAAGAGA AAATGAATGA GAATTGGAAG AAAGAACTAG AAAAACATAG AGAAAAACTA 
TTAAGTGGAA ATGAGAGCTC ATCCAAAAAG CGACAGAAAA AGAAAAAAGA AAAGAAGAAA 
TCTGGTAGGT ATTCATCTTC TTCTTCATCG AGCTCTGATT CTTCCAGCAG TTCTTCAGAT 
TCTGAGGAGG AGGATAAAAA GCAAACAAAA AGAAGGAAGA AAAAGAAGAG CCATTGCCAT 
AAGTCTCCGG AGACCTCCGT GTCGGATTCA GACTCAGACA GCAAGGTGAG ACTCAGCCCT 
GGACTGCTGA GAGCAAAAAC AGCCATTTTC CTGTCTGCTT TTCCTGTCTA GCGCTTCAGT 
TAGAAAGCAC ATTTGATTTC ATTTTTGGAT TTTTGAGACA GAGTTTTTCT CTGTATAGAC 
CTAGATCAGG CTGGCCTCAA AGTCACTGAG ATCCAACCTG CCTTCCTGTG CAGCCTGAGT 
GCTGGCACTA AAGGGGTGCA CTAGCACCAC CACTCCCAGC CACATTTGAC TTTTGTACTT 
TGAGGTTCTG CACCAGTCGA CAGGTGTATT TAATATTGTA CATGTAGCAT CTTTTTATCC 
TTTATTCTTC ATATGCATGT TTGTATGATT CCATGATAGT GTTTCCTTTG TTTGTAAAAT  
AATATTTGCA ATTCTAGGTT 
 
B 
 
 
Figure 7.11: Sequence data for the predicted transcript of urma.  A, The sequences of ESTs 
AI169020, BF542993, CF977261, CB765971, BF288214, BF522287 and transcript 
ENSRNOT00000012253 in genomic order.  B, The collated sequence of the predicted urma 
transcript after sequential BLAST analyses of the ESTs presented in A.  Primer locations of 
AI169020 forward and Tr12253 forward are in bold.  Additional primers for sequencing are 
underlined.  
 
This protein sequence is 86% homologous to the protein sequence detailed for 
ENSRNOT00000012253 on Ensembl and 86% homologous to that of MGC40405 
as detailed by NCBI (with areas of similarity differing slightly).  Upstream EST 
sequences to that of urma (CF977260 and BF393377) were collated and added to 
the 5‘end and the extended sequence run through both protein prediction websites 
again.  This did not alter the translation start site of the protein, suggesting that the 
true translational start site has indeed been located. 
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As a control, the Rattus norvegicus gephyrin genome sequence (as detailed on 
NCBI, accession number NM_022865) was entered into the ATGpr website.  A 
protein sequence with 99% homology to the experimentally derived protein 
sequence detailed on NCBI, accession number NP_074056, and with the correct 
translational start site, was retrieved. 
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C 
1 _________________________NNNNNNNNNNNNNANNANNTTNN 
1 CAAAATGAATTCAAATGACGCAACACAACGTAACCCTAAAAACATTCA 
 
GTTATTATTGATGTGGAGGTAATTCCAGAGCTTTGGGGGCTTTCTCATGCTGCAAAGGGCCGGGTACCT 
GTTATTATTGATGTGGAGGTAATTCCAGAGCTTTGGGGGCTTTCTCATGCTGCAAAGGGCCGGGTACCT 
 
CTGGTTCATTCCAAGCAGCATACGACAAAGTCTAAGGATGTCATTAACCTCAGTCAGGGCAGGACTGAC 
CTGGTTCATTCCAAGCAGCTTACGACAAAGTCTAAGGATGTCATTAACCTCAGTCAGGGCAGGACTGAC 
 
CGTGCCCAGCTCTGTCCTCCCAGGAAGCATGGCTACTGTGTCCACAAAAGTAGGATGTGTGAGATCAAA 
CGTGCCCAGCTCTGTCCTCCCAGGAAGCATGGCTACTGTGTCCACAAAAGTAGGATGTGTGAGATCAAA 
 
GGCACGCTGTTCTGGTAGCTAAAGAGATAGCAAACCACCCCCTCTTTAAAAGCTCCTTCCCCAAGTAAA 
GGCACGCTGTTCTGGTAGCTAAAGAGATAGCAAACCACCCCCTCTTTAAAAGCTCCTTCCCCAAGTAAA 
 
TCAAAGCATACGTGGGGAANAATTAAAATATACTTATCTACAGAGTAAGGATTTTGAAATATTAATGAA 
TCAAAGCATACGTGGGGAAAAATTAAAATATACTTATCTACAGAGTAAGGATTTTGAAATATTAATGAA 
 
ATCCCTACTTTGAAAATCTTTACTAGAGTCATCTCGTTATTTCTGGTTACATCTTAAAAGATGGATCCA 
ATCCCTACTTTGAAAATCTTTA__________CTCGTTATTTCTGGTTACATCTTAAAAGATGGATCCA 
 
GATTCAGT_________TCCTGTTGATTTATTCTTAAGTACTTCTAGTAAAAAATATTAGCTTTATTCC 
GATTCAGTTCCCCCAGTTCCTGTTAATTTATTCTTAAGTACTTCTAGTAAAAAATATTAGCTTTATTCC 
 
AAATATCTTAACCACTAGTATGACTGCAAAGTACTATCTCCCAGAGTCACCAAGCACTGGAAGAGGAAA 
AAATATCTTAACCACTAGTATGACTGCAAAGTACTATCTCCCAGAGTCACCAAGCACTGGAAGAGGAAA 
 
AGGTGTTCAAGCAGCAGGCAACATTCATGGCCCTTCACACAGCGGAATCCAAGTGACTACTGACTAGTC 
AGGTGTTCAAGCAGCAGGCAACATTCATGGCCCTTCACACAGCGGAATCCAAGTGACTACTGACTAGTC 
 
CAGGACAAGTCTAAAAACAAGGGGATTCATGCACGTTACTAAGTAAGTCATAATCTTCACAGTTGAGAG 
CAGGACAAGTCTAAAAACAAGGGGATTCATGCACGTTACTAAGTAAGTCATAATCTTCACAGTTGAGAG 
 
CTCCTTTGACATTGCACTCTGTAAGGACCCTGGTCTTCTGGATGCTACGGCGAGTCTGAGCTTGAACTG 
CTCCTTTGACATTGCACTCTGTAAGGACCCTGGTCTTCTGGATGCTACGGCGAGTCTGAGCTTGAACTG 
 
GCAGCCTTCTTTTTCTTCTTCTTGCTGTGTTTCTTATGCTTCCTTCTCTTTTTAGCTTTGTCTGTTGTT 
GCAGCCTTCTTTTTCTTCTTCTTGCTGGGTTTCTTATGCTTCCTTCTCTTTTTAGCTTTGTCTGTTGTT 
 
CTCTCTCGCTCTTCACCGCTTTTCTTCTTTTTCGCTTGCACCTCTCCACAGTCTGACTCTGACAATGAC 
CTCTCTCGCTCTTCACCGCTTTTCTTCTTTTTCGCTTGCACCTCTCCACAGTCTGACTCTGACAATGAC 
 
TCAGATGACAAAGGTTTATCCTCATACATCTTTCTCTTTTTGCTGAGTCCTTTAGTGTCCTTTTCTCTT 
TCAGATGACAAAGGTTTATCCTCATACATCTTTCTCTTTTTGCTGAGTCCTTTAGTGTCCTT_______ 
 
TCNNTTATATCCTTTGACTTCTTTTTCTTTTTTGAACCATCCTTGCTGTCTGAGTCTGAATCCGACACG 
____________________________________________GCTGTCTGAGTCTGAATCCGACACG 
 
GAGGTCTCCGGANACTTATGGNANTGGCTCTTCTTTTTCTTCCTTCTTTTTGTTTGCTTTTTATCCTCC 
GAGGTCTCCGGAGACTTATGGCAATGGC__________________________________ATCCTCC 
 
TCCTCAGAATCTGAAGAACTGCTGGAAGAATCAGAGCTCGATGAAGAAGAAGATGAATACCTACCAGAT 
TCCTCAGAATCTGAAGAACTGCTGGAAGAATCAGAGCTCGATGAAGAAGAAGATGAATACCTACCAGAT 
 
TTCTTCTTTTCTTTTTTCTTTTTCTGTCGCTTTTTGGATGAGCTCTCATTTCCACTTAATAGTTTTTCT 
TTCTTCTTTTCTTTTTTCTTTTTCTGTCGCTTTTTGGATGAGCTCTCATTTCCACTTAATAGTTTTTCT 
 
CTATGTTTTTCTAGTTCTTTCTTCCAATTCTCATTCATTTTCTCTTCAAACTCAGCCAAAGCCTTGGAG 
CTATGTTTTTCTAGTTCTTTCTTCCAATTCTCATTCATTTTCTCTTCAAACTCAGCCAAAGCCTTGGAG 
 
CCCTTCTTTTTCTTTTCCAGCTGCTCCTTCACTTCCTCCCAGGTAGGCCTTGGTCGATTCAGATAATCC 
CCCTTCTTTTTCTTTTCCAGCTGCTCCTTCACTTCCTCCCAGGTAGGCCTTGGTCGATTCAGATAATCC 
 
TGGATTGTTGGTCCTGAAGACTGGATTGGACCCCTTGACCGAGCCATTGCTATTGGATTCATGTAGGCC 
TGGATTGTTGGTCCTGAAGACTGGATTGGACCCCTTGACCGAGCCATTGCTATTGGATTCATGTAGGCC 
 
ACGCGATTGTCTAA 
ACGCGATTGTCT 
Figure 7.12: Sequencing data from urma transcript. A, The collated sequence returned from 
Geneservice (Cambridge, UK). B, Sequence information of urma once the N‘s have been replaced 
with bases derived from the chromatograms and NCBI.  C, Alignment of the predicted sequence 
(from figure 7.11B) (in red text) and the actual sequence (from A) (in black text).  
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Figure 7.13: Predicted protein sequence of urma.  A, The predicted protein sequence of urma 
as returned from ExPASy.  B, The predicted protein sequence of urma as returned from ATGpr.   
The urma protein sequence is not predicted to span the cell membrane nor be 
secreted, as per the Centre for Biological Sequence Analysis 
(http://www.cbs.dtu.dk/services/TMHMM/).  Presumably, this implies that urma 
does not contain a hydrophobic membrane-spanning domain.  Furthermore, when 
investigated using the PredictProtein website (http://www.predictprotein.org), urma 
is predicted to contain 7 cAMP- and cGMP-dependent protein kinase 
phosphorylation sites and 7 PKC phosphorylation sites.  In addition, it may be 
localised to the nucleus and bind to DNA, as various nuclear localisation signals 
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and DNA binding domains were identified throughout the protein sequence.  
These data suggest that urma may be a transcription factor. 
Although the translation start site is predicted, the transcription initiation site has 
still to be elucidated.  However, by examining 11,000 base pairs of the rat genome 
upstream of the translation start site, we reasoned that any exons, introns and the 
promoter region would be included.  Using Signal Scan 
(http://thr.cit.nih.gov/molbio/signal/) to investigate, we found evidence of 3 TATA 
boxes, 2 CAAT boxes, 1 CREB site and 1 zif268 binding site with an overlapping 
Sp-1 recognition sequence, all within 2000 base pairs of each other (see figure 
7.14). 
7.3.9 Urma is significantly downregulated in primary cortical neurons 
after zif268 induction by NMDA stimulation 
The predicted protein results were used to design primers within the coding region 
of urma.  These were used to monitor effects within that part of the transcript that 
may have direct, or indirect, actions on other cellular components.  Evaluating 
RNA levels after 6-hour stimulation of primary cortical neurones with NMDA, urma 
mRNA levels are not significantly different from those in primary cortical neurones 
treated with vehicle for 6 hours (p=0.09, F(1, 11) = 3.46, n=3, see figure 7.15). In 
contrast, NMDA stimulation (100µM NMDA in 20mM KCl) of cultured primary 
cortical neurones for 24 hours induced a statistically significant downregulation in 
mRNA levels when compared to vehicle as determined by RT-PCR (ANCOVA, 
p<0.05, F(1,11) = 4.93, n=3; see figure 7.16).  A window of 3 PCR cycles within 
the logarithmic phase of the PCR reaction was established empirically for both 
urma and the co-variate, GAPDH.   
 
 
 
 
 
Donna M McDade, 2007  Chapter 7, 196 
 
 
Figure 7.14: A diagram of the DNA recognition sequences upstream of the urma translation 
start site.  Positions of some of the possible binding sites for CREB, Zif268 and Sp1, as well as 
TATA and CAAT box locations are presented.  Note that distances in kb are to the translation start 
site as the transcription start site is not known. 
 
 
 
Figure 7.15:  The effect of 6 hour NMDA stimulation on urma mRNA levels in primary cortical 
neurones. Graph illustrating urma coding amplimer ln pixel intensity as a function of GAPDH ln 
pixel intensity, as determined by RT-PCR of cultured primary cortical neurones stimulated for 6 
hours with either 100µM NMDA in 20mM KCl or vehicle (control).  ANCOVA, p>0.05, F(1, 11) = 
3.46, n=3. 
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Figure 7.16: The effect of 24 hour NMDA stimulation on urma mRNA levels in primary 
cortical neurones.  Graph illustrating urma coding amplimer ln pixel intensity as a function of 
GAPDH ln pixel intensity, as determined by RT-PCR of cultured primary cortical neurones 
stimulated for 24 hours with either 100µM NMDA in 20mM KCl or vehicle (control).  ANCOVA, 
*p<0.05, F(1, 11) = 4.93, n=3. 
 
7.3.10 Urma is significantly down regulated in zif268 knockout 
mice 
Urma mRNA is significantly downregulated by 7% in cerebral cortex tissue from 
zif268 knockout mice compared to their counterpart wildtype mice as determined 
by RT-PCR (p<0.01 F(1,13) = 9.61, ANCOVA, n=9; see figure 7.17). 
 
 
Figure 7.17:  The effect of genotype on urma RNA levels.  Graph illustrating urma log pixel 
intensity as a function of GAPDH log pixel intensity, as determined by RT-PCR of adult cerebral 
cortex tissue from either wildtype or zif268 knockout mice.  ANCOVA, #p<0.01 F(1,13) = 9.61, n=9. 
Donna M McDade, 2007  Chapter 7, 198 
7.3.11 Updated Bioinformatics for Urma  
On the 25th November 2004, both Ensembl and NCBI were contacted to clarify the 
mismatched information regarding the whereabouts of protein MGC40405.  Both 
organisations replied that they would investigate and update their databases.  In 
Ensembl version 42 (December 2006), AI169020 is lined up with Ensembl known 
protein coding NP_001019970.1 (Ensembl Gene ENSRNOG00000009163, 
transcript ENSRNOT00000012253), which still has no functional description, but 
has an orthologue prediction straight to an MGC40405 fragment (although this is 
still placed on chromosome 5) (see figure 7.18).  The NP_001019970.1 
information is described as 'hypothetical protein LOC362320 [Rattus norvegicus]', 
which now has no variants and presents data that was originally associated with 
isoform 1.  The updated predicted protein sequence of ENSRNOT00000012253 
matches this, although our results suggest that the transcript had a greater 
similarity to their, now missing, isoform 2.  The information is from the Sanger 
Institute and was updated in December 2005.  This Ensembl entry 
NP_001019970.1 corresponds to the Rat Genome database RGD1306302 (Rattus 
norvegicus similar to RIKEN cDNA 5830415L20). 
In contrast, the entry on NCBI regarding MGC40405 now has 2 variants:  
MGC40405 isoform 1, described as 'hypothetical protein LOC257415 isoform 1' 
and MGC40405 isoform 2, described as 'hypothetical protein LOC257415 isoform 
2'.  This information was updated in November 2006.  Our predicted protein results 
for urma are similar to MGC40405 isoform 2 protein results. 
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Figure 7.18 Updated BLAST search of urma, using only the sequenced nucleotide 
information returned from Geneservice.  Highlighted are the BLAST results for urma, Ensembl 
Known Protein Coding NP_001019970.1 and EST AI169020. 
AI169020 
Urma 
BLAST 
result 
Known protein 
NP_001019970.1 
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7.4 Discussion 
This chapter is a first introduction to the novel gene urma and describes it as a 
downstream target of zif268 and predicted transcription factor.  Increasing levels of 
zif268 in PC-12 cells shows a tendency to suppress urma mRNA levels, NMDA 
stimulation in cortical neurones decreases urma mRNA levels, and the absence of 
zif268 altogether significantly decreases urma levels in the cerebral cortex in 
zif268 knockout mice.  
Microarrays can produce enormous amounts of information, which can be 
effectively interpreted with the use of SAM analysis.  The use of this statistical 
package provides an accurate estimate of the percentage of genes identified by 
chance, and hence is superior to the performance of multiple uncorrected 
statistical tests.  Of the 144 ESTs affected, only 4 were nominated for further 
investigation.  The remaining 140 ESTs, mainly of known origin, warrant further 
investigation to determine their potential role in plasticity via the transcription factor 
zif268.  Gene identification is one of the major tasks of bioinformatics and the 
comparison of ESTs to each other and to genome sequences is useful for gene 
discovery.  ESTs are characteristically redundant and naturally error prone due to 
the fact that they are single-read sequences, however, they are generated from 
oligo(dT)-primed cDNA libraries and can therefore identify authentic mRNAs, even 
when there are long 3‘UTRs.   
More than half of the genes within the genome of an organism can be located 
through their homology to other known proteins.  In order to determine the 
remaining genes, genefinder programs can be utilised.  GENSCAN, in the most 
basic of explanations, is a probabilistic HMM-based2 program that searches for 
consensus sequences on both strands of DNA, allowing for occurrences of 
multiple genes.  In general it scans for features recognised by transcriptional, 
splicing and translational machinery which process all of the protein coding genes; 
therefore it locates such characteristics as exons, introns, splice sites and 
promoters.  It was chosen as a benchmark model for locating areas of interest as, 
in 1997, it could identify 75-80% of exons completely (Burge & Karlin 1997) and is 
                                         
 
2
 Hidden Markov Model - A probabilistic model used to align and analyze sequence datasets by 
generalization from a sequence profile 
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currently recommended by others (Nadershahi et al. 2004).  GENSCAN can 
predict about 65% of translation initiation sites and 76% of termination codons 
exactly, whilst correctly identifying 90% of internal splice sites (Burge & Karlin 
1997). 
EST AI176839 is significantly downregulated by an increase in zif268 levels as 
determined by RT-PCR within a cell line and verified in primary neurones.  The 
effect within cultured primary neurones may be time dependent as RNA levels of 
the EST were significantly downregulated at 6 hours, an effect that had diminished 
by 24 hours.  These results indicate that an area of interest has been identified.  
There is now an ‗Ensembl known protein coding‘ (transcript 
ENSRNOT00000055127, NP_001041325.1, gene ENSRNOG00000008194, 
similar to known gene NFX1-type zinc finger-containing protein 1 (ZNFX1)) in this 
area however, AI176839 does not line up with any of the exons and is situated at 
the 5‘ end, suggesting that it may not be part of the annotated gene.  Additional 
exploration of the genomic region is warranted to determine the full-length 
sequence of this mRNA, investigate the presence of a novel gene, and locate the 
transcription and translation start sites, the open reading frame and overall 
function. 
The generation of a product from oligo(dT) primed cDNA by pooling the primers 
designed for EST AI169020 and transcript ENSRNOT00000012253 shows that an 
actual transcript can be recovered from this area of the genome.  In addition to 
this, knitting together other expressed transcripts in the form of ESTs produced the 
information for the overall sequenced product returned from Geneservice.  This 
suggested that the predicted transcript ENSRNOT00000012253 was in fact a real 
transcript with an extended, only just discovered, 3‘ UTR.  Once the coding 
sequence of urma had been predicted by two separate programs, and delivered 
very similar results to those published for transcript ENSRNOT00000012253 and 
MGC40405 on Ensembl and NCBI respectively, primers were designed to monitor 
effects within this region only.  This assumes that any effects noted are true 
responses of a novel gene modulated by the transcription factor zif268.  An 
increase in zif268 by NMDA stimulation in cultured primary cortical neurones 
caused RNA levels of urma to decrease after 24 hours, an effect that seems slow 
acting as there was no difference in RNA levels between NMDA stimulated cells 
and controls after only 6 hours.  This may imply that zif268 has an indirect effect 
on urma, whereby an unknown transcription factor gene could mediate the 
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activation of urma.  However, the presence of a zif268 binding site in the proposed 
'promoter' area may argue a direct interaction.  
The likely translation start site was identified using the software ATGpr, which is 
the most sensitive and accurate of the various approaches available (Nadershahi 
et al. 2004).  The optimal context for initiation of translation is GCCRCCaugG 
whereby R denotes a purine (adenine or guanine).  Within this sequence, the 
purine (-3) and the G (+4) (the only effective base in this position) are most 
important for strong activation of the start codon (Kozak 1986; Kozak 1997).  
When both of these are intact, the AUG is in its strongest context and can function 
more than 10 times more efficiently than any gene with the start codon in a weak 
context (Kozak 1987).  Urma has a kozak sequence of GCCTACatgA, where 
underlined letters indicate the important bases, and in both cases it can be seen 
that the environment is less than optimal.  When the context is less than 
favourable and translation is not strongly stimulated, some protein synthesis may 
occur but most will start at the next downstream AUG codon.  This means that 
some ribosomes may bypass the weak context AUG codon in favour of a stronger 
context further downstream, in a manner termed leaky scanning (Kozak 2005).  
This can enable the generation of long and short forms of the protein, if they are in 
the same frame, or completely different proteins if they are in different frames.  
However, less than 10% of all eukaryotic mRNAs do not use the first ATG for the 
start codon (Kozak 1989).  Additional possible effects may be an alteration in 
mRNA stability or splicing (Kozak 2003).  Indeed, it is reported that 35-59% of 
human genes display evidence of at least one splice variant (Modrek & Lee 2002).  
Further experimentation is required to determine whether the suboptimal context 
of the kozak rule within urma has any effect on protein length, number, sequence 
and/or function.  
Analysing gene promoters bioinformatically to identify transcription factor 
consensus sequences has aided the detection of functional transcription factor 
binding sites (Tullai et al. 2004; Chowdhary et al. 2005; Kamalakaran et al. 2005; 
Xie et al. 2005).  The difficulty in this instance is that we have not definitively 
identified a transcriptional start site and it is very difficult to obtain data on the 
average length of 5‘UTRs in the Rattus norvegicus genome.  However, a statistical 
analysis in 1999 (Deutsch & Long 1999) of 74 genes with descriptive 5‘UTRs, 
taken from 10 eukaryotic model organisms, records a range of 96 to 8214 
nucleotides for intron length in this area.  Eukaryotic genes tend to have very long 
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genes with very short exons (e.g. Arabidopsis has exons of 3 bps) and long introns 
(e.g. the human dystrophin gene has introns of >100 kbs) (Mathe et al. 2002).  In 
fact, first introns in the human genome were found to be longer than median length 
introns more often than expected at random (Kalari et al. 2006).  In addition, it has 
been shown that transcripts with an optimal start codon context tend to have 
shorter 5' UTRs, whereas an increased length of 5' UTR correlates with a 'weak' 
start codon context (Rogozin et al. 2001).  Overall, this therefore led to the 
analysis of a large genomic area. 
The urma promoter may contain a TATA box, CAAT box, CREB site and a zif268 
binding site with an overlapping Sp-1 recognition sequence.  An interesting feature 
of these consensus sequences is that they are all located within 2000 base pairs 
of each other.  The TATA box to cap site is 30 to 36 bps from the first T of the 
TATA box matrix to the cap site (start of transcription), and the CAAT is generally 
found upstream at –60 to –100.  However, the TATA box only seems to be present 
in about 70% of human promoters, and the CAAT box found in about 50% of 
vertebrate promoters (Fickett & Hatzigeorgiou 1997).  The presence of a zif268 
binding site located close to recognition sites that may signal the immediacy of the 
transcriptional start site is very encouraging.  In many known zif268 targets the 
consensus sequence(s) are in proximal promoter regions (James et al. 2006).  
The presence of a zif268 binding site does not prove an interaction with urma but 
does increase the likelihood that it is a direct target.  Interestingly, the zif268 
binding site is overlapped by an Sp-1 binding site.  It has been reported that the 
competitive binding between Sp-1 and zif268 at overlapping sites leads to a 
suppression in transcription mediated by zif268 as it blocks the binding of Sp-1 to 
its recognition sequence (Ackerman et al. 1991; Bahouth et al. 2002).  
Furthermore, additional studies suggest that displaced Sp1 binds to and activates 
the endogenous zif268 gene, thereby leading to "facilitated inhibition" of Sp1 
function by the resulting increased zif268 (Liu et al. 1996).   
The bioinformatically-derived localisation of urma to the nucleus, with the 
prediction that it will bind to DNA, suggests that urma may be transcription factor.  
The presence of many PKA/PKC/PKG phosphorylation sites within the protein 
sequence are also typical of a transcription factor responding to extracellular 
signals, to rapidly induce or suppress gene expression.  This allows several layers 
of control with overlapping functions to tightly regulate the activity of transcription 
factors and therefore, their downstream targets. 
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Within zif268 knockout mice, urma levels are significantly downregulated.  As with 
the ubiquilin results, this is surprising as the expected result would be an 
upregulation in the absence of zif268, however, it does identify urma as a genuine 
downstream target.  It was planned to determine the distribution of urma mRNA 
throughout the whole mouse brain, as well as comparing mRNA levels in the 
striatum of zif268 knockout and wildtype mice after haloperidol administration, by 
in situ hybridisation.  However, there was not enough time to optimise these 
experiments. 
Evidence that urma could be involved in synaptic plasticity comes from a paper 
published recently describing a girl of 10.5 years of age with mental retardation.  
This has been located to an interstitial deletion of chromosome 7q21.1-q22 and is 
the third case of its kind (Young et al. 1984; Chitayat et al. 1988; Manguoglu et al. 
2005).  In addition a case of a 7q21.2 to q22.1 duplication resulted in moderate 
mental retardation (Lukusa & Fryns 1998), and a proximal interstitial deletion of 7q 
(q11.23q22) produced severe mental retardation (McElveen et al. 1995).  In all of 
the above cases, many other symptoms were also reported, most frequently of 
which is ectrodactyly (split hand/split foot malformation), which appears to be 
localised between 7q21.2 and 7q22.1.  While clearly there are many genes located 
in this region that could be responsible for the mental retardation, the above 
evidence linking urma to neuronal plasticity makes urma an interesting candidate. 
Biological websites are updated continuously but the annotation of all the 
information presented by researchers is not keeping pace with the volume of raw 
sequence data.  In addition, the multitude of databases, each with their specific 
accession numbers, can be very confusing.  However, as each part of genome is 
investigated and interpreted, the situation should become more manageable.  
Experimental approaches remain necessary in order to confirm the exact 
locations, transcriptional activity and splicing patterns of novel genes and the 
existence of virtual proteins, their biological functions and condition of expression 
within an organism.  Although the complete gene structure and physical evidence 
of the protein have not been elucidated yet, urma may be a rarely expressed 
transcription factor that can target genes involved in plasticity.  
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8.1 Discussion 
8.1.1 Significance of Investigation 
This thesis introduces gephyrin, ubiquilin and a novel gene, urma, as downstream 
targets of the plasticity-related immediate early gene, zif268.  It also proposes that 
zif268, activated during neuronal plasticity, transcriptionally downregulates gene 
expression of gephyrin and ubiquilin, which impacts on the number of GABAARs 
localised to the synapse.  This effect may also indirectly influence proteasome 
activity and the cytoskeleton at inhibitory synapses. 
8.1.2 Plasticity 
It is assumed that memories are represented in the brain as spatio-temporal 
patterns of cellular activity within a neural network, with adaptations occurring at a 
cellular level to store experiences.  LTP is the pairing of input stimulation and 
postsynaptic depolarisation, with a resulting long-term increase in the strength and 
efficiency of the synaptic connection.  Stable LTP has been produced in the medial 
and lateral perforant pathways for up to a year (Abraham et al. 2002).  It is 
therefore studied as a possible cellular correlate of learning and memory. 
Several protein kinases, including Src, ERK, CaMKII, PKC, cGMP-dependent 
kinase (PKG) and PKA are downstream effectors of synaptic signalling, as 
selectively inhibiting their actions can prevent hippocampal LTP induction.  
Interactions between kinase pathways suggests that ERK may be a point of 
convergence integrating CaMK, PKA and PKC signals (Impey et al. 1998).  These 
kinases are thought to play a role in the early phases of LTP, leading to the 
changes necessary for the slower, more sustained phases requiring increased 
gene transcription and new protein synthesis which occur after approximately 3 
hours of LTP maintenance (Krug et al. 1984; Otani et al. 1989; Fazeli et al. 1993). 
Many articles cite the effects that plasticity have on excitatory synapses.  
Seventeen to twenty percent of the neurones in the brain are GABAergic, each of 
which receives approximately 6000 connections (Somogyi et al. 1998).  Seventeen 
percent of these cells innervate other GABAergic cells (Freund & Buzsaki 1996).  
This body of work looks at inhibitory synapses found on cells that are involved in 
excitatory synaptic transmission; those cells that may be glutamatergic, but 
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contain synapses that are activated by GABA, leading to a suppression of their 
activity. 
8.1.3 The transcription factor, zif268 
Zif268 is one of the few proteins consistently implicated in many different forms of 
plasticity.  Within 1 hour of LTP induction, zif268 mRNA is increased (Cole et al. 
1989; Wisden et al. 1990; Richardson et al. 1992).  It is also induced during 
periods of learning, whilst the threshold and duration of hippocampal LTP 
correlates with the degree of zif268 induction (Richardson et al. 1992; Worley et al. 
1993).  Sustained changes in neuronal activity with a concurrent induction of 
zif268 has been recorded in the hippocampus, visual or temporal cortex and spinal 
cord, in diverse species from primates to songbirds (Cole et al. 1989; Wisden et al. 
1990; Jarvis et al. 1998; Kaczmarek et al. 1999; Mello et al. 2004; Morris, 2004). 
Zif268 knockout mice show an intact short-term memory but display deficits in late 
phase LTP, whilst long term memory is significantly impaired (Jones et al. 2001), 
confirming the importance of zif268 induction for long term plasticity.  With training 
however, these mice can overcome deficits in memory as illustrated by a number 
of memory tasks (Jones et al. 2001).  This may suggest that other mechanisms 
can compensate for the lack of zif268 in certain behavioural conditions.  For 
instance, egr-2 mRNA is upregulated and returns to basal levels within a 
timeframe similar to that of zif268.  However, the corresponding egr-2 protein 
increase outlasts that of zif268 by approximately 16 hours (Williams et al. 1995).  
In addition, certain binding sites on the promoter region of zif268 are equally 
present on egr-2 and egr-4, as well as other IEGs such as c-fos and arg3.1 (Davis 
et al. 2003), and egr-2 and egr-3 are induced during periods of synaptic activity in 
the CNS (Yamagata et al. 1994; Beckmann et al. 1997).  This may go some way 
to explain our results for gephyrin, ubiquilin and urma in the knockout mouse.  A 
preferable paradigm would have included a targeted deletion that could be 
induced in the adult mouse and knock down the zif268 gene in a controlled 
manner. 
Within this thesis both primary cortical neurones and PC-12 cells were utilised.  
Zif268 has been identified within the PC-12 cell line, and although it is activated by 
the addition of 50ng/mL NGF (Milbrandt 1987), this returns to basal level within 
120 minutes (Day et al. 1990), the minimum amount of time that was allowed to 
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elapse after NGF treatment of PC-12 cells before transient transfection of the full-
length or truncated zif268 constructs.  In addition, NMDA stimulation with a 
depolarising agent induced zif268 in primary cultured cortical cells in a 
physiologically relevant manner.  However, zif268 is also activated during cellular 
stress & pathology (Jones & Agani 2003; Pignatelli et al. 2003; Quinones et al. 
2003) which could feasibly occur through in vitro cell culture work.  We performed 
the majority of experiments on aged cultures, when presumably, any stress-related 
IEG activation has returned to basal levels.  If time had allowed, gephyrin, ubiquilin 
and urma would have been monitored with an in vivo LTP model; haloperidol 
administration to zif268 knockout mice in order to block striatal D2 receptors.  This 
induces glutamate release from corticostriatal neurones, and produces LTP at 
corticostriatal synapses, whilst increasing protein levels of zif268 (Nguyen et al. 
1992; Simpson & Morris 1994; Keefe & Gerfen 1995; Calabresi et al. 1997; 
Cepeda et al. 2001). 
8.1.4 Urma as a neuronal target of zif268 
A full characterisation of urma is still required to elucidate many aspects of this 
potential neuronal plasticity gene.  However, this thesis has presented a 
transcribed sequence that is downregulated in response to an increase in zif268 
as determined by microarray and NMDA stimulation of primary cortical neurones.  
In addition, urma mRNA levels are downregulated in zif268 knockout mice.  This 
information was collected after the design of unique primers using an EST and 
closely located predicted transcript.  The sequence provided from this product 
after only amplifying the transcriptome was used to locate a putative translation 
start site.  This information drove the design of further primers to examine the 
translated region of the gene after experimental manipulation.  The likelihood of a 
novel gene within this area of the genome is increased by the annotations now 
found on regularly used bioinformatic websites.  Although the descriptions on 
these websites are currently blank, the presence of a known gene symbol adds to 
the probability that urma is a newly discovered transcript.  The submission of urma 
to genomic databases will officially flag this locus as a zif268-modulated gene.  
Urma may be a transcription factor involved in learning and memory, as it has 
putative sites for nuclear localisation, DNA binding, contains multiple 
phosphorylation sites and is regulated by zif268 in primary cultured neurones. 
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8.1.5 Gephyrin as a neuronal target of zif268 
The downstream target genes of zif268 in neurones were recently discovered and 
published by James et al. (2005).  In their microarray experiment, gephyrin mRNA 
was suggested to be downregulated by 26% in response to an increase in zif268 
expression.  A downregulation of gephyrin in response to elevated zif268 
expression was confirmed within this thesis.  
8.1.5.1 Gephyrin and the cytoskeleton 
Gephyrin has a tendency to assemble into highly structured complexes both in 
vitro and in transfected cells (Schmitt et al. 1987; Kirsch & Betz 1995; Meyer et al. 
1995), which can occur without the aid of additional proteins (Choquet & Triller 
2003) to form a submembraneous scaffold.  It is highly enriched at the cytoplasmic 
face of inhibitory postsynaptic membrane differentiations and is proposed to recruit 
membrane receptors and subsynaptic structural and signalling proteins to 
inhibitory synapses.  In only one study however, gephyrin clusters have been 
found opposite glutamate synapses in cultured hippocampal neurones (Brunig et 
al. 2002). 
Gephyrin, a major structural component of inhibitory postsynaptic membranes, 
localises and anchors inhibitory receptors at the synapse, minimising receptor 
diffusion.  Although individual GABAA receptors at the synapse are continually 
recycled and exchanged between the cell surface and intracellular compartments 
the number of receptors at the plasma membrane is generally a stable 
arrangement.  The exception is during periods of intense activity, like that 
encountered during long-term potentiation and synaptic plasticity.  It is thought that 
synaptic activity could control the cytoskeleton to influence the number of 
receptors at synapses.  Cytoskeleton disruption has been shown to induce rapid 
variations in GlyR numbers at synapses, decreasing receptor dwell times and 
causing a rapid diffusion of receptors in the extrasynaptic membrane (Kirsch & 
Betz 1995; van Zundert et al. 2002; van Zundert et al. 2004; Charrier et al. 2006). 
Cytoskeletal anchoring of inhibitory receptors may be mediated by an interaction 
of gephyrin with tubulin (Kirsch et al. 1991) as evidence shows that alkaloids, 
which disrupt the microtubular network, cause a loss of gephyrin from synaptic 
sites in cultured spinal cells (Kirsch & Betz 1995; van Zundert et al. 2004).  In 
addition, gephyrin interacts with the 'barbed' end of filamentous F-actin, a crucial 
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protein at the early stages of synaptogenesis (Zhang & Benson 2001).  Gephyrin 
may be laid down at GABAAR containing membrane domains by an interaction 
with actin, as microfilaments are essential for gephyrin scaffold formation during 
postsynaptic membrane development.  However this interaction could be transient, 
as disruption of the actin cytoskeleton and microtubule network in differentiated 
cells has no effect on the number of postsynaptic GABAAR and gephyrin clusters 
(Allison et al. 2000).  This may suggest that the receptor and scaffold complex, 
once formed, remains clustered independently without the aid of conventional 
cytoskeletal proteins. 
Mena/VASP acts as an adaptor between actin and gephyrin (Bausen et al. 2006) 
and, along with profilin, is considered an essential and ubiquitous component of 
the cortical microfilament web, linking gephyrin and GlyRs to the microfilament 
system (Mammoto et al. 1998; Giesemann et al. 2003).  Profilin, which stimulates 
actin polymerisation (Mammoto et al. 1998), is a gephyrin ligand that may 
contribute to the activity dependent processes underlying synaptic plasticity, as 
both profilin I and II are redistributed to dendritic spines after synaptic activity, 
which, in the case of profilin II, occurs after calcium influx (Ackermann & Matus 
2003; Neuhoff et al. 2005). 
Gephyrin mRNA and protein levels were downregulated by increased zif268 levels 
in PC-12 cells, and following NMDA treatment of primary cortical neurones, as 
determined by reverse transcription PCR, western blotting, immunocytochemistry 
and ELISA.  A zif268-mediated downregulation of gephyrin therefore could 
decrease cytoskeletal elements at the cell membrane either directly, or indirectly, 
decreasing the number of receptors at the synapse.  The sub-synaptic scaffolds in 
general govern the mobility of many membrane-associated or transmembrane 
proteins.  As synaptic gephyrin appears to restrict the mobility of inhibitory 
receptors diffusing in the plane of the plasma membrane, the loss of gephyrin 
would decrease the protein availability for interaction with the cortical 
microfilament web, resulting in a reduced size and low packing density of gephyrin 
scaffolds, alleviating restrictions on the lateral mobility of neuronal receptors.  This 
would directly influence the number of postsynaptic receptors localised to the 
synapse, and therefore the size of the synaptic response and ultimately the 
synaptic efficacy (Lim et al. 1999; Meier et al. 2001).  Gephyrin, via a plasticity-
induced upregulation of zif268, may therefore act as a molecular switch that 
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converts alterations in synaptic activity into morphological changes of synaptic 
structure.   
In addition to the static gephyrin lattices located to the postsynaptic cell 
membrane, there are a number of small mobile gephyrin particles located 
throughout the cytoplasm.  These represent approximately 2% of the total clusters 
(Lorenzo et al. 2004; Maas et al. 2006), and seem to combine and dissociate with 
the bigger clusters.  This mechanism could increase, and reduce, the size of pre-
existing gephyrin scaffolds.  This infers that 98% of gephyrin locates at plasma 
membrane regions (Lorenzo et al. 2004), and confirms our immunocytochemical 
results as depicting gephyrin immunoreactivity at the membrane.  However, if the 
2% of mobile gephyrin has been included in the immunocytochemistry result, it 
would illustrate a reduction of global gephyrin, therefore depleting the available 
pool of gephyrin protein that seems to be reserved for maintaining large gephyrin 
clusters, or represents the gephyrin molecules transportation from their site of 
production in the cytoplasm.  Global gephyrin levels were detected by western 
blotting and showed a significant downregulatory effect of NMDA treatment on 
protein levels within primary cultured cortical neurones. 
8.1.5.2 Gephyrin and the GABAA Receptor 
During plastic processes, the lateral diffusion of neurotransmitter receptors in and 
out of synapses rapidly alters receptor numbers and is a key component of 
receptor renewal and concentration as shown by electrophysiology (Tovar & 
Westbrook 2002; Adesnik et al. 2005; Thomas et al. 2005) and imaging 
techniques (Dahan et al. 2003; Tardin et al. 2003; Groc et al. 2004).  This serves 
to swiftly restore synaptic function during periods of intense activity, whereby 
lateral diffusion reduces once the receptor reaches the postsynaptic specialisation 
(Jacob et al. 2005).   
Gephyrin colocalises with both GlyRs and GABAARs in spinal cord, retina and 
various brain regions (Triller et al. 1985; Sassoe-Pognetto et al. 1995; Todd et al. 
1996; Sassoe-Pognetto et al. 2000).  GABAA and glycine receptors together with 
gephyrin can also accumulate at the same postsynaptic sites (Dumoulin et al. 
2001) indicating that gephyrin can provide a common anchoring scaffold for both 
types of inhibitory neurotransmitter receptors, although glycine receptors are 
relatively rare in the forebrain (Luscher & Keller 2004).  Gephyrin restricts the 
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mobility of diffusing hetero-oligomeric GlyRs (Meier et al. 2001), and regulates 
their packing density at the postsynaptic membrane (Kirsch & Betz 1995).  In 
addition, gephyrin has a strong association with the 2 subunit of GABAAR, 
restricts lateral mobility and regulates clustering and cluster stability of GABAAR at 
postsynaptic sites (Essrich et al. 1998, Kneussel et al. 1999; Jacob et al. 2005). 
Gephyrin knockout mice display a total loss of postsynaptic GABAAR 2 and 2 
immunoreactivities (Kneussel et al. 1999), and the targeted deletion of the 2 
subunit of GABAARs prevents postsynaptic clustering (Essrich et al. 1998).  In 
addition, gephyrin KO mice have a marked increase in the number of intracellular 
aggregates of GABAARs (Kneussel et al. 1999).  Therefore, clusters of GABAARs 
at the synapse may be formed by the intracellular loop of the 2 subunit interacting 
with gephyrin, as part of a postsynaptic scaffold, which then increases their half-
life at the synapse and prevents internalisation (Kneussel et al. 1999).  LTP driven 
gephyrin protein downregulation would therefore decrease the number of 
GABAARs at the postsynaptic membrane.  Indeed, decreasing gephyrin 
expression by RNAi does not modify the total cell surface expression levels of 
GABAARs, but significantly reduces the number of synaptic receptor clusters 
(Jacob et al. 2005).  Our results displayed a significant reduction in 2 containing, 
but not  containing, GABAARs in cortical neurones after NMDA treatment.  
Although the neurones were not simultaneously stained with anti-gephyrin and 
anti-GABAAR, the experimental procedures in all treatment groups were identical 
and therefore a relationship can be drawn between the decrease in gephyrin 
immunoreactivity and corresponding decrease in 2 subunit containing GABAARs.  
It has been suggested that gephyrin and GABAARs are not stably organised with 
the cytoskeleton and instead rely on the 2 subunit for long term maintenance at 
the synapse and recycling at post synaptic sites (Schweizer et al. 2003).  Our 
results specifically monitored and reported a significant decrease in the 2 subunit 
of GABAARs.  Although a significant fraction of GABAARs at postsynaptic sites are 
not accessible to antibodies in intact cells (van Rijnsoever et al. 2005), and 
GABAARs can gephyrin-independently cluster at non-synaptic sites (Christie et al. 
2002; Scotti & Reuter 2001), the cultured cells were permeabilised with triton X-
100 (Sigma-Aldrich, Dorset, UK) and therefore may have allowed the labelling of 
the majority of the 82% of 2 subunits that are localised to the synapse (Danglot et 
al. 2003). 
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A prerequisite for fast and efficient synaptic transmission is a high concentration of 
neurotransmitter-gated ion channels located directly opposite presynaptic nerve 
terminals.  Inhibitory synaptic currents are significantly affected by the number of 
synaptic GABAARs at the plasma membrane (Otis et al. 1994; Nusser et al. 1997; 
Nusser et al. 1998), so a reduction of GABAARs at the synapse by a zif268-
induced downregulation of gephyrin would decrease the likelihood of receptor 
activation and therefore inhibitory currents entering the cell.  GABAARs are located 
to and exert their effects preferentially in the neuronal dendrites (Miles et al. 1996; 
Allison et al. 2000; Megias et al. 2001), whilst gephyrin immunoreactivity is 
localised mainly to the dendrites after 3 weeks in culture (Craig et al. 1996).  As 
mechanisms that regulate the density and localisation of GABAARs on the surface 
of cortical neurones influence neuronal excitability and inhibitory GABAergic 
networks are known to adapt to changes in the strength of their excitatory inputs 
(Nusser et al. 1998; Ives et al. 2002; Leroy et al. 2004; Suzuki et al. 2005), it is 
therefore likely that this adaptation could include a downregulation of inhibitory 
receptors at synapses. 
It is possible that the downstream effects of LTP directly interact with the 
GABAARs at the synapse as they are phosphorylated by PKA, PKC, PKG, CaMKII 
and Src, an interaction that is thought to cause enhancement or inhibition of 
inhibitory currents (Moss & Smart 2001; Smart 1997; McDonald et al. 1998).  After 
PKC activation, receptors containing the 2 subunit are reduced at the plasma 
membrane (Connolly et al. 1999b) as this prevents internalised receptors from 
returning to the surface, although conflicting evidence has been reported (Chapell 
et al. 1998; Cinar & Barnes 2001).  Although this may be the case, this thesis 
presents evidence that zif268 activation directly downregulates gephyrin levels in 
neurones in the first instance and that this downregulation is remarkably mirrored 
in the downregulation of GABAARs, a receptor that gephyrin has been linked with 
on many occasions.   
Circumstantial evidence has previously linked gephyrin and zif268 within a 
learning and memory paradigm.  It was reported that kainic acid-induced plasticity 
and fear conditioning by light shock treatment and odour-shock associative 
learning, induces an upregulation of zif268 mRNA after 0 to 60 minutes and 
extensive downregulation of gephyrin after 30 – 120 minutes, implying that 
gephyrin may be involved in the long-term storage of fear memory (Resslar et al. 
2002).  These alterations were detected by in situ hybridisation and paired within 
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the basolateral amygdala, the piriform cortex, perirhinal cortex and habenula.  
Strikingly, in the areas displaying no changes in zif268 mRNA levels, the 
investigators also found that gephyrin levels were unaffected (Ressler et al. 2002). 
8.1.6 Ubiquilin as a neuronal target of zif268 
The decrease of gephyrin, which causes a decrease of GABAARs localised to the 
synapse could increase the number of intracellular receptor microclusters 
throughout the cell, as reported in gephyrin knockout mice (Feng et al. 1998).  
These microclusters would either be recycled or require clearance from the cell.  
Ubiquilin, found to be downregulated in the microarray experiment (James et al. 
2005) and in this thesis, has been linked to the GABAAR and the proteasome.  
Ubiquilin therefore may play a role in receptor degradation. 
8.1.6.1 Ubiquilin and GABAARs  
GABAARs are constantly removed from the cell surface by endocytosis and cycled 
between synaptic sites and intracellular endocytic structures, in a ‗holding and 
recycling‘ pattern (Tehrani & Barnes 1993; Kittler et al. 2000).  This allows the 
quick recovery and reinsertion of receptors into the plasma membrane during 
periods of intense synaptic activity.  Ubiquilin is associated with the plasma 
membrane (N'Diaye & Brown 2003) and is found in clathrin-coated vesicles as well 
as on intracellular membranes, so is well placed to stabilise recycled and de novo 
synthesised receptors (Bedford et al. 2001).  It can modulate the membrane 
insertion of GABAAR, by binding its UBA domain to GABAAR  and  subunits, 
which has a profound effect on the efficacy of synaptic transmission by inhibiting 
GABAAR polyubiquitylation, reducing receptor targeting to the proteasome and 
promoting their recruitment to the cell surface.  Importantly, blocking the 
interaction of ubiquilin with GABAAR reduces the number of receptors at the cell 
surface (Bedford et al. 2001). 
Ubiquilin possesses an N-terminal ubiquitin like domain, which interacts with 
subunits of the 19S complex, and a C-terminal UBA domain that interacts with 
K48-linked polyubiquitin chains (Funakoshi et al. 2002; Ko et al. 2002; Raasi & 
Pickart 2003), interfering with the degradation of ubiquitin-dependent proteasome 
substrates in-vivo, increasing their half-life (Kleijnen et al. 2000).  Ubiquilin 
interacts with the ubiquitin ligase E6-AP and proteasomes in large complexes 
(Kleijnen et al. 2000), and polyubiquitylated proteins are recognised by a complex 
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containing the E4 enzymes cdc48/p97 and ubiquitin-fusion degradation 2 enzyme 
(Ufd2).  Ufd2 extends the ubiquitin chain by a few ubiquitin residues and recruits 
Dsk2, an ubiquilin homologue, which may bind to the ubiquitin-protein conjugate 
and interact with the proteasome via Rpn1/S2 (Funakoshi et al. 2002; Kim et al. 
2004; Richly et al. 2005).  This could suggest that ubiquilin delivers the substrate 
to the proteasome.  However, evidence that increasing ubiquilin levels increases 
GABAAR immunoreactivity (Bedford et al. 2001) suggests that the interaction with 
the proteasome blocks the degradation of ubiquilin-bound polyubiquitylated 
proteins, at least in the case of GABAAR at the synapse. 
This thesis reports a reduction in ubiquilin mRNA and protein levels in PC-12 cells 
and primary neurones as determined by RT-PCR and immunocytochemistry after 
treatment upregulating zif268 levels.  In addition, ubiquilin mRNA is downregulated 
in zif268 mice compared to wildtypes.  As we did not look at proteasome activity 
directly, this leads to a purely theoretical relationship between LTP, zif268, 
ubiquilin, GABAAR and the proteasome.  Thus, a zif268 mediated decrease in 
ubiquilin could increase the degradation of the GABAAR, as ubiquilin would no 
longer be able to 'protect' the GABAAR from the proteasome.  This in turn would 
decrease the size of the intracellular pool of inhibitory receptors in GABA receptive 
synapses available for membrane insertion.  It has been shown that PKC 
activation prevents the recycling of receptors back to the cell surface after 
endocytosis (Connolly et al. 1999b; Kittler & Moss 2001), though this does not 
seem to be due to a direct phosphorylation of the receptor.  It is feasible therefore 
that this effect could be induced via zif268 and a resultant decrease in the 
availability of ubiquilin protein. 
Ubiquilin interacts with the  and  subunits of GABAAR, subunits that are found 
throughout the cell and not specifically localised to synapses.  In fact,  and  
subunits are preferentially extrasynaptic (Fritschy et al. 1998; Sassoe-Pognetto et 
al. 2000) suggesting that ubiquilin may play a role in the regulation of global 
GABAAR, rather than synapse specific receptors.  Although Bedford et al. (2001) 
localised ubiquilin to subsynaptic spaces and internal structures, there is the 
capacity for ubiquilin to exert its effects on extrasynaptic GABAAR and therefore 
influence tonic inhibition.  Extrasynaptic receptors are not in a cluster formation 
and therefore the threshold setting for measuring the immunocytochemistry results 
may have overlooked those receptors that did not meet the minimum size 
requirements.  This would explain why our results do not show a significant 
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reduction in  subunit containing GABAARs throughout the cell, although there was 
a trend for a reduction of these subunits after NMDA treatment.  A reduction of 
GABAARs involved in tonic inhibition would lower the threshold needed for action 
potentials, allowing the cell to act more responsively to afferent excitatory input. 
8.1.6.2 Plasticity and the proteasome 
James et al. (2005) were the first to discover that many downstream targets of 
zif268 are either subunits of the proteasome or proteins that function with the 
proteasome within the CNS.  This is additional evidence that LTP and neuronal 
plasticity are dependent on protein degradation, as well as protein formation, and 
that regulation of the proteasome could be essential for normal CNS function.  
Zif268 is involved in the suppression of these genes, leading to a corresponding 
decrease in proteasome activity, whereas the absence of zif268 by gene knockout 
is associated with elevated cerebral cortex proteasome activity.  These alterations 
may be subtle but prolonged, as CNS plasticity has been associated with long-
term modifications of proteasome gene expression.  
The levels of proteins involved in synaptic communication are regulated by the 
proteasome (Boehmer et al. 2003; Colledge et al. 2003; Ehlers 2003; Pak & 
Sheng 2003; Boehmer et al. 2004), and the altered expression of a number of 
proteasome genes has been observed in a variety of plasticity models (El-Khodor 
et al. 2001; Becker et al. 2003; Blalock et al. 2003; Cirelli et al. 2004).  In addition, 
NMDAR activation leads to proteasome sequestration to synaptic spines (Bingol & 
Schuman 2004) however, APV does not block HFS-induced protein degradation 
(Karpova et al. 2006).  HFS-induced phosphorylation of the transcription factor 
CREB (Leutgeb et al. 2005) depends on a functional proteasome system (Ehlers 
2003), and therefore the activity of postsynaptic glutamate receptors may regulate 
the expression of proteasome subunits via zif268 and possibly other inducible 
transcription factors. 
In light of these findings, the activation of zif268, which decreases ubiquilin levels 
and therefore potentially increases proteasome activity, seems contradictory.  It is 
possible that a zif268 mediated decrease in ubiquilin and in proteasome subunits 
may not increase GABAAR degradation, but the GABAARs are spatially restricted 
from returning to the membrane or that the downregulation of gephyrin means 
internalised GABAARs cannot be re-localised and anchored to the synapse.  
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However, our immunocytochemistry results display a decrease in GABAAR 
immunoreactivity in response to NMDA treatment.  An explanation therefore could 
be that GABAAR subunits interact with the AP2 complex (Marsh & McMahon 1999; 
Kittler et al. 2000), which in turn interacts with Eps-15 (Benmerah et al. 1995; 
Morgan et al. 2003).  Eps-15 also interacts with polyubiquitinated receptors, 
possibly to sort them into endocytic compartments (Polo et al. 2002; Riezman 
2002; Bache et al. 2003; de Melker et al. 2004).  Ubiquilin binds to GABAAR 
(Bedford et al. 2001) and can interact with Eps-15 (Regan-Klapisz et al. 2005).  
During periods of proteasome downregulation, ubiquilin forms cytoplasmic 
aggresomes that are highly enriched in polyubiquitinated proteins.  The GABAAR, 
through its interaction with Eps-15, ubiquilin, and its possible ubiquitination as a 
signal for endocytosis, could be recruited to cytoplasmic aggregates after a zif268-
induced downregulation of the proteasome.  Antibodies would encounter 
difficulties in trying to penetrate the aggresome and could therefore give the 
impression of reduced proteins levels of GABAAR and could explain our western 
blotting results for ubiquilin.   
A simpler explanation could be that the proteasome is indeed upregulated at 
inhibitory synapses in response to LTP, an effect that would not be identified using 
the techniques of James et al. (2005), which looked at global proteasome activity.  
Excitatory synapses along the dendrites of cultured hippocampal neurones 
outnumber inhibitory synapses by 4:1 (Liu et al. 2004).  An overriding 
downregulation at excitatory synapses would therefore overshadow any specific 
effect at inhibitory synapses when monitored at the cellular level. 
The role of the proteasome within LTP therefore remains controversial and is 
probably due to the precise balance of proteins required throughout the cell to 
provide alterations in neural network properties. 
8.1.7 Inhibitory transmission and Long Term Potentiation 
Normal brain function relies on tightly controlled synaptic inhibition to influence 
neuronal excitability.  GABA ensures that neurones avoid overexcitation, 
preventing the development of pathological states of network activity; experimental 
animal models of temporal lobe epilepsy often involve impaired dendritic inhibition 
(Cossart et al. 2001).  Clinically, GABAARs deal with disorders of excitability and 
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are the site of action for benzodiazepines, barbiturates and neurosteroids to 
combat such conditions as stress, anxiety, epilepsy and pain (McKernan & Whiting 
1996; Moss & Smart 2001). 
Regulating the number of receptors at the postsynaptic membrane allows 
alterations in the efficacy of inhibitory synaptic transmission.  A decrease in 
inhibition may be required for the potentiated activation of excitatory synapses 
allowing the encoding of new information.  To this end, it has been reported that 
interneurones display a reduced level of activity during novel spatial experiences 
as determined by electrophysiology (Wilson & McNaughton 1993; Fyhn et al. 
2002). Enhancing network activity in hippocampal slices leads to increased 
internalisation of GABAARs (Blair et al. 2004).  Decreasing GABAAR at the 
synapse would increase the probability of neuronal firing as the cell would be more 
receptive to repeated action potentials due to a decrease in the voltage threshold 
for firing. This may play some part in the strengthening of synapses that occurs 
during LTP implying that changes in excitability could be secondary to, or 
facilitated by, changes in inhibitory synaptic transmission.   
Synaptic scaling, a form of homeostatic plasticity, has been described for both 
AMPAR and NMDAR (Watt et al. 2000).  This phenomenon affects all the 
synapses of a cell, proceeds over long periods of time and scales synapses 
proportionally to their synaptic strength (Turrigiano et al. 1998). As all neurones in 
the CNS appear to be responsive to GABA (Peran et al. 2001), this could imply 
that changes in synaptic efficacy at excitatory synapses would result in a cellular 
decrease in GABAARs. 
The site of action for benzodiazepines, a treatment for anxiety and stress, is the  
subunit of the GABAAR, suggesting that GABAA receptor–mediated inhibitory 
currents are most likely involved in fear and associated behaviours.  The 
frontotemporal amygdala has been implicated in fear memory acquisition 
(Fanselow & Gale 2003), and contains a powerful GABA inhibitory circuit within 
the basolateral amygdala complex (Takagi & Yamamoto 1981; Washburn & 
Moises 1992a, b).  The formation of new fear memories displays a requirement for 
reduced GABA inhibitory neurotransmission (Rodriguez et al. 2005).  Zif268 has 
also been implicated in fear conditioning and behavioural learning (Malkani & 
Rosen 2000; Hall et al. 2000). 
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There is evidence to suggest that synaptic GABAARs may be downregulated 
during forms of plasticity involving zif268 induction.  Hippocampal LTP is 
associated with the suppression of GABAergic synaptic events (Lu et al. 2000).  
Similarly BDNF treatment or epileptogenesis cause a downregulation of synaptic 
GABAARs (Brunig et al. 2001; Blair et al. 2004).  Activity dependent modulation of 
GABAergic transmission may therefore contribute to long-lasting plasticity.  The 
potential suppression by zif268 by gephyrin and/or ubiquilin expression provides a 
molecular substrate for this phenomenon. 
8.1.8 Summary 
In summary, neuronal plasticity can stimulate the activation of the inducible 
transcription factor zif268.  Zif268 in turn suppresses the transcription of the 
neuronal proteins gephyrin, ubiquilin and also the novel gene urma.  This 
downregulation is accompanied by a downregulation of synaptically located 
GABAARs.  Postsynaptic receptor accumulation is likely to depend on several 
highly regulated processes, such as receptor synthesis, intracellular trafficking, 
membrane insertion, lateral diffusion, internalisation and degradation.  Each 
neurone in the mammalian brain receives, on average, 103-104 synaptic inputs 
from other nerve cells.  In cultured hippocampal neurones, neural output is 
determined by the dynamic balance of active excitatory and inhibitory synapses 
(Liu 2004).  The neurone therefore must act as a whole entity, with the nucleus 
directing overall protein movement; subsequently, orchestrated local protein 
synthesis would be briefly outsourced to the dendrites during periods of intense 
activity.  Thus, zif268 may play a role in inhibitory synapse receptor clustering 
during synaptic plasticity. 
Donna M McDade, 2007  Chapter 8, 220 
8.2 Future Studies 
 Double stained immunocytochemistry of gephyrin with GABAARs or with 
synapse specific proteins VIAAT, synapsin or the GABA synthesising 
enzyme GAD-65 would confirm a relationship between the gephyrin and 
GABAARs after zif268 activation. 
 The elucidation of endocytosis at the membrane driven by direct LTP 
induced phosphorylation of GABAAR or lack of gephyrin could prove 
interesting in ascertaining zif268 actions at inhibitory synapses.  Therefore, 
co-immunofluorescence with endogenous, constitutively recycling, 
transferrin receptors in permeabilised cells could be informative. 
 In order to determine the full sequence of urma, rapid amplification of cDNA 
ends (RACE) or a primer extension reaction could be performed. 
 A yeast 2 hybrid assay would determine the binding partners of urma and 
enable further characterisation of the function of the urma protein. 
 To characterise urma further, the gene could be cloned into a FLAG-tagged 
vector (or equivalent), transfected into neurones, or a cell line and 
immunocytochemistry performed to determine the subcellular localisation, 
as well as any physical effects.  In addition, western blotting could also be 
performed to find the molecular mass of the protein and in situ hybridisation 
would determine the neuro-anatomical expression pattern. 
 Transient transfection of zif268 into cultured neurones would elucidate the 
specific effect of this transcription factor on gephyrin, ubiquilin and a tagged 
urma by immunocytochemistry.   
 Culturing cortical tissue from zif268 knockout mice could verify the effect of 
zif268 on gephyrin, ubiquilin and urma protein levels as determined by 
immunocytochemistry. 
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 CAT reporter assays could be performed for ubiquilin and urma to 
investigate promoter regulation by zif268.  In addition, an interaction with, 
and direct binding of, zif268 with the promoters of the genes encoding 
gephyrin, ubiquilin and urma could be determined by EMSA.   
 A behavioural paradigm of synaptic plasticity, in which gephyrin, ubiquilin 
and urma mRNA levels are monitored after zif268 induction in the striatum, 
could be examined by in situ hybridisation. 
 Hippocampal tissue, where LTP has been induced 3 hours previously, 
could be scrutinized relative to control tissue for alterations in mRNA levels 
of gephyrin, ubiquilin and urma. 
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The details of the results for GeneChips® B & C in the microarray experiment 
(James et al. 2005), whereby PC-12 cells were transiently transfected with either a 
full-length zif268 or a truncated control, as described in Chapter 7, are tabulated 
on the following pages. 
In each table, the individual ESTs are listed with the fold change reported by the 
microarray experiment (Fold Change) and length of the EST (Length (bp)).  In 
addition, the results from the BLAST analysis (www.ensembl.org) are detailed.  
The percentage of similarity to that area of the genome (BLAST Similarity (%)), 
how many base pairs are involved in this percentage (Length Similarity) and the 
precise location of the genomic area are all presented (Chromosome Location).  
Then follows a database reference for any known gene within the vicinity of the 
BLAST hit (Database Reference), the description that accompanies this reference 
(Description) and whether a known gene is annotated within the area (Known 
Gene?).  
 
Table Key: 
mm  Mus musculus 
hs Homo sapiens 
rn Rattus norvegicus 
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
1 AA851237 5.697356 494 97.65 383 4q42     
rn: predicted (EST) (genscan 
exon) 
2 AA850583 6.775527 391 99.74 391 12q16 hs: Q15646 hs&mm: 2' 5' oligoadenylate synthetase 
rn: predicted (ensembl, genscan, 
NCBI) 
           mm: NM_145209 like protein (P59OASL) (Thyroid R  hs: OASL or TRIP14     
            interacting protein 14) (TRIP14) mm: OASL1 or OASL2 
3 AA899109 4.858614 430 100 413 10q32.3 hs: Q98HCL8 NCBI: similar to chromosome 17 open  
rn: predicted (ensembl) (genscan, 
NCBI exons) 
            reading frame 27 hs: Q98HCL8 
              mm: predicted 
4 AA849827 3.290448 446 96.71 243 9q22 rn: NM_032612 rn: Signal transducer and  rn: NM_032612 
           hs: P42224 activator of transcription 1 hs: STAT1 
           mm: P42225   mm: Stat1 
              *** 4kbp away from BLAST 
5 AA998964 4.615527 511 99.8 496 4q13 hs: NM_0152703 no description rn: predicted (ensembl, genscan) 
              mm: AA175286   hs: NM_0152703 (BRH) 
                  mm: AA175286 (RHS) 
6 AI014130 6.250391 431 100 431 6q16 hs: Q96AL8 mm: Thymidylate Kinase family LPS  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: NM_020557 inducible member; thymidylate kinase hs: Q96AL8 
            homologue mm: Tyki 
7 AI030615 4.981072 278 81.25 160 11q12 rn: P18589 rn: interferon-induced GTP-binding  rn: MX2_RAT 
           hs: P20591 protein MX2 hs: MX1 (BRH) 
           mm: NM_13606   mm: MX2 
8 AA945915 2.41762 671 100 434 11q22 hs: NM_138287 hs: Rhysin 2 
rn: predicted (ensembl, EST, 
genscan) 
              hs: NM_138287 
              mm: predicted 
                    
          
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
9 AA943147 5.983724 437 99.31 437 4q24 hs: NM_017912  mm: HECT domain and RLD3 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: NM_028075   hs: NM_017912 (RHS) 
              mm: Herc3 (RHS) 
10 AA965186 6.084946 525 100 340 1q37 hs: Q92985 hs&mm: Interferon regulatory protein 7 
rn: predicted (ensembl, genscan, 
NCBI) 
           mm: P704434   hs: IRF7    
               mm: Irf7 
           opposite direction: rn: CTD-binding SR-like protein rA9 rn: NM_139093 
           rn: NM_139093   hs: Q9P1Y6 
              hs: Q9P1Y6   mm: predicted 
11 AA999171 2.617801 403 99.74 386 9q22   rn: Signal transducer and  rn: NM_032612 
           hs: P42224 activator of transcription 1 hs: STAT1 
           mm: P42225   mm: Stat1 
              *** 4kbp away from BLAST 
12 AA924764 2.489172 520 98.82 169 8q24     
***closest prediction 6kbp away 
from BLAST 
                  ***no other EST's in vicinity 
13 AA997288 2.962963 417 99.74 388 4q22 hs: NM_02275 NCBI: similar to 9930021O16 protein 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: NM_172893   hs: NM_02275 
              mm: NM_172893 
14 AA955246 6.131208 249 94.83 232 10q21 rn: NM_172019  rn: Interferon gamma inducible  rn: NM_172019  
           mm: NM_008330 protein 1 mm: Ifi47 
15 AA997077 2.701461 367 100 350 8q32 mm: NM_011637 mm: three prime repair exonuclease 1;   
rn: predicted (ensembl, EST, 
genscan, NCBI) 
             trophoblast expressed 1; three prime  mm: Trex1 
             exonuclease 1   
                 
          
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
16 AI012235 1.991437 636 98.58 636 14p22 hs: O14625 hs&mm: Small inducible cytokine b11  
rn: predicted (ensembl, EST, 
NCBI) (genscan exon)  
          mm:Q9JHH5 precursor (cxcl11) (interferon-inducible  hs: CXCL11     
           t-cell alpha chemoattractant) (i-tac)  mm: Cxcl11 
           (interferon-gamma-inducible protein-9)    
           (ip-9) (h174) (beta-r1).    
17 AA946088 1.675014 493 97.57 493 1q55 rn: NM_022260  rn: Caspase-7 rn: NM_022260  
           hs: P55210   hs: CASP7 
           mm: P97864   mm: Casp7 
18 AA946160 1.572179 430 93.49 430 20p12 hs: Q12899 hs&mm: Zinc finger protein 173  
rn: predicted (ensembl, genscan, 
NCBI) 
           mm: Q9WUH5 (tripartite motif-containing protein 26)  hs: TRIM26 or ZNF173 
            (acid finger protein) (AFP) mm: Trim26 or RNF9 or HERF1 
19 AI008397 1.774528 485 75.49 102 18q12.2     rn: predicted (genscan exon) 
                    
20 AA998576 2.128611 457 99.78 457 4q22    removed from further distribution  
             at the submitters request 
21 AA851040 1.602795 494 92.42 396 20p12     
*** closest exon 5kbp away from 
BLAST 
             *** EST clusters 
22 AA945683 2.032149 411 95.39 412 1q54 hs: NM_031212 hs&mm: Putative mitochondrial solute  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: NM_145156 carrier; hypothetical protein NPD016; hs: NM_031212 
           putative mitochondrial solute carrier mm: Mrs3/4-pending 
23 AI045789 3.264773 388 100 376 7q34 hs: NM_032789 NCBI: similar to Plec1 protein 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: Q8R133   hs: NM_032789 
              mm: Q8R133 
          
                
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
24 AI029217 2.097755 389 97.3 370 12q16 hs: Q9Y6K5 hs&mm: 2'-5'-oligoadenylate synthetase  rn: OAS1_RAT 
           mm: P11928 
3 (ec 2.7.7.-) ((2-5')oligo(a) synthetase 3) 
(2-5a synthetase 3)  
hs: OAS3 (BRH) 
             (p100 OAS) (p100oas) mm: Oas1g (BRH) 
25 AI009156 1.931285 493 98.51 403 3q42 hs: Q9Y508 hs&mm: zinc finger protein 313 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: Q9ET26   hs: ZNF313 
             mm: Zfp313 
26 AA955213 1.867483 496 99.79 471 18q12.1 mm: Q8R5D8 NCBI: similar to interferon-inducible  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           GTPase mm: Q8R5D8 (BRH) 
27 AI045075 2.888838 395 92.1 367 1q31 hs: NM_002201 hs&mm: interferon stimulated gene 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: NM_020583 (20kDa) hs: ISG20     
             mm: Isg20 
28 AI070325 2.959543 280 98.09 262 7q34 hs: O95236 hs: apoliprotein L3 (apolipoprotein L-III)  
rn: predicted (ensembl, EST, 
genscan) 
           mm: Q8VDU3 
(APOL-III) (TNF-inducible protein CG12-
1) 
hs: APOL3 (RHS) 
             (CG12_1) mm: Q8VDU3 
29 AI070313 2.453626 543 87.5 384 9q35 hs: Q9HB58 hs: nuclear body protein (speckled 110 
rn: predicted (ensembl, EST, 
NCBI) 
           kDa) (transcriptional co-activator hs: SP110     
           SP110) (interferon induced protein  mm: predicted 
                41/75)   
30 AI012552 1.743102 565 98.22 561 1q32 hs: NM_033034 hs&mm: tripartite motif protein trim5 
rn: predicted (ensembl, genscan, 
NCBI) 
          mm: P15533 isoform alpha; tripartite motif protein  hs: TRIM5 
            trim5; tripartite motif protein 5 mm: TRIM30 
            (down regulatory protein of interleukin    
                2 receptor)   
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
31 AA848811 1.542258 367 92.16 255 3q35 hs: P01884 hs&mm: Beta-2-microglobulin precursor rn: B2MG_RAT 
          mm: P01887   hs: BM2 
             mm: Bm2 
32 AA945204 1.845121 587 85.56 374 6q32 rn: NM_130743 rn: Interferon, alpha-inducible protein rn: NM_130743  
          hs: Q96BMO 27-like hs: FAM14A or TLH29 (RHS)  
          hs: Q9H2X8   hs: FAM14B (RHS) 
              mm: D12Ertd647e 
33 AI044879 1.970482 410 99.72 355 9q33 hs: NM_005444 hs&mm: RCD1 required for cell  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: NM_021383 differentiaton 1 homolog; protein involved hs: RQCD1    
           in sexual development  mm: Rqcd1 (or FL10) 
34 AI044792 1.807697 429 76.46 429 11q21 rn: NM_019195 rn: integrin-associated protein rn: NM_019195 
           hs: Q08722  hs: CD47     
           mm: NM_010581  mm: Cd47  
35 AA955249 1.488516 298 100 281 5q22 hs: Q14142 hs: Tripartite motif protein TRIM14 
rn: predicted (ensembl, genscan, 
NCBI) 
             hs: TRIM14 
             mm: 5830400N10Rik 
                  
*** ensembl 4kbp away from 
BLAST 
36 AI011981 1.443584 476 99.58 239 15p13 rn: Q63798 lines up with exon of rn: PSE2_RAT 
           hs: Q9UL46 Proteosome activator complex hs: PSME2 
             mm: P97372 subunit 2 mm: PSE2_MOUSE 
       99.52 208 17p14 rn: NM_017257   RGD: Psme2 
37 AI059254 1.860603 436 89.86 148 3q42 hs: Q9Y508 hs&mm: Zinc finger protein 313 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: Q9ET26   hs: ZNF313 
              mm: Zfp313 
                    
          
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
38 AA997015 1.732952 476 99.13 460 1q43     rn: predicted (EST, genscan) 
39 AA849015 1.491958 623 99.7 334 10q11 rn: Q9QX78 hs&mm: suppressor of cytokine  rn: SOC1_RAT 
           hs: O15524 signalling(Jak binding protein) (STAT  hs: SOCS1 or SSI1 or TIP3 
           mm: O35716 induced STAT inhibitor 1) (tec- mm: Socs1 
                interacting protein 3)    
40 AA944197 1.272005 537 98.08 260 10q24 rn: NM_023092 rn: unconventional myosin MYR2 1  rn: NM_023092 
           hs: O00159 heavy chain hs: MYO1C 
           mm: Q9WT17   mm: Myo1c 
41 AA850552 1.242266 496 100 496 4q24     
genscan prediction (approx. 3kbp 
upstream) 
42 AA963884 1.517473 504 99.66 296 3q42     genscan prediction  
                  (& EST in opposite direction) 
43 AI010116 1.394991 528 98.3 528 8q12 hs: Q9NVC6 hs&mm: co-factor required for SP1  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: NM_144933 transcriptional activation subunit 6 hs: CRSP6 or DRIP80 or 
            (transcriptional co-activator CRSP77) TRAP80 or ARC77 
            (vitamin D3 receptor-interacting protein  mm: Crsp6 
            complex 80kDa component DRIP80)   
            (thyroid hormone receptor-assoc.protein   
            complex 80kDa component TRAP80)   
44 AA851265 1.736533 230 76.21 227 20p12 rn: P15978 rn: Class 1 histocompatibility antigen  rn: HA11_RAT 
           hs: P30460 non-RT1.A Alpha-1 chain precursor hs: HLA-B or HLAB 
45 AI043759 1.964945 429 93.45 412 8q13 hs: NM_018381 no description rn: predicted (ensembl) 
           mm: NM_175687   hs: NM_018381 
                  mm: NM_175687 
           opposite direction:     
           hs: NM_031917 hs&mm: angiopoietin-related protein 5 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: NM_145154   hs: ANGPTL6 
                  mm: 6330404E11Rik 
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
46 AA850907 1.372024 560 95.72 561 1p12  no description 
rn: predicted (ensembl, genscan 
exon) 
47 AI060296 1.213283 345 92.75 207 3q21 hs: NM_172070 hs: similar to F10G7.10.P (KIAA2024) 
rn: predicted (ensembl, EST, 
genscan, NCBI 
              exons) 
              hs: NM_172070 
                  mm: predicted 
48 AI012340 1.930762 512 97.57 288 20p12 rn: P28077 rn: proteasome subunit beta type 9  rn: PSB9_RAT 
           hs: P28065 precursor (proteasome chain 7)  hs: PSMB9 
           mm: P28076 (macropain chain 7) (multicatalytic  mm: Psmb9 
            endopeptidase complex chain 7) (ring    
                12 protein) (low mol. mass protein 2)   
49 AI044795 2.022081 359 99.65 286 3q43 rn: Q9QXY4 rn: opioid growth factor receptor (OGFR) rn: OGFR_RAT 
           hs: Q9NZT2 (zeta type opioid receptor) hs: OGFR 
           mm: Q99PG2   mm: Ogfr 
50 AA851169 1.450284 403 80.49 287 15p13 rn: Q63798 Proteosome activator complex rn: PSE2_RAT 
           hs: Q9UL46 subunit 2 (proteasome activator 28-beta hs: PSME2 
           mm: P97372 subunit) (PA28BETA) (PA28B) (activator mm: PSE2_MOUSE 
            of multicatalytic protease subunit 2)   
            (11S regulator complex beta subunit)    
                (reg-beta)   
51 AI058400 1.292373 351 99.05 316 2q45 hs: O14772 hs: Fucose-1-phosphate guanalyl  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
            
tansferase (GDP-L-
Fucosepyrophosphor- 
hs: FPGT or GFPP 
            ylase) (GDP-L-Fucosediphosphorylase)   
                
52 AA850608 1.464707 556 100 277 6q16     no predictions within 2kbp 
                  
*** Ensembl & genscan approx 
3kbp away 
 B EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
53 AA851017 1.244911 423 99.21 253 2q14   NCBI:similar to Molybdenum cofactor  
rn: predicted (EST, genscan, 
NCBI) 
            synthesis protein 2 large subunit    
            (Molybdopterin synthase large subunit)    
            (MPT synthase large subunit) (MOCS2B)   
                (MOCO1-B   
54 AA900198 1.350785 400 100 383 1q21     rn: predicted (EST & genscan) 
55 AI059449 1.450641 515 92.4 500 1q34 hs: NM_002645 hs&mm: phosphoinositide-3-kinase,  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: O11083 class 2, alpha polypeptide; C2-containing hs: PIK3C2A 
            phosphatidylinositol kinase  mm: Pik3c2a 
56 AI070270 1.392079 400 99.74 381 7q34 hs: Q14106 hs: TOB2 protein (transducer of ERBB-2 
rn: predicted (ensembl, EST, 
genscan, NCBI)  
           mm: Q9JM55 2) hs: TOB2 or TOB4 or KIAA1663 
              mm: Tob2 
57 AA848487 1.516116 539 96.1 539 17q12.1   NCBI : similar to proteasome 
rn: predicted (ensembl, genscan, 
NCBI) 
            activator complex unit 1   
            
Proteasome activator 28-alpha subunit) 
(PA28alpha) (PA28a) (Activator of 
multicatalytic protease subunit 1) (11S 
regulator complex alpha subunit) (REG-
alpha) 
  
58 AA850501 1.569242 620 92.59 486 5q22 rn: NM_138871 rn: Tudor repeat associator with pctaire 2 rn: NM_138871 
           hs: NM_014290   hs: NM_014290 
           mm: AI447170   mm: AI447170 
59 AA956379 1.311905 456 99.76 421 15p14 hs: NM_153331 NCBI: similar to hypothetical protein  
rn: predicted (ensembl, NCBI, 
genscan) 
            MGC27385 hs: NM_153331 
              mm: predicted 
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60 AA849560 1.633453 442 99.1 442 3p12 rn: NM_153303 rn: dystonia 1, torsin (autosomal  rn: NM_153303 
           hs: O14657 dominant; torsin A) hs: TOR1B or DQ1 or FKSG18 
           mm: Q9ER41 hs&mm: Torsin B precursor (torsin family mm: Tor1b 
                1 member B)   
           opposite direction     
           hs: O14656 hs&mm: Torsin A precursor (torsin family 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: Q9ER39 1 member A) dystonia 1 protein hs: DYT1 or TOR1A or DQ2 
                  mm: Dyt1 
61 AA998506 2.112735 419 98.01 402 18q12.1 mm: Q8R5D8 NCBI: similar to interferon-inducible  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
            GTPase 
mm: Q8R5D8 (BRH also several 
RHS) 
62 AA850909 1.415247 641 96.72 641 1q21 hs: Q92692 hs&mm: poliovirus receptor related 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: P32507 protein 2 precursor (herpes virus entry 
hs: PVRL2 (BRH) or PRR2 or 
HVEB 
            mediator B) (HVEB) (nectin 2) (CD112 mm: Pvrl2 
                antigen)   
63 AA942995 1.338276 461 99.69 320 5q36 hs: NM_018715 hs: RCC1-like (TD-60) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
            NCBI: similar to CG9135-PA hs: NM_018715 
              mm: predicted 
64 AA800994 1.455138 489 99.8 489 2q41 hs: NM_021190 hs&mm: polypyrimidine tract binding  
rn: predicted (ensembl, EST, 
NCBI) 
           mm: NM_019550 protein 2; neural polypyrimidine tract hs: PTBP2 
            binding protein; ptb-like protein mm: NM_019550 
65 AA943011 1.277416 595 99.13 461 8q22 hs: Q9H270 hs&mm: vacuolar protein sorting 11 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: Q91W86 (HVSP11) (APP3476) hs: VPS11 
              mm: Vps11 
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66 AI059844 1.856010 424 99.43 351 12q16 rn: Q99MM4 rn: Traf-interacting zinc finger protein rn: Q99MM4 
           hs: NM_006700 fln29 (fragment) hs: NM_006700 
           mm: NM_172275 hs&mm: FLN29 gene product mm: NM_172275 
67 AA849028 1.410556 657 97.87 957 6q24 hs: P25788 hs&mm: proteasome subunit alpha type 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: O70435 3 (proteasome component C8) hs: PSMA3 or PSC8 
            (macropain subunit C8) (multicatalytic mm: Psma3 
                endopeptidase complex subunit C8) ***large EST Cluster  
68 AA955175 1.260318 512 97.58 495 10q26 hs: P52429 hs&mm: diacylglycerol kinase, epsilon rn: predicted (ensembl, genscan) 
           mm: Q9R1C6 (diglyceride kinase) (DGK-epsilon) (DAG hs: DGKE or DAGK5 
            kinase epsilon)  mm: Dgke 
                  *** 4kbp away from BLAST 
69 AI044222 1.397194 479 99.34 151 14p22 rn: NM_145672 rn: small inducible cytokine B9 rn: NM_145672 
           hs: Q07325 hs&mm: small inducible cytokine B9 hs: CXCL9 or SCYB9 or MIG 
           mm: P18340 precursor (gamma interferon induced  mm: Cxc19 
                monokine) (MIG)   
70 AA900506 1.270857 527 99.17 361 3q36 hs: NM_022662 hs: anaphase-promoting complex 1  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           mm: P53995 (meiotic checkpoint regulator) (ANAPC1) hs: NM_022662 
            mm: protein TSG24 (meiotic regulator) mm: Mcpr 
71 AI070047 1.448225 479 99.57 462 5q36 hs: Q9Y692 hs&mm: glucocorticoid modulatory rn: predicted (ensembl, genscan) 
           mm: Q9JL60 element binding protein 1 (GMEB-1) hs: GMEB1 
            (parvovirus initiation factor P96) (DNA mm: Gmeb1 
                binding protein P96PIF)   
72 AI030755 1.503307 523 99.8 492 17p14   NCBI: similar to 1110064L07Rik protein 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
                  mm: predicted  
Table i: Table containing all the information gleaned from www.ensembl.org pertaining to the ESTs significantly affected by zif268 on GeneChip
®
 B of the 
microarray experiment performed by James et al. (2005).  Please see Chapter 7. 
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1 AI112362 5.812263 440 99.52 417 4q13     rn: predicted (genscan) 
2 AI111492 8.059316 414 92.95 397 6q16 hs: Q96AL8 mm: Thymidylate kinase  
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: NM_020557 family LPS-inducible member; hs: Q96AL8 
           thymidylate kinase homologue mm: Tyki 
3 AI180075 3.419621 423 98.58 423 7q11   NCBI: similar to signal transducer rn: predicted (EST, genscan, NCBI) 
           & activator of transcription 2   
4 AI073001 4.377708 463 99.22 383 10q24 hs: NM_153230 NCBI: similar to hypothetical rn: predicted (ensembl, NCBI exon) 
           protein MGC35179 hs: NM_153230 
             mm: predicted 
5 AA819679 2.725092 554 99.44 537 11q22 hs: NM_031458 B aggressive lymphoma gene (BAL) 
rn: predicted (ensembl, genscan 
exon, NCBI) 
             hs: NM_031458 
             mm: BC003281 
6 AI169624 4.349338 602 84.72 458 12q16 rn: Q05961 rn: 2'-5' oligoadenylate synthetase 1 rn: OAS1_RAT 
          hs: Q9Y6K5   hs: OAS3   
          mm: P11928    mm: Oas1g  
7 AI176721 2.242152 599 100 599 1q32 hs: Q8NH66 hs: seven transmembrane helix rn: predicted (ensembl, genscan) 
          mm: NM_147079  receptor hs: Q8NH66   
           mm: olfactory receptor Mor31-4 mm: NM_147079  
8 AI137038 2.667022 495 98.76 483 13q21 hs: NM_022371 hs&mm: torsin family 3, member A; 
rn: predicted (ensembl, genscan, 
NCBI) 
          mm: NM_023141 ATP-dependent interferon response hs: TOR_3A 
           protein 1; ATP-dependent interferon mm: Tor3a 
           Responsive, NCBI: similar to ADIR1 EST cluster close with no predictions 
9 AA799298 1.964366 593 99.42 515 1q52 hs: P09913 hs&mm: interferon induced protein 
rn: predicted (ensembl, genscan, 
NCBI) 
          mm: Q64112 with tetratricopeptide repeats 2  hs: IFIT2 
           (glucocorticoid-attenuated response mm: Ifit2 
                gene 39 protein GARG-39)   
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10 AI236003 2.399980 529 87.95 332 14q22 hs: NM_033109 hs&mm: 3'-5' RNA exonuclease;  rn: predicted (ensembl, EST, NCBI) 
          mm: NM_027869 polynucleotide phosphorylase-like hs: PNPT1 
           
(polyribonucleotide 
nucleotidyltransferase 1) 
mm: 1200003F12Rik 
11 AA858505 2.177984 558 98.7 539 7q34 hs: O95236 hs: apoliprotein L3 (APOL-III) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
            (TNF-inducible protein CG12-1) hs: APOL3 
             mm: 9130022K13Rik 
12 AI102236 2.117253 518 98.84 518 3q42 hs: Q9Y3Z3 hs&mm: sam domain & HD domain- rn: predicted (ensembl) 
          mm: Q60710 
containing protein 1 (dendritic cell-
derived  
hs: SAMHD1 or MOP5 
           IFNG-induced protein DCIP) (monocyte  mm: Samhd1 
           protein 5 MOP_5) (interferon-gamma   
             inducible protein MGII)   
           in opposite direction   
           NCBI: similar to dJ132F21.2 - contains a  rn: predicted (EST, genscan, NCBI) 
           novel protein similar to the L82E from    
                drosophila   
13 AA819034 2.945161 458 100 209 6q32 hs: Q9H2X8 
hs: protein fam14a precursor (TLH29 
protein) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: NM_145449 (pif127-like protein) hs: FAM14A (BRH) or TLH29 
             mm: NM_145449 
14 AI169676 1.785363 583 100 572 7q13 hs: Q9NV91 NCBI: similar to CGi3957-PA rn: predicted (EST, genscan, NCBI) 
             hs: Q9NV91 
             mm: predicted  
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15 AI178800 1.937421 568 100 559 3q24 hs: O14933 
hs&mm: ubiquitin-conjugating enzyme 
E2- 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
            mm: NM_19949 18kDa UBCH8 (ubiquitin-protein ligase) hs: UBE2L6 or UBCH8 
             (ubiquitin carrier protein) (retinoic acid  mm: Ubce8 
             induced gene B protein) (RIG-B)   
               riken cDNA 2810489121   
              opposite direction   
             
NCBI: similar to RIKEN cDNA 
1110030K22 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
               hs: predicted 
                  mm: 1110030K22Rik 
16 AI105268 2.842362 514 100 367 9q22 rn: NM_032612 rn: signal transducer and activator of  rn: NM_032612 
          hs: P42224 transcription 1  hs: STAT1 
          mm: P42225   mm: Stat1 
                  *** 4kbp away from BLAST 
17 AI071868 1.642953 271 100 254 1q32 hs: P19474 hs&mm: 52kDa RO protein (SJOGREN   
rn: predicted (ensembl, genscan, 
NCBI) 
          mm: Q62191 syndrome type A antigen) (RO(SS-A))  hs: SSA1 (BRH) 
           (52kDa ribonucleoprotein autoantigen  mm: Trim 21 
                ro/ss-A) (SS-A) (tripartite motif protein 2)   
18 AI177755 1.818049 590 99.83 590 6q16 rn: NM_177928 rn: pre-B-cell colony-enhancing factor rn: NM_177928 
          hs: P43490   hs: PBEF_Human 
          mm: NM_021524   mm: NM_021524 
19 AA818937 3.017592 394 99.47 377 20p12 rn: P15978 
rn: Class 1 histocompatibility antigen, B-
8 
rn: HAII_RAT 
          hs: P30460 B*0801 alpha chain precursor hs: HLA-B 
                    
20 AA818055 1.651773 594 100 457 15q12 rn: NM_053520 rn: E74-like factor 1 (ETS domain  rn: NM_053520 
          hs: P32519 transcription factor)  hs: ELF1 
          mm: Q60775   mm: Elf1 
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21 AI178386 1.867204 443 96.06 254 9q21 hs: NM_138798 NCBI: similar to hypothetical protein  rn: predicted (ensembl, EST, NCBI) 
           BC018453 hs: NM_138798 
             mm: 1500032H18Rik 
22 AI229172 2.188327 319 97.48 318 8q13 hs: NM_018381 no description rn: predicted (ensembl)  
          mm: NM_175687   hs: NM_018381 
              mm: NM_175687 
          hs: NM_031917 hs&mm: angiopoietin-related protein 5 
rn: predicted (ensembl, EST, 
genscan, NCBI)  
          mm: NM_145154   hs: ANGPTL6 
             rn:6330404E11Rik 
23 AI171280 1.831267 628 71.92 146 4q34 hs: NM_014497 hs&mm: NP220 nuclear protein; CTCL 
rn: predicted (EST) (ensembl, NCBI 
exons) 
          mm: NM_008717 tumour antigen SE33-1 hs: NM_014497 
             mm: Np220 
                  *** >2kbp away 
24 AI231086 1.518925 541 99.6 252 2q43 rn: Q9QXN1 rn: lymphoid enhancer binding factor 1 rn: LEF1_RAT 
          hs: Q9UJU2   hs: LEF1 
          mm: P27782   mm: Lef1 
25 AI171480 1.517404 519 100 519 1q32     rn: predicted (genscan) 
26 AI102643 1.612565 496 92.14 496 15p13 hs: Q00978 hs&mm: transcriptional regulator ISGF3 
rn: predicted (ensembl, EST, 
genscan, NCBI)  
          mm: Q61179 gamma subunit (IFN-alpha responsive hs: ISGF3G 
           transcription factor subunit) (interferon  mm: Isgf3g 
           stimulated gene factor 3 gamma) (ISGF3   
                P48 subunit) (ISGF-3 gamma)   
27 AA818887 1.712270 522 99.79 477 20p12 rn: NM_012646 rn: RTI class 1B gene, H2-TL-like, GRC rn: NM_012646 
          hs: P30460 region hs: HLA-B 
          mm: P14432   mm: H2-T10 
28 AI071755 1.261304 263 100 146 9q31     rn: predicted (genscan)  
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29 AI227666 1.651391 573 96.86 573 11q21 rn: NM_019195 rn: integrin-associated protein rn: NM_019195 
          hs: Q08722   hs: CD47 
          mm: NM_010581   mm: Cd47 
30 AI234967 1.793207 416 100 376 20p12 hs: Q9C019 hs&mm: tripartite motif protein 15 (zinc  
rn: predicted (ensembl, EST, 
genscan, NCBI)  
          mm: Q8R096 finger protein B7) hs: Trim15 or ZNFB7 
             mm: Q8R096 (BRH) 
31 AI103500 1.616213 519 87.35 304 20p1 rn: P15978 
rn: Class 1 histocompatibility antigen, 
non- 
rn: HAII_RAT 
          hs: P30460 rH.A alpha-1 chain precursor hs: HLA-B 
32 AI177396 1.819174 507 9137 241 8q32   
NCBI: similar to ubiquitin-activating 
enzyme 
rn: predicted (EST) (genscan, NCBI 
exons) 
           E1-like; ubiquitin-activating enzyme-2;    
           ubiquitin-activating enzyme E1 like   
33 AA818849 2.103757 417 86.8 250 10q32.1 hs: NM_024119 NCBI: similar to hypothetical protein  rn: (ensembl, genscan, NCBI) 
           FLJ11354 hs: NM_024119 
             mm: DIILgp2e 
34 AA819788 1.878639 517 99.8 503 11q23   NCBI: similar to 5830458k16Rik protein rn: predicted (EST, genscan, NCBI) 
35 AI177481 
2.160807
28 
457 97.92 289 20p12 rn: P28077 rn: proteasome subunit beta type 9  rn: PSB9_RAT 
          hs: P28065 precursor (proteasome chain 7)  hs: PSMB9 
          mm: P28076 (macropain chain 7) (multicatalytic  mm: Psmb9 
           endopeptidase complex chain 7) (ring    
                12 protein) (low mol. mass protein 2)   
36 AI170410 1.436327 638 99.84 638 11p12 hs: NM_173824 NCBI: similar to 4930453N24Rik 
rn: predicted (ensembl, EST, 
genscan, NCBI)  
             hs: NM_173824 
             mm: predicted 
37 AI176839 1.853808 478 97.63 211 3q42     rn: predicted (EST, genscan) 
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38 AI228291 1.841349 461 98.26 287 1q22 hs: NM_031448 NCBI: similar to cDNA 160001410 
rn: predicted (ensembl, genscan, 
NCBI) 
             hs: NM_031448 
             mm: 1600014C10Rik 
39 AA819629 1.460664 529 98.82 510 2.fragment hs: NM_006820 hs: histocompatibility 28 
rn: predicted (ensembl, EST) 
(genscan exon) 
             hs: Clorf29 
40 AI179939 1.917067 398 100 268 20p12 rn: NM_033098 rn: Tapasin rn: NM_033098 
          hs: O15533   hs: TAPBP or TAPA or NGS17 
          mm: Q9R233   mm: TPSN_MOUSE 
          hs: O15211 hs&mm: RAL guanine nucleotide  rn: predicted (ensembl, EST, NCBI) 
          mm: Q61193 
dissociation stimulator-like 2 (RALGDS-
like 
hs: RAB2L or RGL2 
                factor (ras-associated protein rab21) mm: RGL2_Mouse 
41 AI235748 1.819836 537 98.19 497 9q12   NCBI: similar to cDNA 0610009D16 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
             hs: MAD2LIBP 
             mm: 0610009D16Rik 
42 AI113020 1.588865 503 97.94 486 20p12 hs: NM_015050 
NCBI: similar to Riken cDNA 
1300018105 
rn:predicted(ensembl,EST,genscan)(
NCBI exon) 
             hs: NM_015050 
              mm: 1300018105Rik 
                no description rn: predicted (EST, genscan) 
43 AI071800 1.292724 259 99.08 109 14q21 rn: NM_031352 rn: Drebrin-like rn: NM_031352 (Ensembl exon) 
          hs: NM_014063   hs: NM_014063 
          mm: NM_013810   mm: Dbn1 
44 AA818912 1.701085 615 95.32 598 1q41 hs: NM_022466 
hs: zinc finger protein, subfamily 1A,5; 
zinc 
rn: predicted (ensembl, genscan, 
NCBI) 
           finger transcription factor pegasus hs: NM_022466 
             mm: predicted 
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45 AI178869 1.717091 408 99.65 289 3p12 rn: NM_153303 rn: dystonia 1, torsin (autosomal  rn: NM_153303 
          hs: O14657 dominant; torsin A) hs: TOR1B or DQ1 or FKSG18 
          mm: Q9ER41 hs&mm: Torsin B precursor (torsin family mm: Tor1b 
                1 member B)   
46 AI177734 1.334543 550 99.64 551 11q11   NCBI: similar to hypothetical protein  rn: predicted (NCBI) (genscan exon) 
                KIAA0136   
47 AI145609 1.800893 528 98.79 495 18q11 hs: P23508 
hs: Colorectal mutant cancer protein 
(MCC 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
           protein hs: MCC 
             mm: predicted 
             *** 4kbp away from Blast 
                  ***Large EST Cluster 
48 AA817937 1.683501 360 100 343 16p14 rn: Q811A2 rn: DAMP-1 protein rn: Q811A2 
          hs: Q10589   hs: BST2 
          mm: Q8R2Q8   mm: Q8R2Q8 
49 AI104907 1.432870 587 99.63 534 14q22 rn: NM_023986 mm: similar to TEMO (fragment) rn: NM_023986 
          mm: Q8K0K0 NCBI: TEMO (WITHDRAWN) hs: PSME4 
             mm: AA409398 (BRH) 
50 AA684879 1.729296 326 93.19 235 20p12 rn: Q8V1B2 rn: death domain-associated protein 6  rn: DAXX_RAT 
          hs: Q9UER7 (DAXX) hs: DAXX or BING2 
          mm: O35613   mm: DAXX_MOUSE 
51 AA858877 1.501456 487 100 459 2q43 rn: Q9QXN1 rn: lymphoid enhancer binding factor 1 rn: LEF1_RAT 
           hs: Q9UJU2   hs: LEF1 
           mm: P27782   mm: Lef1 
52 AA818264 1.760532 494 100 402 12q12 hs: NM_006989 
hs: Ca++-promoted Ras inactivator; 
GTPase 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
           
activating protein-like; Ca++-promoted 
ras 
hs: NM_006989 
           inactivator (Rasp21 protein activator 4 mm: predicted 
                (RASA4))   
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53 AI176976 1.369938 510 98.2 501 3q24 hs: NM_15308 hs&mm: formin binding protein 4 (or 30) 
rn: predicted (ensembl, genscan, 
EST, NCBI) 
          mm: NM_018828   hs: FNBP4 
             mm: Fnbp4 
54 AI231494 1.518741 588 98.13 588 15p14 rn: P22288 
rn: GTP cyclohydrolase 1 precursor 
(GTP- 
rn: GCH1_RAT 
          hs: P30793 CH-1) hs: GCH1 or GCH or DYT5 
          mm: Q05915   mm: Gch 
55 AI178629 1.641470 438 98.97 290 20p12 rn: P28064 rn: proteasome subunit beta type 8  rn: PSB8_RAT 
          hs: P28062 precursor (proteasome component C13) 
hs: PSMB8 or LMP7 or RING10 or 
Y2 
          mm: P28063 (multicatalytical endopeptidase complex  mm: Psmb8 
                subunit C13) (fragment)   
56 AI176183 1.350876 453 97.57 453 Xq34 hs: P06280 hs&mm: alpha galactosidase A precursor  
rn: predicted (ensembl, genscan, 
NCBI) 
          mm: P51569 
(melibiase) (alpha-D-galactoside 
galactohyd- 
hs: GLA 
           rolase) (alpha-D-galactosidase A) mm: Gla 
57 AI176479 1.341039 416 100 261 1q41 rn: P26376 rn: interferon-inducible protein rn: INIB_RAT 
          hs: Q01628   hs: IFITM3 
          mm:NM_0285378   mm: Fgls - pending (BRH) 
                    
58 AI072951 1.363177 516 94.44 216 10q26 hs: NM_144975 NCBI: similar to hypothetical protein  rn: predicted (ensembl, EST, NCBI) 
           FLJ34922 hs: NM_144975 
             mm: predicted (RHS only) 
59 AI071534 1.292306 464 97.54 447 11p12 hs: NM_173824 NCBI: similar to 4930453N24Rik protein 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
             hs: NM_173824 
             mm: predicted (BRH) 
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60 AI179403 1.560792 541 99.81 532 20q13 hs: NM_022091 hs: DJ467N11.1 protein 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
           NCBI: similar to RNA helicase family hs: NM_006828 
             mm: Q8K292 
61 AI232313 1.628982 575 97.91 575 4q11 hs: Q9Y5A7 
hs&mm: BS4 protein (NY-REN-18 
antigen) 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: P54729 (NEDD8 ultimate buster-1) 
hs: BS4_Human or NUB1 or NYREN 
18 
             mm: Nyren 18 - pending 
62 AI112633 1.272086 446 96.74 429 12p12   
NCBI: similar to proteasome subunit 
alpha  
rn: predicted (genscan) (ensembl 
pseudogene) 
           
type 6 (proteasome iota 
chain)(macropain iota chain) 
  
           (multicatalytic endopeptidase   
           
complex iota chain)(27kDa prosomal 
protein) (PROS-27) (p27k) 
  
63 AI176007 1.695461 653 99 400 4q44     rn: predicted (EST) 
64 AI137689 1.272232 457 98.44 384 14q22 rn: NM_173147 rn: VPS54-like rn: NM_173147 
          hs: NM_016516 hs&mm: Tumour antigen SLP-8P  hs: VPS54 
          mm: NM_139061   mm: Vps54 
66 AI071570 1.220613 429 100 118 20p12 hs: P00751 hs&mm: complement factor B precursor 
rn: predicted (ensembl, EST, 
genscan, NCBI) 
          mm: P04186 (C3/C5 convertase) (properdin factor B)  hs: BF 
           
(glycine-rich beta 
glycoprotein)(GBG)(PBF2) 
mm: CFAB_Mouse 
67 AI171503 1.436843 479 74.31 432 2q11 rn: Q9JJ22 
rn: adipocyte-derived leucine 
aminopeptidase 
rn: ART1-RAT 
          hs: Q9NZ08 
precursor (A-lap) (ARTS-1) 
(aminopeptidase 
hs: ART1-HUMAN 
          mm: Q9EQH2 
pils) (puromycin-insensitive leucyl-
specific 
mm: Arts-1 pending 
                aminopeptidase) (pils-AP)   
 C EST Name 
Fold 
Change 
Length 
(bp) 
BLAST 
similarity 
(%) 
Length 
similarity 
(bp) 
Chromosome 
Location 
(Rat) 
Database 
Reference 
Description Known Gene? 
68 AI227647 1.227656 339 80.07 301 19p12 rn: O55145 rn: fractalkaline precursor (CX3CLI)  rn: SYD1-RAT 
          hs: P78423 
(neurotactin) (CX3C membrane-
anchored  
hs: CX3CLI or SCYDI or FKN or NTT 
or A-152E5.2 
          mm: O35188 chemokine) (small inducible cytokine D1) mm: AB030188 
69 AI169020 1.420293 577 99.31 577 4q13   no description rn: predicted (ensembl) 
                  mm: 1700109H08Rik 
              hs: NM_152789 no description rn: predicted (ensembl) 
                  hs: NM_152789 (BRH) 
                  mm: 5830415L20Rik (RHS only) 
70 AI227994 1.487453 569 94.76 572 11q21 rn: NM_019195 rn: integrin-associated protein rn: NM_019195 
          hs: Q08722   hs: CD47 
          mm: NM_010581   mm: Cd47 
71 AI071265 1.489646 443 99.29 424 15p13 hs: Q00978 hs&mm: transcriptional regulator ISGF3 
rn: predicted (ensembl, EST, 
genscan, NCBI)  
           mm: Q61179 gamma subunit (IFN-alpha responsive hs: ISGF3G 
            transcription factor subunit) (interferon  mm: Isgf3g 
            stimulated gene factor 3 gamma) (ISGF3   
                P48 subunit) (ISGF-3 gamma)   
72 AI178746 1.400854 542 97.42 542 8q32   
NCBI: similar to TGF-beta induced 
apoptosis 
rn: predicted (EST, genscan, NCBI)  
           protein 3   
Table ii: Table containing all the information gleaned from www.ensembl.org pertaining to the ESTs significantly affected by zif268 on GeneChip
®
 C of the 
microarray experiment performed by James et al. (2005).  Please see Chapter 7.
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